Page last updated: 2024-11-07

prednisone and Precursor Cell Lymphoblastic Leukemia-Lymphoma

prednisone has been researched along with Precursor Cell Lymphoblastic Leukemia-Lymphoma in 601 studies

Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.

Precursor Cell Lymphoblastic Leukemia-Lymphoma: A neoplasm characterized by abnormalities of the lymphoid cell precursors leading to excessive lymphoblasts in the marrow and other organs. It is the most common cancer in children and accounts for the vast majority of all childhood leukemias.

Research Excerpts

ExcerptRelevanceReference
"In the present prospective trial, 15 children with acute lymphoblastic leukemia and hyperleukocytosis (range 101-838 x 10(9)/l) were treated with intravenous low-dose prednisone continuous infusion (6 mg/m(2)/24 h)."9.14Management of hyperleukocytosis and prevention of tumor lysis syndrome with low-dose prednisone continuous infusion in children with acute lymphoblastic leukemia. ( Karakukcu, M; Kose, M; Ozdemir, MA; Patiroglu, T; Torun, YA, 2009)
"In 1971, Cancer and Leukemia Group B (CALGB) mounted a study of acute lymphocytic leukemia (ALL) that compared the effects of the two steroid hormones dexamethasone and prednisone."9.07Lower incidence of meningeal leukemia when prednisone is replaced by dexamethasone in the treatment of acute lymphocytic leukemia. ( Chevalier, L; Freeman, AI; Jacquillat, C; Jones, B; Koch, K; Maurer, HM; Pochedly, C; Shuster, JJ; Sinks, L; Weil, M, 1991)
"Lubiprostone was more effective than stimulant laxatives at treating vinca alkaloid-induced intractable constipation in patients with hematological malignancies, and its use could enable safe vinca alkaloid chemotherapy."5.56Effect of lubiprostone on vinca alkaloid-induced constipation in patients with hematological malignancies: a propensity score-matched analysis. ( Fukuda, H; Hayashi, T; Imai, T; Kawada, K; Miyamura, M; Morita, Y; Ohta, T; Tanaka, K, 2020)
"Ponatinib treatment was well tolerated and considered safe with easily manageable side effects."5.46Ponatinib-Induced Graft-versus-Host Disease/Graft-versus-Leukemia Effect in a Patient with Philadelphia-Positive Acute Lymphoblastic Leukemia without the T315I Mutation Relapsing after Allogeneic Transplant. ( Bossio, S; De Stefano, L; Gentile, M; Greco, R; Mazzone, C; Morabito, F; Morelli, R; Musolino, C; Palummo, A; Petrungaro, A; Recchia, AG; Uccello, G; Vigna, E, 2017)
"We describe a 57-year-old woman with acute lymphoblastic leukemia who had a cavitary lesion develop in the right upper lobe caused by Cunninghamella bertholletiae, a zygomycete."5.33Treatment of cavitary pulmonary zygomycosis with surgical resection and posaconazole. ( Colson, YL; Marty, FM; Paul, S, 2006)
"During treatment Hepatitis B was reactivated and after termination, of chemotherapy she developed fulminant hepatitis with hyperbilirubinemia, coagulopathy, hypoalbuminemia and ascites."5.31[Effective treatment with Lamivudine of patients with reactivation of hepatitis B following chemotherapy administration]. ( Haran, M; Klepfish, A; Lurie, Y; Malnick, S; Shtalrid, M, 2001)
"In the present prospective trial, 15 children with acute lymphoblastic leukemia and hyperleukocytosis (range 101-838 x 10(9)/l) were treated with intravenous low-dose prednisone continuous infusion (6 mg/m(2)/24 h)."5.14Management of hyperleukocytosis and prevention of tumor lysis syndrome with low-dose prednisone continuous infusion in children with acute lymphoblastic leukemia. ( Karakukcu, M; Kose, M; Ozdemir, MA; Patiroglu, T; Torun, YA, 2009)
" In this study, adrenal function and signs and symptoms of adrenal insufficiency were prospectively assessed in children with acute lymphoblastic leukemia (ALL) after induction treatment including high-dose prednisone (PDN) or dexamethasone (DXM)."5.13Adrenal axis function after high-dose steroid therapy for childhood acute lymphoblastic leukemia. ( Barisone, E; Bertorello, N; Corrias, A; Einaudi, S; Farinasso, L; Masera, N; Pastore, G; Riva, F; Rizzari, C; Saracco, P; Villa, A, 2008)
"In 1971, Cancer and Leukemia Group B (CALGB) mounted a study of acute lymphocytic leukemia (ALL) that compared the effects of the two steroid hormones dexamethasone and prednisone."5.07Lower incidence of meningeal leukemia when prednisone is replaced by dexamethasone in the treatment of acute lymphocytic leukemia. ( Chevalier, L; Freeman, AI; Jacquillat, C; Jones, B; Koch, K; Maurer, HM; Pochedly, C; Shuster, JJ; Sinks, L; Weil, M, 1991)
"The hyper-CVAD/methotrexate-cytarabine (H-CVAD/ MTX-AraC) chemotherapy protocol has been one of the standard treatments for hematological malignancies, such as mantle cell lymphoma (MCL), Burkitt lymphoma (BL), and B-cell and T-cell acute lymphoblastic leukemia."4.02Efficacy of chemotherapy protocols for hematological malignancies: H-CVAD versus GELA/BURKIMAB/PETHEMA LAL. ( Algarra-Algarra, JL; Gómez-Catalán, I; Hernández-Fernández, F; Ibañez-García, Á; Marín-Sánchez, A; Martínez-Fernández, G; Montoya-Morcillo, MC; Romero-Macías, JR, 2021)
"The authors report the occurrence of fatal or near-fatal sepsis in 16 of 38 children with newly diagnosed acute lymphoblastic leukemia (ALL) treated with a new induction regimen that differed from its predecessor by the substitution of dexamethasone for prednisone."3.70Substituting dexamethasone for prednisone complicates remission induction in children with acute lymphoblastic leukemia. ( Clavell, LA; Dalton, VK; Gelber, RD; Glick, KM; Hurwitz, CA; Sallan, SE; Schorin, MA; Silverman, LB, 2000)
" Patients treated with a combination of prednisone and dexamethasone had as a late effect the highest prevalence of obesity (44%)."3.69Obesity after successful treatment of acute lymphoblastic leukemia in childhood. ( De Groot, A; Egeler, RM; Hählen, K; Hokken-Koelega, AC; Tromp, CG; Van Dongen-Melman, JE, 1995)
"Outpatient adherence to oral medication regimens was evaluated in 50 adolescents and young adults with cancer: 21 patients with acute lymphoblastic leukemia or Hodgkin disease who were to take prednisone as a component of their chemotherapy regimen, and 29 patients with Hodgkin disease whose chemotherapy had been discontinued and who were to take penicillin for postsplenectomy prophylaxis."3.68Therapeutic adherence to oral medication regimens by adolescents with cancer. I. Laboratory assessment. ( Chasalow, F; Festa, RS; Lanzkowsky, P; Tamaroff, MH, 1992)
"Two children with bone marrow necrosis at diagnosis or at relapse of acute lymphoblastic leukemia (ALL) had thrombotic complications 15 and 17 days after starting remission induction therapy including prednisone, vincristine, and L-asparaginase."3.68Bone marrow necrosis and thrombotic complications in childhood acute lymphoblastic leukemia. ( Eguiguren, JM; Pui, CH, 1992)
"The protocol included minimal residual disease (MRD) analysis at two different time-points (TP), that is, at the end of induction IA and consolidation IB, and a modulation in post-consolidation intensity according to MRD."3.01Adolescent and young adult acute lymphoblastic leukemia. Final results of the phase II pediatric-like GIMEMA LAL-1308 trial. ( Candoni, A; Canichella, M; Cavalli, M; Chiaretti, S; Conter, V; D'Aloisio, M; De Propris, MS; Elia, L; Fazi, P; Foà, R; Guarini, A; Luppi, M; Martino, B; Messina, M; Moleti, ML; Piciocchi, A; Starza, ID; Testi, AM; Vignetti, M; Vitale, A, 2021)
"Pentoxifylline is a xanthine that possesses antitumor properties and that can induce higher apoptosis in the leukemic cells of pediatric patients with acute lymphoblastic leukemia (ALL) during treatment with prednisone."2.87Pentoxifylline Added to Steroid Window Treatment Phase Modified Apoptotic Gene Expression in Pediatric Patients With Acute Lymphoblastic Leukemia. ( Aguilar-Lemarroy, A; Bravo-Cuellar, A; Gonzalez-Ramella, O; Hernández-Flores, G; Jave-Suárez, LF; Meza-Arroyo, J; Ortiz-Lazareno, P; Padilla-Corona, M; Sanchez-Zubieta, F, 2018)
"Approximately 30% of childhood acute lymphoblastic leukemia (ALL) cases are high hyperdiploid (HD)."2.84High hyperdiploid acute lymphoblastic leukemia (ALL)-A 25-year population-based survey of the Austrian ALL-BFM (Berlin-Frankfurt-Münster) Study Group. ( Attarbaschi, A; Dworzak, M; Haas, OA; König, M; Mann, G; Meister, B; Pichler, H; Pötschger, U; Reismüller, B; Schmitt, K; Steiner, M; Urban, C, 2017)
"The idarubicin dose was adjusted according to the degree of myelosuppression."2.84Outcome of Reinduction Chemotherapy with a Modified Dose of Idarubicin for Children with Marrow-Relapsed Acute Lymphoblastic Leukemia: Results of the Childhood Acute Lymphoblastic Leukemia (CALL)-0603 Study. ( Ahn, HS; Im, HJ; Kang, HJ; Kim, H; Koh, KN; Koo, HH; Lee, JW; Lim, YT; Park, BK; Park, HJ; Park, JE; Park, KD; Seo, JJ; Shin, HY; Sung, KW; Yoo, KH, 2017)
"Pentoxifylline (PTX) has been shown to increase chemotherapy-induced apoptosis."2.82Pentoxifylline during steroid window phase at induction to remission increases apoptosis in childhood with acute lymphoblastic leukemia. ( Bravo-Cuellar, A; Gallegos-Castorena, S; Gonzalez-Ramella, O; Hernández-Flores, G; Jave-Suárez, LF; Jiménez-López, X; Lerma-Díaz, JM; Medina-Barajas, F; Meza-Arroyo, J; Ortiz-Lazareno, PC; Sánchez-Zubieta, F, 2016)
"Induction therapy for childhood acute lymphoblastic leukemia (ALL) traditionally includes prednisone; yet, dexamethasone may have higher antileukemic potency, leading to fewer relapses and improved survival."2.82Dexamethasone vs prednisone in induction treatment of pediatric ALL: results of the randomized trial AIEOP-BFM ALL 2000. ( Aricò, M; Attarbaschi, A; Barisone, E; Bartram, CR; Basso, G; Beier, R; Biondi, A; Caruso, R; Cazzaniga, G; Conter, V; Greiner, J; Harbott, J; Kremens, B; Kulozik, AE; Lo Nigro, L; Locatelli, F; Mann, G; Möricke, A; Niggli, F; Parasole, R; Ratei, R; Rössig, C; Schrappe, M; Silvestri, D; Stanulla, M; Valsecchi, MG; von Stackelberg, A; Zimmermann, M, 2016)
"Methyprednisone was administrated and the symptoms relieved gradually."2.82Predominant cerebral cytokine release syndrome in CD19-directed chimeric antigen receptor-modified T cell therapy. ( Cui, Q; Hu, Y; Huang, H; Jin, A; Liang, B; Luo, Y; Pu, C; Shi, J; Sun, J; Wu, Z; Xiao, L; Yu, J, 2016)
"The level of minimal residual disease during remission induction is the most important prognostic indicator in patients with acute lymphoblastic leukaemia (ALL)."2.80Clinical utility of sequential minimal residual disease measurements in the context of risk-based therapy in childhood acute lymphoblastic leukaemia: a prospective study. ( Bhojwani, D; Bowman, WP; Campana, D; Cheng, C; Coustan-Smith, E; Downing, JR; Evans, WE; Gruber, TA; Inaba, H; Jeha, S; Leung, WH; Pei, D; Pui, CH; Relling, MV; Ribeiro, RC; Rubnitz, JE; Sandlund, JT, 2015)
"Acute lymphoblastic leukemia (ALL) is the most frequent childhood malignancy."2.80[The prospects for children with acute lymphoblastic leukemia of being cured has increased in the Czech Republic in the 21st century to 90% - outcome of the ALL-IC BFM 2002 trial]. ( Blažek, B; Černá, Z; Domanský, J; Hak, J; Houdková, A; Hrušák, O; Jabali, Y; Janotová, I; Jarošová, M; Mejstříková, E; Mihál, V; Novák, Z; Procházková, D; Ptoszková, H; Sedláček, P; Smíšek, P; Starý, J; Štěrba, J; Timr, P; Trka, J; Zdráhalová, K; Zemanová, Z; Zuna, J, 2015)
"Children with acute lymphoblastic leukemia (ALL) and high minimal residual disease (MRD) levels after initial chemotherapy have a poor clinical outcome."2.78High-risk childhood acute lymphoblastic leukemia in first remission treated with novel intensive chemotherapy and allogeneic transplantation. ( Alvaro, F; Bierings, MB; Cross, S; Dalla Pozza, L; de Bont, ES; de Groot-Kruseman, HA; de Haas, V; Haber, M; Hoogerbrugge, PM; Kaspers, GJ; Law, T; Maarten Egeler, R; Marshall, GM; Mueller, H; Ng, A; Norris, MD; Pieters, R; Révész, T; Suppiah, R; Sutton, R; van den Berg, H; van der Schoot, E; van der Velden, VH; van Dongen, J; Venn, NC, 2013)
"The detection of minimal residual disease (MRD) via molecular genetic methods provides - in comparison with conventional clinical and biological parameters - much more sensitive approaches to monitor individual treatment response."2.78[Molecular genetic detection of minimal residual disease (MRD) in children with acute lymphoblastic leukemia]. ( Bartram, CR; Koehler, R, 2013)
"In the ALL-BFM studies for treatment of acute lymphoblastic leukemia, reduction of leukemic blasts in peripheral blood after a one-week prednisone pre-phase - the so-called prednisone response - has been used for risk stratification since the 1980s and has been one of the most relevant factors for identification of high-risk patients."2.78Prediction of outcome by early response in childhood acute lymphoblastic leukemia. ( Attarbaschi, A; Beier, R; Lauten, M; Möricke, A; Niggli, F; Odenwald, E; Schrappe, M; Stanulla, M; Zimmermann, M, 2013)
"Localized lymphoblastic lymphoma (LL) is rare in pediatric patients."2.77Outcome of newly diagnosed children and adolescents with localized lymphoblastic lymphoma treated on Children's Oncology Group trial A5971: a report from the Children's Oncology Group. ( Abromowitch, M; Finlay, JL; Gross, TG; Lones, M; Perkins, SL; Smith, LM; Termuhlen, AM; Weinstein, H, 2012)
"Treatment of acute lymphoblastic leukemia (ALL) has included the use of prophylactic cranial irradiation in up to 20% of children with high-risk disease despite known cognitive risks of this treatment modality."2.77Cognitive outcomes following contemporary treatment without cranial irradiation for childhood acute lymphoblastic leukemia. ( Cheng, C; Conklin, HM; Krull, KR; Pei, D; Pui, CH; Reddick, WE, 2012)
"Osteonecrosis is a severe glucocorticoid-induced complication of acute lymphoblastic leukemia treatment."2.76Pharmacokinetic, pharmacodynamic, and pharmacogenetic determinants of osteonecrosis in children with acute lymphoblastic leukemia. ( Cai, X; Cheng, C; Evans, WE; Howard, SC; Kaste, SC; Kawedia, JD; Neale, G; Panetta, JC; Pei, D; Pui, CH; Relling, MV, 2011)
"coli asparaginase in children with acute lymphoblastic leukemia in second bone marrow relapse."2.76Polyethylene Glycol-conjugated L-asparaginase versus native L-asparaginase in combination with standard agents for children with acute lymphoblastic leukemia in second bone marrow relapse: a Children's Oncology Group Study (POG 8866). ( Asselin, B; Bernstein, M; Buchanan, GR; Camitta, BM; Kurtzberg, J; Pollock, BH, 2011)
"A total of 201 pediatric cases of acute lymphoblastic leukemia were treated with the ALL-96 protocol by the Kyushu-Yamaguchi Children's Cancer Study Group."2.75Randomized trial to compare LSA2L2-type maintenance therapy to daily 6-mercaptopurine and weekly methotrexate with vincristine and dexamethasone pulse for children with acute lymphoblastic leukemia. ( Fujita, K; Hidaka, Y; Hotta, N; Inada, H; Itonaga, N; Kawakami, K; Kawano, Y; Matsuzaki, A; Moritake, H; Nagatoshi, Y; Nakayama, H; Okamura, J; Suminoe, A; Ueda, K; Yamanaka, T; Yanai, F, 2010)
"Acute lymphoblastic leukemia (ALL) is the most common childhood malignancy."2.75[Long-term observations of children with acute lymphoblastic leukemia and high leukocytosis treated according to modified "New York" protocols (1987-2003)]. ( Balcerska, A; Balwierz, W; Chybicka, A; Derwich, K; Dobaczewski, G; Kowalczyk, JR; Kwiecińska, K; Matysiak, M; Moryl-Bujakowska, A; Pawelec, K; Płoszyńska, A; Sońta-Jakimczyk, D; Styczyński, J; Szczepański, T; Tomaszewska, R; Wachowiak, J; Wiśniewska-Slusarz, H; Wysocki, M, 2010)
"Treatment of childhood relapsed acute lymphoblastic leukemia (ALL) remains a significant challenge."2.73Reinduction platform for children with first marrow relapse of acute lymphoblastic Leukemia: A Children's Oncology Group Study[corrected]. ( Borowitz, MJ; Camitta, BM; Carroll, WL; Devidas, M; Gaynon, PS; Hunger, SP; Linda, SB; Raetz, EA; Winick, NJ, 2008)
"To improve the outcome of children with acute lymphoblastic leukemia (ALL) treated at the National Cancer Institute, Bogota, Colombia, a protocol based on the BFM-90 (Berlin, Frankfurt, Munster study) and the LSA2L2 regimens was implemented in the year 1993."2.73The impact of acute lymphoblastic leukemia treatment on central nervous system results in Bogota, Colombia. ( Buendia, MT; Guevara, G; Lozano, JM; Saavedra, C; Suarez, GE, 2008)
"Two toxic deaths were observed, and infections and neuropathy were the most common toxicities."2.73Augmented and standard Berlin-Frankfurt-Munster chemotherapy for treatment of adult acute lymphoblastic leukemia. ( Chang, JE; Esterberg, E; Juckett, MB; Kahl, BS; Kim, J; Kim, K; Lionberger, J; Longo, WL; Medlin, SC; Williams, EC, 2008)
"Only 20-30% of elderly patients with acute lymphoblastic leukemia (ALL) are enrolled in clinical trials because of co-morbid disorders or poor performance status."2.73Results of the PETHEMA ALL-96 trial in elderly patients with Philadelphia chromosome-negative acute lymphoblastic leukemia. ( Abella, E; Bethencourt, C; Brunet, S; Debén, G; del Potro, E; Feliu, E; Hernández-Rivas, JM; López, R; Morgades, M; Novo, A; Oriol, A; Ortega-Rivas, F; Ortín, X; Ribera, JM; Sancho, JM; Sanz, MA; Tormo, M; Xicoy, B, 2007)
" The population mean peak serum concentration of asparaginase enzymatic activity was 1 IU/mL, the elimination half-life was 7 days, and the volume of distribution was 2."2.73Pharmacodynamics and safety of intravenous pegaspargase during remission induction in adults aged 55 years or younger with newly diagnosed acute lymphoblastic leukemia. ( Avramis, VI; Cohen, LJ; Douer, D; Levine, AM; Periclou, AP; Watkins, K; Yampolsky, H, 2007)
"Thirty-six untreated lymphoblastic lymphoma patients aged from 3 to 18 years were included, with 1 patient in stage II , 9 in stage III and 26 in stage IV."2.73[Modified BFM-90 regimen greatly improves treatment outcomes of chinese childhood and adolescent lymphoblastic lymphoma]. ( Guan, ZZ; Huang, HQ; Li, YH; Ling, JY; Liu, DG; Sun, XF; Xia, Y; Xia, ZJ; Zhang, L; Zhen, ZJ; Zhou, ZM, 2007)
"Cure rates for adult acute lymphoblastic leukemia (ALL) in developing countries are significantly lower because of problems unique to these countries."2.73Outcome of adult acute lymphoblastic leukemia with BFM protocol in a resource-constrained setting. ( Ahluwalia, J; Das, R; Jain, S; Kumari, S; Mahi, S; Malhotra, P; Radhika, S; Sharma, SC; Varma, N; Varma, S, 2007)
"Fifty-two infants with acute lymphoblastic leukemia (ALL) enrolled in the AIEOP ALL-91 and ALL-95 studies were treated with the intermediate or high risk protocols according to their presenting features and early response to treatment."2.72Role of treatment intensification in infants with acute lymphoblastic leukemia: results of two consecutive AIEOP studies. ( Aricò, M; Basso, G; Biondi, A; De Lorenzo, P; De Rossi, G; Lo Nigro, L; Locatelli, F; Masera, G; Rizzari, C; Valsecchi, MG, 2006)
"The regimen for acute lymphocytic leukemia was idarubicin 8 mg/m2, dl - 3; vincristine 2 mg/mr, dl; cyclophosphamide 750 mg/m2, dl ; plus prednisone 60 mg/m(2),dl - 14 for 1-2 cycles."2.72[Multicenter randomized control trial on safety of domestic idarubicin for acute leukemia]. ( Du, X; Ke, XY; Liu, Y; Lu, ZS; Lv, JQ; Ma, J; Shen, ZX; Xu, XH; Zeng, XY; Zhan, ZM; Zhang, XH; Zhao, YM, 2006)
" During delayed intensification, all patients received a dexamethasone dosage of 10 mg/m(2)/d for 21 days, with taper."2.71Dexamethasone versus prednisone and daily oral versus weekly intravenous mercaptopurine for patients with standard-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group. ( Bostrom, BC; Erdmann, GR; Gaynon, PS; Gold, S; Heerema, NA; Hutchinson, RJ; Johnston, K; La, MK; Provisor, AJ; Sather, HN; Sensel, MR; Trigg, ME, 2003)
"Relapse was diagnosed in 17."2.71[Improved results in children with acute lymphoblastic leukemia treated with the ALL-BFM 90 protocol in the Czech Republic]. ( Blazek, B; Cerná, Z; Dembická, D; Gajdos, P; Hak, J; Hrstková, H; Hrusák, O; Jabali, Y; Kopecná, L; Mihál, V; Mydlil, J; Pospísilová, D; Procházková, D; Ptoszková, H; Slavík, Z; Starý, J; Timr, P; Trka, J; Vávra, V; Zahálka, F, 2003)
"In all, 236 adults with newly diagnosed acute lymphoblastic leukemia (ALL) were randomly assigned to receive either granulocyte colony-stimulating factor (G-CSF), or granulocyte-macrophage CSF (GM-CSF), or no CSF during a 4-week 4-drugs induction chemotherapy."2.71Efficacy of granulocyte and granulocyte-macrophage colony-stimulating factors in the induction treatment of adult acute lymphoblastic leukemia: a multicenter randomized study. ( Boiron, JM; Boulat, O; Espinouse, D; Fiere, D; Garban, F; Gardin, C; Huguet, F; Lhéritier, V; Reman, O; Sutton, L; Thomas, X; Turlure, P, 2004)
"Children with acute lymphoblastic leukemia (ALL) receive as part of induction therapy a 4-week course of high-dose glucocorticoid, which is either abruptly discontinued or shortly tapered."2.71Steroid withdrawal syndrome during steroid tapering in childhood acute lymphoblastic leukemia: a controlled study comparing prednisone versus dexamethasone in induction phase. ( Altare, F; Barisone, E; Bertorello, N; Corrias, A; Einaudi, S; Farinasso, L; Pastore, G; Saracco, P, 2005)
" Gender, ALL-immunophenotype, steroid-type or ASP dosing schedule did not alter the risk but older age and HR-disease were factors predisposing to TE associated with DFCI-ALL protocols."2.71Thromboembolism in children with acute lymphoblastic leukaemia treated on Dana-Farber Cancer Institute protocols: effect of age and risk stratification of disease. ( Athale, UH; Barr, RD; Chan, AK; Crowther, M; Siciliano, SA, 2005)
"Patients with advanced-stage Burkitt lymphoma, including those with bone marrow and/or central nervous system involvement, can be cured with a short-term intensive chemotherapy regime tailored to the tumor burden."2.71Burkitt lymphoma in adults: a prospective study of 72 patients treated with an adapted pediatric LMB protocol. ( Bosq, J; Casassus, P; Diviné, M; Dupriez, B; Koscielny, S; Le Maignan, C; Pico, JL; Raphaël, M; Ribrag, V; Sebban, C; Stamattoulas, A, 2005)
" The distribution of adverse prognostic factors was comparable in the two-induction arm."2.70Daunorubicin continuous infusion induces more toxicity than bolus infusion in acute lymphoblastic leukemia induction regimen: a randomized study. ( Bernard, M; Casassus, P; Delain, M; Desablens, B; Guilhot, F; Hunault-Berger, M; Ifrah, N; Jouet, JP; Milpied, N; Sadoun, A, 2001)
"Glucocorticoid treatment in childhood acute lymphoblastic leukemia increases energy intake markedly, and this effect contributes to the excess weight gain and obesity characteristic of patients being treated for acute lymphoblastic leukemia."2.70Effect of glucocorticoid therapy on energy intake in children treated for acute lymphoblastic leukemia. ( Brougham, M; Gibson, BE; Kelly, A; Montgomery, C; Reilly, JJ; Richardson, F, 2001)
" These results suggest that increasing DNM dosage in induction is one of the possible approaches to improve the outcome of adult ALL by decreasing the relapse occurrence."2.69Estimated 6-year event-free survival of 55% in 60 consecutive adult acute lymphoblastic leukemia patients treated with an intensive phase II protocol based on high induction dose of daunorubicin. ( April, F; Meneghini, V; Perona, G; Pizzolo, G; Ricetti, MM; Solero, P; Tecchio, C; Todeschini, G; Veneri, D; Zanotti, R, 1998)
"Twenty-one patients (ALL:10, NHL:8, ATLL:2, ATL:1) were assessable for response and toxicity."2.69[EPOCH therapy for relapsed/refractory lymphoid malignancies]. ( Asai, O; Dobashi, N; Kato, A; Katori, M; Kobayashi, T; Kuraishi, Y; Nagamine, M; Tajima, N; Usui, N; Watanabe, H; Yamazaki, H; Yano, S, 1998)
"CD45 was detected on the surface of childhood ALL cells (cut-off > or = 20% positive cells) in only 88."2.69Immunophenotype and clinical characteristics of CD45-negative and CD45-positive childhood acute lymphoblastic leukemia. ( Harbott, J; Karawajew, L; Ludwig, WD; Ratei, R; Riehm, H; Schott, G; Schrappe, M; Sperling, C, 1998)
"The prednisone response was defined as the cytoreduction (number of blood blasts per microliter at day 8) to a 7-day prednisone prephase and 1 intrathecal dose of methotrexate on day 1."2.69Prednisone response is the strongest predictor of treatment outcome in infant acute lymphoblastic leukemia. ( Borkhardt, A; Dördelmann, M; Gadner, H; Götz, N; Ludwig, WD; Reiter, A; Riehm, H; Schrappe, M; Viehmann, S, 1999)
"Patients with refractory or recurrent acute lymphoblastic leukemia (ALL) were treated with a combination of methotrexate (MTX), vincristine, PEG-asparaginase, and prednisone (MOAP)."2.69Combination therapy with methotrexate, vincristine, polyethylene-glycol conjugated-asparaginase, and prednisone in the treatment of patients with refractory or recurrent acute lymphoblastic leukemia. ( Aguayo, A; Cortes, J; Kantarjian, H; Keating, M; Pierce, S; Thomas, D, 1999)
"Children with acute lymphoblastic leukemia (ALL) who experience hematologic recurrence while receiving chemotherapy or within 6 months after its cessation have a low cure rate."2.69Alternating drug pairs with or without periodic reinduction in children with acute lymphoblastic leukemia in second bone marrow remission: a Pediatric Oncology Group Study. ( Boyett, JM; Buchanan, GR; Chauvenet, AR; Crist, WM; Maybee, DA; Pinkel, D; Pollock, BH; Rivera, GK; Wagner, H, 2000)
"G-CSF can increase CDI in high-risk childhood ALL."2.69Use of recombinant human granulocyte colony-stimulating factor to increase chemotherapy dose-intensity: a randomized trial in very high-risk childhood acute lymphoblastic leukemia. ( Auclerc, MF; Auvrignon, A; Baruchel, A; Bauduer, F; Berthou, C; Bordigoni, P; Demeocq, F; Lamagnere, JP; Landman-Parker, J; Leblanc, T; Legall, E; Leverger, G; Mathey, C; Michel, G; Pautard, B; Perel, Y; Schaison, G; Schneider, P, 2000)
" There was a highly significant difference in CR rates between weekly (69 of 71; 97%) and biweekly (60 of 73; 82%) PEG-Asp dosing (P =."2.69Weekly polyethylene glycol conjugated L-asparaginase compared with biweekly dosing produces superior induction remission rates in childhood relapsed acute lymphoblastic leukemia: a Pediatric Oncology Group Study. ( Abshire, TC; Billett, AL; Bradley, P; Buchanan, GR; Pollock, BH, 2000)
"Disease progression, which includes recurrence at the primary tumor site, is a major cause of treatment failure in patients with mediastinal presentations."2.68Comparison of treatment regimens for pediatric lymphoblastic non-Hodgkin's lymphoma: a Childrens Cancer Group study. ( Kadin, M; Kersey, JH; King, D; Krailo, MD; Meadows, AT; Morse, M; Rosenstock, J; Steinherz, PG; Tubergen, DG, 1995)
"673 of them suffered from acute lymphoblastic leukemia (ALL) at primary diagnosis and a transcription of the chimeric gene was detected in 21 of 648 with a successful analysis (3."2.68Incidence and clinical outcome of children with BCR/ABL-positive acute lymphoblastic leukemia (ALL). A prospective RT-PCR study based on 673 patients enrolled in the German pediatric multicenter therapy trials ALL-BFM-90 and CoALL-05-92. ( Bartram, CR; Borkhardt, A; Harbott, J; Janka-Schaub, G; Janssen, JW; Kabisch, H; Lampert, F; Ludwig, WD; Ratei, R; Reinisch, I; Repp, R; Riehm, H; Ritterbach, J; Schlieben, S; Schrappe, M; Zimmermann, M, 1996)
"The cure rate of childhood acute lymphoblastic leukemia (ALL) has improved dramatically."2.68Intermediate-dose methotrexate versus cranial irradiation in childhood acute lymphoblastic leukemia: a ten-year follow-up. ( Boyett, JM; Brecher, ML; Freeman, AI; Glicksman, AS; Holland, JF; Leventhal, BG; Sinks, LF, 1997)
"A total of 119 children (1990-95) with acute lymphoblastic leukemia (ALL) B-lineage either CD10+ or CD10- were registered into a single non-randomized chemotherapy protocol."2.68B-lineage acute lymphoblastic leukemia of childhood. An institutional experience. ( Cardenas-Cardos, R; Gómez-Martínez, R; Leal-Leal, C; Meza-Coria, C; Navarro-Alegría, I; Rivera-Luna, R; Vega-Vega, L, 1997)
"Improved survival of children with acute lymphoblastic leukemia (ALL) has made it more difficult to develop new protocols to further improve results."2.67Development of a new intensive therapy for acute lymphoblastic leukemia in children at increased risk of early relapse. The Memorial Sloan-Kettering-New York-II protocol. ( Heller, G; Meyers, P; Redner, A; Steinherz, L; Steinherz, PG; Tan, C, 1993)
" Gastrointestinal morbidity was less in the cohort treated without Ara-C; however, infectious morbidity persisted at unacceptable levels and this program was terminated as too toxic to administer."2.67Severe toxicity limits intensification of induction therapy for acute lymphoblastic leukemia. ( Berman, E; Gaynor, J; Gee, T; Kempin, S; Kritz, A; Little, C; Scheinberg, D; Sogoloff, H; Telford, P; Weiss, M, 1993)
"Vindesine was more toxic than Vincristine."2.67A study of toxicity and comparative therapeutic efficacy of vindesine-prednisone vs. vincristine-prednisone in children with acute lymphoblastic leukemia in relapse. A Pediatric Oncology Group study. ( Beardsley, GP; Buchanan, G; Hvizdale, E; Krischer, J; Link, M; Maybee, D; Mehta, P; Nitschke, R; Ragab, A; Vats, T, 1992)
"Initial treatment and relapse therapy were similar in all patients according to the BFM- and CoALL-protocols (front line: 38 patients according to BFM-protocols and 13 patients according to CoALL-protocols; relapse: 12 patients in study ALL-REZ-BFM 83, 17 in ALL-REZ-BFM 85, 20 in ALL-REZ-BFM 87, and two in ALL-REZ-BFM 90)."2.67Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission after intensive primary and relapse therapy according to the BFM- and CoALL-protocols: results of the German Cooperative Study. ( Bender-Götze, C; Dopfer, R; Ebell, W; Ehninger, G; Friedrich, W; Gadner, H; Henze, G; Klingebiel, T; Peters, C; Riehm, H, 1991)
"58% of the non-Hodgkin's lymphomas occurred in patients with marked immunodeficiency, 85% were high grade malignancies and 47% had primary extranodal disease."2.67[Malignant lymphoma associated with HIV infection]. ( Becker, K; Clemens, MR; Fischer, T; Helm, EB; Knauf, W; Mitrou, PS; Pohl, C; Schrappe-Bächer, M; Serke, M; Westerhausen, M, 1991)
"Boys with acute lymphoblastic leukemia (ALL) who have overt testicular relapse (OTR) during initial continuation chemotherapy or within 6 months thereafter have poor outcomes, with long-term survival similar to patients with marrow relapse during treatment."2.67Improved treatment results in boys with overt testicular relapse during or shortly after initial therapy for acute lymphoblastic leukemia. A Pediatric Oncology group study. ( Boyett, JM; Buchanan, GR; Crist, WM; Ghim, T; Johnson, W; Pollock, BH; Smith, SD; Vietti, TJ; Wharam, MD; Yanofsky, RA, 1991)
"Daunorubicin was associated with more early deaths but improved disease-free survival for those achieving remission."2.67Results of Medical Research Council Childhood Leukaemia Trial UKALL VIII (report to the Medical Research Council on behalf of the Working Party on Leukaemia in Childhood). ( Eden, OB; Lilleyman, JS; Peto, J; Richards, S; Shaw, MP, 1991)
"Among 3,638 children with acute lymphoblastic leukemia (ALL) entered on Pediatric Oncology Group (POG) protocols between June 1981 and April 1989, successful cytogenetic studies were available for 2,519, 58 (2."2.67Philadelphia chromosome positive childhood acute lymphoblastic leukemia: clinical and cytogenetic characteristics and treatment outcome. A Pediatric Oncology Group study. ( Behm, F; Borowitz, M; Carroll, A; Crist, W; Head, D; Jackson, J; Link, M; Ragab, A; Shuster, J; Steuber, P, 1990)
" It is generally agreed that dexamethasone is the steroid of choice for groups using a delayed intensification phase, but dosing schedules (intermittent versus continuous) vary."2.46The optimal use of steroids in paediatric acute lymphoblastic leukaemia: no easy answers. ( McNeer, JL; Nachman, JB, 2010)
"By contrast, B-cell lymphoblastic lymphoma/leukemia is a rare high-grade malignancy that comprises approximately 10% of all lymphoblastic lymphomas."2.44Rare oral cavity presentation of a B-cell lymphoblastic lymphoma. A case report and review of the literature. ( Cox, DP; Dong, R; Jordan, RC; Treseler, P, 2007)
"The risk of thrombosis in children with acute lymphoblastic leukemia (ALL) reportedly ranges between 1% and 37%."2.43Thrombotic complications in childhood acute lymphoblastic leukemia: a meta-analysis of 17 prospective studies comprising 1752 pediatric patients. ( Caruso, V; de Gaetano, G; Di Castelnuovo, A; Donati, MB; Iacoviello, L; Mariani, G; Storti, S, 2006)
"The poor prognosis of lymphoblastic leukemia in children under 1 year of age is attributed largely to rearrangements involving the mixed lineage leukemia (mll, also known as all1, htrx, trx1, or hrx) gene that occur with increased frequency in this population."2.42Lymphoblastic leukemia with mature B-cell phenotype in infancy. ( Batanian, JR; Frater, JL; Grosso, LE; O'Connor, DM, 2004)
"Acute lymphoblastic leukemia (ALL) is one of the few malignant disease for which substantial improvement was achieved during the last two decades."2.40[Treatment of acute lymphoblastic leukemias in adults]. ( Krykowski, E; Wrzesień-Kuś, A, 1997)
"Among 4,760 acute lymphoblastic leukemia (ALL) patients enrolled from 1986 to 1995 in two subsequent trials of the BFM and AIEOP study group, 61 patients were found to have Philadelphia chromosome-positive (Ph+) ALL."2.40Philadelphia chromosome-positive (Ph+) childhood acute lymphoblastic leukemia: good initial steroid response allows early prediction of a favorable treatment outcome. ( Aricò, M; Bartram, CR; Basso, G; Biondi, A; Conter, V; Gadner, H; Harbott, J; Lampert, F; Masera, G; Reiter, A; Riehm, H; Schrappe, M; Valsecchi, MG; Zimmermann, M, 1998)
"Treatment of childhood acute lymphoblastic leukemia has included glucocorticosteroids for almost 50 years."2.40Glucocorticosteroid therapy in childhood acute lymphoblastic leukemia. ( Carrel, AL; Gaynon, PS, 1999)
"Acute myelofibrosis (AMF), as defined by an acute panmyelopathy associated with marked megakaryocytic hyperplasia and marrow fibrosis, appears to be a stem cell disorder."2.39Acute myelofibrosis terminating in acute lymphoblastic leukemia: case report and review of the literature. ( Dunphy, CH; Kitchen, S; Saravia, O; Velasquez, WS, 1996)
"We reviewed all reported cases of Burkitt's lymphoma and/or Burkitt's leukemia (BLL) occurring following therapy for Hodgkin's disease."2.39Burkitt's lymphoma-leukemia in patients treated for Hodgkin's disease. ( Cooper, DL; Levy, A; Salloum, E; Tallini, G, 1996)
"Chemotherapeutic regimens for childhood acute lymphoblastic leukemia (ALL) include a remission induction period with high, daily doses of prednisone among other agents."2.38Reduced incidence of the somnolence syndrome in leukemic children with steroid coverage during prophylactic cranial radiation therapy. Results of a pilot study. ( Fuks, Z; Mandell, LR; Steinherz, P; Walker, RW, 1989)
"Besides, the PLK4 expression in childhood ALL patients was also determined at day 15 after the initiation of induction therapy (D15)."1.91Polo-like Kinase 4: the Variation During Therapy and its Relation to Treatment Response and Prognostic Risk Stratification in Childhood Acute Lymphoblastic Leukemia Patients. ( Xu, J; Zhao, L, 2023)
"The prognosis of childhood acute lymphoblastic leukemia (ALL) in Indonesia, a lower-middle-income country (LMIC), is lower than in high income countries (HICs)."1.72Childhood acute lymphoblastic leukemia: Four years evaluation of protocols 2013 and 2016 in a single center in Indonesia, a lower-middle-income country. ( Adelin, CP; Ardianto, B; Christian, SD; Kaspers, GJL; Kors, WA; Lestari, RP; Mulatsih, S; Pangarso, AWS; Purwanto, I; Sabrina, DS; Sagoro, L; Supriyadi, E; Sutaryo, S; Veerman, AJP; Verena, N; Widjajanto, PH, 2022)
"We represent here an atypical case of lymphoblastic lymphoma revealed by an isolated third cranial nerve palsy."1.62Disseminated lymphoblastic lymphoma revealed by an isolated third cranial nerve palsy. ( Bahloul, Z; Ben Salah, R; Bouattour, Y; Chabchoub, I; Feki, J; Frikha, F; Kammoun, S, 2021)
"The prognosis of childhood acute lymphoblastic leukemia (ALL) is optimistic with a 5-year event-free survival (EFS) rate of 70-85%."1.62Reduced intensity of early intensification does not increase the risk of relapse in children with standard risk acute lymphoblastic leukemia - a multi-centric clinical study of GD-2008-ALL protocol. ( Chen, HQ; Fang, JP; Li, CG; Li, CK; Li, JQ; Li, XY; Lin, YD; Liu, RY; Luo, XQ; Sun, X; Sun, XF; Wu, XD; Xu, HG, 2021)
"Childhood acute lymphoblastic leukemia (cALL) is a common hematological malignancy in children with unfavorable prognosis."1.62Long non-coding RNA MEG3 as a candidate prognostic factor for induction therapy response and survival profile in childhood acute lymphoblastic leukemia patients. ( Gao, W, 2021)
"Therapy for childhood acute lymphoblastic leukemia (ALL) is associated with substantial health care utilization and burden on families."1.62Phase-specific risks of outpatient visits, emergency visits, and hospitalizations during Children's Oncology Group-based treatment for childhood acute lymphoblastic leukemia: A population-based study. ( Athale, U; Bassal, M; Breakey, VR; Gibson, PJ; Gupta, S; Li, Q; Mittmann, N; Patel, S; Pechlivanoglou, P; Pole, JD; Silva, M; Sutradhar, R; Zabih, V, 2021)
"In contrast to previous studies, childhood ALL patients with TCF3-PBX1 transcripts do not appear to show a better outcome than their negative counterparts."1.62Clinical features and prognostic impact of TCF3-PBX1 in childhood acute lymphoblastic leukemia: A single-center retrospective study of 837 patients from China. ( Hu, BF; Jia, M; Li, SS; Tang, YM; Xu, XJ; Zhang, JY, 2021)
"Lubiprostone was more effective than stimulant laxatives at treating vinca alkaloid-induced intractable constipation in patients with hematological malignancies, and its use could enable safe vinca alkaloid chemotherapy."1.56Effect of lubiprostone on vinca alkaloid-induced constipation in patients with hematological malignancies: a propensity score-matched analysis. ( Fukuda, H; Hayashi, T; Imai, T; Kawada, K; Miyamura, M; Morita, Y; Ohta, T; Tanaka, K, 2020)
"Four children suffered from oral mucositis graded 1 or higher between days 8 and 22."1.56Salivary immunoglobulin A level during steroids and chemotherapy treatment administered in remission induction phase among pediatric patients with acute lymphoblastic leukemia. ( Młynarski, W; Proc, P; Szczepańska, J; Wyka, K; Zubowska, M, 2020)
"Acute lymphoblastic leukemia (ALL) is characterized by abnormal lymphoblasts accumulation in the bone marrow and blood."1.51TCF7L2 activated HOXA-AS2 decreased the glucocorticoid sensitivity in acute lymphoblastic leukemia through regulating HOXA3/EGFR/Ras/Raf/MEK/ERK pathway. ( Li, J; Liu, J; Qian, C; Wang, H; Zhang, H; Zhao, Q; Zhao, S; Zhao, Y, 2019)
"Thromboembolism is one of the most common complications during induction therapy of pediatric acute lymphoblastic leukemia (ALL)."1.51Analysis of apoptotic, platelet-derived, endothelial-derived, and tissue factor-positive microparticles of children with acute lymphoblastic leukemia during induction therapy. ( Ateş, H; Erdem, M; Kızmazoğlu, D; Ören, H; Tüfekçi, Ö; Yenigürbüz, FD; Yılmaz, Ş, 2019)
"Although childhood acute lymphoblastic leukemia (ALL) is characterized by high remission rates, there are still patients who experience poor response to therapy or toxic effects due to intensive treatment."1.48Clinical utility of miR-143/miR-182 levels in prognosis and risk stratification specificity of BFM-treated childhood acute lymphoblastic leukemia. ( Avgeris, M; Baka, M; Drakaki, I; Gourgiotis, D; Kossiva, L; Marmarinos, A; Piatopoulou, D; Pourtsidis, A; Scorilas, A; Xagorari, M, 2018)
"In childhood B-precursor acute lymphoblastic leukemia (B-ALL), the ETV6/RUNX1 fusion transcript is considered to have an excellent outcome."1.48ETV6/RUNX1-positive childhood acute lymphoblastic leukemia in China: excellent prognosis with improved BFM protocol. ( Wang, Y; Zeng, HM; Zhang, LP, 2018)
"Children with acute lymphoblastic leukemia (ALL) in low-income countries have disproportionately lower cure rates than those in high-income countries."1.48Outcomes of Low-Intensity Treatment of Acute Lymphoblastic Leukemia at Butaro Cancer Center of Excellence in Rwanda. ( Driscoll, C; Elmore, S; Fehr, AE; Gilbert, UD; Hategekimana, V; Larrabee, K; Lehmann, L; May, L; Moore, M; Mpunga, T; Muhayimana, C; Rubagumya, F; Shulman, LN; Shyirambere, C; Uwizeye, FR; Xu, MJ, 2018)
"Although cure rates in pediatric acute lymphoblastic leukemia (ALL) are quite high with combined chemotherapy regimens, complete response (CR) and long-term survival rates in adults are 80-90 and 30-40%, respectively."1.48Comparison between Hyper-CVAD and PETHEMA ALL-93 in Adult Acute Lymphoblastic Leukemia: A Single-Center Study. ( Akidan, O; Erkut, N; Karabacak, V; Selim Batur, D; Sonmez, M, 2018)
"Ponatinib treatment was well tolerated and considered safe with easily manageable side effects."1.46Ponatinib-Induced Graft-versus-Host Disease/Graft-versus-Leukemia Effect in a Patient with Philadelphia-Positive Acute Lymphoblastic Leukemia without the T315I Mutation Relapsing after Allogeneic Transplant. ( Bossio, S; De Stefano, L; Gentile, M; Greco, R; Mazzone, C; Morabito, F; Morelli, R; Musolino, C; Palummo, A; Petrungaro, A; Recchia, AG; Uccello, G; Vigna, E, 2017)
"Patients ages 1 to 17 years with acute lymphoblastic leukemia (ALL) were treated according to modified ALL Intercontinental Berlin-Frankfurt-Münster (IC-BFM) 2002 protocol."1.46The treatment of childhood acute lymphoblastic leukemia in Guatemala: Biologic features, treatment hurdles, and results. ( Antillón, FG; Blanco, JG; Borrayo, DA; Castellanos, M; Conter, V; Garrido, CP; Girón, V; Letona, TR; Lorenzana, R; Mack, RA; Melgar, MA; Metzger, M; Osorio, EJ; Ribeiro, RC; Rossi, E; Valsecchi, MG; Valverde, PD, 2017)
"Precursor B-cell lymphoblastic lymphoma arising from the ovary is extremely rare and to our knowledge, only 5 cases have been reported in the literature."1.46Lymphoblastic Lymphoma Presenting as Bilateral Ovarian Mass in an Adolescent Girl. ( Narayanan, G; Soman, LV, 2017)
"(2) Burkitt's lymphoma was the most common (34/43, 79."1.43[Clinical and Prognostic analysis of 43 Children with Mature B-cell Non-Hodgkin's Lymphoma/Acute Lymphoblastic Leukemia]. ( Gao, J; Guo, J; Guo, X; Jia, CS; Li, Q; Zhou, CY; Zhu, YP, 2016)
"In total, 346 pediatric patients with acute lymphoblastic leukemia were enrolled in our study."1.43Some GCR Polymorphisms (N363S, ER22/23EK, and Bcl-1) May Influence Steroid-induced Toxicities and Survival Rates in Children With ALL. ( Csóka, M; Csordás, K; Eipel, O; Erdélyi, D; Hegyi, M; Kovács, G; Luczay, A; Németh, K; Török, D, 2016)
"Survival for childhood acute lymphoblastic leukemia (ALL) has improved significantly, but these benefits may not be available to many children from low and middle income countries, where reasons for treatment failure may be unique to their environment."1.43The Impact of Socioeconomic Factors on the Outcome of Childhood Acute Lymphoblastic Leukemia (ALL) Treatment in a Low/Middle Income Country (LMIC). ( Ashraf, MS; Belgaumi, AF; Iftikhar, S; Jabeen, K, 2016)
"B cell acute lymphoblastic leukemia (B-ALL) exhibits phenotypes reminiscent of normal stages of B-cell development."1.43Development-associated immunophenotypes reveal the heterogeneous and individualized early responses of adult B-acute lymphoblastic leukemia. ( Huang, QR; Jia, YQ; Jiang, NG; Jin, YM; Li, HF; Li, X; Meng, WT; Mo, XM; Xu, H; Zeng, TT, 2016)
"The identification of childhood acute lymphoblastic leukemia (ch-ALL) patients who are at a higher risk of chemotherapy resistance and relapse is essential for successful treatment decisions, despite the application of novel therapies."1.42Overexpression of BCL2 and BAX following BFM induction therapy predicts ch-ALL patients' poor response to treatment and short-term relapse. ( Anastasiou, T; Avgeris, M; Baka, M; Gourgiotis, D; Kosmidis, H; Piatopoulou, D; Scorilas, A; Stamati, L, 2015)
"Prednisone response has been confirmed to be still great prognostic value and PPR children patients have poor outcomes generally."1.42[Prognostic Value of Prednisone Response in CCLG-ALL 2008]. ( An, WB; Chang, LX; Liu, TF; Ren, YY; Wan, Y; Zhang, JL; Zhu, XF; Zou, Y, 2015)
"Cataract was prospectively assessed by serial slip lamp tests in 517 patients."1.40Prevalence and risk factors of cataract after chemotherapy with or without central nervous system irradiation for childhood acute lymphoblastic leukaemia: an LEA study. ( Alloin, AL; Auquier, P; Barlogis, V; Bertrand, Y; Chambost, H; Chastagner, P; Contet, A; Demeocq, F; Herrmann, I; Kanold, J; Michel, G; Plantaz, D; Poiree, M; Sirvent, N; Villes, V, 2014)
"Mitoxantrone is a reasonable replacement for daunorubicin in times of drug shortage."1.40Mitoxantrone as a substitute for daunorubicin during induction in newly diagnosed lymphoblastic leukemia and lymphoma. ( Bergsagel, J; Cooper, T; Daves, M; Keller, F; Lew, G; Nickel, RS; Sabnis, H, 2014)
"Being obese or underweight at diagnosis and for ≥ 50% of the time between end of induction and start of maintenance therapy resulted in inferior EFS (hazard ratios, 1."1.40Impact on survival and toxicity by duration of weight extremes during treatment for pediatric acute lymphoblastic leukemia: A report from the Children's Oncology Group. ( Freyer, DR; Gaynon, PS; Ladas, E; Malvar, J; Orgel, E; Seibel, NL; Sposto, R, 2014)
" Population pharmacokinetic parameters were estimated by the NLME software."1.40[SLCO1B1c. 521T>C gene polymorphisms are associated with high-dose methotrexate pharmacokinetics and clinical outcome of pediatric acute lymphoblastic leukemia]. ( Chen, Y; Gao, P; He, X; Li, J; Niu, C; Wang, C; Wang, Y; Zhang, H, 2014)
"The prognosis of acute lymphoblastic leukemia is poorer in adults than in children."1.39Risk group assignment differs for children and adults 1-45 yr with acute lymphoblastic leukemia treated by the NOPHO ALL-2008 protocol. ( Abrahamsson, J; Åsberg, A; Bernell, P; Birgens, H; Griškevičius, L; Hallböök, H; Heyman, M; Holm, MS; Hulegårdh, E; Jónsson, OG; Klausen, TW; Marquart, HV; Nielsen, OJ; Quist-Paulsen, P; Schmiegelow, K; Taskinen, M; Toft, N; Vaitkeviciene, G; Vettenranta, K, 2013)
"The BFM studies for relapsed childhood acute lymphoblastic leukemia (ALL) were started in 1983, at a time when cure rates for ALL were still lower and the number of children with ALL relapse equaled about the number of children with newly diagnosed neuroblastoma."1.39ALL-REZ BFM--the consecutive trials for children with relapsed acute lymphoblastic leukemia. ( Eckert, C; Henze, G; v Stackelberg, A, 2013)
"Acute lymphoblastic leukemia (ALL) is the most common pediatric cancer."1.39The BCL2-938 C > A promoter polymorphism is associated with risk group classification in children with acute lymphoblastic leukemia. ( Bachmann, HS; Eggert, A; Grosse-Lordemann, A; Künkele, A; Schramm, A; Schulte, JH, 2013)
"MLL-rearranged acute lymphoblastic leukemia (ALL) in infants is characterized by a poor clinical outcome and resistance to glucocorticoids (for example, prednisone and dexamethasone)."1.38Elevated S100A8/S100A9 expression causes glucocorticoid resistance in MLL-rearranged infant acute lymphoblastic leukemia. ( de Boer, J; Hulleman, E; Pieters, R; Schneider, P; Spijkers-Hagelstein, JA; Stam, RW; Williams, O, 2012)
"Acute lymphoblastic leukemia (ALL) with distinct fusion transcripts has unique clinical features."1.38Clinical features, early treatment responses, and outcomes of pediatric acute lymphoblastic leukemia in China with or without specific fusion transcripts: a single institutional study of 1,004 patients. ( Cui, L; Gao, C; Jiao, Y; Li, WJ; Li, ZG; Liu, SG; Wu, MY; Yue, ZX; Zhao, W; Zhao, XX, 2012)
"We report a girl with acute lymphoblastic leukemia of B-cell type who initially presented with numb chin syndrome resulting from skull base infiltration."1.37Numb chin syndrome in acute lymphoblastic leukemia. ( Benesch, M; Lackner, H; Pansy, J; Urban, C, 2011)
"Methotrexate is a key drug in acute lymphoblastic leukemia (ALL) treatment; it inhibits DNA replication by blocking the conversion of 5,10 methylene tetrahydrofolate to 5-methylene tetrahydrofolate by methylene tetrahydrofolate reductase (MTHFR)."1.36Methylene tetrahydrofolate reductase gene polymorphism in Egyptian children with acute lymphoblastic leukemia. ( Abdulghaffar, EE; Abou El Asrar, M; Adly, AA; El-Bostany, EA; El-Ghouroury, EA; Tantawy, AA, 2010)
"MLL-rearranged acute lymphoblastic leukemia (ALL) represents an unfavorable type of leukemia that often is highly resistant to glucocorticoids such as prednisone and dexamethasone."1.36Association of high-level MCL-1 expression with in vitro and in vivo prednisone resistance in MLL-rearranged infant acute lymphoblastic leukemia. ( Armstrong, SA; Brady, HJ; de Boer, J; de Lorenzo, P; Den Boer, ML; Hagelstein, J; Pieters, R; Sallan, SE; Schneider, P; Stam, RW; Valsecchi, MG, 2010)
"Risperidone is an effective short-term pharmacologic agent for controlling steroid-related psychiatric adverse effects when cessation or dose reduction of steroid therapy is not an option."1.36Concurrent treatment of steroid-related mood and psychotic symptoms with risperidone. ( Dahl, G; Shaw, RJ; Tzuang, D; Ularntinon, S, 2010)
"In a group of newly diagnosed acute lymphocytic leukemia (ALL) children we evaluated a number of hemostatic and inflammatory markers at diagnosis and at different time points during chemotherapy for the remission induction to identify alterations in the plasma levels of prothrombotic markers before and during the course of chemotherapy."1.36Prospective study of hemostatic alterations in children with acute lymphoblastic leukemia. ( Altomare, M; Crescenzio, N; De Mattia, D; Del Vecchio, GC; Falanga, A; Giordano, P; Marchetti, M; Molinari, AC; Perutelli, P; Russo, G; Santoro, N; Saracco, P, 2010)
"A 4-year-old boy with acute lymphoblastic leukemia (ALL) was inserted a central venous catheter into right vena jugularis interna, whereas on BFM-ALL (Protocol 1) therapy."1.36Schistocytic hemolytic anemia owing to central venous catheter in a child with acute lymphoblastic leukemia. ( Akyay, A; Bçakç, Z; Cetin, II; Olcay, L; Oztürkmen, S; Paç, A; Polat, TB; Senayl, A, 2010)
"Overt hyperglycemia was seen in 56 (34%) patients."1.35Hyperglycemia during induction therapy is associated with poorer survival in children with acute lymphocytic leukemia. ( Haymond, MW; Margolin, JF; McKay, SV; Okcu, MF; Sonabend, RY; Yan, J, 2009)
"Treatment for childhood acute lymphoblastic leukemia (ALL) regularly includes the use of thiopurine drugs."1.35Thiopurine methyltransferase genetics is not a major risk factor for secondary malignant neoplasms after treatment of childhood acute lymphoblastic leukemia on Berlin-Frankfurt-Münster protocols. ( Cario, G; Coulthard, SA; Dördelmann, M; Eichelbaum, M; Kaatsch, P; Möricke, A; Reiter, A; Riehm, H; Schaeffeler, E; Schrappe, M; Schrauder, A; Schwab, M; Stanulla, M; Welte, K; Zimmermann, M, 2009)
"In previous clinical trials of childhood acute lymphoblastic leukemia (ALL), dexamethasone resulted in higher event-free survival rates than prednisone, presumably due to greater central nervous system penetration."1.35A comparison of neurocognitive functioning in children previously randomized to dexamethasone or prednisone in the treatment of childhood acute lymphoblastic leukemia. ( Bostrom, B; Breiger, D; Brouwers, P; Chen, L; Dziura, J; Kadan-Lottick, NS; Kaleita, T; Liu, H; Neglia, JP; Nicoletti, M; Stork, L, 2009)
"Successful treatment of higher risk childhood ALL was associated with obesity, independent of cranial irradiation."1.35Weight patterns in children with higher risk ALL: A report from the Children's Oncology Group (COG) for CCG 1961. ( Hawks, RG; Meza, JL; Post-White, JE; Sacks, N; Seibel, NL; Smith, LM; Withycombe, JS, 2009)
"To retrospectively analyze and compare the treatment efficiency of CHOP-based regimens with or without high-dose consolidation treatment combined with hematopoietic stem cell transplantation (HDT-HSCT) in the patients with lymphoblastic lymphoma (LBL)."1.35[Comparison of the efficiency of CHOP-based regimen with or without high dose consolidation treatment combined with hematopoietic stem cell transplantation in 63 lymphoblastic lymphoma patients]. ( Dong, M; Feng, FY; Han, XH; He, XH; Liu, P; Qin, Y; Shi, YK; Sun, Y; Wang, JW; Yang, JL; Yang, S; Zhang, CG; Zhou, LQ; Zhou, SY, 2009)
"The occurrence rates of peripheral leukocytosis and hepatosplenomegaly were significantly higher in the patients with EBV infection than in the patients without EBV infection (P <0."1.34[Infection status and clinical significance of Epstein-Barr virus in pediatric leukemia---a report of 35 cases]. ( Lu, Y; Lu, ZH; Pang, XY; Sui, AH; Sun, LR, 2007)
"In childhood acute lymphoblastic leukemia (ALL), persistence of leukemic blasts during therapy is of crucial prognostic significance."1.34Gene expression shift towards normal B cells, decreased proliferative capacity and distinct surface receptors characterize leukemic blasts persisting during induction therapy in childhood acute lymphoblastic leukemia. ( Hagemeier, C; Karawajew, L; Kirschner-Schwabe, R; Ludwig, WD; Moericke, A; Ratei, R; Rhein, P; Scheid, S; Schrappe, M; Seeger, K; Spang, R, 2007)
"Ninety-seven consecutive patients with childhood ALL were studied prospectively by magnetic resonance imaging (MRI) of the lower extremities at the end of the treatment."1.34High body mass index increases the risk for osteonecrosis in children with acute lymphoblastic leukemia. ( Harila-Saari, AH; Jartti, AE; Lanning, M; Möttönen, MI; Niinimäki, RA; Pääkkö, EL; Riikonen, PV; Seuri, RM, 2007)
"Disseminated intravascular coagulation was defined by International Society of Thrombosis and Hemostasis criteria."1.34Disseminated intravascular coagulation in acute leukemia at presentation and during induction therapy. ( Chatterjee, T; Choudhry, DR; Choudhry, VP; Dixit, A; Kannan, M; Mahapatra, M; Mishra, P; Saxena, R, 2007)
"Between 15% and 30% of children with acute lymphoblastic leukemia (ALL) experience disease recurrence."1.33Second induction in pediatric patients with recurrent acute lymphoid leukemia using DFCI-ALL protocols. ( Barrette, S; Bernstein, ML; Champagne, J; Champagne, MA; Dalle, JH; David, M; Demers, J; Duval, M; Hume, H; Leclerc, JM; Meyer, P; Moghrabi, A; Rousseau, P, 2005)
"Children with acute lymphoblastic leukemia (ALL) are treated with intermittent steroid therapy."1.33Recent steroid therapy increases severity of varicella infections in children with acute lymphoblastic leukemia. ( Chauvenet, AR; Hill, G; Lovato, J; McLean, TW, 2005)
"Philadelphia chromosome positive (Ph(+)) acute lymphoblastic leukemia (ALL) includes at least one-quarter of all adults with ALL."1.33Treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia. ( Ottmann, OG; Wassmann, B, 2005)
"The authors describe an adolescent with acute lymphocytic leukemia and WNV encephalitis."1.33West Nile virus infection in a teenage boy with acute lymphocytic leukemia in remission. ( Buescher, ES; Byrd, R; Dory, C; Frank, LM; Hindo, H; Pettit, D, 2005)
"We describe a 57-year-old woman with acute lymphoblastic leukemia who had a cavitary lesion develop in the right upper lobe caused by Cunninghamella bertholletiae, a zygomycete."1.33Treatment of cavitary pulmonary zygomycosis with surgical resection and posaconazole. ( Colson, YL; Marty, FM; Paul, S, 2006)
"From 1981 to 1986, children with acute lymphoblastic leukemia (ALL) and initial WBC above 50,000/mm3, achieved significantly worse treatment results than children with lower WBC: over 6-year disease-free survival were respectively 33% and 60%."1.33[Acute lymphoblastic leukemia in children with initial leucocytosis above 50,000/mm3: summary of treatment results of Polish Pediatric Leukemia/Lymphoma Study Group]. ( Balcerska, A; Balwierz, W; Chybicka, A; Derwich, K; Dobaczewski, G; Juszczak, K; Kowalczyk, J; Krauze, A; Luszczyńska, A; Matysiak, M; Moryl-Bujakowska, A; Pawelec, K; Pawińska, K; Płoszyńska, A; Skoczeń, S; Sońta-Jakimczyk, D; Styczyńskii, J; Swiatkiewicz, V; Tomaszewska, R; Wachowiak, J; Wiśniewska-Slusarz, H; Wysocki, M, 2006)
" All errors were due to incorrect dosing or failure to administer an indicated medication."1.33Oral outpatient chemotherapy medication errors in children with acute lymphoblastic leukemia. ( Geyer, LJ; Hawkins, DS; Taylor, JA; Winter, L, 2006)
"Prednisone treatment induced a decrease in Bcl-2 and Bcl-xl levels in 17 and 16 of the 28 patients, respectively, while Bax protein increased in 14 of the 21 patients."1.32Determination of the in vivo effects of prednisone on Bcl-2 family protein expression in childhood acute lymphoblastic leukemia. ( Addeo, R; Casale, F; Crisci, S; D'Angelo, V; Di Tullio, MT; Indolfi, P; Morgera, C; Poggi, V, 2003)
"Acute pneumonitis was diagnosed, and MTX was stopped."1.32Successful reintroduction of methotrexate after acute pneumonitis in a patient with acute lymphoblastic leukemia. ( Bächli, EB; Fehr, T; Jacky, E, 2003)
"Etoposide is a substrate for P-glycoprotein, CYP3A4, CYP3A5, and UGT1A1."1.32Effects of prednisone and genetic polymorphisms on etoposide disposition in children with acute lymphoblastic leukemia. ( Boureau, B; Chen, P; Cook, EH; Das, S; Kishi, S; Morand, S; Pui, CH; Relling, MV; Rosner, GL; Schuetz, E; Yang, W, 2004)
" In addition, before the modification, patients with Stage IV disease received a cumulative dose of 15,600 mg/m(2) of cyclophosphamide for 3 years; after 1980, these patients received the same dosage as the other patients (i."1.32Lymphoblastic lymphoma of childhood and the LSA2-L2 protocol: the 30-year experience at Memorial-Sloan-Kettering Cancer Center. ( Filippa, DA; Mora, J; Qin, J; Wollner, N, 2003)
"Childhood Acute Lymphoblastic Leukemia (ALL) represents approximately 40% of pediatric cancers, but molecular mechanisms involved in the therapeutic resistance of ALL are still unclear."1.32Glucocorticoids induce G1 arrest of lymphoblastic cells through retinoblastoma protein Rb1 dephosphorylation in childhood acute lymphoblastic leukemia in vivo. ( Abbruzzese, A; Addeo, R; Caraglia, M; Casale, F; Crisci, S; D'Angelo, V; Di Tullio, MT; Indolfi, P, 2004)
"Up to 80% of pediatric patients with acute lymphoblastic leukemia (ALL) can be cured if intensive therapy is applied."1.32Evolution of BFM trials for childhood ALL. ( Schrappe, M, 2004)
"A final diagnosis of acute lymphoblastic leukemia (ALL) was established in a fourth, repeated bone marrow biopsy performed more than 2 months after the first presenting symptom appeared."1.32Prolonged fever of unknown origin and hemophagocytosis evolving into acute lymphoblastic leukemia. ( Goldschmidt, N; Gural, A; Kornberg, A; Paltiel, O; Shopen, A; Spectre, G, 2004)
"Twenty cases had additional cytogenetic aberrations, such as t(9;22) with -7, +8, -5."1.32[Analysis of 32 cases of acute leukemia with abnormality of chromosome 7]. ( Chen, ZM; Jin, J; Lou, JY; Lu, Y; Xu, WL, 2004)
"T-cell lymphoblastic lymphoma in childhood and adolescence is an aggressive malignant disease with higher mortality."1.32[Efficacy of modified BFM-90 regimen on children and adolescents with T cell lymphoblastic lymphoma: a report of 20 cases]. ( Guan, ZZ; He, YJ; Huang, HQ; Jiang, WQ; Li, YH; Liu, DG; Sun, XF; Xia, Y; Xia, ZJ; Zhang, L; Zhen, ZJ; Zhou, ZM, 2004)
"Extending the principle of conventional acute lymphoblastic leukemia (ALL) therapy to transplantation, 77 adult patients receiving autografts in first remission after melphalan with or without total body irradiation were scheduled to receive 6-mercaptopurine (6MP), methotrexate (MTX), and vincristine-prednisone (VP) for 2 years after transplantation to reduce relapse."1.31The role of posttransplantation maintenance chemotherapy in improving the outcome of autotransplantation in adult acute lymphoblastic leukemia. ( Kulkarni, S; Mehta, J; Powles, R; Singhal, S; Sirohi, B; Tait, D; Treleaven, J, 2002)
"Precursor B-cell lymphoblastic lymphoma (PBLL) is a rare subtype of childhood non-Hodgkin lymphoma (NHL)."1.31Precursor B-cell lymphoblastic lymphoma in childhood and adolescence: clinical features, treatment, and results in trials NHL-BFM 86 and 90. ( Jansen, P; Ludwig, WD; Mann, G; Neth, O; Reiter, A; Riehm, H; Seidemann, K; Tiemann, M, 2000)
"The acute treatment of hypercalcemia is independent of the underlying cause (rehydration with physiologic saline, renal excretion with furosemide, inhibition of osteoclastic activity)."1.31[Life threatening hypercalcemia in a young man with ALL]. ( Boesken, WH; Schneider, T; Seydlitz, F; Sontag, B; Zimmermann, U, 2001)
"Prednisone was used as the corticosteroid during postremission therapy from 1987 to 1991, and dexamethasone was used from 1991 to 1995."1.31Bony morbidity in children treated for acute lymphoblastic leukemia. ( Dalton, VM; Gelber, RD; Sallan, SE; Silverman, LB; Strauss, AJ; Su, JT, 2001)
"Acute lymphoblastic leukemia (ALL) is a bone marrow disease."1.31Intact T-cell regenerative capacity in childhood acute lymphoblastic leukemia after remission induction therapy. ( Eder, J; Heitger, A; Meister, B; Moritz, B, 2001)
"During treatment Hepatitis B was reactivated and after termination, of chemotherapy she developed fulminant hepatitis with hyperbilirubinemia, coagulopathy, hypoalbuminemia and ascites."1.31[Effective treatment with Lamivudine of patients with reactivation of hepatitis B following chemotherapy administration]. ( Haran, M; Klepfish, A; Lurie, Y; Malnick, S; Shtalrid, M, 2001)
"Prednisone good response was defined as a blast count of less than 1,000/microL and a prednisone poor response (PPR) as a blast count of at least 1,000/microL, both in peripheral smears, after 7 days of oral prednisone (60 mg/m2 per day) and one intrathecal dose of methotrexate."1.31Childhood acute lymphoblastic leukemia: prognostic value of initial peripheral blast count in good responders to prednisone. ( Alfaro, EM; Felice, MS; Sackmann-Muriel, F; Zubizarreta, PA, 2001)
"Precursor B cell lymphoblastic lymphoma has not been previously reported as a form of posttransplant lymphoproliferative disease."1.31Epstein-Barr virus-negative precursor B cell lymphoblastic lymphoma after liver transplantation: a unique form of posttransplant lymphoproliferative disease. ( Borges, E; Ferry, JA; Friedmann, AM, 2002)
"Concerning ANLL, the MOPP regimen was significantly associated with a higher risk: 3."1.31Fifteen-year secondary leukaemia risk observed in 761 patients with Hodgkin's disease prospectively treated by MOPP or ABVD chemotherapy plus high-dose irradiation. ( Andrieu, JM; Colonna, P; Delwail, V; Jais, JP, 2002)
"Childhood acute lymphoblastic leukemia (ALL) has a 5-year disease-free survival (DFS) of more than 70%."1.30Modified BFM protocol for childhood acute lymphoblastic leukemia: a retrospective analysis. ( Aziz, Z; Mahmood, R; Maqbool, S; Zahid, M, 1997)
"Initial and relapsed childhood acute lymphoblastic leukemias (ALL) were investigated for mutations and expression of deoxycytidine kinase (dCK)."1.30Deoxycytidine kinase mRNA expression in childhood acute lymphoblastic leukemia. ( Sauerbrey, A; Stammler, G; Volm, M; Zintl, F, 1997)
"We prospectively assessed the pharmacokinetics of methotrexate, mercaptopurine, and erythrocyte thioguanine nucleotide levels in a homogenous population of children with lower risk acute lymphoblastic leukemia and correlated pharmacokinetic parameters with disease outcome."1.30Pharmacokinetics and pharmacodynamics of oral methotrexate and mercaptopurine in children with lower risk acute lymphoblastic leukemia: a joint children's cancer group and pediatric oncology branch study. ( Ames, MM; Balis, FM; Bleyer, WA; Ge, J; Gilchrist, GS; Holcenberg, JS; Murphy, RF; Poplack, DG; Sather, HN; Tubergen, DG; Waskerwitz, MJ; Zimm, S, 1998)
"Infants diagnosed with acute lymphoblastic leukemia (ALL) are considered the patient subgroup at the highest risk for central nervous system (CNS) disease, both at presentation and as an isolated extramedullary relapse."1.30Neurodevelopmental outcome of infants with acute lymphoblastic leukemia: a Children's Cancer Group report. ( Kaleita, TA; MacLean, WE; Reaman, GH; Sather, HN; Whitt, JK, 1999)
"We studied 95 survivors of childhood acute lymphoblastic leukemia a median of 11 yr (range, 3-23 yr) after diagnosis."1.30Degree of fatness after treatment for acute lymphoblastic leukemia in childhood. ( Hertz, H; Holm, K; Michaelsen, KF; Müller, J; Mølgaard, C; Nysom, K, 1999)
"Lymphoblastic lymphoma (LBL) and Burkitt's lymphoma belong to the very aggressive lymphomas requiring intensive therapy."1.30Non-Hodgkin's lymphoma protocols in the treatment of patients with Burkitt's lymphoma and lymphoblastic lymphoma: a report on 58 patients. ( Havemann, K; Kaiser, U; Uebelacker, I, 1999)
"To report four acute lymphoblastic leukemia(ALL) patients who developed tumor lysis syndrome(TLS) after initial chemotherapy."1.30[Acute lymphoblastic leukemia complicated with tumor lysis syndrome--four cases report]. ( Han, M; He, H; Li, C, 1999)
"Four of these patients had an isolated recurrence, in 3 patients < or = 3 months and in 1 patient < or = 6 months after the initial event."1.29Prognosis and treatment of seizures in children with acute lymphoblastic leukemia. ( Eviatar, L; Grossman, R; Karayalycin, G; Lanzkowsky, P; Maytal, J; Schaul, N; Shende, AC; Yusuf, FH, 1995)
"The incidence of severe hyperlipidemia during therapy of patients with acute lymphoblastic leukemia (ALL) who received prednisone and asparaginase was evaluated."1.29Transient, severe hyperlipidemia in patients with acute lymphoblastic leukemia treated with prednisone and asparaginase. ( Steinherz, PG, 1994)
" This was associated with delivery of 100% of the planned dosage of vincristine, prednisone, and daunorubicin at induction."1.29Poor outcome of intensive chemotherapy for adult acute lymphoblastic leukemia: a possible dose effect. ( Chan, LC; Chan, TK; Chiu, EK; Kwong, YL; Liang, R; Lie, A; Todd, D, 1994)
"In the past 16 years, 2004 children with acute lymphoblastic leukemia (ALL) have been treated in the Polish Pediatric Group centers."1.29Relapses after termination of therapy of acute lymphoblastic leukemia in children. ( Armata, J; Balwierz, W; Bogusławska-Jaworska, J; Chybicka, A; Jackowska, T; Jakowicka, M; Kulus, M; Matysiak, M; Michalewska, D; Ochocka, M, 1993)
"We describe a case of a recurrence of ALL in the uterine cervix during hematopoietic remission."1.29Childhood acute lymphoblastic leukemia relapse in the uterine cervix. ( Okamura, J; Tsuruchi, N, 1996)
"Two boys with acute lymphocytic leukemia (ALL) who presented with muscle pain, shortly after receiving induction chemotherapy, were evaluated."1.29Pyomyositis during induction chemotherapy for acute lymphocytic leukemia. ( Corden, TE; Morgan, ER, 1996)
"Relapsed acute lymphoblastic leukemia (ALL) usually carries a dire prognosis."1.29Effectiveness of intensified rotational combination chemotherapy for late hematologic relapse of childhood acute lymphoblastic leukemia. ( Benaim, E; Crist, WM; Hudson, MM; Liu, Q; Pui, CH; Ribeiro, RC; Rivera, GK, 1996)
" The bioavailability of both IGF-I and IGF-II is regulated by specific IGF-binding proteins (IGFBPs)."1.29Serum levels of insulin-like growth factor-I, -II and insulin-like growth factor binding proteins -2 and -3 in children with acute lymphoblastic leukaemia. ( Aumann, V; Blum, WF; Kluba, U; Mittler, U; Mohnike, KL; Vorwerk, P, 1996)
"Information about elderly patients with acute lymphoblastic leukemia is scarce."1.28[Treatment of elderly patients with hematological malignancies]. ( Mizoguchi, H; Saito, H, 1992)
"45 cases of acute lymphocytic leukemia (ALL) were treated with vincristine, daunorubicin, cyclophosphamide, prednisone with a CR rate of 88."1.28[Treatment of various types of acute leukemia in adult. An analysis of 98 cases. The Leukemia Cooperation Group of Beijing City]. ( , 1992)
" coli L-asparaginase (L-ase) in the induction phase at a dosage of 6000 U/m2/day x 7 d starting on d 15, as well as vincristine, prednisone, daunorubicin and cyclophosphamide, the last-named by random 1:1."1.28Incidence of thrombotic complications in adult patients with acute lymphoblastic leukaemia receiving L-asparaginase during induction therapy: a retrospective study. The GIMEMA Group. ( Annino, L; Defazio, D; Gugliotta, L; Leone, G; Mandelli, F; Mattioli-Belmonte, M; Mazzucconi, MG; Tura, S, 1992)
"More effective treatment for adult lymphoblastic lymphoma is required."1.28Intensive chemotherapy for adult lymphoblastic lymphomas. ( Chan, TK; Chiu, E; Ho, FC; Liang, R; Lie, A; Loke, SL; Todd, D, 1991)
" Maintenance with the same drugs in a modified dosage schedule continued for approximately 2 years."1.28Multiagent chemotherapy in relapsed acute lymphoblastic leukemia in children. ( Belasco, JB; Luery, N; Scher, C, 1990)
"Thirty-nine patients with relapsed acute lymphoblastic leukemia (ALL) and four with primarily refractory ALL were treated with a regimen that included cytarabine 1 gm/m2 (2-hour infusion) twice daily days 1 to 5, mitoxantrone 12mg/m2 daily days 1 to 5, prednisone 0."1.28Successful treatment of adult acute lymphoblastic leukemia after relapse with prednisone, intermediate-dose cytarabine, mitoxantrone, and etoposide (PAME) chemotherapy. ( Auzanneau, G; Gisselbrecht, C; Gratecos, N; Harousseau, JL; LeBlond, V; Michallet, M; Milpied, N; Sebban, C; Troussard, X; Witz, F, 1990)
"Twenty children with acute lymphoblastic leukemia (ALL) in relapse were treated with various combinations of anti-leukemic agents in approach to the induction of remission."1.28[Study of reinduction chemotherapy in bone marrow relapse of childhood acute lymphoblastic leukemia]. ( Ikeda, Y; Ito, E; Ito, R; Miyano, T; Onodera, N; Saito, T; Sato, Y; Suto, Y; Tachibana, N; Tateoka, N, 1989)
" For total prednisolone, the mean elimination half-life was relatively short (1."1.28Pharmacokinetics of prednisolone in children with acute lymphoblastic leukaemia. ( Blackburn, M; Choonara, I; Lewis, I; Rayner, P; Wheeldon, J, 1989)
"Thirteen children with acute lymphoblastic leukemia (ALL) were investigated before and during cytotoxic therapy."1.27Changes in the EEG background activity of children with acute lymphoblastic leukemia during cytotoxic therapy. ( Benninger, C; Brandeis, WE; Lichter-Konecki, U; Matthis, P; Scheffner, D, 1987)
"Many children with acute lymphoblastic leukemia (ALL) develop a marrow relapse during or shortly following initial continuation chemotherapy."1.27Reinduction therapy in 297 children with acute lymphoblastic leukemia in first bone marrow relapse: a Pediatric Oncology Group Study. ( Boyett, JM; Buchanan, GR; Chauvenet, AR; Crist, WM; Rivera, GK; Vietti, TJ, 1988)

Research

Studies (601)

TimeframeStudies, this research(%)All Research%
pre-199040 (6.66)18.7374
1990's180 (29.95)18.2507
2000's199 (33.11)29.6817
2010's143 (23.79)24.3611
2020's39 (6.49)2.80

Authors

AuthorsStudies
Martinelli, G2
Papayannidis, C1
Piciocchi, A2
Robustelli, V1
Soverini, S2
Terragna, C1
Marconi, G1
Lemoli, RM1
Guolo, F1
Fornaro, A1
Lunghi, M1
de Fabritiis, P1
Candoni, A2
Selleri, C1
Simonetti, F1
Bocchia, M1
Vitale, A2
Frison, L1
Tedeschi, A1
Cuneo, A1
Bonifacio, M1
Martelli, MP1
D'Ardia, S1
Trappolini, S1
Tosi, P1
Galieni, P1
Fabbiano, F2
Abbenante, MC1
Granier, M1
Zhu, Z1
Wang, M2
Sartor, C1
Paolini, S2
Cavo, M1
Foà, R2
Fazi, P2
Vignetti, M2
Baccarani, M3
Zhang, Y2
Qian, JJ2
Shen, YJ1
Hang, SJ1
Jin, J4
Zhu, HH4
Moriya, K1
Imamura, T1
Katayama, S1
Kaino, A1
Okamoto, K1
Yokoyama, N1
Uemura, S1
Kitazawa, H1
Sekimizu, M1
Hiramatsu, H1
Usami, I1
Ishida, H1
Hasegawa, D1
Hama, A1
Moriya-Saito, A1
Sato, A1
Sasahara, Y1
Suenobu, S1
Horibe, K1
Hara, J1
Kośmider, K1
Karska, K1
Kozakiewicz, A1
Lejman, M3
Zawitkowska, J3
Sutaryo, S1
Widjajanto, PH1
Mulatsih, S1
Ardianto, B1
Pangarso, AWS1
Supriyadi, E1
Purwanto, I1
Adelin, CP1
Lestari, RP1
Sagoro, L1
Christian, SD1
Sabrina, DS1
Verena, N1
Kors, WA1
Kaspers, GJL1
Veerman, AJP1
Xu, J1
Zhao, L1
García-Villaseñor, E1
Cortés, JE2
Reyes-Cisneros, OA1
Fernández-Gutiérrez, JA1
Sánchez-Bonilla, D1
Bojalil-Álvarez, L1
Murrieta-Álvarez, I1
Ruiz-Delgado, GJ1
Ruiz-Argüelles, GJ1
Advani, AS1
Moseley, A1
O'Dwyer, KM1
Wood, BL1
Park, J1
Wieduwilt, M1
Jeyakumar, D1
Yaghmour, G1
Atallah, EL1
Gerds, AT1
O'Brien, SM2
Liesveld, JL1
Othus, M1
Litzow, M1
Stone, RM4
Sharon, E1
Erba, HP1
Benarous, X1
Brocheton, C1
Bonnay, C1
Boissel, L1
Crovetto, C1
Lahaye, H1
Guilé, JM1
Theret, P1
Gondry, J1
Foulon, A1
Kim, E1
Yoo, SH1
Chen, Z1
Sousa, JA1
Batista, E1
Demeyer, S1
Fischer, N1
Pellegrino, O1
Ribeiro, AS1
Martins, LL1
Worthy, FR1
Goldberg, SD1
Ranjitkar, S1
Xu, JC1
Asmara, AAGY1
Karna, MB1
Meregawa, PF1
Deslivia, MF1
Carula, BC1
Giostri, GS1
Bebber, F1
Batista, MFDS1
Silva, FBD1
Novak, EM1
Vilela, JCS1
Franco, N1
Campos, G1
Deligne, LM1
Machado, TLA1
Degasperi, FA1
Scatigna, BF1
Falótico, GG1
Romero, V1
Basile, R1
Takata, ET1
Kaleka, CC1
Debieux, P1
Antonioli, E1
Zucconi, E1
Cohen, M1
Ferretti, M1
Bampidis, V2
Azimonti, G2
Bastos, ML2
Christensen, H2
Fašmon Durjava, M2
Kouba, M2
López-Alonso, M2
López Puente, S2
Marcon, F2
Mayo, B2
Pechová, A2
Petkova, M2
Ramos, F2
Sanz, Y2
Villa, RE2
Woutersen, R2
Brantom, P2
Chesson, A2
Westendorf, J2
Manini, P2
Pizzo, F2
Dusemund, B2
Aron, J1
Albert, PS1
Gribble, MO1
Samankul, A1
Senawong, G1
Swatsitang, P1
Sripa, B1
Phaosiri, C1
Kanokmedhakul, S1
Senawong, T1
Sirajudeen, MS1
Alzhrani, M1
Alanazi, A1
Alqahtani, M1
Waly, M1
Unnikrishnan, R1
Muthusamy, H1
Alrubaia, W1
Alanazi, N1
Seyam, MK1
Kashoo, F1
Miraj, M1
Channmgere Govindappa, S1
Alghamdi, KA1
Al-Hussinan, NM1
Wang, Z2
Qu, T1
Qi, H1
Zhao, S2
Shi, H2
Bai, W1
Yu, Y3
Wu, X1
Zhao, P1
Yakubov, S1
Stockerl, WJ1
Tian, X2
Shahin, A1
Mandigma, MJP1
Gschwind, RM1
Barham, JP1
Li, R1
Jiang, D1
Du, P1
Yuan, C1
Cui, X1
Tang, Q1
Zheng, J1
Li, Y4
Lu, K1
Ren, X2
Gao, S1
Zhan, X1
Ramgoolam, KH1
Dolphin, AC1
Shi, Q1
Zhou, YJ1
Fang, JG1
Zhong, X1
Chen, LZ1
Hou, HZ1
Ma, L1
Feng, SZ1
He, JW1
Huang, R1
Wang, YF1
Yang, Y1
Guo, FL1
Li, LJ2
Ruan, XH2
Fu, GM1
Zhao, JZ2
Hou, XK1
Gao, M2
Zheng, XQ2
Zeng, Y1
Huang, DM1
Zhang, JM1
Zhang, H4
Kang, M1
Zhu, J2
Xu, YJ1
Li, SN1
Lai, JM1
Liu, JJ1
Wen, S2
Yan, HH1
Cheng, R1
Zhu, F1
Gao, PF1
Zou, HY1
Huang, CZ1
Wang, J5
AbdElgawad, H1
Zinta, G1
Hornbacher, J1
Papenbrock, J1
Markakis, MN1
Asard, H1
Beemster, GTS1
Fukushi, Y1
Akamine, Y1
Abumiya, M1
Tozawa, N1
Yamashita, T1
Nara, M1
Kameoka, Y1
Takahashi, N1
Miura, M1
Qi, G1
Yu, T1
Li, J5
Guo, Z1
Ma, K1
Jin, Y1
Lucon-Xiccato, T1
Montalbano, G1
Gatto, E1
Frigato, E1
D'Aniello, S1
Bertolucci, C1
Shi, W1
Ge, N1
Yu, S1
Wu, J1
Hu, T1
Wei, J2
Yan, X1
Wang, X2
Lin, K1
Deng, T1
Qu, H1
Ou, H1
Huang, Q1
Gao, B1
Li, X4
Wei, N1
von Haeften, K1
Laarmann, T1
Wabnitz, H1
Möller, T1
Gries, KJ1
Hart, CR1
Kunz, HE1
Ryan, Z1
Zhang, X1
Parvizi, M1
Liu, Y3
Dasari, S1
Lanza, IR1
Perez, HL1
Andonian, C1
Wan, KX1
Potts, D1
Gonzalez, P1
Smith, I1
Kavetska, O1
Ferrari, LC1
Rivas, MM1
Navickas, AB1
Dick, H1
Mela Osorio, MJ1
Agamennoni, L1
Rey, IH1
Carnelutto, NE1
Cazap, N1
Castro, MB1
Aranguren, PN1
Fischman, LA1
Yupanki, ML1
Milone, JH1
Fernández, II1
Moirano, MM1
Belli, CB1
Zhao, Y3
Li, C3
Cai, C1
Fu, H1
Zhao, Z1
Han, J1
Zhang, F2
Cassaday, RD1
Zarling, LC1
Garcia, KA1
Sala-Torra, O1
Stevenson, PA1
Martino, CH1
Liu, YJ1
Fang, M1
Percival, MM1
Halpern, AB1
Becker, PS1
Oehler, VG1
Shustov, AR1
Cooper, JP1
Orozco, JJ1
Hendrie, PC1
Walter, RB1
Radich, JP1
Soma, LA1
Estey, EH1
Sharma Poudyal, B1
Paudel, B1
Tuladhar, S1
Neupane, S1
Bhattarai, K1
Joshi, U1
Xie, M1
Lu, Y3
Ouyang, G1
Shi, T1
Yang, M2
Le, J1
Hu, H1
Zhang, L5
Feng, W1
Meng, H1
Mai, W1
Qian, J1
Xu, G1
Yang, C1
Lin, Y1
Qian, S1
Kuang, Y1
Zhu, W1
Yao, G1
Wu, G1
Hu, S1
Huang, X2
Wang, Y4
Tong, H1
Haddad, FG1
Kourie, HR1
Saleh, K1
Trobisch, A1
Marterer, R1
Gorkiewicz, G1
Flaschberger, S1
Lackner, H2
Seidel, M1
Sperl, D1
Karastaneva, A1
Kohlmaier, B1
Egger, M1
Urban, C3
Benesch, M2
Strenger, V1
Kowalczyk, JR3
Drabko, K1
Samardakiewicz, M1
Matysiak, M12
Romiszewski, M2
Balwierz, W12
Ćwiklińska, M3
Kazanowska, B3
Owoc-Lempach, J2
Wachowiak, J7
Derwich, K6
Adamkiewicz-Drożyńska, E2
Niedźwiecki, M2
Trelińska, J2
Młynarski, W3
Wysocki, M10
Kołtan, A3
Szczepański, T6
Krawczuk-Rybak, M5
Kitszel, A1
Wieczorek, M4
Urasiński, T6
Ociepa, T4
Sobol-Milejska, G2
Mizia-Malarz, A2
Karolczyk, G2
Stary, J7
Ben Salah, R1
Kammoun, S1
Frikha, F1
Bouattour, Y1
Chabchoub, I1
Feki, J1
Bahloul, Z1
Aisyi, M1
Andriastuti, M1
Kurniati, N1
Kersten, MJ1
van Ettekoven, CN1
Heijink, DM1
Rausch, CR1
Jabbour, EJ1
Kantarjian, HM6
Kadia, TM1
Attarbaschi, A7
Mann, G10
Zimmermann, M15
Bader, P1
Barisone, E10
Basso, G18
Biondi, A11
Cario, G10
Cazzaniga, G5
Colombini, A2
Flotho, C1
Kuhlen, M1
Lang, P1
Lauten, M10
Linderkamp, C1
Locatelli, F11
Lo Nigro, L7
Möricke, A10
Niggli, F6
Panzer-Grümayer, R3
Parasole, R6
Peters, C2
Caterina Putti, M1
Rizzari, C12
Suttorp, M1
Valsecchi, MG16
Conter, V18
Schrappe, M37
Tidwell, C1
Willman, A1
Saygin, C1
Grieselhuber, N1
Blachly, J1
Byrd, JC1
Vasu, S1
Larkin, K1
Behbehani, G1
Long, M1
Walker, A1
Bhatnagar, B1
Mims, A1
Sun, JB1
Lu, YY1
Huang, LL1
Yu, QQ1
Tu, SJ1
Xie, ZW1
Pedrosa, F1
Coustan-Smith, E3
Zhou, Y3
Cheng, C4
Pedrosa, A1
Lins, MM1
Pedrosa, M1
Lucena-Silva, N1
Ramos, AML1
Vinhas, E1
Rivera, GK5
Campana, D5
Ribeiro, RC8
Schieck, M1
Lentes, J1
Thomay, K1
Hofmann, W1
Behrens, YL1
Hagedorn, M1
Ebersold, J1
Davenport, CF1
Fazio, G1
Buchmann, S1
Alten, J2
Bergmann, AK1
Stanulla, M12
Steinemann, D1
Schlegelberger, B3
Göhring, G2
Hogan, JJ1
Li, XY2
Wang, SS1
Meng, HT1
Yu, WJ1
Tong, HY1
Ye, XJ1
Mir, TH1
Sharma, A1
Nisar, S1
Khan, AA1
Shah, TA1
Wani, NA1
Jelinek, T1
Zuchnicka, J1
Kawada, K1
Ohta, T1
Fukuda, H1
Hayashi, T1
Tanaka, K1
Imai, T1
Morita, Y1
Miyamura, M1
Proc, P1
Szczepańska, J1
Zubowska, M1
Wyka, K1
Tomaszewska, R4
Płonowski, M1
Urbańska-Rakus, J1
Machnik, K1
Kowalczyk, J6
Testi, AM7
Canichella, M1
Guarini, A1
Starza, ID1
Cavalli, M1
De Propris, MS1
Messina, M1
Elia, L1
Moleti, ML5
Martino, B1
Luppi, M2
D'Aloisio, M1
Chiaretti, S1
Li, JQ2
Luo, XQ1
Wu, XD1
Sun, X2
Xu, HG1
Li, CG1
Liu, RY1
Sun, XF5
Chen, HQ1
Lin, YD1
Li, CK2
Fang, JP1
Jacola, LM1
Baran, J1
Noll, RB1
Willard, VW1
Hardy, KK1
Embry, L1
Hullmann, SE1
Larsen, EC1
Winick, N3
Kairalla, JA1
Gao, W1
Seetharam, S1
Thankamony, P1
Gopakumar, KG1
Nair, RA1
Jacob, PM1
Jagathnath Krishna, KM1
Rajeswari, B1
Nair, M1
Guruprasad, CS1
Prasanth, VR1
Bassal, M1
Silva, M1
Patel, S1
Gibson, PJ1
Breakey, VR1
Athale, U1
Zabih, V1
Li, Q4
Pechlivanoglou, P1
Pole, JD1
Mittmann, N1
Sutradhar, R1
Gupta, S1
Jia, M1
Hu, BF1
Xu, XJ1
Zhang, JY1
Li, SS1
Tang, YM1
Cao, W1
Zhang, S1
Li, L2
Jiang, Z1
Wan, D1
Yu, J2
Marín-Sánchez, A1
Martínez-Fernández, G1
Gómez-Catalán, I1
Montoya-Morcillo, MC1
Algarra-Algarra, JL1
Ibañez-García, Á1
Hernández-Fernández, F1
Romero-Macías, JR1
Schmäh, J1
Fedders, B1
Fischer, S1
Dagdan, E2
Bens, S1
Schewe, D1
Moericke, A2
Bleckmann, K2
Siebert, R1
Chen, P2
Sun, Y2
Chen, Y5
Mao, M1
Jiang, T1
Ouyang, J1
Hinze, L1
Junk, S1
Kratz, CP1
Piatopoulou, D3
Avgeris, M3
Marmarinos, A2
Xagorari, M2
Baka, M3
Doganis, D1
Kossiva, L2
Scorilas, A3
Gourgiotis, D3
Petrungaro, A1
Gentile, M1
Mazzone, C1
Greco, R1
Uccello, G1
Recchia, AG1
De Stefano, L1
Bossio, S1
Palummo, A1
Morelli, R1
Musolino, C1
Morabito, F1
Vigna, E1
Landmann, E1
Burkhardt, B1
Meyer, U2
Woessmann, W1
Klapper, W1
Wrobel, G2
Rosolen, A2
Pillon, M2
Escherich, G1
Beishuizen, A1
Mellgren, K1
Wynn, R1
Ratei, R7
Plesa, A2
Reiter, A10
Bergeron, C2
Patte, C5
Bertrand, Y3
Hong, CR1
Kang, HJ2
Park, KD2
Shin, HY2
Ahn, HS2
Rensen, N1
Gemke, RJ2
van Dalen, EC1
Rotteveel, J2
Kaspers, GJ3
Bartram, CR6
Niemeyer, C2
Ziino, O3
Schäfer, B1
Beier, R5
Ludwig, WD13
Casale, F4
Schlegel, PG1
Yamamoto, M1
Hori, T1
Igarashi, K1
Iesato, K1
Saito, M1
Miyanishi, K1
Kikuchi, N1
Fujita, H1
Tsutsumi, H1
Ceppi, F2
Gagné, V2
Douyon, L1
Quintin, CJ1
Buldini, B1
Krajinovic, M2
Sulis, ML1
Blonquist, TM1
Stevenson, KE2
Hunt, SK1
Kay-Green, S1
Athale, UH2
Clavell, LA3
Cole, PD1
Kelly, KM1
Laverdiere, C2
Leclerc, JM3
Michon, B1
Schorin, MA2
Welch, JG1
Neuberg, DS3
Sallan, SE9
Silverman, LB8
Tantawy, AAG1
Ebeid, FSE1
Adly, AAM1
El-Ghoroury, E1
Mostafa, M1
Sciumè, M1
Fracchiolla, NS1
Cortelezzi, A1
Vallacha, A1
Haider, G1
Raja, W1
Kumar, D1
Drakaki, I1
Pourtsidis, A1
Meza-Arroyo, J2
Bravo-Cuellar, A2
Jave-Suárez, LF2
Hernández-Flores, G2
Ortiz-Lazareno, P1
Aguilar-Lemarroy, A1
Padilla-Corona, M1
Sanchez-Zubieta, F2
Gonzalez-Ramella, O2
Malhotra, P2
Kapoor, G1
Jain, S2
Garg, B1
Zheng, Y1
Cai, YW1
Fu, QC1
Wang, Q1
Ji, XQ1
Cai, LL1
Pennella, CL1
Rossi, JG3
Baialardo, EM1
Alonso, CN3
Guitter, MR3
Sánchez La Rosa, CG1
Millán, NC1
Alfaro, EM4
Zubizarreta, PA4
Felice, MS5
Zeng, HM1
Zhang, LP1
Rubagumya, F1
Xu, MJ1
May, L1
Driscoll, C1
Uwizeye, FR1
Shyirambere, C1
Larrabee, K1
Fehr, AE1
Gilbert, UD1
Muhayimana, C1
Hategekimana, V1
Elmore, S1
Mpunga, T1
Moore, M1
Shulman, LN1
Lehmann, L1
Sun, YN1
Hu, YX1
Gao, L1
Xiao, PF1
Lu, J2
Wu, SY1
Shao, XJ1
Zhou, CY3
Ling, J1
Pan, J1
Gao, J4
Hu, SY1
Erkut, N1
Akidan, O1
Selim Batur, D1
Karabacak, V1
Sonmez, M1
Liu, WJ1
Zhao, Q1
Qian, C1
Wang, H2
Liu, J1
Fu, Y1
Zhai, X1
Qian, X1
Meng, J1
Miao, H1
Zhu, X3
Lu, F1
Perol, L1
Grignano, E1
Contejean, A1
Gastaud, L1
Legoff, M1
Franchi, P1
Deau-Fischer, B1
Willems, L1
Bouscary, D1
Tamburini, J1
Çifçi Sunamak, E1
Özdemir, N1
Celkan, T2
Zhang, XD1
Madjidyar, J1
Peters, S1
Yenigürbüz, FD1
Kızmazoğlu, D1
Ateş, H1
Erdem, M1
Tüfekçi, Ö2
Yılmaz, Ş2
Ören, H3
Kuang, CY1
Luo, AL1
Cai, MS1
Xu, L1
Zhang, WY2
Marshall, GM1
Dalla Pozza, L1
Sutton, R1
Ng, A1
de Groot-Kruseman, HA1
van der Velden, VH1
Venn, NC1
van den Berg, H1
de Bont, ES1
Maarten Egeler, R1
Hoogerbrugge, PM1
Bierings, MB3
van der Schoot, E1
van Dongen, J1
Law, T1
Cross, S1
Mueller, H1
de Haas, V1
Haber, M1
Révész, T1
Alvaro, F1
Suppiah, R2
Norris, MD1
Pieters, R9
Toft, N2
Birgens, H2
Abrahamsson, J2
Bernell, P1
Griškevičius, L2
Hallböök, H2
Heyman, M5
Holm, MS1
Hulegårdh, E1
Klausen, TW2
Marquart, HV1
Jónsson, OG2
Nielsen, OJ3
Quist-Paulsen, P2
Taskinen, M1
Vaitkeviciene, G2
Vettenranta, K3
Åsberg, A2
Schmiegelow, K5
Hassan, IB1
Kristensen, J1
Alizadeh, H1
Bernsen, R1
Koehler, R1
Gaynon, P1
Odenwald, E1
Henze, G9
Welte, K9
Gadner, H9
Ritter, J1
Harbott, J7
Klingebiel, T2
Gruhn, B3
Kremens, B2
Debatin, KM1
Schrauder, A4
v Stackelberg, A1
Eckert, C1
Waber, DP2
McCabe, M1
Sebree, M1
Forbes, PW1
Adams, H1
Alyman, C1
Sands, SA2
Robaey, P1
Romero, I1
Routhier, MÈ1
Girard, JM1
Ravandi, F2
Jorgensen, JL1
Thomas, DA2
O'Brien, S2
Garris, R1
Faderl, S2
Burger, JA1
Ferrajoli, A1
Kebriaei, P1
Champlin, RE1
Estrov, Z2
Challagundla, P1
Wang, SA1
Luthra, R1
Rousseau, J1
Labuda, M1
Sharif-Askari, B1
Brukner, I1
Neuberg, D1
Kutok, JL1
Sinnett, D1
Naumann, T1
Gruner, D1
Walther, M1
Wittig, S1
Becker, S2
Beck, JF2
Sonnemann, J1
Bernt, KM1
Künkele, A1
Grosse-Lordemann, A1
Schramm, A1
Eggert, A1
Schulte, JH1
Bachmann, HS1
Alloin, AL1
Barlogis, V2
Auquier, P2
Contet, A2
Poiree, M2
Demeocq, F3
Herrmann, I1
Villes, V2
Plantaz, D2
Kanold, J1
Chastagner, P2
Chambost, H2
Sirvent, N2
Michel, G3
Güttel, C1
Härtel, C1
Erdlenbruch, B1
Huang, XJ1
Jiang, B1
Jiang, Q1
Lu, XJ1
Xu, LP1
Liu, DH1
Chen, H1
Bao, L1
Jiang, H1
Nickel, RS1
Keller, F1
Bergsagel, J1
Cooper, T1
Daves, M1
Sabnis, H1
Lew, G1
Kunin-Batson, A1
Kadan-Lottick, N2
Neglia, JP3
Orgel, E1
Sposto, R1
Malvar, J1
Seibel, NL3
Ladas, E1
Gaynon, PS9
Freyer, DR1
Kletzel, M1
Powers, K1
Hayes, M1
de Ruiter, RD1
Gordijn, MS1
van den Bos, C1
Koper, JW1
van Rossum, EF1
Kaspers, GL1
Liu, F1
Wan, Y3
Chang, L2
Guo, Y2
Yang, W4
Wang, S2
Chen, X2
Liu, T3
Ruan, M1
Liu, X2
Zou, Y3
DeAngelo, DJ1
Dahlberg, SE2
Couban, S1
Supko, JG1
Amrein, PC1
Ballen, KK1
Seftel, MD1
Turner, AR1
Leber, B1
Howson-Jan, K1
Kelly, K1
Cohen, S1
Matthews, JH1
Savoie, L1
Wadleigh, M1
Sirulnik, LA1
Galinsky, I1
Malkan, AD1
Wahid, FN1
Rao, BN1
Sandoval, JA1
Pinheiro Junior, ED1
Pracchia, LF1
Beitler de Mauriño, B1
Martinez, GA1
Dorlhiac-Llacer, PE1
Medina, AB1
Velloso, ED1
Hu, Y2
Zhao, X1
Wu, LL1
Cai, CP1
Zhao, WL1
Wang, L2
Koh, K1
Fossat, C1
Roussel, M1
Arnoux, I1
Asnafi, V1
Brouzes, C1
Garnache-Ottou, F1
Jacob, MC1
Kuhlein, E1
Macintyre-Davi, E1
Robillard, N1
Tkaczuk, J1
Ifrah, N2
Dombret, H1
Béné, MC1
Baruchel, A6
Garand, R1
He, X1
Wang, C1
Niu, C1
Gao, P1
Zhen, Z1
Lu, S1
Xia, Y5
Sun, F1
Cai, R1
Li, P1
Guo, X4
Xue, L1
Sun, W1
Ma, C1
He, Y1
Cai, L1
Pui, CH12
Pei, D3
Jeha, S1
Bowman, WP2
Sandlund, JT5
Rubnitz, JE3
Inaba, H1
Bhojwani, D1
Gruber, TA1
Leung, WH1
Downing, JR1
Evans, WE3
Relling, MV6
Palk, K1
Pruunsild, K1
Helt, LR1
Frandsen, T1
Alacacioglu, I1
Medeni, SS1
Ozsan, GH1
Payzin, B1
Sevindik, OG1
Acar, C1
Katgi, A1
Ozdemirkan, F1
Piskin, O1
Ozcan, MA1
Undar, B1
Demirkan, F1
Jiménez-Hernández, E1
Jaimes-Reyes, EZ1
Arellano-Galindo, J1
García-Jiménez, X1
Tiznado-García, HM1
Dueñas-González, MT1
Martínez Villegas, O1
Sánchez-Jara, B1
Bekker-Méndez, VC1
Ortíz-Torres, MG1
Ortíz-Fernández, A1
Marín-Palomares, T1
Mejía-Aranguré, JM2
Stamati, L1
Kosmidis, H1
Anastasiou, T1
Zdráhalová, K1
Štěrba, J1
Domanský, J1
Blažek, B4
Ptoszková, H2
Mihál, V4
Novák, Z1
Hak, J3
Procházková, D2
Černá, Z2
Timr, P3
Jabali, Y3
Sedláček, P1
Smíšek, P1
Zemanová, Z1
Jarošová, M1
Houdková, A1
Mejstříková, E1
Hrušák, O3
Zuna, J2
Janotová, I1
Trka, J2
Ren, YY1
Chang, LX1
An, WB1
Zhang, JL1
Liu, TF1
Zhu, XF1
Wei, W1
An, W1
Dekking, SA1
van der Graaf, R1
de Vries, MC1
van Delden, JJ1
Kodish, E1
Lantos, JD1
Ortiz-Lazareno, PC1
Jiménez-López, X1
Gallegos-Castorena, S1
Medina-Barajas, F1
Lerma-Díaz, JM1
Listernick, R1
van der Linden, MH1
Boer, JM1
Schneider, P4
Willekes, M1
Seslija, L1
De Lorenzo, P4
den Boer, ML3
Stam, RW3
Park, HW1
Tse, S1
Kelly, HW1
Kaste, SC3
Tantisira, KG1
Aricò, M14
Silvestri, D4
Kulozik, AE2
Greiner, J1
Caruso, R1
von Stackelberg, A3
Rössig, C1
Guo, J1
Zhu, YP2
Jia, CS1
Eipel, O1
Hegyi, M1
Csordás, K1
Németh, K1
Luczay, A1
Török, D1
Csóka, M1
Erdélyi, D1
Kovács, G1
Daniel, LC1
Kloss, JD1
Reilly, AF1
Barakat, LP1
Zaliova, M1
Hovorkova, L1
Vaskova, M1
Jabeen, K1
Ashraf, MS1
Iftikhar, S1
Belgaumi, AF1
Sun, J1
Wu, Z1
Cui, Q1
Pu, C1
Liang, B1
Luo, Y1
Shi, J1
Jin, A1
Xiao, L1
Huang, H1
Li, HF1
Meng, WT1
Jia, YQ1
Jiang, NG1
Zeng, TT1
Jin, YM1
Huang, QR1
Xu, H1
Mo, XM1
Antillón, FG1
Blanco, JG1
Valverde, PD1
Castellanos, M1
Garrido, CP1
Girón, V1
Letona, TR1
Osorio, EJ1
Borrayo, DA1
Mack, RA1
Melgar, MA1
Lorenzana, R1
Metzger, M1
Rossi, E1
Reismüller, B1
Steiner, M1
Pichler, H1
Dworzak, M1
Meister, B4
Schmitt, K1
Pötschger, U1
König, M1
Haas, OA3
Narayanan, G1
Soman, LV1
El-Cheikh, J1
El Dika, I1
Massoud, R1
Charafeddine, M1
Mahfouz, R1
Kharfan-Dabaja, MA1
Bazarbachi, A1
Dujua, AC1
Hernandez, FG1
Koh, KN1
Im, HJ1
Kim, H1
Lee, JW1
Yoo, KH1
Sung, KW1
Koo, HH1
Lim, YT1
Park, JE1
Park, BK1
Park, HJ1
Seo, JJ1
Chiang, LY1
Crawford, JR1
Kuo, DJ1
Fetz, A1
Bretscher, C1
Tucci, F1
Raetz, EA1
Borowitz, MJ3
Devidas, M4
Linda, SB3
Hunger, SP4
Winick, NJ1
Camitta, BM4
Carroll, WL3
Paganin, M1
Zecca, M2
Fabbri, G1
Polato, K1
Buendia, MT2
Lozano, JM2
Suarez, GE1
Saavedra, C1
Guevara, G1
Leeper, NJ1
Dhaliwal, G1
Saint, S1
Witteles, RM1
Inthal, A1
Krapf, G1
Beck, D1
Joas, R1
Kauer, MO1
Orel, L1
Fuka, G1
Panzer-Grümayer, ER2
Chang, JE1
Medlin, SC1
Kahl, BS1
Longo, WL1
Williams, EC1
Lionberger, J1
Kim, K2
Kim, J1
Esterberg, E1
Juckett, MB1
Fernandez-Munoz, I2
Gerdes, K3
von Neuhoff, N2
Beger, C4
Gandemer, V1
Auclerc, MF2
Perel, Y4
Vannier, JP1
Le Gall, E1
Schmitt, C1
Piguet, C1
Stephan, JL1
Lejars, O2
Debre, M1
Jonveaux, P1
Cayuela, JM1
Chevret, S1
Leverger, G5
Behm, FG3
Onciu, M1
Razzouk, BI2
Hijiya, N1
Hudson, MM2
Kaushik, A1
Bansal, D1
Khandelwal, N1
Trehan, A1
Marwaha, RK1
Lowas, SR1
Marks, D1
Malempati, S1
Qiu, L1
Zou, D1
Mi, Y1
Nowak-Göttl, U4
Kenet, G1
Mitchell, LG1
Ozdemir, MA1
Karakukcu, M1
Patiroglu, T1
Torun, YA1
Kose, M1
Sonabend, RY1
McKay, SV1
Okcu, MF1
Yan, J1
Haymond, MW1
Margolin, JF1
Urasińska, E3
Grabarek, J1
Fydryk, J2
Domagała, W3
Schaeffeler, E1
Coulthard, SA1
Kaatsch, P1
Dördelmann, M4
Eichelbaum, M1
Riehm, H11
Schwab, M1
Kadan-Lottick, NS1
Brouwers, P1
Breiger, D1
Kaleita, T1
Dziura, J1
Liu, H1
Chen, L1
Nicoletti, M1
Stork, L1
Bostrom, B1
Marino, S1
Verzegnassi, F1
Tamaro, P3
Stocco, G1
Bartoli, F1
Decorti, G1
Rabusin, M1
Zhen, ZJ4
Ling, JY2
Tong, GL1
Lin, L1
Cai, Y1
Kristinsson, J1
Mogensen, UB1
Rosthøj, S1
Wesenberg, F1
Saarinen-Pihkala, U1
Withycombe, JS1
Post-White, JE1
Meza, JL1
Hawks, RG1
Smith, LM2
Sacks, N1
Santos, FP1
Rodrigues, M1
Mac-Donald Bley do Nascimento, C1
Kerbauy, FR1
Ribeiro, AA1
Mauro Kutner, J1
Hamerschlak, N1
Jaing, TH1
Lin, JL1
Lin, YP1
Yang, SH1
Lin, JJ1
Hsia, SH1
Tantawy, AA1
El-Bostany, EA1
Adly, AA1
Abou El Asrar, M1
El-Ghouroury, EA1
Abdulghaffar, EE1
Qin, Y1
Shi, YK1
He, XH1
Han, XH1
Zhou, SY1
Liu, P1
Yang, JL1
Yang, S1
Zhang, CG1
Dong, M1
Zhou, LQ1
Wang, JW1
Feng, FY1
de Boer, J2
Hagelstein, J1
Brady, HJ1
Armstrong, SA1
Ularntinon, S1
Tzuang, D1
Dahl, G1
Shaw, RJ1
McNeer, JL1
Nachman, JB3
Giordano, P1
Molinari, AC1
Del Vecchio, GC1
Saracco, P3
Russo, G1
Altomare, M1
Perutelli, P1
Crescenzio, N1
Santoro, N5
Marchetti, M1
De Mattia, D1
Falanga, A1
Petruzziello, F1
Menna, G1
Mangione, A1
Cianciulli, E1
Buffardi, S1
Marchese, L1
Nastro, A1
Misuraca, A1
Poggi, V3
Oztürkmen, S1
Paç, A1
Senayl, A1
Polat, TB1
Cetin, II1
Bçakç, Z1
Akyay, A1
Olcay, L1
Nagatoshi, Y1
Matsuzaki, A1
Suminoe, A1
Inada, H1
Ueda, K1
Kawakami, K1
Yanai, F1
Nakayama, H1
Moritake, H1
Itonaga, N1
Hotta, N1
Fujita, K1
Hidaka, Y1
Yamanaka, T1
Kawano, Y1
Okamura, J2
Canova, F1
Marino, D1
Trentin, C1
Soldà, C1
Ghiotto, C1
Aversa, SM1
Bélien-Pallet, V1
Cabrol, S1
Fasola, S1
Petit, A1
Landman-Parker, J2
Auvrignon, A2
Pillozzi, S1
Masselli, M1
De Lorenzo, E1
Accordi, B1
Cilia, E1
Crociani, O1
Amedei, A1
Veltroni, M1
D'Amico, M1
Becchetti, A1
Arcangeli, A1
Kawedia, JD1
Panetta, JC1
Cai, X1
Neale, G1
Howard, SC1
Fouda, A1
Kandil, SM1
Zalata, K1
Mansour, A1
Al-Tonbary, Y1
Maloney, E1
Kamieńska, E3
Kurylak, A2
Kwiecińska, K1
Moryl-Bujakowska, A2
Pawelec, K3
Chybicka, A9
Dobaczewski, G2
Wiśniewska-Slusarz, H3
Sońta-Jakimczyk, D11
Styczyński, J2
Balcerska, A5
Płoszyńska, A3
Larsen, EL1
Blach, L1
Carroll, AJ2
Pullen, DJ2
Shuster, J4
Willman, CL1
Gallego, MS2
Fraquelli, LE2
Scopinaro, MJ1
Renard, M1
Suciu, S3
Uyttebroeck, A2
Ferster, A3
van der Werff Ten Bosch, J1
Mazingue, F2
Plouvier, E3
Robert, A2
Boutard, P2
Millot, F2
Munzer, M1
Mechinaud, F2
Lescoeur, B1
Baila, L1
Vandecruys, E1
Benoit, Y2
Philippet, P2
Simmons, JH1
Chow, EJ1
Koehler, E1
Esbenshade, A1
Smith, LA1
Sanders, J1
Friedman, D1
Teuffel, O1
Kuster, SP1
Hitzler, J1
Ethier, MC1
Shah, PS1
Beyene, J1
Sung, L2
Amirghofran, Z1
Daneshbod, Y1
Gholijani, N1
Esmaeilbeig, M1
Bernasconi, AR1
Rubio, PL1
Mrakotsky, CM1
Alyman, MC1
Queally, JT1
Miller, TP1
Cranston, A1
Le Meignen, M1
Simeoni, MC1
Galambrun, C1
Play, B1
Berbis, J1
Bordigoni, P2
Pansy, J1
Szymon, S1
Bik-Multanowski, M1
Pietrzyk, JJ1
Surmiak, M1
Strojny, W3
Galicka-Latala, D1
Gozdzik, J1
Willer, A1
Gerss, J1
König, T1
Franke, D1
Kühnel, HJ1
Boos, J1
Lanvers-Kaminsky, C1
Dopfer, C1
Kentouche, K1
Dopfer, R2
Mentzel, HJ1
Mainz, JG1
Kurtzberg, J2
Asselin, B1
Bernstein, M1
Buchanan, GR6
Pollock, BH4
Koltin, D1
Naqvi, A1
Urbach, SL1
Tsukasaki, K1
Tobinai, K1
Hotta, T1
Shimoyama, M1
Tsukamoto, S1
Takeuchi, M2
Kawajiri, C1
Tanaka, S1
Nagao, Y1
Sugita, Y1
Yamazaki, A1
Kawaguchi, T1
Muto, T1
Sakai, S1
Takeda, Y1
Ohwada, C1
Sakaida, E1
Shimizu, N1
Yokote, K1
Iseki, T1
Nakaseko, C1
Spijkers-Hagelstein, JA1
Hulleman, E1
Williams, O1
Liang, ZY1
Degnan, AJ1
Levy, LM1
Termuhlen, AM1
Perkins, SL2
Lones, M1
Finlay, JL1
Weinstein, H1
Gross, TG1
Abromowitch, M1
Salvador, C1
Crazzolara, R1
Kropshofer, G2
Ribera, JM5
García, O1
Montesinos, P1
Brunet, S2
Abella, E3
Barrios, M1
González-Campos, J1
Bravo, P1
Amigo, ML1
Hernández-Rivas, JM2
Sang, W1
Wang, CF1
Cheng, YF1
Li, XX1
Gulinar, A1
Li, JZ1
Zhang, W1
Mattano, LA2
Sather, HN14
Steinherz, PG7
Gao, C1
Zhao, XX1
Li, WJ1
Cui, L1
Zhao, W1
Liu, SG1
Yue, ZX1
Jiao, Y1
Wu, MY1
Li, ZG1
Brackmann, F1
Dörr, HG1
Hinderhofer, K1
Holter, W1
Langer, T2
Conklin, HM1
Krull, KR1
Reddick, WE1
Lee, CS1
Shim, JW1
Yoon, JS1
Lee, SC1
Çankal, A1
Gözmen, S1
Yüksel, F1
Vergin, C1
Irken, G2
Russo, D1
Orlando, MA1
Benigno, V1
Jakab, Z1
Balogh, E1
Karászi, E1
Kappelmayer, J1
Kiss, C1
Oláh, E1
Ozkan, A1
Apak, H1
Kuruoglu, S1
Yuksel, L1
Yildiz, I1
Matthias, T1
Madkaikar, M1
Ghosh, K1
Jijina, F1
Gupta, M1
Rajpurkar, M1
Mohanty, D1
Dabaja, BS1
Ha, CS2
Wilder, RB2
Gopal, R1
Cortes, J4
Bueso-Ramos, C1
Hess, MA2
Cox, JD2
Powles, R1
Sirohi, B1
Treleaven, J1
Kulkarni, S1
Tait, D1
Singhal, S1
Mehta, J1
Messina, C7
Rondelli, R7
Lanino, E1
Sacchi, N1
Uderzo, C1
Fagioli, F1
Bonetti, F1
Favre, C2
Porta, F2
Giorgiani, G2
Pession, A8
Gülen, H1
Duman, M1
Uçar, C1
Atabay, B1
Uysal, K1
Cevik, N1
Addeo, R2
D'Angelo, V2
Indolfi, P3
Morgera, C1
Crisci, S2
Di Tullio, MT3
Minicucci, EM1
Lopes, LF1
Crocci, AJ1
Ahlke, E1
Fleischhack, G1
Schwabe, D1
Schobess, R1
Schumann, C1
Junker, R3
Bostrom, BC1
Sensel, MR1
La, MK1
Johnston, K1
Erdmann, GR1
Gold, S1
Heerema, NA1
Hutchinson, RJ1
Provisor, AJ1
Trigg, ME6
el Omri, H1
Kraiem, I1
Amara, H1
Ben Youssef, Y1
Skouri, H1
Ennabli, S1
Fehr, T1
Jacky, E2
Bächli, EB1
Corbacioglu, S1
Eber, S1
Gungor, T1
Hummerjohann, J1
Chessells, JM1
Camitta, B2
Boyett, JM7
Carroll, A2
Eden, OB3
Harms, DO1
Harrison, CJ1
Harrison, PL2
Heerema, N1
Janka-Schaub, G2
Kamps, W1
Masera, G8
Pullen, J2
Raimondi, SC3
Richards, S2
Sallan, S1
Sather, H3
Vilmer, E2
Yetgin, S1
Cetin, M1
Heath, JA1
Altman, A1
Jhanwar, S1
Halpern, S1
Shah, N1
Steinherz, L3
Tannous, R1
Terry, W1
Gupta, V1
Kamel-Reid, S1
Minden, MD1
Lipton, JH2
Brandwein, J1
Messner, HA2
Park, SR1
Kim, JH1
Kim, DY1
Lee, S1
Lee, SY1
Choi, IS1
Yoon, SS1
Park, S1
Kim, BG1
Kim, NK1
Yoshida, I1
Colović, M1
Bogdanović, A1
Janković, G1
Kraguljac, N1
Suvajdzić, N1
Wehl, G1
Högler, W1
Heitger, A2
Nussbaumer, W1
Tissing, WJ1
Efferth, T1
Sauerbrey, A3
Steinbach, D1
Gebhart, E1
Drexler, HG1
Miyachi, H1
Chitambar, CR1
Becker, CM1
Zintl, F3
Humeny, A1
Boccalatte, MF2
Chiesa, R1
Lippi, A2
Gallisai, D1
De Rossi, G9
Asgedom, G2
Kardinal, C2
Esparza, SD1
Moore, TB1
Feig, SA2
Kishi, S1
Boureau, B1
Morand, S1
Das, S1
Cook, EH1
Rosner, GL1
Schuetz, E1
Mora, J1
Filippa, DA1
Qin, J1
Wollner, N2
GUPTA, NN1
MITTAL, SP1
MILLER, JN1
MEYERS, RL1
CARPENTER, CM1
BELMUSTO, L1
REGELSON, W1
OWENS, G1
HANANIAN, J1
NIGOGOSYAN, G1
ALPERIN, JB1
LEVIN, WC1
Gajdos, P2
Pospísilová, D2
Hrstková, H2
Dembická, D1
Kopecná, L2
Slavík, Z1
Zahálka, F1
Vávra, V1
Mydlil, J2
Wiernik, PH1
Cassileth, PA2
Leong, T1
Hoagland, HC2
Bennett, JM2
Paietta, E2
Oken, MM1
Tang, W1
Ziring, D1
Gershman, G1
French, S1
Zalewska-Szewczyk, B1
Przybysz, K1
Kowalewska-Pietrzak, M1
Stolarska, M1
Bodalski, J1
Caraglia, M1
Abbruzzese, A1
Piccaluga, PP1
Malagola, M1
Rondoni, M1
Amabile, M1
Gaitani, S1
Visani, G2
Benatti, C1
Gnocchi, M1
Travaglino, E1
Invernizzi, R2
Ascari, E1
Goldschmidt, N1
Gural, A1
Kornberg, A1
Spectre, G1
Shopen, A1
Paltiel, O1
Bhatia, M1
Kher, K1
Minniti, CP1
Thomas, X3
Boiron, JM1
Huguet, F1
Reman, O1
Sutton, L2
Turlure, P1
Garban, F1
Gardin, C1
Espinouse, D1
Boulat, O1
Lhéritier, V1
Fiere, D2
Frater, JL1
Batanian, JR1
O'Connor, DM1
Grosso, LE1
Bürger, B1
Beck, JD2
Hajduch, M1
Noskova, V1
Janostakova, A1
Safarova, M1
Orel, M1
Kouzmina, G1
Holownia, A1
Trofimiuk, E1
Jakubow, P1
Kaliszewski, J1
Muszynska-Roslan, K2
Braszko, JJ1
Zhang, CQ1
Wang, ZH1
Wang, ZQ1
Chen, ZM1
Lou, JY1
Xu, WL1
Jiang, WQ1
Liu, DG2
Xia, ZJ2
Huang, HQ2
Li, YH2
Zhou, ZM2
He, YJ1
Guan, ZZ2
Janić, D1
Dokmanović, L1
Jovanović, N1
Skorić, D1
Lazić, J1
Luczyński, W1
Stasiak-Barmuta, A1
Zak, J1
Athanassiadou, F2
Kourti, M1
Papageorgiou, T1
Stamou, M1
Makedou, A1
Boufidou, A1
Kaczmarek-Kanold, M1
Chełmecka-Hanuszewicz, L1
Jackowska, T4
Odój, T1
Steczowicz, M1
Wojciechowska, V1
Wójtowicz, A1
Dalle, JH1
Moghrabi, A1
Rousseau, P1
Barrette, S1
Bernstein, ML1
Champagne, J2
David, M1
Demers, J1
Duval, M1
Hume, H1
Meyer, P1
Champagne, MA1
Bertorello, N2
Farinasso, L2
Einaudi, S2
Altare, F1
Corrias, A2
Pastore, G2
van Imhoff, GW1
van der Holt, B1
MacKenzie, MA1
Ossenkoppele, GJ1
Wijermans, PW1
Kramer, MH1
van 't Veer, MB2
Schouten, HC2
van Marwijk Kooy, M1
van Oers, MH1
Raemaekers, JM1
Sonneveld, P1
Meulendijks, LA1
Kluin, PM1
Kluin-Nelemans, HC1
Verdonck, LF1
Brodtman, DH1
Rosenthal, DW1
Redner, A3
Lanzkowsky, P3
Bonagura, VR1
Aoki, CA1
Bowlus, CL1
Rossaro, L1
Eiser, C1
Davies, H1
Jenney, M1
Stride, C1
Glaser, A1
Siciliano, SA1
Crowther, M1
Barr, RD4
Chan, AK1
Merkle, M1
Rupprecht, HD1
Mazur, B1
Karpe, J1
Bubała, H3
Torbus, M1
Ferrari, A2
Potenza, L1
Riva, G1
Morselli, M1
Imovilli, A1
Volzone, F1
Rossi, G1
Codeluppi, M1
Guaraldi, G1
Torelli, G1
Micalizzi, C2
Ji, H1
Liu, WP1
Li, GD1
Hill, G1
Chauvenet, AR4
Lovato, J1
McLean, TW1
D'Urbano, LE1
De Benedetti, F1
Rodriguez, V1
Anderson, PM1
Trotz, BA1
Arndt, CA1
Allen, JA1
Khan, SP1
Diviné, M1
Casassus, P2
Koscielny, S1
Bosq, J1
Sebban, C3
Le Maignan, C1
Stamattoulas, A1
Dupriez, B1
Raphaël, M2
Pico, JL1
Ribrag, V1
Ottmann, OG1
Wassmann, B1
Kalkanci, A1
Kokturk, N1
Senol, E1
Acar, K1
Guzel, O1
Sancak, B1
Kustimur, S1
Haznedar, R1
Hindo, H1
Buescher, ES1
Frank, LM1
Pettit, D1
Dory, C1
Byrd, R1
Papadhimitriou, SI1
Polychronopoulou, S1
Tsakiridou, AA1
Androutsos, G1
Paterakis, GS1
Abla, O1
Gassas, A1
Stevens, R1
Grant, R1
Abdelhaleem, M1
Appel, IM1
Hop, WC1
Dixit, A2
Kannan, M2
Mahapatra, M2
Choudhry, VP2
Saxena, R2
Klimza, MJ1
Sońta-Jakimczyk, DJ1
Breit, S1
Flohr, T1
Tolle, G1
Happich, M1
Muckenthaler, MU1
Kober, T1
Hülsewede, H1
Bohlius, J1
Engert, A1
Schrøder, H3
Kjeldahl, M1
Boesen, AM2
Schmidt, K1
Johnsen, HE2
Gregersen, H2
Gustafsson, G2
Paul, S1
Marty, FM1
Colson, YL1
Caruso, V1
Iacoviello, L1
Di Castelnuovo, A1
Storti, S1
Mariani, G1
de Gaetano, G1
Donati, MB1
Kjeldstad, M1
Schmidt, KG1
Skoczeń, S3
Pawińska, K1
Luszczyńska, A1
Juszczak, K3
Krauze, A2
Styczyńskii, J1
Swiatkiewicz, V1
Taylor, JA1
Winter, L1
Geyer, LJ1
Hawkins, DS1
Pérez Martínez, A1
Alonso Ojembarrena, A1
Ramírez Orellana, M1
García Castro, J1
González-Vicent, M1
Contra Gómez, T2
Madero López, L1
Díaz Pérez, MA1
Sawicka-Zukowska, M1
Kajdas, L1
Sancho, JM1
Xicoy, B1
Morgades, M1
Oriol, A2
Tormo, M2
del Potro, E2
Debén, G1
Bethencourt, C2
Ortín, X1
Ortega-Rivas, F1
Novo, A1
López, R1
Sanz, MA2
Feliu, E2
Douer, D1
Yampolsky, H1
Cohen, LJ1
Watkins, K1
Levine, AM1
Periclou, AP1
Avramis, VI1
Sun, LR1
Pang, XY1
Lu, ZH1
Sui, AH1
Ke, XY1
Ma, J1
Shen, ZX1
Zhang, XH1
Du, X1
Zhao, YM1
Lv, JQ1
Zhan, ZM1
Zeng, XY1
Xu, XH1
Lu, ZS1
Mantadakis, E1
Amoiridis, G1
Kondi, A1
Kalmanti, M1
Sakić, M1
Berbić-Fazlagić, J1
Yamanoha, A1
Nagasaki, A1
Nakachi, S1
Kinjo, S1
Takasu, N1
Rhein, P1
Scheid, S1
Hagemeier, C1
Seeger, K1
Kirschner-Schwabe, R1
Spang, R1
Karawajew, L2
Kroczka, S1
Steczkowska-Klucznik, M1
Romaniszyn, A1
Martin, PL1
Bell, BA1
Pettenati, MJ1
Shuster, JJ4
Niinimäki, RA1
Harila-Saari, AH1
Jartti, AE1
Seuri, RM1
Riikonen, PV1
Pääkkö, EL1
Möttönen, MI1
Lanning, M1
Cox, DP1
Treseler, P1
Dong, R1
Jordan, RC1
Bornhauser, BC1
Bonapace, L1
Lindholm, D1
Martinez, R1
Niggli, FK1
Schäfer, BW1
Bourquin, JP1
Varma, S1
Varma, N1
Kumari, S1
Das, R1
Ahluwalia, J1
Mahi, S1
Sharma, SC1
Radhika, S1
González Pérez, P1
Serrano-Pozo, A1
Franco-Macías, E1
Montes-Latorre, E1
Gómez-Aranda, F1
Campos, T1
Chatterjee, T1
Mishra, P1
Choudhry, DR1
Hann, I1
Felice, M1
Hovi, L1
LeBlanc, T3
Janka, G2
Rubnitz, J1
Silverman, L1
Campbell, M2
Vora, A1
Niklowitz, P1
Wiesel, T1
Andler, W1
Menke, T1
Karachunskiĭ, AI1
Miakova, NV1
Rumiantseva, IuV1
Timakov, AM1
Makhortykh, TZh1
Fechina, LG1
Shamardina, AV1
Dudkin, SA1
Lebedev, VV1
Varfolomeeva, SR1
Timofeeva, VN1
Herold, R2
Stakelberg, A1
Rumiantsev, AG1
Masera, N1
Villa, A1
Riva, F1
Li, XH1
Pan, LL1
Li, FY1
Liu, HT2
Fernández Canal, C1
Campoamor Serrano, M1
García Alcalde Fernández, ML1
Kager, L1
Lion, T2
Koenig, M1
Strehl, S1
Dworzak, MN1
Dynybil, C1
Bartels, DB1
Löning, L1
Claviez, A1
Luciani, M1
Gu, LJ1
Xue, HL1
Tang, JY1
Chen, J3
Zhao, HJ1
Ye, H1
Pan, C1
Karachunskiy, A1
Miakova, N1
Timakow, A1
Mahortih, T1
Bajdun, L1
Maschan, A1
Fechina, L1
Shamardina, A1
Dudkin, S1
Lebedev, V1
Varfolomeeva, S1
Timofeeva, V1
Roumiantseva, J1
Chipsanova, N1
Rumjanzew, A1
Akiyama, M1
Yamada, O2
Agawa, M1
Yuza, Y1
Yanagisawa, T1
Eto, Y1
Yamada, H1
Fernández-Abellán, P1
Bueno, J2
Parody, R1
Bastida, P1
Grande, C1
Heras, I1
Ortega, JJ1
Han, AR1
Jang, JH1
Kim, WS1
Ahn, JS1
Jung, CW1
Lee, MH1
Kang, WK1
Van Dongen-Melman, JE1
Hokken-Koelega, AC1
Hählen, K2
De Groot, A1
Tromp, CG1
Egeler, RM1
Safadi, R1
Or, R1
Bar Ziv, J1
Polliack, A2
Archimbaud, E1
Charrin, C1
Magaud, JP1
Jost, LM1
Dommann-Scherrer, C1
Honegger, HP1
Maurer, R1
Sauter, C1
Stahel, RA1
Holtgrave, EA1
Heinze, F1
Annino, L6
Crescenzi, S1
Romani, C1
Mandelli, F12
Hancock, ML2
Krance, RA1
Mahmoud, HH1
Benítez, H1
Arreguín, L1
Velásquez, L1
Bernaldez, R1
Juan, L1
Farfán, J1
Díaz, S1
Gaona, A1
Martínez, MC1
Mori, PG2
Miniero, R3
Colella, R1
Maytal, J1
Grossman, R1
Yusuf, FH1
Shende, AC1
Karayalycin, G1
Schaul, N1
Eviatar, L1
Inhorn, RC1
Aster, JC1
Roach, SA1
Slapak, CA1
Soiffer, R1
Tantravahi, R1
Pierce, S3
Keating, MJ1
Freireich, EJ1
de Stefano, V1
Gugliotta, L2
Mazzucconi, MG2
Leone, G4
Bartlett, NL1
Kwak, LW1
Horning, SJ1
Wu, GQ1
Slavotinek, A1
Thomson, A1
Eynaud, P1
Perry, P1
Steel, CM1
Waits, TM1
Greco, FA1
Greer, JP1
Hainsworth, JD1
Larson, RA1
Dodge, RK1
Burns, CP2
Lee, EJ2
Schulman, P1
Duggan, D1
Davey, FR1
Sobol, RE1
Frankel, SR1
Mahoney, DH1
Leventhal, BG2
Civin, CJ1
Ganick, DJ1
Lauer, SJ1
Steuber, CP1
Kamen, BA1
Peregud-Pogorzelski, J1
Krygier-Stojałowska, A1
Tubergen, DG2
Krailo, MD2
Meadows, AT4
Rosenstock, J1
Kadin, M1
Morse, M1
King, D1
Kersey, JH3
Rubio, JA1
Pulpón, LA1
Cavero, MA1
Oteo, JF1
Maicas, C1
Silva, L1
Serrano-Fiz, S1
Burgos, R1
Artaza, M1
Téllez, G1
Johnson, F1
Hunt, S1
Xiang, AH1
Azen, SP1
Sica, S3
Salutari, P2
Di Mario, A2
D'Onofrio, G1
Etuk, B2
Omura, GA2
Vogler, WR2
Martelo, O1
Gordon, DS2
Bartolucci, AA2
Colgan, JP1
Andersen, J1
Habermann, TM1
Earle, JD1
O'Connell, MJ1
Neiman, RS1
Mann, RB1
Glick, JH1
Danaïla, C1
Bach, QK1
Dufour, P1
Christian, B1
Corront, B1
Bosly, A1
Bastion, Y1
Gratecos, N2
Leblay, R1
Willemze, R2
Zijlmans, JM1
den Ottolander, GJ1
Kluin-Nelemans, JC1
Falkenburg, JH1
Starrenburg, CW1
van der Burgh, JF1
Fibbe, WE1
Mertens, R1
Rubbert, F1
Büssing, A1
Hiddemann, W4
Sauter, S1
Lampert, F3
Havers, W1
Niethammer, D1
Lepage, E2
Vernant, JP1
Gluckman, E1
Attal, M1
Reiffers, J1
Racadot, E1
Michallet, M2
Maraninchi, D1
Cheatham, BD1
Henry, RJ1
Kudva, GC1
Chandy, M1
Dennison, D1
Srivastava, A1
Bhushan, V1
Chiu, EK1
Chan, LC1
Liang, R2
Lie, A2
Kwong, YL1
Todd, D2
Chan, TK2
Zemlickis, D1
Lishner, M1
Erlich, R1
Koren, G1
Gururangan, S1
Horner, M1
Rodman, JH1
Marina, NM1
Putti, MC1
Cantù Rajnoldi, A1
Granchi, D1
Cocito, MG1
Saitta, M1
Santostasi, T1
Guglielmi, C3
Ras, E1
Michaeli, J1
Rosenmann, E1
Popovtzer, MM1
Shouval, D1
Meyers, P2
Tan, C2
Heller, G1
Ochocka, M2
Kulus, M1
Armata, J9
Bogusławska-Jaworska, J7
Jakowicka, M3
Michalewska, D1
Cherlow, JM2
Grossman, NJ2
Johnstone, HS2
Breneman, JC2
Hammond, GD6
Rivard, GE1
Infante-Rivard, C1
Dresse, MF2
Hoelzer, D1
Thiel, E1
Löffler, H1
Büchner, T1
Freund, M3
Heil, G3
Maschmeyer, G1
Völkers, B1
Brandalise, S1
Odone, V1
Pereira, W1
Andrea, M1
Zanichelli, M1
Aranega, V1
Mughal, T1
Morleda, J1
Goldman, J1
Cyklis, R3
Grześkowiak-Melanowska, J1
Radwańska, U1
Swiatły, A1
Katz, JA1
Hvizdala, E1
Falletta, JM2
Schwenn, M1
Murphy, SB2
Wolfrom, C1
Hartmann, R1
Fengler, R1
Brühmüller, S1
Ingwersen, A1
Weiss, M4
Telford, P1
Kempin, S2
Kritz, A1
Sogoloff, H1
Gee, T3
Berman, E3
Scheinberg, D2
Little, C1
Gaynor, J1
Dunphy, CH1
Kitchen, S1
Saravia, O1
Velasquez, WS1
Lange, BJ1
Blatt, J2
Chappell, R1
Hammond, D1
Bleyer, WA5
Azzi, A1
Ciappi, S1
De Santis, R1
Fanci, R1
Leoni, F1
Colli, S1
Rossi-Ferrini, PL1
Groot-Loonen, JJ1
Otten, BJ1
van't Hof, MA1
Lippens, RJ1
Stoelinga, GB1
Soslow, RA1
Davis, RE1
Warnke, RA1
Cleary, ML1
Kamel, OW1
Nordgren, A1
Jeddi-Tehrani, M1
Rasool, O1
Grander, D1
Ost, A1
Wallberg, B1
Johansson, B1
Schlieben, S1
Borkhardt, A2
Reinisch, I1
Ritterbach, J1
Janssen, JW1
Repp, R1
Kabisch, H1
Tsuruchi, N1
Corden, TE1
Morgan, ER1
Liu, Q1
Benaim, E1
Crist, WM5
Beretta, F1
Sanna, P1
Ghielmini, M1
Marini, G1
Cavalli, F1
Weisdorf, D1
Stammler, G2
Volm, M2
Mohnike, KL1
Kluba, U1
Mittler, U1
Aumann, V1
Vorwerk, P1
Blum, WF1
Maslak, P1
Feldman, E1
Bertino, J2
Megherian, L1
Seiter, K1
Golde, D1
Nishikawa, K1
Aziz, Z1
Zahid, M1
Mahmood, R1
Maqbool, S1
Salloum, E1
Tallini, G1
Levy, A1
Cooper, DL1
Terselich, G1
Viscaino, MP1
Freeman, AI2
Glicksman, AS1
Brecher, ML1
Sinks, LF1
Holland, JF1
Nachman, J2
Lukens, JN3
Wolff, L1
Rivera-Luna, R1
Cardenas-Cardos, R1
Leal-Leal, C1
Navarro-Alegría, I1
Meza-Coria, C1
Gómez-Martínez, R1
Vega-Vega, L1
Fajardo-Gutíerrez, A1
Bernáldez-Ríos, R1
Rodríguez-Zepeda, MC1
Espinoza-Hernández, L1
Martínez-García, MC1
Giona, F3
Arcese, W3
Meloni, G4
Amadori, S6
Resegotti, L1
Tabilio, A2
Ladogana, S2
Fioritoni, G2
Camera, A3
Liso, V1
Leoni, P2
Geissler, K1
Koller, E1
Hubmann, E1
Niederwieser, D1
Hinterberger, W1
Geissler, D1
Kyrle, P1
Knöbl, P1
Pabinger, I1
Thalhammer, R1
Schwarzinger, I1
Mannhalter, C1
Jaeger, U1
Heinz, R1
Linkesch, W1
Lechner, K1
Ueberall, MA1
Skirl, G1
Strassburg, HM1
Wenzel, D1
Hertzberg, H1
Meier, W1
Berger-Jones, K1
Huk, WJ1
Korinthenberg, R1
Ceci, A1
Madon, E2
Comis, M1
Wrzesień-Kuś, A1
Krykowski, E1
Todeschini, G1
Tecchio, C1
Meneghini, V1
Pizzolo, G1
Veneri, D1
Zanotti, R1
Ricetti, MM1
Solero, P1
April, F1
Perona, G1
Dobashi, N1
Usui, N1
Kobayashi, T1
Yamazaki, H1
Asai, O1
Yano, S1
Kato, A1
Watanabe, H1
Nagamine, M1
Katori, M1
Tajima, N1
Kuraishi, Y1
Mentzer, SJ1
Fingeroth, J1
Reilly, JJ2
Perrine, SP1
Faller, DV1
Sepet, E1
Aytepe, Z1
Ozerkan, AG1
Yalman, N1
Guven, Y1
Anak, S1
Devecioglu, O1
Agaoglu, L1
Gedikoglu, G1
Schott, G2
Sperling, C2
Martin, M1
Kuribara, R1
Muroi, K1
Yoshida, M1
Suzuki, T1
Izumi, T1
Hatake, K1
Amemiya, Y1
Miura, Y1
Durian, M1
van Wering, ER3
Veerman, AJ2
Balis, FM1
Holcenberg, JS2
Poplack, DG1
Ge, J1
Murphy, RF1
Ames, MM1
Waskerwitz, MJ1
Zimm, S1
Gilchrist, GS1
Testi, A1
Mauger, DC1
Skeen, JE1
Vivanco Martínez, JL1
López Pérez, J1
Melero Moreno, C1
Torres Valdivieso, MJ1
Palacios López, ME1
Martín Ramos, N1
Bernacer Borja, M1
Gil López, C1
Valverde Moreno, F1
Grossi, C1
Kaleita, TA1
Reaman, GH1
MacLean, WE1
Whitt, JK1
Salgado, C1
Quintana, J1
Becker, A1
Vargas, L1
Cabrera, ME1
Beresi, V1
Rojas, J1
Paez, E1
Tapia, S1
Zolezzi, P1
Advis, P1
Götz, N1
Viehmann, S1
Gaiger, A1
Linnerth, B1
Schmid, D1
Heinze, G1
Tisljar, K1
Carrel, AL1
Aguayo, A1
Thomas, D2
Keating, M1
Kantarjian, H1
Nysom, K1
Holm, K1
Michaelsen, KF1
Hertz, H1
Müller, J1
Mølgaard, C1
Kaiser, U1
Uebelacker, I1
Havemann, K1
Zuazu, J1
Villalba, T1
Julià, A1
Schneider, M1
Panzer, S1
Fasching, K1
Wagner, H1
Maybee, DA1
Pinkel, D1
Gorczyńska, E2
Filiks-Litwin, B2
Kołecki, P3
Lukowska, K2
Rokicka-Milewska, R9
Rola-Kurc, E2
Stencel, D2
Zelenay, E3
Dłuzniewska, A1
Sopyło, B1
Stefaniak, MJ1
Stefańska, K1
Stańczak, E1
Mathey, C1
Legall, E1
Lamagnere, JP2
Berthou, C1
Bauduer, F1
Pautard, B1
Schaison, G2
Hurwitz, CA1
Dalton, VK1
Glick, KM1
Gelber, RD4
Jiang, S1
Serke, S1
van Lessen, A1
Hummel, M1
Szczepek, A1
Huhn, D1
Stein, H1
Neth, O1
Seidemann, K1
Jansen, P1
Tiemann, M1
Mauz-Körholz, C1
Göbel, U1
Sklar, CA1
Mertens, AC1
Walter, A1
Mitchell, D1
Nesbit, ME2
O'Leary, M1
Hutchinson, R1
Robison, LL2
Gao, H1
Ruano, D1
Diaz, MA1
Tutor, O1
Garcia-Sanchez, F1
Martinez, P1
Madero, L1
Hammermuller, E1
De Dávila, MT1
Ciocca, ME1
Lorusso, AM1
Sackmann-Muriel, F2
Abshire, TC1
Billett, AL1
Bradley, P1
Lange, B1
Sancho, J1
Soriano Guillén , L1
Muñoz Calvo , MT1
Pozo Román , J1
Contra Gómez , T1
Buño Soto , M1
Argente Oliver , J1
Garcia-Manero, G1
Tucker, SL1
Rodriguez, MA1
Cabanillas, FF1
Anderer, G1
Brechlin, AM1
Muti, P1
Schneider, T1
Seydlitz, F1
Zimmermann, U1
Sontag, B1
Boesken, WH1
Philippe, N1
Lutz, P2
Marguerite, G1
Rialland, X1
Behard, C1
Norton, L1
Thyss, A1
Dastugue, N1
Waterkeyn, C1
Otten, J2
Atra, A1
Gerrard, M1
Hobson, R1
Imeson, JD1
Hann, IM1
Pinkerton, CR1
Ichikawa, M1
Okamoto, T1
Park, C1
Motoji, T1
Mizoguchi, H2
Shibuya, A1
Auperin, A1
Michon, J1
Behrendt, H2
Frappaz, D1
Coze, C1
Terrier-Lacombe, MJ1
Strauss, AJ1
Su, JT1
Dalton, VM1
Paolucci, G2
Vecchi, V2
Fletcher, BD1
Kennedy, W1
Neel, MD1
Hunault-Berger, M1
Milpied, N2
Bernard, M1
Jouet, JP1
Delain, M1
Desablens, B1
Sadoun, A1
Guilhot, F1
Moritz, B1
Eder, J1
Brougham, M1
Montgomery, C1
Richardson, F1
Kelly, A1
Gibson, BE1
Petroni, GR1
Schiffer, CA1
Freter, CE1
Johnson, JL1
Barcos, M1
Frizzera, G1
Bloomfield, CD1
Peterson, BA1
Heinecke, A1
von Kries, R1
Nürnberger, W1
Münchow, N1
He, H1
Han, M1
Grenzebach, J1
Parwaresch, R1
Chen, YC1
Ho, CL1
Kao, WY1
Hwang, JM1
Sheu, LF1
Chao, TY1
Shtalrid, M1
Haran, M1
Klepfish, A1
Lurie, Y1
Malnick, S1
Vegna, ML3
Specchia, G1
Ferrara, F2
Peta, A1
Ciolli, S2
Deplano, W2
Di Raimondo, F1
Cascavilla, N1
Rotoli, B1
Raetz, E1
Moos, PJ1
Bruggers, CS1
Smith, F1
Borges, E1
Ferry, JA1
Friedmann, AM1
Kingma, A1
Van Dommelen, RI1
Mooyaart, EL1
Wilmink, JT1
Deelman, BG1
Kamps, WA1
Giles, FJ1
Huh, YO1
Linker, C1
Damon, L1
Ries, C1
Navarro, W1
Klus, K1
Kolecki, P1
Boguslawska-Jaworska, J1
Pisarek, J1
Łuszczynska, A1
Bubala, H1
Łukowska, K1
Sakiroglu, C1
Ansoborlo, S1
Pacquement, H1
Babin-Boilletot, A1
Micalizzi, MC1
Delwail, V1
Jais, JP1
Colonna, P1
Andrieu, JM1
Pacholska, J1
Paciorkiewicz, W1
Jastrzebska, M1
Månsson-Rahemtulla, B1
Techanitiswad, T1
Rahemtulla, F1
McMillan, TO1
Bradley, EL1
Wahlin, YB1
Saito, H1
Jacobs, P2
Wood, L2
Mattioli-Belmonte, M1
Defazio, D1
Tura, S1
Huismans, DR1
Loonen, AH1
Peters, GJ1
van der Does-van den Berg, A2
Vats, T1
Buchanan, G1
Mehta, P1
Ragab, A2
Hvizdale, E1
Nitschke, R1
Link, M2
Beardsley, GP1
Maybee, D1
Krischer, J1
Tacik, J1
Martelli, M2
Papa, G2
Holowiecki, J2
Koehler, M1
Zintl, Z1
Kardos, G1
Lutz, D1
Krzemien, S1
Rewesz, T1
Brugiatelli, M1
Callea, V1
Kachel, L2
Thun-Hohenstein, L1
Frisch, H1
Schuster, E1
Rytwiński, K1
Konopacka, M1
Ciechanowska, U1
Rajagopal, S1
Yue, BB1
Komada, Y1
Zhang, SL1
Zhou, YW1
Hanada, M1
Shibata, T1
Azuma, E1
Sakurai, M1
Maschan, AA1
Samochatova, EV1
Kryzhanovskiĭ, OI1
Pagano, L1
DeVeber, LL2
Pai, KM1
Andrew, M2
Halton, J1
Cairney, AE1
Whitton, AC1
Festa, RS3
Tamaroff, MH2
Chasalow, F1
Martelo, OJ1
Raney, M1
Adesman, AR1
Walco, GA1
Sommelet, D1
Bancillon, A2
Pavlovsky, S1
Sackmann Muriel, F1
Santarelli, MT1
Svarch, E1
Jiménez, E1
Kohan, R1
Rosso, A1
Fabiano, F1
Muti, G1
Andersen, JW1
Mazza, JJ1
O'Connell, MC1
Wiernik, P1
Derulska, D4
Duczmal, B1
García Zueco, JC1
Torres Gómez, M1
López Gómez, L1
Martín Guerrero, Y1
Murakawa, M1
Okamura, T1
Shibuya, T1
Harada, M1
Otsuka, T1
Niho, Y1
Chiu, E1
Ho, FC1
Loke, SL1
Drigan, R1
Spirito, A1
Eguiguren, JM1
Diedrich, H2
Ganser, A2
Gramatzki, M1
Heyll, A2
Henke, M2
Haas, R1
Kuse, R1
Kalifa, C1
Flamant, F1
Hartmann, O1
Brugières, L1
Valteau-Couanet, D1
Bayle, C1
Caillaud, JM1
Lemerle, J1
Harris, RE1
Baum, E1
Kaizer, H1
Pendergrass, TW1
Saunders, EF1
Warkentin, PL1
Clarkson, B1
Philips, GK1
Crowell, EB1
Mani, A1
Cerezo, L1
Brock, B1
Head, DR1
Bozzola, M1
Gambarana, D1
Moretta, A1
Valtorta, A1
Cisternino, M1
Severi, F1
Niemeyer, CM1
Tarbell, NJ1
Donnelly, M1
Blattner, SR1
Donahue, K1
Cohen, HJ1
Bender-Götze, C1
Ebell, W1
Ehninger, G1
Friedrich, W1
Darmal, B1
Rudzka, E1
Lawniczek, T1
Pajak, J1
Ridgway, D2
Wolff, LJ1
Deforest, A1
Mitrou, PS1
Serke, M1
Pohl, C1
Becker, K1
Schrappe-Bächer, M1
Knauf, W1
Westerhausen, M1
Clemens, MR1
Helm, EB1
Fischer, T1
Balsom, WR1
Heyn, RM1
Sitarz, A1
Philip, T1
Rodary, C1
Zucker, JM1
Gentet, JC1
Dufillot, D1
Pein, F1
Loosveld, OJ1
Gaillard, CA1
Blijham, GH1
Nickerson, HJ1
Coccia, PF2
Finklestein, JZ1
Miller, DR4
Littman, PS1
Siegel, SE2
Yamada, S1
Miyagawa, Y1
Komiyama, A1
Smith, SD1
Yanofsky, RA1
Ghim, T1
Wharam, MD1
Vietti, TJ2
Johnson, W1
Jones, B1
Jacquillat, C1
Weil, M1
Pochedly, C1
Sinks, L1
Chevalier, L1
Maurer, HM1
Koch, K1
Lilleyman, JS1
Shaw, MP1
Peto, J1
De Salvo Cardullo, L1
Weir Madina, J1
Gómez Sánchez, O1
Plumacher, Z1
Salas, D1
Okpala, IE1
Olatunji, PO1
Okunade, MA1
Ogunsanwo, BA1
Jeje, OM1
Shokunbi, WA1
Essien, EM1
De Boben, M1
Knauf, U1
Koch, P1
Janka-Schaub, GE1
Goebel, U1
Graubner, U1
Haas, RJ1
Juergens, H1
Spaar, HJ1
Winkler, K1
Belasco, JB1
Luery, N1
Scher, C1
Leikin, SL2
Albo, VC2
Palmer, NF1
Murphy, RG1
Greenberg, ML1
Novitzky, N1
Shimamoto, T1
Ohyashiki, J1
Utsumi, K1
Ohyashiki, K1
Toyama, K1
Grañena, A2
Rozman, C2
Urbano-Ispizua, A2
Bladé, J1
Carreras, E1
Cervantes, F1
Marín, P1
Sierra, J2
Nomdedeu, B1
Bader-Meunier, B1
Garel, D1
Dommergues, JP1
Venencie, PY1
Crist, W1
Jackson, J1
Head, D1
Borowitz, M1
Behm, F1
Steuber, P1
Gisselbrecht, C1
Harousseau, JL1
Witz, F1
Troussard, X1
LeBlond, V1
Auzanneau, G1
Kreitzer, PM1
Blethen, SL1
Chasalow, FI1
Iannetti, P1
Fabbri, A1
Ulisse, S1
Isidori, A1
Imperato, C1
Pulczynska, MK1
Hejl, M1
Sato, Y1
Ito, R1
Saito, T1
Suto, Y1
Tateoka, N1
Onodera, N1
Ikeda, Y1
Ito, E1
Miyano, T1
Tachibana, N1
Radford, JE1
Jones, MP1
Gingrich, RD1
Kemp, JD1
Edwards, RW1
McFadden, DB1
Dick, FR1
Wen, BC1
Neerhout, RC1
Bleyer, A1
Steinherz, P2
Mandell, LR1
Walker, RW1
Fuks, Z1
Solbu, G1
Rammeloo, JA1
de Koning, J1
van Zanen, GE1
Shi, YD1
Zhang, ZN1
Choonara, I1
Wheeldon, J1
Rayner, P1
Blackburn, M1
Lewis, I1
Desai, SJ1
Pai, MK1
Piroso, E1
Erslev, AJ1
Caro, J1
Casonato, A1
Lazzaro, AR1
Girolami, A1
Skwarska, E1
Slørdal, L1
Kolmannskog, S1
Moe, PJ1
Prytz, PS1
Aarbakke, J1
Lichter-Konecki, U1
Benninger, C1
Brandeis, WE1
Matthis, P1
Scheffner, D1
Russo, A1
Di Bella, D1
Lo Bianco, M1
Schilirò, G1
Rossi, MR1
Zurlo, MG1
Bagnulo, S1
Carli, M1
Zanesco, L1
Dini, G1
Guazzelli, C1
Pearson, AD1
Darbyshire, PJ1
Mott, MG1
Serra, L1
Rosito, P1
Paolucci, P1
Burnelli, R1
Vivarelli, F1
Mancini, AF1
Wegelius, R1
Venkatarangam, SH1
Kutcher, SP1
Notkin, RM1
Reddemann, H1
Hellwig, C1
Poller, C1
Peters, WG1
Colly, LP1
Brugués, R1
King, DJ1
Brunton, J1
Lewicki, Z1
Yu, A1
Boyett, J1
Abdalla, A1
Badrawy, F1
Khalifa, A1
Hamza, R1

Clinical Trials (30)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Front-line Treatment of Philadelphia Positive/BCR-ABL Positive Acute Lymphoblastic Leukemia With Ponatinib, a New Potent Tyrosine Kinase Inhibitor.[NCT01641107]Phase 244 participants (Actual)Interventional2014-12-04Completed
A Phase II Study of Blinatumomab and POMP (Prednisone, Vincristine, Methotrexate, 6-Mercaptopurine) for Patients ≥ 65 Years of Age With Newly Diagnosed Philadelphia-Chromosome Negative (Ph-) Acute Lymphoblastic Leukemia (ALL) and of Dasatinib, Prednisone [NCT02143414]Phase 253 participants (Actual)Interventional2015-06-30Active, not recruiting
Treatment Protocol for T-Cell and B-Precursor Cell Lymphoblastic Lymphoma of the European Inter-group Co-operation on Childhood Non-Hodgkin-Lymphoma (EICNHL)[NCT00275106]Phase 3600 participants (Anticipated)Interventional2004-09-30Terminated (stopped due to Withdrawn due to an excess of toxic deaths)
ALL-BFM 2000 Multi-Center Study for the Treatment of Children and Adolescents With Acute Lymphoblastic Leukemia[NCT00430118]Phase 34,559 participants (Actual)Interventional2000-07-31Completed
AIEOP LLA 2000 Multicenter Study for the Diagnosis and Treatment of Childhood Acute Lymphoblastic Leukemia[NCT00613457]Phase 32,039 participants (Actual)Interventional2000-09-30Completed
Enhancing Effect on Tumour Apoptosis With the Combined Use of Pentoxifylline Plus Chemotherapeutical Agents in Pediatrics and AYA Patients With Hodgkin´s Lymphoma[NCT05490953]Phase 430 participants (Anticipated)Interventional2022-07-11Recruiting
Ponatinib Plus Reduced-intensity Chemotherapy in the First-line Treatment of Adult Patients With Ph-positive Acute Lymphoblastic Leukemia[NCT04554459]Phase 232 participants (Anticipated)Interventional2021-02-16Active, not recruiting
Use of Levocarnitine to Reduce Asparaginase Hepatotoxicity in Patients With Acute Lymphoblastic Leukemia[NCT05501899]Early Phase 120 participants (Anticipated)Interventional2023-03-03Recruiting
Total XV - Total Therapy Study XV for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia[NCT00137111]Phase 3501 participants (Actual)Interventional2000-07-08Completed
Metformin as an Adjunctive Therapy For Transient Hyperglycemia in Patients With Acute Lymphoblastic Leukemia During Induction Chemotherapy[NCT01486043]4 participants (Actual)Interventional2011-12-31Terminated (stopped due to The research project was terminated due to lower than projected patient recruitment within the period of time allowed for the study.)
Neurobehavioral Outcomes in Childhood Acute Lymphoblastic Leukemia. A Limited Non-Therapeutic Study[NCT00085176]286 participants (Actual)Observational2004-05-31Completed
Treatment of Patients With Acute Lymphoblastic Leukemia With Unfavorable Features: A Phase III Group-wide Study[NCT00002812]Phase 32,078 participants (Actual)Interventional1996-09-30Completed
ALinC 17: Protocol for Patients With Newly Diagnosed High Risk Acute Lymphoblastic Leukemia (ALL) - Evaluation of the Augmented BFM Regimen: A Phase III Study[NCT00005603]Phase 3276 participants (Actual)Interventional2000-03-31Completed
ALL-REZ BFM 2002: Protocol for the Treatment of Children With Relapsed Acute Lymphoblastic Leukemia[NCT00114348]Phase 4338 participants (Actual)Interventional2003-08-31Completed
Randomized Phase III Study for the Treatment of Newly Diagnosed Disseminated Lymphoblastic Lymphoma or Localized Lymphoblastic Lymphoma[NCT00004228]Phase 3393 participants (Actual)Interventional2000-06-30Completed
International Collaborative Treatment Protocol for Infants Under One Year With Acute Lymphoblastic Leukemia[NCT00015873]Phase 3350 participants (Anticipated)Interventional1999-05-31Completed
"Precision Exercise Program in Children With Malignant Hemopathies Undergoing Therapy and/or Hematopoietic Stem Cell Transplantation: The Sport Therapy Project"[NCT04090268]380 participants (Anticipated)Interventional2017-04-03Recruiting
"Geriatric Assessment Adapted Therapy for Ph- ALL Elderly Patients. GIMEMA Protocol LAL1104. EudraCT Code 2005-002156-17"[NCT00475280]Phase 2102 participants (Actual)Interventional2007-11-30Completed
Multicenter, Prospective, Open Label Trial, Uncontrolled to Determine the Efficacy and Safety of Depocyt ® for the Treatment of CNS Relapse in Adult Patients With Lymphoblastic Leucemia or Very Aggressive Lymphoma[NCT00388531]Phase 210 participants (Anticipated)Interventional2006-03-31Completed
PETHEMA LAL-RI/96: Treatment for Patients With Standard Risk Acute Lymphoblastic Leukemia[NCT00494897]Phase 4374 participants (Actual)Interventional1996-06-30Completed
Single Arm Phase II Study of Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation for Acute Lymphoblastic Leukemia (ALL) in Older Patients Using Fludarabine and Total Body Irradiation (FluTBI) Regimen[NCT01991457]Phase 219 participants (Actual)Interventional2013-08-27Completed
Phase 2 Study Evaluating the Efficacy of Rituximab Plus Modified VPDL for Newly Diagnosed CD20-Positive Adult Acute Lymphoblastic Leukemia[NCT01429610]Phase 278 participants (Actual)Interventional2011-11-30Active, not recruiting
A PHASE I TRIAL OF BUTYRATE AND GANCICLOVIR IN EBV-ASSOCIATED MALIGNANCIES[NCT00006340]Phase 10 participants Interventional1994-12-31Completed
A Pilot Study of Allopurinol As A Modifier of 6-MP Metabolism in Pediatric ALL[NCT02046694]Early Phase 134 participants (Actual)Interventional2014-01-06Completed
NOURISH-T+: A Randomized Control Trial Targeting Parents in Promoting Healthy Eating and Exercise Behaviors in Pediatric Cancer Survivors With Overweight/Obesity[NCT04656496]520 participants (Anticipated)Interventional2020-12-08Recruiting
Burkimab:Study Multicenter of Optimization of the Treatment of LLA-B and the Burkitt's Lymphoma in Adult Patients (From 15 Years Old)[NCT00388193]Phase 220 participants (Anticipated)Interventional2006-08-31Completed
HIGH INTENSITY, BRIEF DURATION CHEMOTHERAPY FOR DIFFUSE SMALL NONCLEAVED CELL LYMPHOMA AND THE L-3 SUBTYPE OF ALL: A PILOT STUDY OF A MULTIDRUG REGIMEN[NCT00002494]Phase 2134 participants (Actual)Interventional1992-05-31Completed
Treatment of Mature B-ALL and Burkitt Lymphoma (BL) in Adult Patients. BURKIMAB-14.[NCT05049473]Phase 2100 participants (Anticipated)Interventional2014-01-31Recruiting
A Phase II Study of Punctual, Cyclic, and Intensive Chemotherapy With Liposomal Cytarabine (Depocyt®) CNS Prophylaxis for Adults With Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma[NCT02043587]Phase 231 participants (Actual)Interventional2014-01-31Terminated (stopped due to Original investigator for the trial has left)
A Pilot Study of Adherence to Oral Medication and Health Beliefs of Adolescents With HIV and Their Mothers[NCT00001699]45 participants Observational1998-06-30Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

Disease-free Survival (Cohort II)

An estimate of disease free survival in Ph-positive ALL and Ph-like DSMKF ALL (Cohort II). Disease free survival is measured by the number of years between the date the patient first achieves complete remission (CR) or complete remission with incomplete platelet recovery (CRi) until relapse from CR/CRi or death from any cause. CR is defined as having <5% marrow aspirate blasts, ANC >1,000/mcL, platelets > 100,000/mcL, no blasts in peripheral blood, and C1 extramedullary disease status. CRi is the same as CR but platelet count may be <= 100,000/mcL and/or ANC <=1,000/mcL. (NCT02143414)
Timeframe: Duration of treatment and follow up until death or date of primary analysis (about 7.5 years)

Interventionyears (Median)
Cohort II (Ph+/Ph-like)5.3

Incidence of Dose-limiting Toxicity (Cohort II)

Defined as any grade 4 or higher treatment-related, non-hematologic toxicity in the first cycle of post-remission therapy (blinatumomab/dasatinib) graded by National Cancer Institute (NCI) Common Terminology Criteria for Adverse Events (CTCAE) version 4.0. Only participants with Ph-positive ALL or Ph-like DSMKF ALL were evaluated. (NCT02143414)
Timeframe: Up to day 42 of post-remission therapy

InterventionParticipants (Count of Participants)
Cohort II (Ph+/Ph-like)0

Overall Survival Rate (Cohort I)

To evaluate the 3-year overall survival rate in elderly participants with newly diagnosed Ph-negative ALL treated with blinatumomab followed by POMP maintenance. Overall (NCT02143414)
Timeframe: From the day of registration on study until death from any cause, assessed at 3 years

Interventionpercentage of participants (Number)
Cohort I (Ph-)34

Complete Response Rate (Cohort I)

Complete response rate is measured by the number of participants achieving complete remission (CR) or complete remission with incomplete platelet recovery (CRi) rate. CR is defined as having <5% marrow aspirate blasts, ANC >1,000/mcL, platelets > 100,000/mcL, no blasts in peripheral blood, and C1 extramedullary disease status. CRi is the same as CR but platelet count may be <= 100,000/mcL and/or ANC <=1,000/mcL. (NCT02143414)
Timeframe: Participants are assessed after induction treatment and again after re-induction treatment, if re-induction treatment is received (i.e. up to 85 days after registration)

InterventionParticipants (Count of Participants)
CR or CRiNo CR or CRi
Cohort I (Ph-)1910

Minimal Residual Disease Negativity

To estimate in each cohort the rate of minimal residual disease (MRD) negativity. (NCT02143414)
Timeframe: Participants are assessed after induction treatment and again after re-induction treatment, if re-induction treatment is received (i.e. up to 85 days after registration)

,
InterventionParticipants (Count of Participants)
MRD-MRD+
Cohort I (Ph-)121
Cohort II (Ph+/Ph-like)79

Number of Participants With Grade 3 Through 5 Adverse Events That Are Related to Study Drugs

Number of participants with Grade 3-5 adverse events that are possibly, probably or definitely related to study drug are reported by given type of adverse event. Adverse Events reported using CTCAE v 4.0, whereas Serious Adverse Events were reported with CTCAE v 5.0. (NCT02143414)
Timeframe: Duration of treatment and follow up until death or date of primary analysis (about 7.5 years)

,,,,,
InterventionParticipants (Number)
Abdominal painAdult respiratory distress syndromeAgitationAlanine aminotransferase increasedAlkaline phosphatase increasedAnemiaAnorexiaAspartate aminotransferase increasedAtrial flutterBlood bilirubin increasedCataractCatheter related infectionColitisConfusionCytokine release syndromeDehydrationDiarrheaDizzinessDysarthriaDyspneaEdema limbsEncephalopathyFatigueFebrile neutropeniaFeverGastrointestinal painGeneral disorders and admin site conditions - OtherGeneralized muscle weaknessHeart failureHematomaHyperglycemiaHypertensionHypoalbuminemiaHypocalcemiaHypokalemiaHypophosphatemiaHypotensionHypoxiaInfections and infestations - Other, specifyInfusion related reactionLung infectionLymphocyte count decreasedMetabolism and nutrition disorders - Other, specifyMucositis oralNauseaNervous system disorders - Other, specifyNeutrophil count decreasedNon-cardiac chest painPericardial effusionPlatelet count decreasedPleural effusionPneumonitisPulmonary hypertensionRash maculo-papularRespiratory failureSepsisSoft tissue infectionThrombotic thrombocytopenic purpuraUrinary tract infectionVascular access complicationWeight lossWhite blood cell decreased
Induction: Cohort I (Ph-)000101000000001101013001310000043010111112800011000130100100100011
Induction: Cohort II (Ph+/Ph-like)00010800000100011101200100111110001011102600109008000101001006
Maintenance: Cohort I (Ph-)100204020210100010000032000000111001012014010011002010012100105
Maintenance: Cohort II (Ph+/Ph-like)01001010100010011002000000102004000001001010003110201000000010
Post-remission: Cohort I (Ph-)00000200000000000000001000000011001000000200005000000000000002
Post-remission: Cohort II (Ph+/Ph-like)001101010000020000030100010000220100002006000010010000000000001

Circulating Leukemia Cells in Peripheral Blood Change From Prior to the Methotrexate Infusion to Three Days After Between Two Arms (4 Hours vs. 24 Hours)

"White blood cell (leukocytes) counts in peripheral blood by Complete Blood Count~Measurement: Percentage change of leukemia cells from baseline" (NCT00137111)
Timeframe: Immediately before the methotrexate infusion and three days after subsequent infusion

InterventionPercent change (Mean)
4 hr-44
24 hr-50

Continuous Complete Remission Since Week 56 Therapy.

CCR was measured from end of week 56 therapy to the date of first treatment failure of any kind (relapse, death, lineage switch, or second malignancy) or to the last date of follow-up. Measurement was determined by Kaplan-Meyer estimate. (NCT00137111)
Timeframe: Median follow up time (range) 4.5 (1 to 7.8) years

InterventionPercentage of participants (Number)
Patients With High Risk of CNS Relapse92.2

Mean Difference of Active Methotrexate Polyglutamates (MTXPG) in Leukemia Cells Between Two Arms (4 Hours vs. 24 Hours).

Children were randomly assigned to receive initial single-agent treatment with HDMTX (1g/m^2) as either a 24-hour infusion or a 4-hour infusion and the outcome measure was the accumulation of MTXPG in leukemia cells. (NCT00137111)
Timeframe: 42 hours after start of high dose methotrexate infusion (HDMTX)

Interventionpmol/1,000,000,000 cells (Mean)
4 hr1688
24 hr2521

Overall Event-free Survival (EFS)

EFS was measured from the start of on-study to the date of first treatment failure of any kind (relapse, death, lineage switch, or second malignancy) or to the last date of follow-up. Failure to enter remission was considered an event at time zero. Measurement was determined by Kaplan-Meyer estimate. (NCT00137111)
Timeframe: Median follow-up time (range) 5.6 (1.3 to 8.9) years

InterventionPercentage of Participants (Number)
Total Therapy87.3

Median Difference in CASP1 Gene Expression in Primary Leukemia Cells of Patients in Glucocorticoid-resistant Cells vs Glucocorticoid-sensitive Cells

Prednisolone sensitivity was measured in primary leukemia cells from bone marrow collected at diagnosis. Expression of CASP1 was determined by HG-U133A microarray. Values given are gene expression values, and the unit is arbitrary units (AU) defined as scaled fluorescence measured on microarray. (NCT00137111)
Timeframe: Pre-treatment

Interventionarbitrary units (Median)
Prednisolone-sensitive cellsPrednisolone-resistant cells
Total Therapy341.3447.9

Median Difference in NLRP3 Gene Expression in Primary Leukemia Cells of Patients in Glucocorticoid-resistant Cells vs. Glucocorticoid-sensitive Cells

Prednisolone sensitivity was measured in primary leukemia cells from bone marrow collected at diagnosis. Expression of NLRP3 was determined by HG-U133A microarray. Values given are gene expression values, and the unit is arbitrary units (AU) defined as scaled fluorescence measured on microarray. (NCT00137111)
Timeframe: Pre-treatment

Interventionarbitrary units (Median)
Prednisolone-sensitive cellsPrednisolone-resistant cells
Total Therapy41.2110.7

Minimal Residual Disease (MRD)

Detection of MRD at end of induction where positive MRD was defined as one or more leukemic cell per 10,000 mononuclear bone-marrow cells (>=0.01%). (NCT00137111)
Timeframe: End of Induction (Day 46 MRD measurement)

Interventionparticipants (Number)
Negative <0.01%Positive >= 0.01%
Total Therapy390102

Hemoglobin A1c

(NCT01486043)
Timeframe: At 1 month

Interventionpercent of hemoglobin (Mean)
Metformin and Insulin Therapy4.8

Length of Insulin Therapy (Days)

(NCT01486043)
Timeframe: During the 30 days of induction chemotherapy (plus or minus 2 weeks)

Interventiondays (Mean)
Metformin and Insulin Therapy7.5

Serum Fructosamine Level

(NCT01486043)
Timeframe: At 1 month

InterventionuM (Mean)
Metformin and Insulin Therapy190

Event-free Survival

Assessed by time to treatment failure, occurrence of second malignant neoplasm, or death from any cause. Statistical analysis will be to estimate the difference in the proportion of patients treated with each therapy who are long-term event-free survivors due either to the difference between the backbone therapy regimens (CCG BFM vs NHL/BFM-95), or due to the intensification. (NCT00004228)
Timeframe: 5 years

Interventionpercentage of particpants (Number)
A0 (Localized Disease Stg I/II) Modified CCG BFM88
A1 (Disseminated, No CNS - CCG Mod BFM w/Out Intens82
A2 (Disseminated, No CNS - CCG Mod BFM w/ Intens80
B2 (CNS+) NHL/BFM-95 w/Intens Delayed Radiation Therapy63
B2 (Disseminated,CNS- (< Amend 7B)) NHL/BFM-95 w/Intens82
B1 (Disseminated CNS-) NHL/BFM-95 w/Out Intens84
B1 (NHL/BFM-95 w/Out Intens) Additional Enrollment90

Percentage of Patients With Overall Survival as Assessed by Time to Death

Overall survival will be computed by measuring the rate of deaths during induction due primarily to treatment toxicity and cumulative incidence of toxic deaths in induction or deaths in remission overall and separately for treatment groups defined by the two design factors. (NCT00004228)
Timeframe: 5 years

Interventionpercentage of participants (Number)
A0 (Localized Disease Stg I/II) Modified CCG BFM96
A1 (Disseminated, No CNS - CCG Mod BFM w/Out Intens84
A2 (Disseminated, No CNS - CCG Mod BFM w/Intens88
B2 (CNS+) NHL/BFM-95 w/Intens Delayed Radiation Therapy81
B2 (Disseminated,CNS- (< Amend 7B)) NHL/BFM-95 w/Intens85
B1 (Disseminated CNS-) NHL/BFM-95 w/Out Intens85
B1 (NHL/BFM-95 w/Out Intens) Additional Enrollment92

Number of Subjects Disease-free Survival

Percentage of patients without relapse of disease at 2 years (NCT01991457)
Timeframe: 2 years post-transplant

Interventionpercentage of participants (Number)
Treatment63.2

Reviews

36 reviews available for prednisone and Precursor Cell Lymphoblastic Leukemia-Lymphoma

ArticleYear
Overcoming Steroid Resistance in Pediatric Acute Lymphoblastic Leukemia-The State-of-the-Art Knowledge and Future Prospects.
    International journal of molecular sciences, 2022, Mar-30, Volume: 23, Issue:7

    Topics: Extracellular Signal-Regulated MAP Kinases; Glucocorticoids; Humans; Precursor Cell Lymphoblastic Le

2022
Overcoming Steroid Resistance in Pediatric Acute Lymphoblastic Leukemia-The State-of-the-Art Knowledge and Future Prospects.
    International journal of molecular sciences, 2022, Mar-30, Volume: 23, Issue:7

    Topics: Extracellular Signal-Regulated MAP Kinases; Glucocorticoids; Humans; Precursor Cell Lymphoblastic Le

2022
Overcoming Steroid Resistance in Pediatric Acute Lymphoblastic Leukemia-The State-of-the-Art Knowledge and Future Prospects.
    International journal of molecular sciences, 2022, Mar-30, Volume: 23, Issue:7

    Topics: Extracellular Signal-Regulated MAP Kinases; Glucocorticoids; Humans; Precursor Cell Lymphoblastic Le

2022
    Neuropsychiatrie de l'enfance et de l'adolescence, 2023, Volume: 71, Issue:1

    Topics: Acceptance and Commitment Therapy; Adolescent; Adult; Aged; Aldehydes; Alpinia; Animals; Antibodies,

2023
    Neuropsychiatrie de l'enfance et de l'adolescence, 2023, Volume: 71, Issue:1

    Topics: Acceptance and Commitment Therapy; Adolescent; Adult; Aged; Aldehydes; Alpinia; Animals; Antibodies,

2023
    Neuropsychiatrie de l'enfance et de l'adolescence, 2023, Volume: 71, Issue:1

    Topics: Acceptance and Commitment Therapy; Adolescent; Adult; Aged; Aldehydes; Alpinia; Animals; Antibodies,

2023
Hypothalamic-pituitary-adrenal (HPA) axis suppression after treatment with glucocorticoid therapy for childhood acute lymphoblastic leukaemia.
    The Cochrane database of systematic reviews, 2017, 11-06, Volume: 11

    Topics: Adrenal Insufficiency; Antineoplastic Agents, Hormonal; Child; Cohort Studies; Dexamethasone; Flucon

2017
Hypothalamic-pituitary-adrenal (HPA) axis suppression after treatment with glucocorticoid therapy for childhood acute lymphoblastic leukaemia.
    The Cochrane database of systematic reviews, 2017, 11-06, Volume: 11

    Topics: Adrenal Insufficiency; Antineoplastic Agents, Hormonal; Child; Cohort Studies; Dexamethasone; Flucon

2017
Hypothalamic-pituitary-adrenal (HPA) axis suppression after treatment with glucocorticoid therapy for childhood acute lymphoblastic leukaemia.
    The Cochrane database of systematic reviews, 2017, 11-06, Volume: 11

    Topics: Adrenal Insufficiency; Antineoplastic Agents, Hormonal; Child; Cohort Studies; Dexamethasone; Flucon

2017
Prognostic value of the response to prednisone for children with acute lymphoblastic leukemia: a meta-analysis.
    European review for medical and pharmacological sciences, 2018, Volume: 22, Issue:22

    Topics: Disease-Free Survival; Humans; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis

2018
Prognostic value of the response to prednisone for children with acute lymphoblastic leukemia: a meta-analysis.
    European review for medical and pharmacological sciences, 2018, Volume: 22, Issue:22

    Topics: Disease-Free Survival; Humans; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis

2018
Prognostic value of the response to prednisone for children with acute lymphoblastic leukemia: a meta-analysis.
    European review for medical and pharmacological sciences, 2018, Volume: 22, Issue:22

    Topics: Disease-Free Survival; Humans; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis

2018
[Current treatment of pediatric acute lymphoblastic leukemia].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 2014, Volume: 55, Issue:10

    Topics: Antineoplastic Combined Chemotherapy Protocols; Benzamides; Child, Preschool; Clinical Trials as Top

2014
[Current treatment of pediatric acute lymphoblastic leukemia].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 2014, Volume: 55, Issue:10

    Topics: Antineoplastic Combined Chemotherapy Protocols; Benzamides; Child, Preschool; Clinical Trials as Top

2014
[Current treatment of pediatric acute lymphoblastic leukemia].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 2014, Volume: 55, Issue:10

    Topics: Antineoplastic Combined Chemotherapy Protocols; Benzamides; Child, Preschool; Clinical Trials as Top

2014
Thrombosis in childhood acute lymphoblastic leukaemia: epidemiology, aetiology, diagnosis, prevention and treatment.
    Best practice & research. Clinical haematology, 2009, Volume: 22, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Humans; Precursor Cell Lymphoblastic L

2009
Thrombosis in childhood acute lymphoblastic leukaemia: epidemiology, aetiology, diagnosis, prevention and treatment.
    Best practice & research. Clinical haematology, 2009, Volume: 22, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Humans; Precursor Cell Lymphoblastic L

2009
Thrombosis in childhood acute lymphoblastic leukaemia: epidemiology, aetiology, diagnosis, prevention and treatment.
    Best practice & research. Clinical haematology, 2009, Volume: 22, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Humans; Precursor Cell Lymphoblastic L

2009
The optimal use of steroids in paediatric acute lymphoblastic leukaemia: no easy answers.
    British journal of haematology, 2010, Volume: 149, Issue:5

    Topics: Adolescent; Child; Child, Preschool; Dexamethasone; Drug Administration Schedule; Glucocorticoids; H

2010
The optimal use of steroids in paediatric acute lymphoblastic leukaemia: no easy answers.
    British journal of haematology, 2010, Volume: 149, Issue:5

    Topics: Adolescent; Child; Child, Preschool; Dexamethasone; Drug Administration Schedule; Glucocorticoids; H

2010
The optimal use of steroids in paediatric acute lymphoblastic leukaemia: no easy answers.
    British journal of haematology, 2010, Volume: 149, Issue:5

    Topics: Adolescent; Child; Child, Preschool; Dexamethasone; Drug Administration Schedule; Glucocorticoids; H

2010
Intrathecal chemotherapy in lymphomatous meningitis.
    Critical reviews in oncology/hematology, 2011, Volume: 79, Issue:2

    Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Central Nerv

2011
Intrathecal chemotherapy in lymphomatous meningitis.
    Critical reviews in oncology/hematology, 2011, Volume: 79, Issue:2

    Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Central Nerv

2011
Intrathecal chemotherapy in lymphomatous meningitis.
    Critical reviews in oncology/hematology, 2011, Volume: 79, Issue:2

    Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Central Nerv

2011
Dexamethasone versus prednisone for induction therapy in childhood acute lymphoblastic leukemia: a systematic review and meta-analysis.
    Leukemia, 2011, Volume: 25, Issue:8

    Topics: Child; Dexamethasone; Humans; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone

2011
Dexamethasone versus prednisone for induction therapy in childhood acute lymphoblastic leukemia: a systematic review and meta-analysis.
    Leukemia, 2011, Volume: 25, Issue:8

    Topics: Child; Dexamethasone; Humans; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone

2011
Dexamethasone versus prednisone for induction therapy in childhood acute lymphoblastic leukemia: a systematic review and meta-analysis.
    Leukemia, 2011, Volume: 25, Issue:8

    Topics: Child; Dexamethasone; Humans; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone

2011
Lymphoma study group of JCOG.
    Japanese journal of clinical oncology, 2012, Volume: 42, Issue:2

    Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemother

2012
Lymphoma study group of JCOG.
    Japanese journal of clinical oncology, 2012, Volume: 42, Issue:2

    Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemother

2012
Lymphoma study group of JCOG.
    Japanese journal of clinical oncology, 2012, Volume: 42, Issue:2

    Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemother

2012
[Blastic plasmacytoid dendritic cell neoplasm: a clinicopathologic study].
    Zhonghua bing li xue za zhi = Chinese journal of pathology, 2012, Volume: 41, Issue:5

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; CD56 Antigen; Cyclophosphamid

2012
[Blastic plasmacytoid dendritic cell neoplasm: a clinicopathologic study].
    Zhonghua bing li xue za zhi = Chinese journal of pathology, 2012, Volume: 41, Issue:5

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; CD56 Antigen; Cyclophosphamid

2012
[Blastic plasmacytoid dendritic cell neoplasm: a clinicopathologic study].
    Zhonghua bing li xue za zhi = Chinese journal of pathology, 2012, Volume: 41, Issue:5

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; CD56 Antigen; Cyclophosphamid

2012
Clinical heterogeneity in childhood acute lymphoblastic leukemia with 11q23 rearrangements.
    Leukemia, 2003, Volume: 17, Issue:4

    Topics: Adolescent; Age Factors; Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Child; Child

2003
Clinical heterogeneity in childhood acute lymphoblastic leukemia with 11q23 rearrangements.
    Leukemia, 2003, Volume: 17, Issue:4

    Topics: Adolescent; Age Factors; Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Child; Child

2003
Clinical heterogeneity in childhood acute lymphoblastic leukemia with 11q23 rearrangements.
    Leukemia, 2003, Volume: 17, Issue:4

    Topics: Adolescent; Age Factors; Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Child; Child

2003
Acute lymphoblastic leukemia in a child with nephrotic syndrome.
    Pediatric nephrology (Berlin, Germany), 2004, Volume: 19, Issue:11

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child, Preschool; Cyclosporine; Dexame

2004
Acute lymphoblastic leukemia in a child with nephrotic syndrome.
    Pediatric nephrology (Berlin, Germany), 2004, Volume: 19, Issue:11

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child, Preschool; Cyclosporine; Dexame

2004
Acute lymphoblastic leukemia in a child with nephrotic syndrome.
    Pediatric nephrology (Berlin, Germany), 2004, Volume: 19, Issue:11

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child, Preschool; Cyclosporine; Dexame

2004
Lymphoblastic leukemia with mature B-cell phenotype in infancy.
    Journal of pediatric hematology/oncology, 2004, Volume: 26, Issue:10

    Topics: Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; B-Lymphocytes; DNA-Bindi

2004
Lymphoblastic leukemia with mature B-cell phenotype in infancy.
    Journal of pediatric hematology/oncology, 2004, Volume: 26, Issue:10

    Topics: Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; B-Lymphocytes; DNA-Bindi

2004
Lymphoblastic leukemia with mature B-cell phenotype in infancy.
    Journal of pediatric hematology/oncology, 2004, Volume: 26, Issue:10

    Topics: Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; B-Lymphocytes; DNA-Bindi

2004
Use of infliximab-daclizumab combination for the treatment of acute and chronic graft-versus-host disease of the liver and gut.
    Pediatric blood & cancer, 2007, Volume: 49, Issue:2

    Topics: Acute Disease; Adrenal Cortex Hormones; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; A

2007
Use of infliximab-daclizumab combination for the treatment of acute and chronic graft-versus-host disease of the liver and gut.
    Pediatric blood & cancer, 2007, Volume: 49, Issue:2

    Topics: Acute Disease; Adrenal Cortex Hormones; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; A

2007
Use of infliximab-daclizumab combination for the treatment of acute and chronic graft-versus-host disease of the liver and gut.
    Pediatric blood & cancer, 2007, Volume: 49, Issue:2

    Topics: Acute Disease; Adrenal Cortex Hormones; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; A

2007
Fourth biannual report of the Cochrane Haematological Malignancies Group.
    Journal of the National Cancer Institute, 2006, Apr-19, Volume: 98, Issue:8

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy

2006
Fourth biannual report of the Cochrane Haematological Malignancies Group.
    Journal of the National Cancer Institute, 2006, Apr-19, Volume: 98, Issue:8

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy

2006
Fourth biannual report of the Cochrane Haematological Malignancies Group.
    Journal of the National Cancer Institute, 2006, Apr-19, Volume: 98, Issue:8

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy

2006
Thrombotic complications in childhood acute lymphoblastic leukemia: a meta-analysis of 17 prospective studies comprising 1752 pediatric patients.
    Blood, 2006, Oct-01, Volume: 108, Issue:7

    Topics: Adolescent; Anthracyclines; Antineoplastic Agents, Hormonal; Asparaginase; Child; Child, Preschool;

2006
Thrombotic complications in childhood acute lymphoblastic leukemia: a meta-analysis of 17 prospective studies comprising 1752 pediatric patients.
    Blood, 2006, Oct-01, Volume: 108, Issue:7

    Topics: Adolescent; Anthracyclines; Antineoplastic Agents, Hormonal; Asparaginase; Child; Child, Preschool;

2006
Thrombotic complications in childhood acute lymphoblastic leukemia: a meta-analysis of 17 prospective studies comprising 1752 pediatric patients.
    Blood, 2006, Oct-01, Volume: 108, Issue:7

    Topics: Adolescent; Anthracyclines; Antineoplastic Agents, Hormonal; Asparaginase; Child; Child, Preschool;

2006
Rare oral cavity presentation of a B-cell lymphoblastic lymphoma. A case report and review of the literature.
    Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics, 2007, Volume: 103, Issue:6

    Topics: 12E7 Antigen; Antigens, CD; Antigens, CD20; Antineoplastic Combined Chemotherapy Protocols; Cell Adh

2007
Rare oral cavity presentation of a B-cell lymphoblastic lymphoma. A case report and review of the literature.
    Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics, 2007, Volume: 103, Issue:6

    Topics: 12E7 Antigen; Antigens, CD; Antigens, CD20; Antineoplastic Combined Chemotherapy Protocols; Cell Adh

2007
Rare oral cavity presentation of a B-cell lymphoblastic lymphoma. A case report and review of the literature.
    Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics, 2007, Volume: 103, Issue:6

    Topics: 12E7 Antigen; Antigens, CD; Antigens, CD20; Antineoplastic Combined Chemotherapy Protocols; Cell Adh

2007
A syndrome of lymphoblastic lymphoma, eosinophilia, and myeloid hyperplasia/malignancy associated with t(8;13)(p11;q11): description of a distinctive clinicopathologic entity.
    Blood, 1995, Apr-01, Volume: 85, Issue:7

    Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Prot

1995
A syndrome of lymphoblastic lymphoma, eosinophilia, and myeloid hyperplasia/malignancy associated with t(8;13)(p11;q11): description of a distinctive clinicopathologic entity.
    Blood, 1995, Apr-01, Volume: 85, Issue:7

    Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Prot

1995
A syndrome of lymphoblastic lymphoma, eosinophilia, and myeloid hyperplasia/malignancy associated with t(8;13)(p11;q11): description of a distinctive clinicopathologic entity.
    Blood, 1995, Apr-01, Volume: 85, Issue:7

    Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Prot

1995
[A heart transplant in a patient with doxorubicin-induced myocardiopathy as a complication of the treatment of a lymphoma].
    Revista espanola de cardiologia, 1994, Volume: 47, Issue:11

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cardiomyopathy, Dilated; Cyclophosphamide; Da

1994
[A heart transplant in a patient with doxorubicin-induced myocardiopathy as a complication of the treatment of a lymphoma].
    Revista espanola de cardiologia, 1994, Volume: 47, Issue:11

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cardiomyopathy, Dilated; Cyclophosphamide; Da

1994
[A heart transplant in a patient with doxorubicin-induced myocardiopathy as a complication of the treatment of a lymphoma].
    Revista espanola de cardiologia, 1994, Volume: 47, Issue:11

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cardiomyopathy, Dilated; Cyclophosphamide; Da

1994
Acute myelofibrosis terminating in acute lymphoblastic leukemia: case report and review of the literature.
    American journal of hematology, 1996, Volume: 51, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Blast Crisis; Bone Marrow; Chro

1996
Acute myelofibrosis terminating in acute lymphoblastic leukemia: case report and review of the literature.
    American journal of hematology, 1996, Volume: 51, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Blast Crisis; Bone Marrow; Chro

1996
Acute myelofibrosis terminating in acute lymphoblastic leukemia: case report and review of the literature.
    American journal of hematology, 1996, Volume: 51, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Blast Crisis; Bone Marrow; Chro

1996
[Chemotherapy of relapsed AML and ALL].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 1996, Volume: 37, Issue:8

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cytarabine; Etoposide; Granulocyte Col

1996
[Chemotherapy of relapsed AML and ALL].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 1996, Volume: 37, Issue:8

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cytarabine; Etoposide; Granulocyte Col

1996
[Chemotherapy of relapsed AML and ALL].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 1996, Volume: 37, Issue:8

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cytarabine; Etoposide; Granulocyte Col

1996
Burkitt's lymphoma-leukemia in patients treated for Hodgkin's disease.
    Cancer investigation, 1996, Volume: 14, Issue:6

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Burkitt Lymphoma; Cyclophosphamide

1996
Burkitt's lymphoma-leukemia in patients treated for Hodgkin's disease.
    Cancer investigation, 1996, Volume: 14, Issue:6

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Burkitt Lymphoma; Cyclophosphamide

1996
Burkitt's lymphoma-leukemia in patients treated for Hodgkin's disease.
    Cancer investigation, 1996, Volume: 14, Issue:6

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Burkitt Lymphoma; Cyclophosphamide

1996
[Treatment of acute lymphoblastic leukemias in adults].
    Przeglad lekarski, 1997, Volume: 54, Issue:9

    Topics: Adult; Aged; Anthracyclines; Bone Marrow Transplantation; Combined Modality Therapy; Drug Therapy, C

1997
[Treatment of acute lymphoblastic leukemias in adults].
    Przeglad lekarski, 1997, Volume: 54, Issue:9

    Topics: Adult; Aged; Anthracyclines; Bone Marrow Transplantation; Combined Modality Therapy; Drug Therapy, C

1997
[Treatment of acute lymphoblastic leukemias in adults].
    Przeglad lekarski, 1997, Volume: 54, Issue:9

    Topics: Adult; Aged; Anthracyclines; Bone Marrow Transplantation; Combined Modality Therapy; Drug Therapy, C

1997
Philadelphia chromosome-positive (Ph+) childhood acute lymphoblastic leukemia: good initial steroid response allows early prediction of a favorable treatment outcome.
    Blood, 1998, Oct-15, Volume: 92, Issue:8

    Topics: Adolescent; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Child;

1998
Philadelphia chromosome-positive (Ph+) childhood acute lymphoblastic leukemia: good initial steroid response allows early prediction of a favorable treatment outcome.
    Blood, 1998, Oct-15, Volume: 92, Issue:8

    Topics: Adolescent; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Child;

1998
Philadelphia chromosome-positive (Ph+) childhood acute lymphoblastic leukemia: good initial steroid response allows early prediction of a favorable treatment outcome.
    Blood, 1998, Oct-15, Volume: 92, Issue:8

    Topics: Adolescent; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Child;

1998
Glucocorticosteroid therapy in childhood acute lymphoblastic leukemia.
    Advances in experimental medicine and biology, 1999, Volume: 457

    Topics: Antineoplastic Agents; Apoptosis; Child; Dexamethasone; Drug Resistance, Neoplasm; Glucocorticoids;

1999
Glucocorticosteroid therapy in childhood acute lymphoblastic leukemia.
    Advances in experimental medicine and biology, 1999, Volume: 457

    Topics: Antineoplastic Agents; Apoptosis; Child; Dexamethasone; Drug Resistance, Neoplasm; Glucocorticoids;

1999
Glucocorticosteroid therapy in childhood acute lymphoblastic leukemia.
    Advances in experimental medicine and biology, 1999, Volume: 457

    Topics: Antineoplastic Agents; Apoptosis; Child; Dexamethasone; Drug Resistance, Neoplasm; Glucocorticoids;

1999
[Effects of chemotherapy on the changes of histology and function of the ovary].
    Zhonghua fu chan ke za zhi, 1998, Volume: 33, Issue:10

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Daunorubicin; Female; Fluorouracil; Human

1998
[Effects of chemotherapy on the changes of histology and function of the ovary].
    Zhonghua fu chan ke za zhi, 1998, Volume: 33, Issue:10

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Daunorubicin; Female; Fluorouracil; Human

1998
[Effects of chemotherapy on the changes of histology and function of the ovary].
    Zhonghua fu chan ke za zhi, 1998, Volume: 33, Issue:10

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Daunorubicin; Female; Fluorouracil; Human

1998
The management of neoplastic disorders of haematopoiesis in children with Down's syndrome.
    British journal of haematology, 2000, Volume: 110, Issue:3

    Topics: Acute Disease; Adolescent; Adult; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemother

2000
The management of neoplastic disorders of haematopoiesis in children with Down's syndrome.
    British journal of haematology, 2000, Volume: 110, Issue:3

    Topics: Acute Disease; Adolescent; Adult; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemother

2000
The management of neoplastic disorders of haematopoiesis in children with Down's syndrome.
    British journal of haematology, 2000, Volume: 110, Issue:3

    Topics: Acute Disease; Adolescent; Adult; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemother

2000
The hyper-CVAD regimen in adult acute lymphocytic leukemia.
    Hematology/oncology clinics of North America, 2000, Volume: 14, Issue:6

    Topics: Adolescent; Adult; Aged; Anti-Infective Agents; Antibiotic Prophylaxis; Antibodies, Monoclonal; Anti

2000
The hyper-CVAD regimen in adult acute lymphocytic leukemia.
    Hematology/oncology clinics of North America, 2000, Volume: 14, Issue:6

    Topics: Adolescent; Adult; Aged; Anti-Infective Agents; Antibiotic Prophylaxis; Antibodies, Monoclonal; Anti

2000
The hyper-CVAD regimen in adult acute lymphocytic leukemia.
    Hematology/oncology clinics of North America, 2000, Volume: 14, Issue:6

    Topics: Adolescent; Adult; Aged; Anti-Infective Agents; Antibiotic Prophylaxis; Antibodies, Monoclonal; Anti

2000
Induction therapy of adult acute lymphocytic leukemia without the use of vincristine or prednisone.
    Hematology/oncology clinics of North America, 2001, Volume: 15, Issue:1

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Clinical Trials

2001
Induction therapy of adult acute lymphocytic leukemia without the use of vincristine or prednisone.
    Hematology/oncology clinics of North America, 2001, Volume: 15, Issue:1

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Clinical Trials

2001
Induction therapy of adult acute lymphocytic leukemia without the use of vincristine or prednisone.
    Hematology/oncology clinics of North America, 2001, Volume: 15, Issue:1

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Clinical Trials

2001
Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of cancer and leukemia group B study 9251.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001, Oct-15, Volume: 19, Issue:20

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Cyclophosphamid

2001
Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of cancer and leukemia group B study 9251.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001, Oct-15, Volume: 19, Issue:20

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Cyclophosphamid

2001
Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of cancer and leukemia group B study 9251.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001, Oct-15, Volume: 19, Issue:20

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Cyclophosphamid

2001
Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of cancer and leukemia group B study 9251.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001, Oct-15, Volume: 19, Issue:20

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Cyclophosphamid

2001
Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of cancer and leukemia group B study 9251.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001, Oct-15, Volume: 19, Issue:20

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Cyclophosphamid

2001
Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of cancer and leukemia group B study 9251.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001, Oct-15, Volume: 19, Issue:20

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Cyclophosphamid

2001
Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of cancer and leukemia group B study 9251.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001, Oct-15, Volume: 19, Issue:20

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Cyclophosphamid

2001
Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of cancer and leukemia group B study 9251.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001, Oct-15, Volume: 19, Issue:20

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Cyclophosphamid

2001
Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of cancer and leukemia group B study 9251.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001, Oct-15, Volume: 19, Issue:20

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Cyclophosphamid

2001
Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of cancer and leukemia group B study 9251.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001, Oct-15, Volume: 19, Issue:20

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Cyclophosphamid

2001
Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of cancer and leukemia group B study 9251.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001, Oct-15, Volume: 19, Issue:20

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Cyclophosphamid

2001
Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of cancer and leukemia group B study 9251.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001, Oct-15, Volume: 19, Issue:20

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Cyclophosphamid

2001
Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of cancer and leukemia group B study 9251.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001, Oct-15, Volume: 19, Issue:20

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Cyclophosphamid

2001
Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of cancer and leukemia group B study 9251.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001, Oct-15, Volume: 19, Issue:20

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Cyclophosphamid

2001
Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of cancer and leukemia group B study 9251.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001, Oct-15, Volume: 19, Issue:20

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Cyclophosphamid

2001
Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of cancer and leukemia group B study 9251.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001, Oct-15, Volume: 19, Issue:20

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Cyclophosphamid

2001
Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of cancer and leukemia group B study 9251.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001, Oct-15, Volume: 19, Issue:20

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Cyclophosphamid

2001
Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of cancer and leukemia group B study 9251.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001, Oct-15, Volume: 19, Issue:20

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Cyclophosphamid

2001
Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of cancer and leukemia group B study 9251.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001, Oct-15, Volume: 19, Issue:20

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Cyclophosphamid

2001
Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of cancer and leukemia group B study 9251.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001, Oct-15, Volume: 19, Issue:20

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Cyclophosphamid

2001
Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of cancer and leukemia group B study 9251.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001, Oct-15, Volume: 19, Issue:20

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Cyclophosphamid

2001
Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of cancer and leukemia group B study 9251.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001, Oct-15, Volume: 19, Issue:20

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Cyclophosphamid

2001
Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of cancer and leukemia group B study 9251.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001, Oct-15, Volume: 19, Issue:20

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Cyclophosphamid

2001
Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of cancer and leukemia group B study 9251.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001, Oct-15, Volume: 19, Issue:20

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Cyclophosphamid

2001
Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of cancer and leukemia group B study 9251.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001, Oct-15, Volume: 19, Issue:20

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Cyclophosphamid

2001
Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of cancer and leukemia group B study 9251.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001, Oct-15, Volume: 19, Issue:20

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Cyclophosphamid

2001
Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of cancer and leukemia group B study 9251.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001, Oct-15, Volume: 19, Issue:20

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Cyclophosphamid

2001
Aggressive chemotherapy for acute leukemia relapsed after bone marrow transplantation: a second chance?
    Acta haematologica, 1992, Volume: 87, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Chemotherapy, Adjuvant;

1992
Aggressive chemotherapy for acute leukemia relapsed after bone marrow transplantation: a second chance?
    Acta haematologica, 1992, Volume: 87, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Chemotherapy, Adjuvant;

1992
Aggressive chemotherapy for acute leukemia relapsed after bone marrow transplantation: a second chance?
    Acta haematologica, 1992, Volume: 87, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Chemotherapy, Adjuvant;

1992
Intensive therapy for adult acute lymphoblastic leukemia.
    Seminars in hematology, 1991, Volume: 28, Issue:3 Suppl 4

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cyclophosphamide; Humans; Idaru

1991
Intensive therapy for adult acute lymphoblastic leukemia.
    Seminars in hematology, 1991, Volume: 28, Issue:3 Suppl 4

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cyclophosphamide; Humans; Idaru

1991
Intensive therapy for adult acute lymphoblastic leukemia.
    Seminars in hematology, 1991, Volume: 28, Issue:3 Suppl 4

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cyclophosphamide; Humans; Idaru

1991
Therapy for childhood non-Hodgkin's lymphomas, nonlymphoblastic type. Review of recent studies and current recommendations.
    The American journal of pediatric hematology/oncology, 1990,Fall, Volume: 12, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Brain Neoplasms; Cell Differentiation

1990
Therapy for childhood non-Hodgkin's lymphomas, nonlymphoblastic type. Review of recent studies and current recommendations.
    The American journal of pediatric hematology/oncology, 1990,Fall, Volume: 12, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Brain Neoplasms; Cell Differentiation

1990
Therapy for childhood non-Hodgkin's lymphomas, nonlymphoblastic type. Review of recent studies and current recommendations.
    The American journal of pediatric hematology/oncology, 1990,Fall, Volume: 12, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Brain Neoplasms; Cell Differentiation

1990
Reduced incidence of the somnolence syndrome in leukemic children with steroid coverage during prophylactic cranial radiation therapy. Results of a pilot study.
    Cancer, 1989, May-15, Volume: 63, Issue:10

    Topics: Adolescent; Brain Neoplasms; Child; Child, Preschool; Disorders of Excessive Somnolence; Female; Hea

1989
Reduced incidence of the somnolence syndrome in leukemic children with steroid coverage during prophylactic cranial radiation therapy. Results of a pilot study.
    Cancer, 1989, May-15, Volume: 63, Issue:10

    Topics: Adolescent; Brain Neoplasms; Child; Child, Preschool; Disorders of Excessive Somnolence; Female; Hea

1989
Reduced incidence of the somnolence syndrome in leukemic children with steroid coverage during prophylactic cranial radiation therapy. Results of a pilot study.
    Cancer, 1989, May-15, Volume: 63, Issue:10

    Topics: Adolescent; Brain Neoplasms; Child; Child, Preschool; Disorders of Excessive Somnolence; Female; Hea

1989
[Current status of the treatment of acute lymphocytic leukemia in the adult].
    Zhonghua nei ke za zhi, 1989, Volume: 28, Issue:8

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cyclophosphamide; Doxorubicin;

1989
[Current status of the treatment of acute lymphocytic leukemia in the adult].
    Zhonghua nei ke za zhi, 1989, Volume: 28, Issue:8

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cyclophosphamide; Doxorubicin;

1989
[Current status of the treatment of acute lymphocytic leukemia in the adult].
    Zhonghua nei ke za zhi, 1989, Volume: 28, Issue:8

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cyclophosphamide; Doxorubicin;

1989

Trials

167 trials available for prednisone and Precursor Cell Lymphoblastic Leukemia-Lymphoma

ArticleYear
    Neuropsychiatrie de l'enfance et de l'adolescence, 2023, Volume: 71, Issue:1

    Topics: Acceptance and Commitment Therapy; Adolescent; Adult; Aged; Aldehydes; Alpinia; Animals; Antibodies,

2023
    Neuropsychiatrie de l'enfance et de l'adolescence, 2023, Volume: 71, Issue:1

    Topics: Acceptance and Commitment Therapy; Adolescent; Adult; Aged; Aldehydes; Alpinia; Animals; Antibodies,

2023
    Neuropsychiatrie de l'enfance et de l'adolescence, 2023, Volume: 71, Issue:1

    Topics: Acceptance and Commitment Therapy; Adolescent; Adult; Aged; Aldehydes; Alpinia; Animals; Antibodies,

2023
Phase II study of dose-adjusted EPOCH as initial therapy for adults with high-risk acute lymphoblastic leukemia.
    Leukemia & lymphoma, 2023, Volume: 64, Issue:5

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Hum

2023
Phase II study of dose-adjusted EPOCH as initial therapy for adults with high-risk acute lymphoblastic leukemia.
    Leukemia & lymphoma, 2023, Volume: 64, Issue:5

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Hum

2023
Phase II study of dose-adjusted EPOCH as initial therapy for adults with high-risk acute lymphoblastic leukemia.
    Leukemia & lymphoma, 2023, Volume: 64, Issue:5

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Hum

2023
Dasatinib plus prednisone as induction and consolidation for adults with Ph-positive acute lymphoblastic leukaemia: A single-arm, multicentre, phase 2 trial.
    British journal of haematology, 2023, Volume: 202, Issue:6

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Dasatinib; Disease-Free Survival; Hemat

2023
Dasatinib plus prednisone as induction and consolidation for adults with Ph-positive acute lymphoblastic leukaemia: A single-arm, multicentre, phase 2 trial.
    British journal of haematology, 2023, Volume: 202, Issue:6

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Dasatinib; Disease-Free Survival; Hemat

2023
Dasatinib plus prednisone as induction and consolidation for adults with Ph-positive acute lymphoblastic leukaemia: A single-arm, multicentre, phase 2 trial.
    British journal of haematology, 2023, Volume: 202, Issue:6

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Dasatinib; Disease-Free Survival; Hemat

2023
Long-term treatment results of Polish pediatric and adolescent patients enrolled in the ALL IC-BFM 2002 trial.
    American journal of hematology, 2019, Volume: 94, Issue:11

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cause of Death; Cell Lineage; Child; Chi

2019
Long-term treatment results of Polish pediatric and adolescent patients enrolled in the ALL IC-BFM 2002 trial.
    American journal of hematology, 2019, Volume: 94, Issue:11

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cause of Death; Cell Lineage; Child; Chi

2019
Long-term treatment results of Polish pediatric and adolescent patients enrolled in the ALL IC-BFM 2002 trial.
    American journal of hematology, 2019, Volume: 94, Issue:11

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cause of Death; Cell Lineage; Child; Chi

2019
Randomized post-induction and delayed intensification therapy in high-risk pediatric acute lymphoblastic leukemia: long-term results of the international AIEOP-BFM ALL 2000 trial.
    Leukemia, 2020, Volume: 34, Issue:6

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; C

2020
Randomized post-induction and delayed intensification therapy in high-risk pediatric acute lymphoblastic leukemia: long-term results of the international AIEOP-BFM ALL 2000 trial.
    Leukemia, 2020, Volume: 34, Issue:6

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; C

2020
Randomized post-induction and delayed intensification therapy in high-risk pediatric acute lymphoblastic leukemia: long-term results of the international AIEOP-BFM ALL 2000 trial.
    Leukemia, 2020, Volume: 34, Issue:6

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; C

2020
Characteristics of Blood Transfusion During Induction Remission in Children With Acute Lymphoblastic Leukemia: A Single-Center Retrospective Investigation.
    Journal of pediatric hematology/oncology, 2020, Volume: 42, Issue:6

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Blood Transfusion; Child;

2020
Characteristics of Blood Transfusion During Induction Remission in Children With Acute Lymphoblastic Leukemia: A Single-Center Retrospective Investigation.
    Journal of pediatric hematology/oncology, 2020, Volume: 42, Issue:6

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Blood Transfusion; Child;

2020
Characteristics of Blood Transfusion During Induction Remission in Children With Acute Lymphoblastic Leukemia: A Single-Center Retrospective Investigation.
    Journal of pediatric hematology/oncology, 2020, Volume: 42, Issue:6

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Blood Transfusion; Child;

2020
Adolescent and young adult acute lymphoblastic leukemia. Final results of the phase II pediatric-like GIMEMA LAL-1308 trial.
    American journal of hematology, 2021, 03-01, Volume: 96, Issue:3

    Topics: Adolescent; Adult; Allografts; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Combine

2021
Adolescent and young adult acute lymphoblastic leukemia. Final results of the phase II pediatric-like GIMEMA LAL-1308 trial.
    American journal of hematology, 2021, 03-01, Volume: 96, Issue:3

    Topics: Adolescent; Adult; Allografts; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Combine

2021
Adolescent and young adult acute lymphoblastic leukemia. Final results of the phase II pediatric-like GIMEMA LAL-1308 trial.
    American journal of hematology, 2021, 03-01, Volume: 96, Issue:3

    Topics: Adolescent; Adult; Allografts; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Combine

2021
Adaptive functioning and academic achievement in survivors of childhood acute lymphoblastic leukemia: A report from the Children's Oncology Group.
    Pediatric blood & cancer, 2021, Volume: 68, Issue:4

    Topics: Academic Success; Adaptation, Psychological; Adolescent; Antineoplastic Agents; Cancer Survivors; Ch

2021
Adaptive functioning and academic achievement in survivors of childhood acute lymphoblastic leukemia: A report from the Children's Oncology Group.
    Pediatric blood & cancer, 2021, Volume: 68, Issue:4

    Topics: Academic Success; Adaptation, Psychological; Adolescent; Antineoplastic Agents; Cancer Survivors; Ch

2021
Adaptive functioning and academic achievement in survivors of childhood acute lymphoblastic leukemia: A report from the Children's Oncology Group.
    Pediatric blood & cancer, 2021, Volume: 68, Issue:4

    Topics: Academic Success; Adaptation, Psychological; Adolescent; Antineoplastic Agents; Cancer Survivors; Ch

2021
Molecular characterization of acute lymphoblastic leukemia with high CRLF2 gene expression in childhood.
    Pediatric blood & cancer, 2017, Volume: 64, Issue:10

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; D

2017
Molecular characterization of acute lymphoblastic leukemia with high CRLF2 gene expression in childhood.
    Pediatric blood & cancer, 2017, Volume: 64, Issue:10

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; D

2017
Molecular characterization of acute lymphoblastic leukemia with high CRLF2 gene expression in childhood.
    Pediatric blood & cancer, 2017, Volume: 64, Issue:10

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; D

2017
Results and conclusions of the European Intergroup EURO-LB02 trial in children and adolescents with lymphoblastic lymphoma.
    Haematologica, 2017, Volume: 102, Issue:12

    Topics: Adolescent; Child; Child, Preschool; Dexamethasone; Europe; Female; Humans; Infant; Male; Precursor

2017
Results and conclusions of the European Intergroup EURO-LB02 trial in children and adolescents with lymphoblastic lymphoma.
    Haematologica, 2017, Volume: 102, Issue:12

    Topics: Adolescent; Child; Child, Preschool; Dexamethasone; Europe; Female; Humans; Infant; Male; Precursor

2017
Results and conclusions of the European Intergroup EURO-LB02 trial in children and adolescents with lymphoblastic lymphoma.
    Haematologica, 2017, Volume: 102, Issue:12

    Topics: Adolescent; Child; Child, Preschool; Dexamethasone; Europe; Female; Humans; Infant; Male; Precursor

2017
Reduced-Intensity Delayed Intensification in Standard-Risk Pediatric Acute Lymphoblastic Leukemia Defined by Undetectable Minimal Residual Disease: Results of an International Randomized Trial (AIEOP-BFM ALL 2000).
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2018, 01-20, Volume: 36, Issue:3

    Topics: Adolescent; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cy

2018
Reduced-Intensity Delayed Intensification in Standard-Risk Pediatric Acute Lymphoblastic Leukemia Defined by Undetectable Minimal Residual Disease: Results of an International Randomized Trial (AIEOP-BFM ALL 2000).
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2018, 01-20, Volume: 36, Issue:3

    Topics: Adolescent; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cy

2018
Reduced-Intensity Delayed Intensification in Standard-Risk Pediatric Acute Lymphoblastic Leukemia Defined by Undetectable Minimal Residual Disease: Results of an International Randomized Trial (AIEOP-BFM ALL 2000).
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2018, 01-20, Volume: 36, Issue:3

    Topics: Adolescent; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cy

2018
Reduced-Intensity Delayed Intensification in Standard-Risk Pediatric Acute Lymphoblastic Leukemia Defined by Undetectable Minimal Residual Disease: Results of an International Randomized Trial (AIEOP-BFM ALL 2000).
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2018, 01-20, Volume: 36, Issue:3

    Topics: Adolescent; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cy

2018
Reduced-Intensity Delayed Intensification in Standard-Risk Pediatric Acute Lymphoblastic Leukemia Defined by Undetectable Minimal Residual Disease: Results of an International Randomized Trial (AIEOP-BFM ALL 2000).
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2018, 01-20, Volume: 36, Issue:3

    Topics: Adolescent; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cy

2018
Reduced-Intensity Delayed Intensification in Standard-Risk Pediatric Acute Lymphoblastic Leukemia Defined by Undetectable Minimal Residual Disease: Results of an International Randomized Trial (AIEOP-BFM ALL 2000).
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2018, 01-20, Volume: 36, Issue:3

    Topics: Adolescent; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cy

2018
Reduced-Intensity Delayed Intensification in Standard-Risk Pediatric Acute Lymphoblastic Leukemia Defined by Undetectable Minimal Residual Disease: Results of an International Randomized Trial (AIEOP-BFM ALL 2000).
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2018, 01-20, Volume: 36, Issue:3

    Topics: Adolescent; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cy

2018
Reduced-Intensity Delayed Intensification in Standard-Risk Pediatric Acute Lymphoblastic Leukemia Defined by Undetectable Minimal Residual Disease: Results of an International Randomized Trial (AIEOP-BFM ALL 2000).
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2018, 01-20, Volume: 36, Issue:3

    Topics: Adolescent; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cy

2018
Reduced-Intensity Delayed Intensification in Standard-Risk Pediatric Acute Lymphoblastic Leukemia Defined by Undetectable Minimal Residual Disease: Results of an International Randomized Trial (AIEOP-BFM ALL 2000).
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2018, 01-20, Volume: 36, Issue:3

    Topics: Adolescent; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cy

2018
Reduced-Intensity Delayed Intensification in Standard-Risk Pediatric Acute Lymphoblastic Leukemia Defined by Undetectable Minimal Residual Disease: Results of an International Randomized Trial (AIEOP-BFM ALL 2000).
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2018, 01-20, Volume: 36, Issue:3

    Topics: Adolescent; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cy

2018
Reduced-Intensity Delayed Intensification in Standard-Risk Pediatric Acute Lymphoblastic Leukemia Defined by Undetectable Minimal Residual Disease: Results of an International Randomized Trial (AIEOP-BFM ALL 2000).
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2018, 01-20, Volume: 36, Issue:3

    Topics: Adolescent; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cy

2018
Reduced-Intensity Delayed Intensification in Standard-Risk Pediatric Acute Lymphoblastic Leukemia Defined by Undetectable Minimal Residual Disease: Results of an International Randomized Trial (AIEOP-BFM ALL 2000).
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2018, 01-20, Volume: 36, Issue:3

    Topics: Adolescent; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cy

2018
Effectiveness of antibacterial prophylaxis during induction chemotherapy in children with acute lymphoblastic leukemia.
    Pediatric blood & cancer, 2018, Volume: 65, Issue:5

    Topics: Adolescent; Adult; Antibiotic Prophylaxis; Antineoplastic Combined Chemotherapy Protocols; Asparagin

2018
Effectiveness of antibacterial prophylaxis during induction chemotherapy in children with acute lymphoblastic leukemia.
    Pediatric blood & cancer, 2018, Volume: 65, Issue:5

    Topics: Adolescent; Adult; Antibiotic Prophylaxis; Antineoplastic Combined Chemotherapy Protocols; Asparagin

2018
Effectiveness of antibacterial prophylaxis during induction chemotherapy in children with acute lymphoblastic leukemia.
    Pediatric blood & cancer, 2018, Volume: 65, Issue:5

    Topics: Adolescent; Adult; Antibiotic Prophylaxis; Antineoplastic Combined Chemotherapy Protocols; Asparagin

2018
Pentoxifylline Added to Steroid Window Treatment Phase Modified Apoptotic Gene Expression in Pediatric Patients With Acute Lymphoblastic Leukemia.
    Journal of pediatric hematology/oncology, 2018, Volume: 40, Issue:5

    Topics: Adolescent; Apoptosis; Child; Child, Preschool; Female; Gene Expression Regulation, Leukemic; Humans

2018
Pentoxifylline Added to Steroid Window Treatment Phase Modified Apoptotic Gene Expression in Pediatric Patients With Acute Lymphoblastic Leukemia.
    Journal of pediatric hematology/oncology, 2018, Volume: 40, Issue:5

    Topics: Adolescent; Apoptosis; Child; Child, Preschool; Female; Gene Expression Regulation, Leukemic; Humans

2018
Pentoxifylline Added to Steroid Window Treatment Phase Modified Apoptotic Gene Expression in Pediatric Patients With Acute Lymphoblastic Leukemia.
    Journal of pediatric hematology/oncology, 2018, Volume: 40, Issue:5

    Topics: Adolescent; Apoptosis; Child; Child, Preschool; Female; Gene Expression Regulation, Leukemic; Humans

2018
High-risk childhood acute lymphoblastic leukemia in first remission treated with novel intensive chemotherapy and allogeneic transplantation.
    Leukemia, 2013, Volume: 27, Issue:7

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; C

2013
High-risk childhood acute lymphoblastic leukemia in first remission treated with novel intensive chemotherapy and allogeneic transplantation.
    Leukemia, 2013, Volume: 27, Issue:7

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; C

2013
High-risk childhood acute lymphoblastic leukemia in first remission treated with novel intensive chemotherapy and allogeneic transplantation.
    Leukemia, 2013, Volume: 27, Issue:7

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; C

2013
[Molecular genetic detection of minimal residual disease (MRD) in children with acute lymphoblastic leukemia].
    Klinische Padiatrie, 2013, Volume: 225 Suppl 1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Cyclophosphamide; Cytarabine; D

2013
[Molecular genetic detection of minimal residual disease (MRD) in children with acute lymphoblastic leukemia].
    Klinische Padiatrie, 2013, Volume: 225 Suppl 1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Cyclophosphamide; Cytarabine; D

2013
[Molecular genetic detection of minimal residual disease (MRD) in children with acute lymphoblastic leukemia].
    Klinische Padiatrie, 2013, Volume: 225 Suppl 1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Cyclophosphamide; Cytarabine; D

2013
Prediction of outcome by early response in childhood acute lymphoblastic leukemia.
    Klinische Padiatrie, 2013, Volume: 225 Suppl 1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Biopsy; Bone Marrow; Cell Lineage; Chi

2013
Prediction of outcome by early response in childhood acute lymphoblastic leukemia.
    Klinische Padiatrie, 2013, Volume: 225 Suppl 1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Biopsy; Bone Marrow; Cell Lineage; Chi

2013
Prediction of outcome by early response in childhood acute lymphoblastic leukemia.
    Klinische Padiatrie, 2013, Volume: 225 Suppl 1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Biopsy; Bone Marrow; Cell Lineage; Chi

2013
Neuropsychological outcomes of a randomized trial of prednisone versus dexamethasone in acute lymphoblastic leukemia: findings from Dana-Farber Cancer Institute All Consortium Protocol 00-01.
    Pediatric blood & cancer, 2013, Volume: 60, Issue:11

    Topics: Adolescent; Antineoplastic Agents; Child; Child, Preschool; Cognition; Dexamethasone; Female; Humans

2013
Neuropsychological outcomes of a randomized trial of prednisone versus dexamethasone in acute lymphoblastic leukemia: findings from Dana-Farber Cancer Institute All Consortium Protocol 00-01.
    Pediatric blood & cancer, 2013, Volume: 60, Issue:11

    Topics: Adolescent; Antineoplastic Agents; Child; Child, Preschool; Cognition; Dexamethasone; Female; Humans

2013
Neuropsychological outcomes of a randomized trial of prednisone versus dexamethasone in acute lymphoblastic leukemia: findings from Dana-Farber Cancer Institute All Consortium Protocol 00-01.
    Pediatric blood & cancer, 2013, Volume: 60, Issue:11

    Topics: Adolescent; Antineoplastic Agents; Child; Child, Preschool; Cognition; Dexamethasone; Female; Humans

2013
Long-term outcome of a pediatric-inspired regimen used for adults aged 18-50 years with newly diagnosed acute lymphoblastic leukemia.
    Leukemia, 2015, Volume: 29, Issue:3

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cytarabine; Doxorub

2015
Long-term outcome of a pediatric-inspired regimen used for adults aged 18-50 years with newly diagnosed acute lymphoblastic leukemia.
    Leukemia, 2015, Volume: 29, Issue:3

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cytarabine; Doxorub

2015
Long-term outcome of a pediatric-inspired regimen used for adults aged 18-50 years with newly diagnosed acute lymphoblastic leukemia.
    Leukemia, 2015, Volume: 29, Issue:3

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cytarabine; Doxorub

2015
Methodological aspects of minimal residual disease assessment by flow cytometry in acute lymphoblastic leukemia: A French multicenter study.
    Cytometry. Part B, Clinical cytometry, 2015, Volume: 88, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow; Child; Daunorubici

2015
Methodological aspects of minimal residual disease assessment by flow cytometry in acute lymphoblastic leukemia: A French multicenter study.
    Cytometry. Part B, Clinical cytometry, 2015, Volume: 88, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow; Child; Daunorubici

2015
Methodological aspects of minimal residual disease assessment by flow cytometry in acute lymphoblastic leukemia: A French multicenter study.
    Cytometry. Part B, Clinical cytometry, 2015, Volume: 88, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow; Child; Daunorubici

2015
Clinical utility of sequential minimal residual disease measurements in the context of risk-based therapy in childhood acute lymphoblastic leukaemia: a prospective study.
    The Lancet. Oncology, 2015, Volume: 16, Issue:4

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; D

2015
Clinical utility of sequential minimal residual disease measurements in the context of risk-based therapy in childhood acute lymphoblastic leukaemia: a prospective study.
    The Lancet. Oncology, 2015, Volume: 16, Issue:4

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; D

2015
Clinical utility of sequential minimal residual disease measurements in the context of risk-based therapy in childhood acute lymphoblastic leukaemia: a prospective study.
    The Lancet. Oncology, 2015, Volume: 16, Issue:4

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; D

2015
[The prospects for children with acute lymphoblastic leukemia of being cured has increased in the Czech Republic in the 21st century to 90% - outcome of the ALL-IC BFM 2002 trial].
    Casopis lekaru ceskych, 2015, Volume: 154, Issue:2

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; C

2015
[The prospects for children with acute lymphoblastic leukemia of being cured has increased in the Czech Republic in the 21st century to 90% - outcome of the ALL-IC BFM 2002 trial].
    Casopis lekaru ceskych, 2015, Volume: 154, Issue:2

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; C

2015
[The prospects for children with acute lymphoblastic leukemia of being cured has increased in the Czech Republic in the 21st century to 90% - outcome of the ALL-IC BFM 2002 trial].
    Casopis lekaru ceskych, 2015, Volume: 154, Issue:2

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; C

2015
Pentoxifylline during steroid window phase at induction to remission increases apoptosis in childhood with acute lymphoblastic leukemia.
    Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2016, Volume: 18, Issue:4

    Topics: Adolescent; Anti-Inflammatory Agents; Apoptosis; Child; Child, Preschool; Drug Therapy, Combination;

2016
Pentoxifylline during steroid window phase at induction to remission increases apoptosis in childhood with acute lymphoblastic leukemia.
    Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2016, Volume: 18, Issue:4

    Topics: Adolescent; Anti-Inflammatory Agents; Apoptosis; Child; Child, Preschool; Drug Therapy, Combination;

2016
Pentoxifylline during steroid window phase at induction to remission increases apoptosis in childhood with acute lymphoblastic leukemia.
    Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2016, Volume: 18, Issue:4

    Topics: Adolescent; Anti-Inflammatory Agents; Apoptosis; Child; Child, Preschool; Drug Therapy, Combination;

2016
A genetic factor associated with low final bone mineral density in children after a long-term glucocorticoids treatment.
    The pharmacogenomics journal, 2017, Volume: 17, Issue:2

    Topics: Absorptiometry, Photon; Age Factors; Anti-Asthmatic Agents; Antineoplastic Agents; Asthma; Bone Dens

2017
A genetic factor associated with low final bone mineral density in children after a long-term glucocorticoids treatment.
    The pharmacogenomics journal, 2017, Volume: 17, Issue:2

    Topics: Absorptiometry, Photon; Age Factors; Anti-Asthmatic Agents; Antineoplastic Agents; Asthma; Bone Dens

2017
A genetic factor associated with low final bone mineral density in children after a long-term glucocorticoids treatment.
    The pharmacogenomics journal, 2017, Volume: 17, Issue:2

    Topics: Absorptiometry, Photon; Age Factors; Anti-Asthmatic Agents; Antineoplastic Agents; Asthma; Bone Dens

2017
Dexamethasone vs prednisone in induction treatment of pediatric ALL: results of the randomized trial AIEOP-BFM ALL 2000.
    Blood, 2016, 04-28, Volume: 127, Issue:17

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modali

2016
Dexamethasone vs prednisone in induction treatment of pediatric ALL: results of the randomized trial AIEOP-BFM ALL 2000.
    Blood, 2016, 04-28, Volume: 127, Issue:17

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modali

2016
Dexamethasone vs prednisone in induction treatment of pediatric ALL: results of the randomized trial AIEOP-BFM ALL 2000.
    Blood, 2016, 04-28, Volume: 127, Issue:17

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modali

2016
Dexamethasone vs prednisone in induction treatment of pediatric ALL: results of the randomized trial AIEOP-BFM ALL 2000.
    Blood, 2016, 04-28, Volume: 127, Issue:17

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modali

2016
Dexamethasone vs prednisone in induction treatment of pediatric ALL: results of the randomized trial AIEOP-BFM ALL 2000.
    Blood, 2016, 04-28, Volume: 127, Issue:17

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modali

2016
Dexamethasone vs prednisone in induction treatment of pediatric ALL: results of the randomized trial AIEOP-BFM ALL 2000.
    Blood, 2016, 04-28, Volume: 127, Issue:17

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modali

2016
Dexamethasone vs prednisone in induction treatment of pediatric ALL: results of the randomized trial AIEOP-BFM ALL 2000.
    Blood, 2016, 04-28, Volume: 127, Issue:17

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modali

2016
Dexamethasone vs prednisone in induction treatment of pediatric ALL: results of the randomized trial AIEOP-BFM ALL 2000.
    Blood, 2016, 04-28, Volume: 127, Issue:17

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modali

2016
Dexamethasone vs prednisone in induction treatment of pediatric ALL: results of the randomized trial AIEOP-BFM ALL 2000.
    Blood, 2016, 04-28, Volume: 127, Issue:17

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modali

2016
Dexamethasone vs prednisone in induction treatment of pediatric ALL: results of the randomized trial AIEOP-BFM ALL 2000.
    Blood, 2016, 04-28, Volume: 127, Issue:17

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modali

2016
Dexamethasone vs prednisone in induction treatment of pediatric ALL: results of the randomized trial AIEOP-BFM ALL 2000.
    Blood, 2016, 04-28, Volume: 127, Issue:17

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modali

2016
Dexamethasone vs prednisone in induction treatment of pediatric ALL: results of the randomized trial AIEOP-BFM ALL 2000.
    Blood, 2016, 04-28, Volume: 127, Issue:17

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modali

2016
Predominant cerebral cytokine release syndrome in CD19-directed chimeric antigen receptor-modified T cell therapy.
    Journal of hematology & oncology, 2016, 08-15, Volume: 9, Issue:1

    Topics: Adult; Antigens, CD19; Blood-Brain Barrier; Brain Edema; Cytokines; Female; Humans; Immunotherapy, A

2016
Predominant cerebral cytokine release syndrome in CD19-directed chimeric antigen receptor-modified T cell therapy.
    Journal of hematology & oncology, 2016, 08-15, Volume: 9, Issue:1

    Topics: Adult; Antigens, CD19; Blood-Brain Barrier; Brain Edema; Cytokines; Female; Humans; Immunotherapy, A

2016
Predominant cerebral cytokine release syndrome in CD19-directed chimeric antigen receptor-modified T cell therapy.
    Journal of hematology & oncology, 2016, 08-15, Volume: 9, Issue:1

    Topics: Adult; Antigens, CD19; Blood-Brain Barrier; Brain Edema; Cytokines; Female; Humans; Immunotherapy, A

2016
High hyperdiploid acute lymphoblastic leukemia (ALL)-A 25-year population-based survey of the Austrian ALL-BFM (Berlin-Frankfurt-Münster) Study Group.
    Pediatric blood & cancer, 2017, Volume: 64, Issue:6

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; C

2017
High hyperdiploid acute lymphoblastic leukemia (ALL)-A 25-year population-based survey of the Austrian ALL-BFM (Berlin-Frankfurt-Münster) Study Group.
    Pediatric blood & cancer, 2017, Volume: 64, Issue:6

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; C

2017
High hyperdiploid acute lymphoblastic leukemia (ALL)-A 25-year population-based survey of the Austrian ALL-BFM (Berlin-Frankfurt-Münster) Study Group.
    Pediatric blood & cancer, 2017, Volume: 64, Issue:6

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; C

2017
Outcome of Reinduction Chemotherapy with a Modified Dose of Idarubicin for Children with Marrow-Relapsed Acute Lymphoblastic Leukemia: Results of the Childhood Acute Lymphoblastic Leukemia (CALL)-0603 Study.
    Journal of Korean medical science, 2017, Volume: 32, Issue:4

    Topics: Adolescent; Antibiotics, Antineoplastic; Asparaginase; Bone Marrow; Child; Child, Preschool; Disease

2017
Outcome of Reinduction Chemotherapy with a Modified Dose of Idarubicin for Children with Marrow-Relapsed Acute Lymphoblastic Leukemia: Results of the Childhood Acute Lymphoblastic Leukemia (CALL)-0603 Study.
    Journal of Korean medical science, 2017, Volume: 32, Issue:4

    Topics: Adolescent; Antibiotics, Antineoplastic; Asparaginase; Bone Marrow; Child; Child, Preschool; Disease

2017
Outcome of Reinduction Chemotherapy with a Modified Dose of Idarubicin for Children with Marrow-Relapsed Acute Lymphoblastic Leukemia: Results of the Childhood Acute Lymphoblastic Leukemia (CALL)-0603 Study.
    Journal of Korean medical science, 2017, Volume: 32, Issue:4

    Topics: Adolescent; Antibiotics, Antineoplastic; Asparaginase; Bone Marrow; Child; Child, Preschool; Disease

2017
Reinduction platform for children with first marrow relapse of acute lymphoblastic Leukemia: A Children's Oncology Group Study[corrected].
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2008, Aug-20, Volume: 26, Issue:24

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Neoplasms; Central Ne

2008
Reinduction platform for children with first marrow relapse of acute lymphoblastic Leukemia: A Children's Oncology Group Study[corrected].
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2008, Aug-20, Volume: 26, Issue:24

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Neoplasms; Central Ne

2008
Reinduction platform for children with first marrow relapse of acute lymphoblastic Leukemia: A Children's Oncology Group Study[corrected].
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2008, Aug-20, Volume: 26, Issue:24

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Neoplasms; Central Ne

2008
Minimal residual disease is an important predictive factor of outcome in children with relapsed 'high-risk' acute lymphoblastic leukemia.
    Leukemia, 2008, Volume: 22, Issue:12

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; C

2008
Minimal residual disease is an important predictive factor of outcome in children with relapsed 'high-risk' acute lymphoblastic leukemia.
    Leukemia, 2008, Volume: 22, Issue:12

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; C

2008
Minimal residual disease is an important predictive factor of outcome in children with relapsed 'high-risk' acute lymphoblastic leukemia.
    Leukemia, 2008, Volume: 22, Issue:12

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; C

2008
The impact of acute lymphoblastic leukemia treatment on central nervous system results in Bogota, Colombia.
    Journal of pediatric hematology/oncology, 2008, Volume: 30, Issue:9

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Child;

2008
The impact of acute lymphoblastic leukemia treatment on central nervous system results in Bogota, Colombia.
    Journal of pediatric hematology/oncology, 2008, Volume: 30, Issue:9

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Child;

2008
The impact of acute lymphoblastic leukemia treatment on central nervous system results in Bogota, Colombia.
    Journal of pediatric hematology/oncology, 2008, Volume: 30, Issue:9

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Child;

2008
Augmented and standard Berlin-Frankfurt-Munster chemotherapy for treatment of adult acute lymphoblastic leukemia.
    Leukemia & lymphoma, 2008, Volume: 49, Issue:12

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Daunorubicin; Humans; Inf

2008
Augmented and standard Berlin-Frankfurt-Munster chemotherapy for treatment of adult acute lymphoblastic leukemia.
    Leukemia & lymphoma, 2008, Volume: 49, Issue:12

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Daunorubicin; Humans; Inf

2008
Augmented and standard Berlin-Frankfurt-Munster chemotherapy for treatment of adult acute lymphoblastic leukemia.
    Leukemia & lymphoma, 2008, Volume: 49, Issue:12

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Daunorubicin; Humans; Inf

2008
Impact of age, leukocyte count and day 21-bone marrow response to chemotherapy on the long-term outcome of children with philadelphia chromosome-positive acute lymphoblastic leukemia in the pre-imatinib era: results of the FRALLE 93 study.
    BMC cancer, 2009, Jan-13, Volume: 9

    Topics: Acute Disease; Adolescent; Age Factors; Anthracyclines; Antineoplastic Combined Chemotherapy Protoco

2009
Impact of age, leukocyte count and day 21-bone marrow response to chemotherapy on the long-term outcome of children with philadelphia chromosome-positive acute lymphoblastic leukemia in the pre-imatinib era: results of the FRALLE 93 study.
    BMC cancer, 2009, Jan-13, Volume: 9

    Topics: Acute Disease; Adolescent; Age Factors; Anthracyclines; Antineoplastic Combined Chemotherapy Protoco

2009
Impact of age, leukocyte count and day 21-bone marrow response to chemotherapy on the long-term outcome of children with philadelphia chromosome-positive acute lymphoblastic leukemia in the pre-imatinib era: results of the FRALLE 93 study.
    BMC cancer, 2009, Jan-13, Volume: 9

    Topics: Acute Disease; Adolescent; Age Factors; Anthracyclines; Antineoplastic Combined Chemotherapy Protoco

2009
Management of hyperleukocytosis and prevention of tumor lysis syndrome with low-dose prednisone continuous infusion in children with acute lymphoblastic leukemia.
    Acta haematologica, 2009, Volume: 121, Issue:1

    Topics: Adolescent; Antineoplastic Agents, Hormonal; Child; Child, Preschool; Female; Humans; Infant; Infusi

2009
Management of hyperleukocytosis and prevention of tumor lysis syndrome with low-dose prednisone continuous infusion in children with acute lymphoblastic leukemia.
    Acta haematologica, 2009, Volume: 121, Issue:1

    Topics: Adolescent; Antineoplastic Agents, Hormonal; Child; Child, Preschool; Female; Humans; Infant; Infusi

2009
Management of hyperleukocytosis and prevention of tumor lysis syndrome with low-dose prednisone continuous infusion in children with acute lymphoblastic leukemia.
    Acta haematologica, 2009, Volume: 121, Issue:1

    Topics: Adolescent; Antineoplastic Agents, Hormonal; Child; Child, Preschool; Female; Humans; Infant; Infusi

2009
Response to glucocorticoids and toxicity in childhood acute lymphoblastic leukemia: role of polymorphisms of genes involved in glucocorticoid response.
    Pediatric blood & cancer, 2009, Volume: 53, Issue:6

    Topics: Adolescent; Child; Child, Preschool; Dexamethasone; Female; Glucocorticoids; Glutathione Transferase

2009
Response to glucocorticoids and toxicity in childhood acute lymphoblastic leukemia: role of polymorphisms of genes involved in glucocorticoid response.
    Pediatric blood & cancer, 2009, Volume: 53, Issue:6

    Topics: Adolescent; Child; Child, Preschool; Dexamethasone; Female; Glucocorticoids; Glutathione Transferase

2009
Response to glucocorticoids and toxicity in childhood acute lymphoblastic leukemia: role of polymorphisms of genes involved in glucocorticoid response.
    Pediatric blood & cancer, 2009, Volume: 53, Issue:6

    Topics: Adolescent; Child; Child, Preschool; Dexamethasone; Female; Glucocorticoids; Glutathione Transferase

2009
Oral methotrexate/6-mercaptopurine may be superior to a multidrug LSA2L2 Maintenance therapy for higher risk childhood acute lymphoblastic leukemia: results from the NOPHO ALL-92 study.
    Journal of pediatric hematology/oncology, 2009, Volume: 31, Issue:6

    Topics: Administration, Oral; Adolescent; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemother

2009
Oral methotrexate/6-mercaptopurine may be superior to a multidrug LSA2L2 Maintenance therapy for higher risk childhood acute lymphoblastic leukemia: results from the NOPHO ALL-92 study.
    Journal of pediatric hematology/oncology, 2009, Volume: 31, Issue:6

    Topics: Administration, Oral; Adolescent; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemother

2009
Oral methotrexate/6-mercaptopurine may be superior to a multidrug LSA2L2 Maintenance therapy for higher risk childhood acute lymphoblastic leukemia: results from the NOPHO ALL-92 study.
    Journal of pediatric hematology/oncology, 2009, Volume: 31, Issue:6

    Topics: Administration, Oral; Adolescent; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemother

2009
Randomized trial to compare LSA2L2-type maintenance therapy to daily 6-mercaptopurine and weekly methotrexate with vincristine and dexamethasone pulse for children with acute lymphoblastic leukemia.
    Pediatric blood & cancer, 2010, Volume: 55, Issue:2

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Chemical and Drug Induced Liver Injury;

2010
Randomized trial to compare LSA2L2-type maintenance therapy to daily 6-mercaptopurine and weekly methotrexate with vincristine and dexamethasone pulse for children with acute lymphoblastic leukemia.
    Pediatric blood & cancer, 2010, Volume: 55, Issue:2

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Chemical and Drug Induced Liver Injury;

2010
Randomized trial to compare LSA2L2-type maintenance therapy to daily 6-mercaptopurine and weekly methotrexate with vincristine and dexamethasone pulse for children with acute lymphoblastic leukemia.
    Pediatric blood & cancer, 2010, Volume: 55, Issue:2

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Chemical and Drug Induced Liver Injury;

2010
[Is there a risk of steroid-induced adrenal deficit after induction treatment of acute lymphoblastic leukemia?].
    Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 2010, Volume: 17, Issue:12

    Topics: Adolescent; Adrenal Insufficiency; Child; Child, Preschool; Cosyntropin; Dexamethasone; Female; Gluc

2010
[Is there a risk of steroid-induced adrenal deficit after induction treatment of acute lymphoblastic leukemia?].
    Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 2010, Volume: 17, Issue:12

    Topics: Adolescent; Adrenal Insufficiency; Child; Child, Preschool; Cosyntropin; Dexamethasone; Female; Gluc

2010
[Is there a risk of steroid-induced adrenal deficit after induction treatment of acute lymphoblastic leukemia?].
    Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 2010, Volume: 17, Issue:12

    Topics: Adolescent; Adrenal Insufficiency; Child; Child, Preschool; Cosyntropin; Dexamethasone; Female; Gluc

2010
Pharmacokinetic, pharmacodynamic, and pharmacogenetic determinants of osteonecrosis in children with acute lymphoblastic leukemia.
    Blood, 2011, Feb-24, Volume: 117, Issue:8

    Topics: Antineoplastic Agents, Hormonal; Child; Dexamethasone; Genome-Wide Association Study; Humans; Magnet

2011
Pharmacokinetic, pharmacodynamic, and pharmacogenetic determinants of osteonecrosis in children with acute lymphoblastic leukemia.
    Blood, 2011, Feb-24, Volume: 117, Issue:8

    Topics: Antineoplastic Agents, Hormonal; Child; Dexamethasone; Genome-Wide Association Study; Humans; Magnet

2011
Pharmacokinetic, pharmacodynamic, and pharmacogenetic determinants of osteonecrosis in children with acute lymphoblastic leukemia.
    Blood, 2011, Feb-24, Volume: 117, Issue:8

    Topics: Antineoplastic Agents, Hormonal; Child; Dexamethasone; Genome-Wide Association Study; Humans; Magnet

2011
[Long-term observations of children with acute lymphoblastic leukemia and high leukocytosis treated according to modified "New York" protocols (1987-2003)].
    Przeglad lekarski, 2010, Volume: 67, Issue:6

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; C

2010
[Long-term observations of children with acute lymphoblastic leukemia and high leukocytosis treated according to modified "New York" protocols (1987-2003)].
    Przeglad lekarski, 2010, Volume: 67, Issue:6

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; C

2010
[Long-term observations of children with acute lymphoblastic leukemia and high leukocytosis treated according to modified "New York" protocols (1987-2003)].
    Przeglad lekarski, 2010, Volume: 67, Issue:6

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; C

2010
Augmented therapy improves outcome for pediatric high risk acute lymphocytic leukemia: results of Children's Oncology Group trial P9906.
    Pediatric blood & cancer, 2011, Volume: 57, Issue:4

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; C

2011
Augmented therapy improves outcome for pediatric high risk acute lymphocytic leukemia: results of Children's Oncology Group trial P9906.
    Pediatric blood & cancer, 2011, Volume: 57, Issue:4

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; C

2011
Augmented therapy improves outcome for pediatric high risk acute lymphocytic leukemia: results of Children's Oncology Group trial P9906.
    Pediatric blood & cancer, 2011, Volume: 57, Issue:4

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; C

2011
No advantage of a rotational continuation phase in acute lymphoblastic leukemia in childhood treated with a BFM back-bone therapy.
    Pediatric blood & cancer, 2011, Jul-15, Volume: 57, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child, Preschool; Daunorubicin; Diseas

2011
No advantage of a rotational continuation phase in acute lymphoblastic leukemia in childhood treated with a BFM back-bone therapy.
    Pediatric blood & cancer, 2011, Jul-15, Volume: 57, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child, Preschool; Daunorubicin; Diseas

2011
No advantage of a rotational continuation phase in acute lymphoblastic leukemia in childhood treated with a BFM back-bone therapy.
    Pediatric blood & cancer, 2011, Jul-15, Volume: 57, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child, Preschool; Daunorubicin; Diseas

2011
Polyethylene Glycol-conjugated L-asparaginase versus native L-asparaginase in combination with standard agents for children with acute lymphoblastic leukemia in second bone marrow relapse: a Children's Oncology Group Study (POG 8866).
    Journal of pediatric hematology/oncology, 2011, Volume: 33, Issue:8

    Topics: Adolescent; Antibodies; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow; C

2011
Polyethylene Glycol-conjugated L-asparaginase versus native L-asparaginase in combination with standard agents for children with acute lymphoblastic leukemia in second bone marrow relapse: a Children's Oncology Group Study (POG 8866).
    Journal of pediatric hematology/oncology, 2011, Volume: 33, Issue:8

    Topics: Adolescent; Antibodies; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow; C

2011
Polyethylene Glycol-conjugated L-asparaginase versus native L-asparaginase in combination with standard agents for children with acute lymphoblastic leukemia in second bone marrow relapse: a Children's Oncology Group Study (POG 8866).
    Journal of pediatric hematology/oncology, 2011, Volume: 33, Issue:8

    Topics: Adolescent; Antibodies; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow; C

2011
Outcome of newly diagnosed children and adolescents with localized lymphoblastic lymphoma treated on Children's Oncology Group trial A5971: a report from the Children's Oncology Group.
    Pediatric blood & cancer, 2012, Dec-15, Volume: 59, Issue:7

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Daunorubicin; Disease-Free Survival; H

2012
Outcome of newly diagnosed children and adolescents with localized lymphoblastic lymphoma treated on Children's Oncology Group trial A5971: a report from the Children's Oncology Group.
    Pediatric blood & cancer, 2012, Dec-15, Volume: 59, Issue:7

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Daunorubicin; Disease-Free Survival; H

2012
Outcome of newly diagnosed children and adolescents with localized lymphoblastic lymphoma treated on Children's Oncology Group trial A5971: a report from the Children's Oncology Group.
    Pediatric blood & cancer, 2012, Dec-15, Volume: 59, Issue:7

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Daunorubicin; Disease-Free Survival; H

2012
Treatment of young patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia using increased dose of imatinib and deintensified chemotherapy before allogeneic stem cell transplantation.
    British journal of haematology, 2012, Volume: 159, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Combined Modality Therapy; Cytara

2012
Treatment of young patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia using increased dose of imatinib and deintensified chemotherapy before allogeneic stem cell transplantation.
    British journal of haematology, 2012, Volume: 159, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Combined Modality Therapy; Cytara

2012
Treatment of young patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia using increased dose of imatinib and deintensified chemotherapy before allogeneic stem cell transplantation.
    British journal of haematology, 2012, Volume: 159, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Combined Modality Therapy; Cytara

2012
Effect of alternate-week versus continuous dexamethasone scheduling on the risk of osteonecrosis in paediatric patients with acute lymphoblastic leukaemia: results from the CCG-1961 randomised cohort trial.
    The Lancet. Oncology, 2012, Volume: 13, Issue:9

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; C

2012
Effect of alternate-week versus continuous dexamethasone scheduling on the risk of osteonecrosis in paediatric patients with acute lymphoblastic leukaemia: results from the CCG-1961 randomised cohort trial.
    The Lancet. Oncology, 2012, Volume: 13, Issue:9

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; C

2012
Effect of alternate-week versus continuous dexamethasone scheduling on the risk of osteonecrosis in paediatric patients with acute lymphoblastic leukaemia: results from the CCG-1961 randomised cohort trial.
    The Lancet. Oncology, 2012, Volume: 13, Issue:9

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; C

2012
Cognitive outcomes following contemporary treatment without cranial irradiation for childhood acute lymphoblastic leukemia.
    Journal of the National Cancer Institute, 2012, Sep-19, Volume: 104, Issue:18

    Topics: Adolescent; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Attention; Child; Child, Pr

2012
Cognitive outcomes following contemporary treatment without cranial irradiation for childhood acute lymphoblastic leukemia.
    Journal of the National Cancer Institute, 2012, Sep-19, Volume: 104, Issue:18

    Topics: Adolescent; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Attention; Child; Child, Pr

2012
Cognitive outcomes following contemporary treatment without cranial irradiation for childhood acute lymphoblastic leukemia.
    Journal of the National Cancer Institute, 2012, Sep-19, Volume: 104, Issue:18

    Topics: Adolescent; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Attention; Child; Child, Pr

2012
Treatment outcome of adolescents with acute lymphoblastic leukemia.
    Annals of hematology, 2002, Volume: 81, Issue:11

    Topics: Adolescent; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Fe

2002
Treatment outcome of adolescents with acute lymphoblastic leukemia.
    Annals of hematology, 2002, Volume: 81, Issue:11

    Topics: Adolescent; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Fe

2002
Treatment outcome of adolescents with acute lymphoblastic leukemia.
    Annals of hematology, 2002, Volume: 81, Issue:11

    Topics: Adolescent; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Fe

2002
Thromboembolic events in children with acute lymphoblastic leukemia (BFM protocols): prednisone versus dexamethasone administration.
    Blood, 2003, Apr-01, Volume: 101, Issue:7

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; D

2003
Thromboembolic events in children with acute lymphoblastic leukemia (BFM protocols): prednisone versus dexamethasone administration.
    Blood, 2003, Apr-01, Volume: 101, Issue:7

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; D

2003
Thromboembolic events in children with acute lymphoblastic leukemia (BFM protocols): prednisone versus dexamethasone administration.
    Blood, 2003, Apr-01, Volume: 101, Issue:7

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; D

2003
Dexamethasone versus prednisone and daily oral versus weekly intravenous mercaptopurine for patients with standard-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group.
    Blood, 2003, May-15, Volume: 101, Issue:10

    Topics: Administration, Oral; Antimetabolites, Antineoplastic; Blood Cell Count; Child; Child, Preschool; De

2003
Dexamethasone versus prednisone and daily oral versus weekly intravenous mercaptopurine for patients with standard-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group.
    Blood, 2003, May-15, Volume: 101, Issue:10

    Topics: Administration, Oral; Antimetabolites, Antineoplastic; Blood Cell Count; Child; Child, Preschool; De

2003
Dexamethasone versus prednisone and daily oral versus weekly intravenous mercaptopurine for patients with standard-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group.
    Blood, 2003, May-15, Volume: 101, Issue:10

    Topics: Administration, Oral; Antimetabolites, Antineoplastic; Blood Cell Count; Child; Child, Preschool; De

2003
The dose related effect of steroids on blast reduction rate and event free survival in children with acute lymphoblastic leukemia.
    Leukemia & lymphoma, 2003, Volume: 44, Issue:3

    Topics: Adolescent; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Asparag

2003
The dose related effect of steroids on blast reduction rate and event free survival in children with acute lymphoblastic leukemia.
    Leukemia & lymphoma, 2003, Volume: 44, Issue:3

    Topics: Adolescent; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Asparag

2003
The dose related effect of steroids on blast reduction rate and event free survival in children with acute lymphoblastic leukemia.
    Leukemia & lymphoma, 2003, Volume: 44, Issue:3

    Topics: Adolescent; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Asparag

2003
Human granulocyte colony-stimulating factor in children with high-risk acute lymphoblastic leukemia: a Children's Cancer Group Study.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2003, Apr-15, Volume: 21, Issue:8

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Presc

2003
Human granulocyte colony-stimulating factor in children with high-risk acute lymphoblastic leukemia: a Children's Cancer Group Study.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2003, Apr-15, Volume: 21, Issue:8

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Presc

2003
Human granulocyte colony-stimulating factor in children with high-risk acute lymphoblastic leukemia: a Children's Cancer Group Study.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2003, Apr-15, Volume: 21, Issue:8

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Presc

2003
Long-term survival in acute lymphoblastic leukaemia in adults treated according to the LALA 87 protocol.
    Chemotherapy, 2003, Volume: 49, Issue:3

    Topics: Administration, Oral; Adolescent; Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Pro

2003
Long-term survival in acute lymphoblastic leukaemia in adults treated according to the LALA 87 protocol.
    Chemotherapy, 2003, Volume: 49, Issue:3

    Topics: Administration, Oral; Adolescent; Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Pro

2003
Long-term survival in acute lymphoblastic leukaemia in adults treated according to the LALA 87 protocol.
    Chemotherapy, 2003, Volume: 49, Issue:3

    Topics: Administration, Oral; Adolescent; Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Pro

2003
Osteonecrosis: An emerging complication of intensive chemotherapy for childhood acute lymphoblastic leukemia.
    Haematologica, 2003, Volume: 88, Issue:7

    Topics: Adolescent; Antineoplastic Agents, Hormonal; Child; Dexamethasone; Drug Therapy, Combination; Female

2003
Osteonecrosis: An emerging complication of intensive chemotherapy for childhood acute lymphoblastic leukemia.
    Haematologica, 2003, Volume: 88, Issue:7

    Topics: Adolescent; Antineoplastic Agents, Hormonal; Child; Dexamethasone; Drug Therapy, Combination; Female

2003
Osteonecrosis: An emerging complication of intensive chemotherapy for childhood acute lymphoblastic leukemia.
    Haematologica, 2003, Volume: 88, Issue:7

    Topics: Adolescent; Antineoplastic Agents, Hormonal; Child; Dexamethasone; Drug Therapy, Combination; Female

2003
[Improved results in children with acute lymphoblastic leukemia treated with the ALL-BFM 90 protocol in the Czech Republic].
    Casopis lekaru ceskych, 2003, Volume: 142, Issue:7

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; C

2003
[Improved results in children with acute lymphoblastic leukemia treated with the ALL-BFM 90 protocol in the Czech Republic].
    Casopis lekaru ceskych, 2003, Volume: 142, Issue:7

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; C

2003
[Improved results in children with acute lymphoblastic leukemia treated with the ALL-BFM 90 protocol in the Czech Republic].
    Casopis lekaru ceskych, 2003, Volume: 142, Issue:7

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; C

2003
A randomized trial of induction therapy (daunorubicin, vincristine, prednisone versus daunorubicin, vincristine, prednisone, cytarabine and 6-thioguanine) in adult acute lymphoblastic leukemia with long-term follow-up: an Eastern Cooperative Oncology Grou
    Leukemia & lymphoma, 2003, Volume: 44, Issue:9

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabin

2003
A randomized trial of induction therapy (daunorubicin, vincristine, prednisone versus daunorubicin, vincristine, prednisone, cytarabine and 6-thioguanine) in adult acute lymphoblastic leukemia with long-term follow-up: an Eastern Cooperative Oncology Grou
    Leukemia & lymphoma, 2003, Volume: 44, Issue:9

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabin

2003
A randomized trial of induction therapy (daunorubicin, vincristine, prednisone versus daunorubicin, vincristine, prednisone, cytarabine and 6-thioguanine) in adult acute lymphoblastic leukemia with long-term follow-up: an Eastern Cooperative Oncology Grou
    Leukemia & lymphoma, 2003, Volume: 44, Issue:9

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabin

2003
Prognostic factors in childhood acute lymphoblastic leukemia.
    Indian journal of pediatrics, 2003, Volume: 70, Issue:10

    Topics: Anti-Inflammatory Agents; Child; Child, Preschool; Combined Modality Therapy; Female; Hematopoietic

2003
Prognostic factors in childhood acute lymphoblastic leukemia.
    Indian journal of pediatrics, 2003, Volume: 70, Issue:10

    Topics: Anti-Inflammatory Agents; Child; Child, Preschool; Combined Modality Therapy; Female; Hematopoietic

2003
Prognostic factors in childhood acute lymphoblastic leukemia.
    Indian journal of pediatrics, 2003, Volume: 70, Issue:10

    Topics: Anti-Inflammatory Agents; Child; Child, Preschool; Combined Modality Therapy; Female; Hematopoietic

2003
Efficacy of granulocyte and granulocyte-macrophage colony-stimulating factors in the induction treatment of adult acute lymphoblastic leukemia: a multicenter randomized study.
    The hematology journal : the official journal of the European Haematology Association, 2004, Volume: 5, Issue:5

    Topics: Adolescent; Adult; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Combined M

2004
Efficacy of granulocyte and granulocyte-macrophage colony-stimulating factors in the induction treatment of adult acute lymphoblastic leukemia: a multicenter randomized study.
    The hematology journal : the official journal of the European Haematology Association, 2004, Volume: 5, Issue:5

    Topics: Adolescent; Adult; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Combined M

2004
Efficacy of granulocyte and granulocyte-macrophage colony-stimulating factors in the induction treatment of adult acute lymphoblastic leukemia: a multicenter randomized study.
    The hematology journal : the official journal of the European Haematology Association, 2004, Volume: 5, Issue:5

    Topics: Adolescent; Adult; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Combined M

2004
Steroid withdrawal syndrome during steroid tapering in childhood acute lymphoblastic leukemia: a controlled study comparing prednisone versus dexamethasone in induction phase.
    Journal of pediatric hematology/oncology, 2005, Volume: 27, Issue:3

    Topics: Adolescent; Antineoplastic Agents, Hormonal; Child; Child, Preschool; Dexamethasone; Female; Glucoco

2005
Steroid withdrawal syndrome during steroid tapering in childhood acute lymphoblastic leukemia: a controlled study comparing prednisone versus dexamethasone in induction phase.
    Journal of pediatric hematology/oncology, 2005, Volume: 27, Issue:3

    Topics: Adolescent; Antineoplastic Agents, Hormonal; Child; Child, Preschool; Dexamethasone; Female; Glucoco

2005
Steroid withdrawal syndrome during steroid tapering in childhood acute lymphoblastic leukemia: a controlled study comparing prednisone versus dexamethasone in induction phase.
    Journal of pediatric hematology/oncology, 2005, Volume: 27, Issue:3

    Topics: Adolescent; Antineoplastic Agents, Hormonal; Child; Child, Preschool; Dexamethasone; Female; Glucoco

2005
Short intensive sequential therapy followed by autologous stem cell transplantation in adult Burkitt, Burkitt-like and lymphoblastic lymphoma.
    Leukemia, 2005, Volume: 19, Issue:6

    Topics: Adolescent; Adult; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Ag

2005
Short intensive sequential therapy followed by autologous stem cell transplantation in adult Burkitt, Burkitt-like and lymphoblastic lymphoma.
    Leukemia, 2005, Volume: 19, Issue:6

    Topics: Adolescent; Adult; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Ag

2005
Short intensive sequential therapy followed by autologous stem cell transplantation in adult Burkitt, Burkitt-like and lymphoblastic lymphoma.
    Leukemia, 2005, Volume: 19, Issue:6

    Topics: Adolescent; Adult; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Ag

2005
Thromboembolism in children with acute lymphoblastic leukaemia treated on Dana-Farber Cancer Institute protocols: effect of age and risk stratification of disease.
    British journal of haematology, 2005, Volume: 129, Issue:6

    Topics: Adolescent; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child,

2005
Thromboembolism in children with acute lymphoblastic leukaemia treated on Dana-Farber Cancer Institute protocols: effect of age and risk stratification of disease.
    British journal of haematology, 2005, Volume: 129, Issue:6

    Topics: Adolescent; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child,

2005
Thromboembolism in children with acute lymphoblastic leukaemia treated on Dana-Farber Cancer Institute protocols: effect of age and risk stratification of disease.
    British journal of haematology, 2005, Volume: 129, Issue:6

    Topics: Adolescent; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child,

2005
Burkitt lymphoma in adults: a prospective study of 72 patients treated with an adapted pediatric LMB protocol.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2005, Volume: 16, Issue:12

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophos

2005
Burkitt lymphoma in adults: a prospective study of 72 patients treated with an adapted pediatric LMB protocol.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2005, Volume: 16, Issue:12

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophos

2005
Burkitt lymphoma in adults: a prospective study of 72 patients treated with an adapted pediatric LMB protocol.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2005, Volume: 16, Issue:12

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophos

2005
Changes in hypercoagulability by asparaginase: a randomized study between two asparaginases.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2006, Volume: 17, Issue:2

    Topics: Adolescent; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Blo

2006
Changes in hypercoagulability by asparaginase: a randomized study between two asparaginases.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2006, Volume: 17, Issue:2

    Topics: Adolescent; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Blo

2006
Changes in hypercoagulability by asparaginase: a randomized study between two asparaginases.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2006, Volume: 17, Issue:2

    Topics: Adolescent; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Blo

2006
Role of treatment intensification in infants with acute lymphoblastic leukemia: results of two consecutive AIEOP studies.
    Haematologica, 2006, Volume: 91, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cyclophosphamide; Cytarabine; Daunorub

2006
Role of treatment intensification in infants with acute lymphoblastic leukemia: results of two consecutive AIEOP studies.
    Haematologica, 2006, Volume: 91, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cyclophosphamide; Cytarabine; Daunorub

2006
Role of treatment intensification in infants with acute lymphoblastic leukemia: results of two consecutive AIEOP studies.
    Haematologica, 2006, Volume: 91, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cyclophosphamide; Cytarabine; Daunorub

2006
[Prognostic value of the initial response to corticosteroids for children with acute lymphoblastic leukemia].
    Wiadomosci lekarskie (Warsaw, Poland : 1960), 2005, Volume: 58, Issue:11-12

    Topics: Adolescent; Anti-Inflammatory Agents; Child; Child, Preschool; Disease Progression; Disease-Free Sur

2005
[Prognostic value of the initial response to corticosteroids for children with acute lymphoblastic leukemia].
    Wiadomosci lekarskie (Warsaw, Poland : 1960), 2005, Volume: 58, Issue:11-12

    Topics: Adolescent; Anti-Inflammatory Agents; Child; Child, Preschool; Disease Progression; Disease-Free Sur

2005
[Prognostic value of the initial response to corticosteroids for children with acute lymphoblastic leukemia].
    Wiadomosci lekarskie (Warsaw, Poland : 1960), 2005, Volume: 58, Issue:11-12

    Topics: Adolescent; Anti-Inflammatory Agents; Child; Child, Preschool; Disease Progression; Disease-Free Sur

2005
Activating NOTCH1 mutations predict favorable early treatment response and long-term outcome in childhood precursor T-cell lymphoblastic leukemia.
    Blood, 2006, Aug-15, Volume: 108, Issue:4

    Topics: Adolescent; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Asparag

2006
Activating NOTCH1 mutations predict favorable early treatment response and long-term outcome in childhood precursor T-cell lymphoblastic leukemia.
    Blood, 2006, Aug-15, Volume: 108, Issue:4

    Topics: Adolescent; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Asparag

2006
Activating NOTCH1 mutations predict favorable early treatment response and long-term outcome in childhood precursor T-cell lymphoblastic leukemia.
    Blood, 2006, Aug-15, Volume: 108, Issue:4

    Topics: Adolescent; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Asparag

2006
Results of the PETHEMA ALL-96 trial in elderly patients with Philadelphia chromosome-negative acute lymphoblastic leukemia.
    European journal of haematology, 2007, Volume: 78, Issue:2

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Comorbidity; Cyclophosphamide; C

2007
Results of the PETHEMA ALL-96 trial in elderly patients with Philadelphia chromosome-negative acute lymphoblastic leukemia.
    European journal of haematology, 2007, Volume: 78, Issue:2

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Comorbidity; Cyclophosphamide; C

2007
Results of the PETHEMA ALL-96 trial in elderly patients with Philadelphia chromosome-negative acute lymphoblastic leukemia.
    European journal of haematology, 2007, Volume: 78, Issue:2

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Comorbidity; Cyclophosphamide; C

2007
Pharmacodynamics and safety of intravenous pegaspargase during remission induction in adults aged 55 years or younger with newly diagnosed acute lymphoblastic leukemia.
    Blood, 2007, Apr-01, Volume: 109, Issue:7

    Topics: Adolescent; Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Asparagina

2007
Pharmacodynamics and safety of intravenous pegaspargase during remission induction in adults aged 55 years or younger with newly diagnosed acute lymphoblastic leukemia.
    Blood, 2007, Apr-01, Volume: 109, Issue:7

    Topics: Adolescent; Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Asparagina

2007
Pharmacodynamics and safety of intravenous pegaspargase during remission induction in adults aged 55 years or younger with newly diagnosed acute lymphoblastic leukemia.
    Blood, 2007, Apr-01, Volume: 109, Issue:7

    Topics: Adolescent; Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Asparagina

2007
[Multicenter randomized control trial on safety of domestic idarubicin for acute leukemia].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 2006, Volume: 28, Issue:9

    Topics: Adolescent; Adult; Aged; Agranulocytosis; Antibiotics, Antineoplastic; Antineoplastic Combined Chemo

2006
[Multicenter randomized control trial on safety of domestic idarubicin for acute leukemia].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 2006, Volume: 28, Issue:9

    Topics: Adolescent; Adult; Aged; Agranulocytosis; Antibiotics, Antineoplastic; Antineoplastic Combined Chemo

2006
[Multicenter randomized control trial on safety of domestic idarubicin for acute leukemia].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 2006, Volume: 28, Issue:9

    Topics: Adolescent; Adult; Aged; Agranulocytosis; Antibiotics, Antineoplastic; Antineoplastic Combined Chemo

2006
[Auditory evoked potentials in patients after acute children's lymphoblastic leukemia treatment].
    Przeglad lekarski, 2006, Volume: 63, Issue:11

    Topics: Acoustic Stimulation; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginas

2006
[Auditory evoked potentials in patients after acute children's lymphoblastic leukemia treatment].
    Przeglad lekarski, 2006, Volume: 63, Issue:11

    Topics: Acoustic Stimulation; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginas

2006
[Auditory evoked potentials in patients after acute children's lymphoblastic leukemia treatment].
    Przeglad lekarski, 2006, Volume: 63, Issue:11

    Topics: Acoustic Stimulation; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginas

2006
Antimetabolite therapy for lesser-risk B-lineage acute lymphoblastic leukemia of childhood: a report from Children's Oncology Group Study P9201.
    Blood, 2007, Aug-15, Volume: 110, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; B-Lymphocytes; Cell Lineage; Central N

2007
Antimetabolite therapy for lesser-risk B-lineage acute lymphoblastic leukemia of childhood: a report from Children's Oncology Group Study P9201.
    Blood, 2007, Aug-15, Volume: 110, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; B-Lymphocytes; Cell Lineage; Central N

2007
Antimetabolite therapy for lesser-risk B-lineage acute lymphoblastic leukemia of childhood: a report from Children's Oncology Group Study P9201.
    Blood, 2007, Aug-15, Volume: 110, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; B-Lymphocytes; Cell Lineage; Central N

2007
[Modified BFM-90 regimen greatly improves treatment outcomes of chinese childhood and adolescent lymphoblastic lymphoma].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 2007, Volume: 29, Issue:1

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asian People; Asparaginase; Child; Child

2007
[Modified BFM-90 regimen greatly improves treatment outcomes of chinese childhood and adolescent lymphoblastic lymphoma].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 2007, Volume: 29, Issue:1

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asian People; Asparaginase; Child; Child

2007
[Modified BFM-90 regimen greatly improves treatment outcomes of chinese childhood and adolescent lymphoblastic lymphoma].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 2007, Volume: 29, Issue:1

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asian People; Asparaginase; Child; Child

2007
Outcome of adult acute lymphoblastic leukemia with BFM protocol in a resource-constrained setting.
    Leukemia & lymphoma, 2007, Volume: 48, Issue:6

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Combin

2007
Outcome of adult acute lymphoblastic leukemia with BFM protocol in a resource-constrained setting.
    Leukemia & lymphoma, 2007, Volume: 48, Issue:6

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Combin

2007
Outcome of adult acute lymphoblastic leukemia with BFM protocol in a resource-constrained setting.
    Leukemia & lymphoma, 2007, Volume: 48, Issue:6

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Combin

2007
A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trial.
    Lancet (London, England), 2007, Jul-21, Volume: 370, Issue:9583

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Follow-Up Studies; Humans; Infant; Infan

2007
A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trial.
    Lancet (London, England), 2007, Jul-21, Volume: 370, Issue:9583

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Follow-Up Studies; Humans; Infant; Infan

2007
A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trial.
    Lancet (London, England), 2007, Jul-21, Volume: 370, Issue:9583

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Follow-Up Studies; Humans; Infant; Infan

2007
[The results of a multicenter trial of acute lymphoblastic leukemia treatment on ALL-MB 91/ALL-BFM 90m in children: analysis of efficacy and toxicity].
    Terapevticheskii arkhiv, 2007, Volume: 79, Issue:7

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; C

2007
[The results of a multicenter trial of acute lymphoblastic leukemia treatment on ALL-MB 91/ALL-BFM 90m in children: analysis of efficacy and toxicity].
    Terapevticheskii arkhiv, 2007, Volume: 79, Issue:7

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; C

2007
[The results of a multicenter trial of acute lymphoblastic leukemia treatment on ALL-MB 91/ALL-BFM 90m in children: analysis of efficacy and toxicity].
    Terapevticheskii arkhiv, 2007, Volume: 79, Issue:7

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; C

2007
Adrenal axis function after high-dose steroid therapy for childhood acute lymphoblastic leukemia.
    Pediatric blood & cancer, 2008, Volume: 50, Issue:3

    Topics: Adrenal Cortex; Adrenal Insufficiency; Adrenocorticotropic Hormone; Antineoplastic Combined Chemothe

2008
Adrenal axis function after high-dose steroid therapy for childhood acute lymphoblastic leukemia.
    Pediatric blood & cancer, 2008, Volume: 50, Issue:3

    Topics: Adrenal Cortex; Adrenal Insufficiency; Adrenocorticotropic Hormone; Antineoplastic Combined Chemothe

2008
Adrenal axis function after high-dose steroid therapy for childhood acute lymphoblastic leukemia.
    Pediatric blood & cancer, 2008, Volume: 50, Issue:3

    Topics: Adrenal Cortex; Adrenal Insufficiency; Adrenocorticotropic Hormone; Antineoplastic Combined Chemothe

2008
Long-term results of the AIEOP-ALL-95 Trial for Childhood Acute Lymphoblastic Leukemia: insight on the prognostic value of DNA index in the framework of Berlin-Frankfurt-Muenster based chemotherapy.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2008, Jan-10, Volume: 26, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Chi-Square Distribution; Child, Presch

2008
Long-term results of the AIEOP-ALL-95 Trial for Childhood Acute Lymphoblastic Leukemia: insight on the prognostic value of DNA index in the framework of Berlin-Frankfurt-Muenster based chemotherapy.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2008, Jan-10, Volume: 26, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Chi-Square Distribution; Child, Presch

2008
Long-term results of the AIEOP-ALL-95 Trial for Childhood Acute Lymphoblastic Leukemia: insight on the prognostic value of DNA index in the framework of Berlin-Frankfurt-Muenster based chemotherapy.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2008, Jan-10, Volume: 26, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Chi-Square Distribution; Child, Presch

2008
Clinical outcome of children with newly diagnosed acute lymphoblastic leukemia treated in a single center in Shanghai, China.
    Leukemia & lymphoma, 2008, Volume: 49, Issue:3

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Central Nervous System Neo

2008
Clinical outcome of children with newly diagnosed acute lymphoblastic leukemia treated in a single center in Shanghai, China.
    Leukemia & lymphoma, 2008, Volume: 49, Issue:3

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Central Nervous System Neo

2008
Clinical outcome of children with newly diagnosed acute lymphoblastic leukemia treated in a single center in Shanghai, China.
    Leukemia & lymphoma, 2008, Volume: 49, Issue:3

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Central Nervous System Neo

2008
Results of the first randomized multicentre trial on childhood acute lymphoblastic leukaemia in Russia.
    Leukemia, 2008, Volume: 22, Issue:6

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; C

2008
Results of the first randomized multicentre trial on childhood acute lymphoblastic leukaemia in Russia.
    Leukemia, 2008, Volume: 22, Issue:6

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; C

2008
Results of the first randomized multicentre trial on childhood acute lymphoblastic leukaemia in Russia.
    Leukemia, 2008, Volume: 22, Issue:6

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; C

2008
Comparison of the results of the treatment of adolescents and young adults with standard-risk acute lymphoblastic leukemia with the Programa Español de Tratamiento en Hematología pediatric-based protocol ALL-96.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2008, Apr-10, Volume: 26, Issue:11

    Topics: Adolescent; Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child;

2008
Comparison of the results of the treatment of adolescents and young adults with standard-risk acute lymphoblastic leukemia with the Programa Español de Tratamiento en Hematología pediatric-based protocol ALL-96.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2008, Apr-10, Volume: 26, Issue:11

    Topics: Adolescent; Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child;

2008
Comparison of the results of the treatment of adolescents and young adults with standard-risk acute lymphoblastic leukemia with the Programa Español de Tratamiento en Hematología pediatric-based protocol ALL-96.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2008, Apr-10, Volume: 26, Issue:11

    Topics: Adolescent; Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child;

2008
Short-term weekly chemotherapy followed by high-dose therapy with autologous bone marrow transplantation for lymphoblastic and Burkitt's lymphomas in adult patients.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1995, Volume: 6, Issue:5

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplant

1995
Short-term weekly chemotherapy followed by high-dose therapy with autologous bone marrow transplantation for lymphoblastic and Burkitt's lymphomas in adult patients.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1995, Volume: 6, Issue:5

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplant

1995
Short-term weekly chemotherapy followed by high-dose therapy with autologous bone marrow transplantation for lymphoblastic and Burkitt's lymphomas in adult patients.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1995, Volume: 6, Issue:5

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplant

1995
L-asparaginase may potentiate the leukemogenic effect of the epipodophyllotoxins.
    Leukemia, 1995, Volume: 9, Issue:10

    Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool

1995
L-asparaginase may potentiate the leukemogenic effect of the epipodophyllotoxins.
    Leukemia, 1995, Volume: 9, Issue:10

    Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool

1995
L-asparaginase may potentiate the leukemogenic effect of the epipodophyllotoxins.
    Leukemia, 1995, Volume: 9, Issue:10

    Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool

1995
Extended intrathecal methotrexate may replace cranial irradiation for prevention of CNS relapse in children with intermediate-risk acute lymphoblastic leukemia treated with Berlin-Frankfurt-Münster-based intensive chemotherapy. The Associazione Italiana d
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1995, Volume: 13, Issue:10

    Topics: Adolescent; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Asparag

1995
Extended intrathecal methotrexate may replace cranial irradiation for prevention of CNS relapse in children with intermediate-risk acute lymphoblastic leukemia treated with Berlin-Frankfurt-Münster-based intensive chemotherapy. The Associazione Italiana d
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1995, Volume: 13, Issue:10

    Topics: Adolescent; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Asparag

1995
Extended intrathecal methotrexate may replace cranial irradiation for prevention of CNS relapse in children with intermediate-risk acute lymphoblastic leukemia treated with Berlin-Frankfurt-Münster-based intensive chemotherapy. The Associazione Italiana d
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1995, Volume: 13, Issue:10

    Topics: Adolescent; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Asparag

1995
Hypercoagulability during induction therapy of acute lymphoblastic leukemia is of scarce clinical relevance. Gruppo Italiano Malattie Ematologiche Maligne dell' Adulto.
    Blood, 1993, May-01, Volume: 81, Issue:9

    Topics: Adult; alpha-2-Antiplasmin; Antineoplastic Combined Chemotherapy Protocols; Antithrombin III; Aspara

1993
Hypercoagulability during induction therapy of acute lymphoblastic leukemia is of scarce clinical relevance. Gruppo Italiano Malattie Ematologiche Maligne dell' Adulto.
    Blood, 1993, May-01, Volume: 81, Issue:9

    Topics: Adult; alpha-2-Antiplasmin; Antineoplastic Combined Chemotherapy Protocols; Antithrombin III; Aspara

1993
Hypercoagulability during induction therapy of acute lymphoblastic leukemia is of scarce clinical relevance. Gruppo Italiano Malattie Ematologiche Maligne dell' Adulto.
    Blood, 1993, May-01, Volume: 81, Issue:9

    Topics: Adult; alpha-2-Antiplasmin; Antineoplastic Combined Chemotherapy Protocols; Antithrombin III; Aspara

1993
A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: cancer and leukemia group B study 8811.
    Blood, 1995, Apr-15, Volume: 85, Issue:8

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Asparagi

1995
A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: cancer and leukemia group B study 8811.
    Blood, 1995, Apr-15, Volume: 85, Issue:8

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Asparagi

1995
A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: cancer and leukemia group B study 8811.
    Blood, 1995, Apr-15, Volume: 85, Issue:8

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Asparagi

1995
A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: cancer and leukemia group B study 8811.
    Blood, 1995, Apr-15, Volume: 85, Issue:8

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Asparagi

1995
A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: cancer and leukemia group B study 8811.
    Blood, 1995, Apr-15, Volume: 85, Issue:8

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Asparagi

1995
A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: cancer and leukemia group B study 8811.
    Blood, 1995, Apr-15, Volume: 85, Issue:8

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Asparagi

1995
A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: cancer and leukemia group B study 8811.
    Blood, 1995, Apr-15, Volume: 85, Issue:8

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Asparagi

1995
A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: cancer and leukemia group B study 8811.
    Blood, 1995, Apr-15, Volume: 85, Issue:8

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Asparagi

1995
A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: cancer and leukemia group B study 8811.
    Blood, 1995, Apr-15, Volume: 85, Issue:8

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Asparagi

1995
A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: cancer and leukemia group B study 8811.
    Blood, 1995, Apr-15, Volume: 85, Issue:8

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Asparagi

1995
A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: cancer and leukemia group B study 8811.
    Blood, 1995, Apr-15, Volume: 85, Issue:8

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Asparagi

1995
A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: cancer and leukemia group B study 8811.
    Blood, 1995, Apr-15, Volume: 85, Issue:8

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Asparagi

1995
A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: cancer and leukemia group B study 8811.
    Blood, 1995, Apr-15, Volume: 85, Issue:8

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Asparagi

1995
A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: cancer and leukemia group B study 8811.
    Blood, 1995, Apr-15, Volume: 85, Issue:8

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Asparagi

1995
A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: cancer and leukemia group B study 8811.
    Blood, 1995, Apr-15, Volume: 85, Issue:8

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Asparagi

1995
A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: cancer and leukemia group B study 8811.
    Blood, 1995, Apr-15, Volume: 85, Issue:8

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Asparagi

1995
A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: cancer and leukemia group B study 8811.
    Blood, 1995, Apr-15, Volume: 85, Issue:8

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Asparagi

1995
A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: cancer and leukemia group B study 8811.
    Blood, 1995, Apr-15, Volume: 85, Issue:8

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Asparagi

1995
A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: cancer and leukemia group B study 8811.
    Blood, 1995, Apr-15, Volume: 85, Issue:8

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Asparagi

1995
A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: cancer and leukemia group B study 8811.
    Blood, 1995, Apr-15, Volume: 85, Issue:8

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Asparagi

1995
A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: cancer and leukemia group B study 8811.
    Blood, 1995, Apr-15, Volume: 85, Issue:8

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Asparagi

1995
A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: cancer and leukemia group B study 8811.
    Blood, 1995, Apr-15, Volume: 85, Issue:8

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Asparagi

1995
A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: cancer and leukemia group B study 8811.
    Blood, 1995, Apr-15, Volume: 85, Issue:8

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Asparagi

1995
A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: cancer and leukemia group B study 8811.
    Blood, 1995, Apr-15, Volume: 85, Issue:8

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Asparagi

1995
A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: cancer and leukemia group B study 8811.
    Blood, 1995, Apr-15, Volume: 85, Issue:8

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Asparagi

1995
A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: cancer and leukemia group B study 8811.
    Blood, 1995, Apr-15, Volume: 85, Issue:8

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Asparagi

1995
A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: cancer and leukemia group B study 8811.
    Blood, 1995, Apr-15, Volume: 85, Issue:8

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Asparagi

1995
Repetitive low dose oral methotrexate and intravenous mercaptopurine treatment for patients with lower risk B-lineage acute lymphoblastic leukemia. A Pediatric Oncology Group pilot study.
    Cancer, 1995, May-15, Volume: 75, Issue:10

    Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; B-Lymphocytes; C

1995
Repetitive low dose oral methotrexate and intravenous mercaptopurine treatment for patients with lower risk B-lineage acute lymphoblastic leukemia. A Pediatric Oncology Group pilot study.
    Cancer, 1995, May-15, Volume: 75, Issue:10

    Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; B-Lymphocytes; C

1995
Repetitive low dose oral methotrexate and intravenous mercaptopurine treatment for patients with lower risk B-lineage acute lymphoblastic leukemia. A Pediatric Oncology Group pilot study.
    Cancer, 1995, May-15, Volume: 75, Issue:10

    Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; B-Lymphocytes; C

1995
Comparison of treatment regimens for pediatric lymphoblastic non-Hodgkin's lymphoma: a Childrens Cancer Group study.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1995, Volume: 13, Issue:6

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cause of Death; Child; Chi

1995
Comparison of treatment regimens for pediatric lymphoblastic non-Hodgkin's lymphoma: a Childrens Cancer Group study.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1995, Volume: 13, Issue:6

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cause of Death; Child; Chi

1995
Comparison of treatment regimens for pediatric lymphoblastic non-Hodgkin's lymphoma: a Childrens Cancer Group study.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1995, Volume: 13, Issue:6

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cause of Death; Child; Chi

1995
Power considerations for testing an interaction in a 2 x k factorial design with a failure time outcome.
    Controlled clinical trials, 1994, Volume: 15, Issue:6

    Topics: Child, Preschool; Humans; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Research Desig

1994
Power considerations for testing an interaction in a 2 x k factorial design with a failure time outcome.
    Controlled clinical trials, 1994, Volume: 15, Issue:6

    Topics: Child, Preschool; Humans; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Research Desig

1994
Power considerations for testing an interaction in a 2 x k factorial design with a failure time outcome.
    Controlled clinical trials, 1994, Volume: 15, Issue:6

    Topics: Child, Preschool; Humans; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Research Desig

1994
Late intensification therapy in adult acute lymphoid leukemia: long-term follow-up of the Southeastern Cancer Study Group experience.
    Leukemia & lymphoma, 1994, Volume: 15, Issue:1-2

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy;

1994
Late intensification therapy in adult acute lymphoid leukemia: long-term follow-up of the Southeastern Cancer Study Group experience.
    Leukemia & lymphoma, 1994, Volume: 15, Issue:1-2

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy;

1994
Late intensification therapy in adult acute lymphoid leukemia: long-term follow-up of the Southeastern Cancer Study Group experience.
    Leukemia & lymphoma, 1994, Volume: 15, Issue:1-2

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy;

1994
Long-term follow-up of a CHOP-based regimen with maintenance therapy and central nervous system prophylaxis in lymphoblastic non-Hodgkin's lymphoma.
    Leukemia & lymphoma, 1994, Volume: 15, Issue:3-4

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Central Nervous Sys

1994
Long-term follow-up of a CHOP-based regimen with maintenance therapy and central nervous system prophylaxis in lymphoblastic non-Hodgkin's lymphoma.
    Leukemia & lymphoma, 1994, Volume: 15, Issue:3-4

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Central Nervous Sys

1994
Long-term follow-up of a CHOP-based regimen with maintenance therapy and central nervous system prophylaxis in lymphoblastic non-Hodgkin's lymphoma.
    Leukemia & lymphoma, 1994, Volume: 15, Issue:3-4

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Central Nervous Sys

1994
Sequential induction chemotherapy with vincristine, daunorubicin, cyclophosphamide, and prednisone in adult acute lymphoblastic leukemia.
    Annals of hematology, 1995, Volume: 70, Issue:2

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Confidence Intervals; Cyclo

1995
Sequential induction chemotherapy with vincristine, daunorubicin, cyclophosphamide, and prednisone in adult acute lymphoblastic leukemia.
    Annals of hematology, 1995, Volume: 70, Issue:2

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Confidence Intervals; Cyclo

1995
Sequential induction chemotherapy with vincristine, daunorubicin, cyclophosphamide, and prednisone in adult acute lymphoblastic leukemia.
    Annals of hematology, 1995, Volume: 70, Issue:2

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Confidence Intervals; Cyclo

1995
High-dose Ara-C for remission induction and consolidation of previously untreated adults with ALL or lymphoblastic lymphoma.
    Annals of hematology, 1995, Volume: 70, Issue:2

    Topics: Adolescent; Adult; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplant

1995
High-dose Ara-C for remission induction and consolidation of previously untreated adults with ALL or lymphoblastic lymphoma.
    Annals of hematology, 1995, Volume: 70, Issue:2

    Topics: Adolescent; Adult; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplant

1995
High-dose Ara-C for remission induction and consolidation of previously untreated adults with ALL or lymphoblastic lymphoma.
    Annals of hematology, 1995, Volume: 70, Issue:2

    Topics: Adolescent; Adult; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplant

1995
Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients. Results and conclusions of the multicenter trial ALL-BFM 86.
    Blood, 1994, Nov-01, Volume: 84, Issue:9

    Topics: Adolescent; Child; Child, Preschool; Female; Humans; Immunophenotyping; Infant; Male; Precursor Cell

1994
Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients. Results and conclusions of the multicenter trial ALL-BFM 86.
    Blood, 1994, Nov-01, Volume: 84, Issue:9

    Topics: Adolescent; Child; Child, Preschool; Female; Humans; Immunophenotyping; Infant; Male; Precursor Cell

1994
Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients. Results and conclusions of the multicenter trial ALL-BFM 86.
    Blood, 1994, Nov-01, Volume: 84, Issue:9

    Topics: Adolescent; Child; Child, Preschool; Female; Humans; Immunophenotyping; Infant; Male; Precursor Cell

1994
Allogeneic bone marrow transplantation in adult acute lymphoblastic leukemia in first complete remission: a comparative study. French Group of Therapy of Adult Acute Lymphoblastic Leukemia.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1994, Volume: 12, Issue:12

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cycl

1994
Allogeneic bone marrow transplantation in adult acute lymphoblastic leukemia in first complete remission: a comparative study. French Group of Therapy of Adult Acute Lymphoblastic Leukemia.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1994, Volume: 12, Issue:12

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cycl

1994
Allogeneic bone marrow transplantation in adult acute lymphoblastic leukemia in first complete remission: a comparative study. French Group of Therapy of Adult Acute Lymphoblastic Leukemia.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1994, Volume: 12, Issue:12

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cycl

1994
Development of a new intensive therapy for acute lymphoblastic leukemia in children at increased risk of early relapse. The Memorial Sloan-Kettering-New York-II protocol.
    Cancer, 1993, Nov-15, Volume: 72, Issue:10

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bone Marrow Examinat

1993
Development of a new intensive therapy for acute lymphoblastic leukemia in children at increased risk of early relapse. The Memorial Sloan-Kettering-New York-II protocol.
    Cancer, 1993, Nov-15, Volume: 72, Issue:10

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bone Marrow Examinat

1993
Development of a new intensive therapy for acute lymphoblastic leukemia in children at increased risk of early relapse. The Memorial Sloan-Kettering-New York-II protocol.
    Cancer, 1993, Nov-15, Volume: 72, Issue:10

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bone Marrow Examinat

1993
The role of radiation therapy in the treatment of acute lymphoblastic leukemia with lymphomatous presentation: a report from the Childrens Cancer Group.
    International journal of radiation oncology, biology, physics, 1993, Dec-01, Volume: 27, Issue:5

    Topics: Actuarial Analysis; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Brain Neoplasms; C

1993
The role of radiation therapy in the treatment of acute lymphoblastic leukemia with lymphomatous presentation: a report from the Childrens Cancer Group.
    International journal of radiation oncology, biology, physics, 1993, Dec-01, Volume: 27, Issue:5

    Topics: Actuarial Analysis; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Brain Neoplasms; C

1993
The role of radiation therapy in the treatment of acute lymphoblastic leukemia with lymphomatous presentation: a report from the Childrens Cancer Group.
    International journal of radiation oncology, biology, physics, 1993, Dec-01, Volume: 27, Issue:5

    Topics: Actuarial Analysis; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Brain Neoplasms; C

1993
Circadian time-dependent response of childhood lymphoblastic leukemia to chemotherapy: a long-term follow-up study of survival.
    Chronobiology international, 1993, Volume: 10, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Circadian Rhythm; Drug Administration Schedul

1993
Circadian time-dependent response of childhood lymphoblastic leukemia to chemotherapy: a long-term follow-up study of survival.
    Chronobiology international, 1993, Volume: 10, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Circadian Rhythm; Drug Administration Schedul

1993
Circadian time-dependent response of childhood lymphoblastic leukemia to chemotherapy: a long-term follow-up study of survival.
    Chronobiology international, 1993, Volume: 10, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Circadian Rhythm; Drug Administration Schedul

1993
Follow-up of the first two successive German multicentre trials for adult ALL (01/81 and 02/84). German Adult ALL Study Group.
    Leukemia, 1993, Volume: 7 Suppl 2

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cranial Irradiation

1993
Follow-up of the first two successive German multicentre trials for adult ALL (01/81 and 02/84). German Adult ALL Study Group.
    Leukemia, 1993, Volume: 7 Suppl 2

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cranial Irradiation

1993
Follow-up of the first two successive German multicentre trials for adult ALL (01/81 and 02/84). German Adult ALL Study Group.
    Leukemia, 1993, Volume: 7 Suppl 2

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cranial Irradiation

1993
Treatment results of three consecutive Brazilian cooperative childhood ALL protocols: GBTLI-80, GBTLI-82 and -85. ALL Brazilian Group.
    Leukemia, 1993, Volume: 7 Suppl 2

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Cranial Irradiation

1993
Treatment results of three consecutive Brazilian cooperative childhood ALL protocols: GBTLI-80, GBTLI-82 and -85. ALL Brazilian Group.
    Leukemia, 1993, Volume: 7 Suppl 2

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Cranial Irradiation

1993
Treatment results of three consecutive Brazilian cooperative childhood ALL protocols: GBTLI-80, GBTLI-82 and -85. ALL Brazilian Group.
    Leukemia, 1993, Volume: 7 Suppl 2

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Cranial Irradiation

1993
Randomized comparison of 36-hour intermediate-dose versus 4-hour high-dose methotrexate infusions for remission induction in relapsed childhood acute lymphoblastic leukemia.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1993, Volume: 11, Issue:5

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Cytarabine; Dose-Re

1993
Randomized comparison of 36-hour intermediate-dose versus 4-hour high-dose methotrexate infusions for remission induction in relapsed childhood acute lymphoblastic leukemia.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1993, Volume: 11, Issue:5

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Cytarabine; Dose-Re

1993
Randomized comparison of 36-hour intermediate-dose versus 4-hour high-dose methotrexate infusions for remission induction in relapsed childhood acute lymphoblastic leukemia.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1993, Volume: 11, Issue:5

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Cytarabine; Dose-Re

1993
Severe toxicity limits intensification of induction therapy for acute lymphoblastic leukemia.
    Leukemia, 1993, Volume: 7, Issue:6

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Female; Humans; Idarubicin;

1993
Severe toxicity limits intensification of induction therapy for acute lymphoblastic leukemia.
    Leukemia, 1993, Volume: 7, Issue:6

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Female; Humans; Idarubicin;

1993
Severe toxicity limits intensification of induction therapy for acute lymphoblastic leukemia.
    Leukemia, 1993, Volume: 7, Issue:6

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Female; Humans; Idarubicin;

1993
Randomized comparison of moderate-dose methotrexate infusions to oral methotrexate in children with intermediate risk acute lymphoblastic leukemia: a Childrens Cancer Group study.
    Medical and pediatric oncology, 1996, Volume: 27, Issue:1

    Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Combined

1996
Randomized comparison of moderate-dose methotrexate infusions to oral methotrexate in children with intermediate risk acute lymphoblastic leukemia: a Childrens Cancer Group study.
    Medical and pediatric oncology, 1996, Volume: 27, Issue:1

    Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Combined

1996
Randomized comparison of moderate-dose methotrexate infusions to oral methotrexate in children with intermediate risk acute lymphoblastic leukemia: a Childrens Cancer Group study.
    Medical and pediatric oncology, 1996, Volume: 27, Issue:1

    Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Combined

1996
Cytoreduction and prognosis in acute lymphoblastic leukemia--the importance of early marrow response: report from the Childrens Cancer Group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1996, Volume: 14, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow; Child; Combined Modality

1996
Cytoreduction and prognosis in acute lymphoblastic leukemia--the importance of early marrow response: report from the Childrens Cancer Group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1996, Volume: 14, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow; Child; Combined Modality

1996
Cytoreduction and prognosis in acute lymphoblastic leukemia--the importance of early marrow response: report from the Childrens Cancer Group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1996, Volume: 14, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow; Child; Combined Modality

1996
Incidence and clinical outcome of children with BCR/ABL-positive acute lymphoblastic leukemia (ALL). A prospective RT-PCR study based on 673 patients enrolled in the German pediatric multicenter therapy trials ALL-BFM-90 and CoALL-05-92.
    Leukemia, 1996, Volume: 10, Issue:6

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Base Sequence; Child; Chil

1996
Incidence and clinical outcome of children with BCR/ABL-positive acute lymphoblastic leukemia (ALL). A prospective RT-PCR study based on 673 patients enrolled in the German pediatric multicenter therapy trials ALL-BFM-90 and CoALL-05-92.
    Leukemia, 1996, Volume: 10, Issue:6

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Base Sequence; Child; Chil

1996
Incidence and clinical outcome of children with BCR/ABL-positive acute lymphoblastic leukemia (ALL). A prospective RT-PCR study based on 673 patients enrolled in the German pediatric multicenter therapy trials ALL-BFM-90 and CoALL-05-92.
    Leukemia, 1996, Volume: 10, Issue:6

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Base Sequence; Child; Chil

1996
Acute lymphoblastic leukemia in children: nonrandomized comparison of conventional vs. intensive chemotherapy at the National Cancer Institute of Colombia.
    Medical and pediatric oncology, 1997, Volume: 28, Issue:2

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; C

1997
Acute lymphoblastic leukemia in children: nonrandomized comparison of conventional vs. intensive chemotherapy at the National Cancer Institute of Colombia.
    Medical and pediatric oncology, 1997, Volume: 28, Issue:2

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; C

1997
Acute lymphoblastic leukemia in children: nonrandomized comparison of conventional vs. intensive chemotherapy at the National Cancer Institute of Colombia.
    Medical and pediatric oncology, 1997, Volume: 28, Issue:2

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; C

1997
Intermediate-dose methotrexate versus cranial irradiation in childhood acute lymphoblastic leukemia: a ten-year follow-up.
    Medical and pediatric oncology, 1997, Volume: 28, Issue:2

    Topics: Adolescent; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Asparag

1997
Intermediate-dose methotrexate versus cranial irradiation in childhood acute lymphoblastic leukemia: a ten-year follow-up.
    Medical and pediatric oncology, 1997, Volume: 28, Issue:2

    Topics: Adolescent; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Asparag

1997
Intermediate-dose methotrexate versus cranial irradiation in childhood acute lymphoblastic leukemia: a ten-year follow-up.
    Medical and pediatric oncology, 1997, Volume: 28, Issue:2

    Topics: Adolescent; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Asparag

1997
Augmented Berlin-Frankfurt-Munster therapy abrogates the adverse prognostic significance of slow early response to induction chemotherapy for children and adolescents with acute lymphoblastic leukemia and unfavorable presenting features: a report from the
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1997, Volume: 15, Issue:6

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; D

1997
Augmented Berlin-Frankfurt-Munster therapy abrogates the adverse prognostic significance of slow early response to induction chemotherapy for children and adolescents with acute lymphoblastic leukemia and unfavorable presenting features: a report from the
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1997, Volume: 15, Issue:6

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; D

1997
Augmented Berlin-Frankfurt-Munster therapy abrogates the adverse prognostic significance of slow early response to induction chemotherapy for children and adolescents with acute lymphoblastic leukemia and unfavorable presenting features: a report from the
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1997, Volume: 15, Issue:6

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; D

1997
B-lineage acute lymphoblastic leukemia of childhood. An institutional experience.
    Archives of medical research, 1997,Summer, Volume: 28, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Burkitt Lymphoma; Child; Child, Presch

1997
B-lineage acute lymphoblastic leukemia of childhood. An institutional experience.
    Archives of medical research, 1997,Summer, Volume: 28, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Burkitt Lymphoma; Child; Child, Presch

1997
B-lineage acute lymphoblastic leukemia of childhood. An institutional experience.
    Archives of medical research, 1997,Summer, Volume: 28, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Burkitt Lymphoma; Child; Child, Presch

1997
Treatment of adults with acute lymphoblastic leukaemia in first bone marrow relapse: results of the ALL R-87 protocol.
    British journal of haematology, 1997, Volume: 97, Issue:4

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Comb

1997
Treatment of adults with acute lymphoblastic leukaemia in first bone marrow relapse: results of the ALL R-87 protocol.
    British journal of haematology, 1997, Volume: 97, Issue:4

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Comb

1997
Treatment of adults with acute lymphoblastic leukaemia in first bone marrow relapse: results of the ALL R-87 protocol.
    British journal of haematology, 1997, Volume: 97, Issue:4

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Comb

1997
Granulocyte colony-stimulating factor as an adjunct to induction chemotherapy for adult acute lymphoblastic leukemia--a randomized phase-III study.
    Blood, 1997, Jul-15, Volume: 90, Issue:2

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Blood Transfu

1997
Granulocyte colony-stimulating factor as an adjunct to induction chemotherapy for adult acute lymphoblastic leukemia--a randomized phase-III study.
    Blood, 1997, Jul-15, Volume: 90, Issue:2

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Blood Transfu

1997
Granulocyte colony-stimulating factor as an adjunct to induction chemotherapy for adult acute lymphoblastic leukemia--a randomized phase-III study.
    Blood, 1997, Jul-15, Volume: 90, Issue:2

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Blood Transfu

1997
ALL R-87 protocol in the treatment of children with acute lymphoblastic leukaemia in early bone marrow relapse.
    British journal of haematology, 1997, Volume: 99, Issue:3

    Topics: Adolescent; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation

1997
ALL R-87 protocol in the treatment of children with acute lymphoblastic leukaemia in early bone marrow relapse.
    British journal of haematology, 1997, Volume: 99, Issue:3

    Topics: Adolescent; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation

1997
ALL R-87 protocol in the treatment of children with acute lymphoblastic leukaemia in early bone marrow relapse.
    British journal of haematology, 1997, Volume: 99, Issue:3

    Topics: Adolescent; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation

1997
Estimated 6-year event-free survival of 55% in 60 consecutive adult acute lymphoblastic leukemia patients treated with an intensive phase II protocol based on high induction dose of daunorubicin.
    Leukemia, 1998, Volume: 12, Issue:2

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Combined Moda

1998
Estimated 6-year event-free survival of 55% in 60 consecutive adult acute lymphoblastic leukemia patients treated with an intensive phase II protocol based on high induction dose of daunorubicin.
    Leukemia, 1998, Volume: 12, Issue:2

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Combined Moda

1998
Estimated 6-year event-free survival of 55% in 60 consecutive adult acute lymphoblastic leukemia patients treated with an intensive phase II protocol based on high induction dose of daunorubicin.
    Leukemia, 1998, Volume: 12, Issue:2

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Combined Moda

1998
[EPOCH therapy for relapsed/refractory lymphoid malignancies].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 1998, Volume: 39, Issue:4

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Dr

1998
[EPOCH therapy for relapsed/refractory lymphoid malignancies].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 1998, Volume: 39, Issue:4

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Dr

1998
[EPOCH therapy for relapsed/refractory lymphoid malignancies].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 1998, Volume: 39, Issue:4

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Dr

1998
Immunophenotype and clinical characteristics of CD45-negative and CD45-positive childhood acute lymphoblastic leukemia.
    Annals of hematology, 1998, Volume: 77, Issue:3

    Topics: Antineoplastic Agents, Hormonal; Cell Lineage; Child; DNA, Neoplasm; Humans; Immunophenotyping; Kary

1998
Immunophenotype and clinical characteristics of CD45-negative and CD45-positive childhood acute lymphoblastic leukemia.
    Annals of hematology, 1998, Volume: 77, Issue:3

    Topics: Antineoplastic Agents, Hormonal; Cell Lineage; Child; DNA, Neoplasm; Humans; Immunophenotyping; Kary

1998
Immunophenotype and clinical characteristics of CD45-negative and CD45-positive childhood acute lymphoblastic leukemia.
    Annals of hematology, 1998, Volume: 77, Issue:3

    Topics: Antineoplastic Agents, Hormonal; Cell Lineage; Child; DNA, Neoplasm; Humans; Immunophenotyping; Kary

1998
Intensive BFM chemotherapy for childhood ALL: interim analysis of the AIEOP-ALL 91 study. Associazione Italiana Ematologia Oncologia Pediatrica.
    Haematologica, 1998, Volume: 83, Issue:9

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transplantatio

1998
Intensive BFM chemotherapy for childhood ALL: interim analysis of the AIEOP-ALL 91 study. Associazione Italiana Ematologia Oncologia Pediatrica.
    Haematologica, 1998, Volume: 83, Issue:9

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transplantatio

1998
Intensive BFM chemotherapy for childhood ALL: interim analysis of the AIEOP-ALL 91 study. Associazione Italiana Ematologia Oncologia Pediatrica.
    Haematologica, 1998, Volume: 83, Issue:9

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transplantatio

1998
[The treatment results in children diagnosed with non-Hodgkin's lymphomas and acute B-cell lymphoblastic leukemias treated by the BFM protocols. The report of the POGM (Pediatric Oncology Group of Madrid)].
    Anales espanoles de pediatria, 1998, Volume: 49, Issue:6

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transplantatio

1998
[The treatment results in children diagnosed with non-Hodgkin's lymphomas and acute B-cell lymphoblastic leukemias treated by the BFM protocols. The report of the POGM (Pediatric Oncology Group of Madrid)].
    Anales espanoles de pediatria, 1998, Volume: 49, Issue:6

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transplantatio

1998
[The treatment results in children diagnosed with non-Hodgkin's lymphomas and acute B-cell lymphoblastic leukemias treated by the BFM protocols. The report of the POGM (Pediatric Oncology Group of Madrid)].
    Anales espanoles de pediatria, 1998, Volume: 49, Issue:6

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transplantatio

1998
Management of advanced acute lymphoblastic leukemia in children and adults: results of the ALL R-87 protocol. AIEOP and GIMEMA Cooperative Groups.
    Leukemia & lymphoma, 1998, Volume: 32, Issue:1-2

    Topics: Adolescent; Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transpla

1998
Management of advanced acute lymphoblastic leukemia in children and adults: results of the ALL R-87 protocol. AIEOP and GIMEMA Cooperative Groups.
    Leukemia & lymphoma, 1998, Volume: 32, Issue:1-2

    Topics: Adolescent; Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transpla

1998
Management of advanced acute lymphoblastic leukemia in children and adults: results of the ALL R-87 protocol. AIEOP and GIMEMA Cooperative Groups.
    Leukemia & lymphoma, 1998, Volume: 32, Issue:1-2

    Topics: Adolescent; Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transpla

1998
Improved outcome for acute lymphoblastic leukemia in children of a developing country: results of the Chilean National Trial PINDA 87.
    Medical and pediatric oncology, 1999, Volume: 33, Issue:2

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; C

1999
Improved outcome for acute lymphoblastic leukemia in children of a developing country: results of the Chilean National Trial PINDA 87.
    Medical and pediatric oncology, 1999, Volume: 33, Issue:2

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; C

1999
Improved outcome for acute lymphoblastic leukemia in children of a developing country: results of the Chilean National Trial PINDA 87.
    Medical and pediatric oncology, 1999, Volume: 33, Issue:2

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; C

1999
Prednisone response is the strongest predictor of treatment outcome in infant acute lymphoblastic leukemia.
    Blood, 1999, Aug-15, Volume: 94, Issue:4

    Topics: Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Presc

1999
Prednisone response is the strongest predictor of treatment outcome in infant acute lymphoblastic leukemia.
    Blood, 1999, Aug-15, Volume: 94, Issue:4

    Topics: Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Presc

1999
Prednisone response is the strongest predictor of treatment outcome in infant acute lymphoblastic leukemia.
    Blood, 1999, Aug-15, Volume: 94, Issue:4

    Topics: Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Presc

1999
Combination therapy with methotrexate, vincristine, polyethylene-glycol conjugated-asparaginase, and prednisone in the treatment of patients with refractory or recurrent acute lymphoblastic leukemia.
    Cancer, 1999, Oct-01, Volume: 86, Issue:7

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Drug Administration Sched

1999
Combination therapy with methotrexate, vincristine, polyethylene-glycol conjugated-asparaginase, and prednisone in the treatment of patients with refractory or recurrent acute lymphoblastic leukemia.
    Cancer, 1999, Oct-01, Volume: 86, Issue:7

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Drug Administration Sched

1999
Combination therapy with methotrexate, vincristine, polyethylene-glycol conjugated-asparaginase, and prednisone in the treatment of patients with refractory or recurrent acute lymphoblastic leukemia.
    Cancer, 1999, Oct-01, Volume: 86, Issue:7

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Drug Administration Sched

1999
Alternating drug pairs with or without periodic reinduction in children with acute lymphoblastic leukemia in second bone marrow remission: a Pediatric Oncology Group Study.
    Cancer, 2000, Mar-01, Volume: 88, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transplantation; Child; Cy

2000
Alternating drug pairs with or without periodic reinduction in children with acute lymphoblastic leukemia in second bone marrow remission: a Pediatric Oncology Group Study.
    Cancer, 2000, Mar-01, Volume: 88, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transplantation; Child; Cy

2000
Alternating drug pairs with or without periodic reinduction in children with acute lymphoblastic leukemia in second bone marrow remission: a Pediatric Oncology Group Study.
    Cancer, 2000, Mar-01, Volume: 88, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transplantation; Child; Cy

2000
Use of recombinant human granulocyte colony-stimulating factor to increase chemotherapy dose-intensity: a randomized trial in very high-risk childhood acute lymphoblastic leukemia.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2000, Volume: 18, Issue:7

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamid

2000
Use of recombinant human granulocyte colony-stimulating factor to increase chemotherapy dose-intensity: a randomized trial in very high-risk childhood acute lymphoblastic leukemia.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2000, Volume: 18, Issue:7

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamid

2000
Use of recombinant human granulocyte colony-stimulating factor to increase chemotherapy dose-intensity: a randomized trial in very high-risk childhood acute lymphoblastic leukemia.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2000, Volume: 18, Issue:7

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamid

2000
Changes in body mass index and prevalence of overweight in survivors of childhood acute lymphoblastic leukemia: role of cranial irradiation.
    Medical and pediatric oncology, 2000, Volume: 35, Issue:2

    Topics: Adolescent; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Body Height; Body Mass Inde

2000
Changes in body mass index and prevalence of overweight in survivors of childhood acute lymphoblastic leukemia: role of cranial irradiation.
    Medical and pediatric oncology, 2000, Volume: 35, Issue:2

    Topics: Adolescent; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Body Height; Body Mass Inde

2000
Changes in body mass index and prevalence of overweight in survivors of childhood acute lymphoblastic leukemia: role of cranial irradiation.
    Medical and pediatric oncology, 2000, Volume: 35, Issue:2

    Topics: Adolescent; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Body Height; Body Mass Inde

2000
Weekly polyethylene glycol conjugated L-asparaginase compared with biweekly dosing produces superior induction remission rates in childhood relapsed acute lymphoblastic leukemia: a Pediatric Oncology Group Study.
    Blood, 2000, Sep-01, Volume: 96, Issue:5

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Cells;

2000
Weekly polyethylene glycol conjugated L-asparaginase compared with biweekly dosing produces superior induction remission rates in childhood relapsed acute lymphoblastic leukemia: a Pediatric Oncology Group Study.
    Blood, 2000, Sep-01, Volume: 96, Issue:5

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Cells;

2000
Weekly polyethylene glycol conjugated L-asparaginase compared with biweekly dosing produces superior induction remission rates in childhood relapsed acute lymphoblastic leukemia: a Pediatric Oncology Group Study.
    Blood, 2000, Sep-01, Volume: 96, Issue:5

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Cells;

2000
Osteonecrosis as a complication of treating acute lymphoblastic leukemia in children: a report from the Children's Cancer Group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2000, Sep-15, Volume: 18, Issue:18

    Topics: Adolescent; Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Presch

2000
Osteonecrosis as a complication of treating acute lymphoblastic leukemia in children: a report from the Children's Cancer Group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2000, Sep-15, Volume: 18, Issue:18

    Topics: Adolescent; Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Presch

2000
Osteonecrosis as a complication of treating acute lymphoblastic leukemia in children: a report from the Children's Cancer Group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2000, Sep-15, Volume: 18, Issue:18

    Topics: Adolescent; Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Presch

2000
Value of high-dose cytarabine during interval therapy of a Berlin-Frankfurt-Munster-based protocol in increased-risk children with acute lymphoblastic leukemia and lymphoblastic lymphoma: results of the European Organization for Research and Treatment of
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001, Apr-01, Volume: 19, Issue:7

    Topics: Actuarial Analysis; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Centra

2001
Value of high-dose cytarabine during interval therapy of a Berlin-Frankfurt-Munster-based protocol in increased-risk children with acute lymphoblastic leukemia and lymphoblastic lymphoma: results of the European Organization for Research and Treatment of
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001, Apr-01, Volume: 19, Issue:7

    Topics: Actuarial Analysis; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Centra

2001
Value of high-dose cytarabine during interval therapy of a Berlin-Frankfurt-Munster-based protocol in increased-risk children with acute lymphoblastic leukemia and lymphoblastic lymphoma: results of the European Organization for Research and Treatment of
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001, Apr-01, Volume: 19, Issue:7

    Topics: Actuarial Analysis; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Centra

2001
The Société Française d'Oncologie Pédiatrique LMB89 protocol: highly effective multiagent chemotherapy tailored to the tumor burden and initial response in 561 unselected children with B-cell lymphomas and L3 leukemia.
    Blood, 2001, Jun-01, Volume: 97, Issue:11

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamid

2001
The Société Française d'Oncologie Pédiatrique LMB89 protocol: highly effective multiagent chemotherapy tailored to the tumor burden and initial response in 561 unselected children with B-cell lymphomas and L3 leukemia.
    Blood, 2001, Jun-01, Volume: 97, Issue:11

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamid

2001
The Société Française d'Oncologie Pédiatrique LMB89 protocol: highly effective multiagent chemotherapy tailored to the tumor burden and initial response in 561 unselected children with B-cell lymphomas and L3 leukemia.
    Blood, 2001, Jun-01, Volume: 97, Issue:11

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamid

2001
Treatment of childhood acute lymphoblastic leukemia. Long-term results of the AIEOP-ALL 87 study.
    Haematologica, 2001, Volume: 86, Issue:5

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; D

2001
Treatment of childhood acute lymphoblastic leukemia. Long-term results of the AIEOP-ALL 87 study.
    Haematologica, 2001, Volume: 86, Issue:5

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; D

2001
Treatment of childhood acute lymphoblastic leukemia. Long-term results of the AIEOP-ALL 87 study.
    Haematologica, 2001, Volume: 86, Issue:5

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; D

2001
Daunorubicin continuous infusion induces more toxicity than bolus infusion in acute lymphoblastic leukemia induction regimen: a randomized study.
    Leukemia, 2001, Volume: 15, Issue:6

    Topics: Adolescent; Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols

2001
Daunorubicin continuous infusion induces more toxicity than bolus infusion in acute lymphoblastic leukemia induction regimen: a randomized study.
    Leukemia, 2001, Volume: 15, Issue:6

    Topics: Adolescent; Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols

2001
Daunorubicin continuous infusion induces more toxicity than bolus infusion in acute lymphoblastic leukemia induction regimen: a randomized study.
    Leukemia, 2001, Volume: 15, Issue:6

    Topics: Adolescent; Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols

2001
Effect of glucocorticoid therapy on energy intake in children treated for acute lymphoblastic leukemia.
    The Journal of clinical endocrinology and metabolism, 2001, Volume: 86, Issue:8

    Topics: Body Mass Index; Child; Confidence Intervals; Dexamethasone; Energy Intake; Female; Follow-Up Studie

2001
Effect of glucocorticoid therapy on energy intake in children treated for acute lymphoblastic leukemia.
    The Journal of clinical endocrinology and metabolism, 2001, Volume: 86, Issue:8

    Topics: Body Mass Index; Child; Confidence Intervals; Dexamethasone; Energy Intake; Female; Follow-Up Studie

2001
Effect of glucocorticoid therapy on energy intake in children treated for acute lymphoblastic leukemia.
    The Journal of clinical endocrinology and metabolism, 2001, Volume: 86, Issue:8

    Topics: Body Mass Index; Child; Confidence Intervals; Dexamethasone; Energy Intake; Female; Follow-Up Studie

2001
Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of cancer and leukemia group B study 9251.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001, Oct-15, Volume: 19, Issue:20

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Cyclophosphamid

2001
Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of cancer and leukemia group B study 9251.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001, Oct-15, Volume: 19, Issue:20

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Cyclophosphamid

2001
Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of cancer and leukemia group B study 9251.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001, Oct-15, Volume: 19, Issue:20

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Cyclophosphamid

2001
Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of cancer and leukemia group B study 9251.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001, Oct-15, Volume: 19, Issue:20

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Cyclophosphamid

2001
Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of cancer and leukemia group B study 9251.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001, Oct-15, Volume: 19, Issue:20

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Cyclophosphamid

2001
Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of cancer and leukemia group B study 9251.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001, Oct-15, Volume: 19, Issue:20

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Cyclophosphamid

2001
Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of cancer and leukemia group B study 9251.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001, Oct-15, Volume: 19, Issue:20

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Cyclophosphamid

2001
Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of cancer and leukemia group B study 9251.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001, Oct-15, Volume: 19, Issue:20

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Cyclophosphamid

2001
Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of cancer and leukemia group B study 9251.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001, Oct-15, Volume: 19, Issue:20

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Cyclophosphamid

2001
Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of cancer and leukemia group B study 9251.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001, Oct-15, Volume: 19, Issue:20

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Cyclophosphamid

2001
Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of cancer and leukemia group B study 9251.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001, Oct-15, Volume: 19, Issue:20

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Cyclophosphamid

2001
Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of cancer and leukemia group B study 9251.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001, Oct-15, Volume: 19, Issue:20

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Cyclophosphamid

2001
Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of cancer and leukemia group B study 9251.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001, Oct-15, Volume: 19, Issue:20

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Cyclophosphamid

2001
Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of cancer and leukemia group B study 9251.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001, Oct-15, Volume: 19, Issue:20

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Cyclophosphamid

2001
Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of cancer and leukemia group B study 9251.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001, Oct-15, Volume: 19, Issue:20

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Cyclophosphamid

2001
Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of cancer and leukemia group B study 9251.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001, Oct-15, Volume: 19, Issue:20

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Cyclophosphamid

2001
Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of cancer and leukemia group B study 9251.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001, Oct-15, Volume: 19, Issue:20

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Cyclophosphamid

2001
Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of cancer and leukemia group B study 9251.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001, Oct-15, Volume: 19, Issue:20

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Cyclophosphamid

2001
Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of cancer and leukemia group B study 9251.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001, Oct-15, Volume: 19, Issue:20

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Cyclophosphamid

2001
Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of cancer and leukemia group B study 9251.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001, Oct-15, Volume: 19, Issue:20

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Cyclophosphamid

2001
Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of cancer and leukemia group B study 9251.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001, Oct-15, Volume: 19, Issue:20

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Cyclophosphamid

2001
Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of cancer and leukemia group B study 9251.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001, Oct-15, Volume: 19, Issue:20

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Cyclophosphamid

2001
Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of cancer and leukemia group B study 9251.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001, Oct-15, Volume: 19, Issue:20

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Cyclophosphamid

2001
Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of cancer and leukemia group B study 9251.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001, Oct-15, Volume: 19, Issue:20

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Cyclophosphamid

2001
Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of cancer and leukemia group B study 9251.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001, Oct-15, Volume: 19, Issue:20

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Cyclophosphamid

2001
Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of cancer and leukemia group B study 9251.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001, Oct-15, Volume: 19, Issue:20

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Cyclophosphamid

2001
Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of cancer and leukemia group B study 9251.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001, Oct-15, Volume: 19, Issue:20

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Cyclophosphamid

2001
Favorable outcome for children and adolescents with T-cell lymphoblastic lymphoma with an intensive ALL-type therapy without local radiotherapy.
    Annals of hematology, 2001, Volume: 80 Suppl 3

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Austria; Child; Child, Pre

2001
Favorable outcome for children and adolescents with T-cell lymphoblastic lymphoma with an intensive ALL-type therapy without local radiotherapy.
    Annals of hematology, 2001, Volume: 80 Suppl 3

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Austria; Child; Child, Pre

2001
Favorable outcome for children and adolescents with T-cell lymphoblastic lymphoma with an intensive ALL-type therapy without local radiotherapy.
    Annals of hematology, 2001, Volume: 80 Suppl 3

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Austria; Child; Child, Pre

2001
Treatment of adult acute lymphoblastic leukemia (ALL): long-term follow-up of the GIMEMA ALL 0288 randomized study.
    Blood, 2002, Feb-01, Volume: 99, Issue:3

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophosphamide; Di

2002
Treatment of adult acute lymphoblastic leukemia (ALL): long-term follow-up of the GIMEMA ALL 0288 randomized study.
    Blood, 2002, Feb-01, Volume: 99, Issue:3

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophosphamide; Di

2002
Treatment of adult acute lymphoblastic leukemia (ALL): long-term follow-up of the GIMEMA ALL 0288 randomized study.
    Blood, 2002, Feb-01, Volume: 99, Issue:3

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophosphamide; Di

2002
Improved outcome in high-risk childhood acute lymphoblastic leukemia defined by prednisone-poor response treated with double Berlin-Frankfurt-Muenster protocol II.
    Blood, 2002, Jul-15, Volume: 100, Issue:2

    Topics: Adolescent; Adrenal Cortex Hormones; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; C

2002
Improved outcome in high-risk childhood acute lymphoblastic leukemia defined by prednisone-poor response treated with double Berlin-Frankfurt-Muenster protocol II.
    Blood, 2002, Jul-15, Volume: 100, Issue:2

    Topics: Adolescent; Adrenal Cortex Hormones; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; C

2002
Improved outcome in high-risk childhood acute lymphoblastic leukemia defined by prednisone-poor response treated with double Berlin-Frankfurt-Muenster protocol II.
    Blood, 2002, Jul-15, Volume: 100, Issue:2

    Topics: Adolescent; Adrenal Cortex Hormones; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; C

2002
Treatment of acute lymphoblastic leukaemia (ALL).
    European journal of haematology, 1992, Volume: 49, Issue:2

    Topics: Adolescent; Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cyclop

1992
Treatment of acute lymphoblastic leukaemia (ALL).
    European journal of haematology, 1992, Volume: 49, Issue:2

    Topics: Adolescent; Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cyclop

1992
Treatment of acute lymphoblastic leukaemia (ALL).
    European journal of haematology, 1992, Volume: 49, Issue:2

    Topics: Adolescent; Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cyclop

1992
A study of toxicity and comparative therapeutic efficacy of vindesine-prednisone vs. vincristine-prednisone in children with acute lymphoblastic leukemia in relapse. A Pediatric Oncology Group study.
    Investigational new drugs, 1992, Volume: 10, Issue:3

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Humans; Precurs

1992
A study of toxicity and comparative therapeutic efficacy of vindesine-prednisone vs. vincristine-prednisone in children with acute lymphoblastic leukemia in relapse. A Pediatric Oncology Group study.
    Investigational new drugs, 1992, Volume: 10, Issue:3

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Humans; Precurs

1992
A study of toxicity and comparative therapeutic efficacy of vindesine-prednisone vs. vincristine-prednisone in children with acute lymphoblastic leukemia in relapse. A Pediatric Oncology Group study.
    Investigational new drugs, 1992, Volume: 10, Issue:3

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Humans; Precurs

1992
F-MACHOP in advanced aggressive lymphoma.
    Leukemia & lymphoma, 1992, Volume: 7, Issue:3

    Topics: Actuarial Analysis; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Do

1992
F-MACHOP in advanced aggressive lymphoma.
    Leukemia & lymphoma, 1992, Volume: 7, Issue:3

    Topics: Actuarial Analysis; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Do

1992
F-MACHOP in advanced aggressive lymphoma.
    Leukemia & lymphoma, 1992, Volume: 7, Issue:3

    Topics: Actuarial Analysis; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Do

1992
Late intensification therapy in adult acute lymphoid leukemia. The Southeastern Cancer Study Group Experience.
    American journal of clinical oncology, 1992, Volume: 15, Issue:1

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubic

1992
Late intensification therapy in adult acute lymphoid leukemia. The Southeastern Cancer Study Group Experience.
    American journal of clinical oncology, 1992, Volume: 15, Issue:1

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubic

1992
Late intensification therapy in adult acute lymphoid leukemia. The Southeastern Cancer Study Group Experience.
    American journal of clinical oncology, 1992, Volume: 15, Issue:1

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubic

1992
Treatment of acute lymphoblastic leukemia French protocol Fralle 83-87.
    Leukemia, 1992, Volume: 6 Suppl 2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cyclophospham

1992
Treatment of acute lymphoblastic leukemia French protocol Fralle 83-87.
    Leukemia, 1992, Volume: 6 Suppl 2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cyclophospham

1992
Treatment of acute lymphoblastic leukemia French protocol Fralle 83-87.
    Leukemia, 1992, Volume: 6 Suppl 2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cyclophospham

1992
An update of the results of intensive therapy in children with acute lymphoblastic leukemia.
    Leukemia, 1992, Volume: 6 Suppl 2

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cause of Death; Child; Chi

1992
An update of the results of intensive therapy in children with acute lymphoblastic leukemia.
    Leukemia, 1992, Volume: 6 Suppl 2

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cause of Death; Child; Chi

1992
An update of the results of intensive therapy in children with acute lymphoblastic leukemia.
    Leukemia, 1992, Volume: 6 Suppl 2

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cause of Death; Child; Chi

1992
GIMEMA ALL 0288: a multicentric study on adult acute lymphoblastic leukemia. Preliminary results.
    Leukemia, 1992, Volume: 6 Suppl 2

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Clinical Prot

1992
GIMEMA ALL 0288: a multicentric study on adult acute lymphoblastic leukemia. Preliminary results.
    Leukemia, 1992, Volume: 6 Suppl 2

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Clinical Prot

1992
GIMEMA ALL 0288: a multicentric study on adult acute lymphoblastic leukemia. Preliminary results.
    Leukemia, 1992, Volume: 6 Suppl 2

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Clinical Prot

1992
Adult acute lymphocytic leukemia: the Eastern Cooperative Oncology Group experience.
    Leukemia, 1992, Volume: 6 Suppl 2

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabin

1992
Adult acute lymphocytic leukemia: the Eastern Cooperative Oncology Group experience.
    Leukemia, 1992, Volume: 6 Suppl 2

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabin

1992
Adult acute lymphocytic leukemia: the Eastern Cooperative Oncology Group experience.
    Leukemia, 1992, Volume: 6 Suppl 2

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabin

1992
[Second cessation of therapy in children with acute lymphoblastic leukemia].
    Acta haematologica Polonica, 1992, Volume: 23, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cyclophospham

1992
[Second cessation of therapy in children with acute lymphoblastic leukemia].
    Acta haematologica Polonica, 1992, Volume: 23, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cyclophospham

1992
[Second cessation of therapy in children with acute lymphoblastic leukemia].
    Acta haematologica Polonica, 1992, Volume: 23, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cyclophospham

1992
Determination of the maximum tolerated dose of idarubicin when used in a combination chemotherapy program of reinduction of childhood ALL at first marrow relapse and a preliminary assessment of toxicity compared to that of daunorubicin: a report from the
    Medical and pediatric oncology, 1992, Volume: 20, Issue:2

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow; Child; Child,

1992
Determination of the maximum tolerated dose of idarubicin when used in a combination chemotherapy program of reinduction of childhood ALL at first marrow relapse and a preliminary assessment of toxicity compared to that of daunorubicin: a report from the
    Medical and pediatric oncology, 1992, Volume: 20, Issue:2

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow; Child; Child,

1992
Determination of the maximum tolerated dose of idarubicin when used in a combination chemotherapy program of reinduction of childhood ALL at first marrow relapse and a preliminary assessment of toxicity compared to that of daunorubicin: a report from the
    Medical and pediatric oncology, 1992, Volume: 20, Issue:2

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow; Child; Child,

1992
[Treatment of acute lymphoblastic leukemia in children. Results of the FRALLE 83 protocol].
    Archives francaises de pediatrie, 1991, Volume: 48, Issue:8

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Clinical Prot

1991
[Treatment of acute lymphoblastic leukemia in children. Results of the FRALLE 83 protocol].
    Archives francaises de pediatrie, 1991, Volume: 48, Issue:8

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Clinical Prot

1991
[Treatment of acute lymphoblastic leukemia in children. Results of the FRALLE 83 protocol].
    Archives francaises de pediatrie, 1991, Volume: 48, Issue:8

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Clinical Prot

1991
Intensive therapy for adult acute lymphoblastic leukemia.
    Seminars in hematology, 1991, Volume: 28, Issue:3 Suppl 4

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cyclophosphamide; Humans; Idaru

1991
Intensive therapy for adult acute lymphoblastic leukemia.
    Seminars in hematology, 1991, Volume: 28, Issue:3 Suppl 4

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cyclophosphamide; Humans; Idaru

1991
Intensive therapy for adult acute lymphoblastic leukemia.
    Seminars in hematology, 1991, Volume: 28, Issue:3 Suppl 4

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cyclophosphamide; Humans; Idaru

1991
Low-dose versus high-dose methotrexate during remission induction in childhood acute lymphoblastic leukemia (Protocol 81-01 update).
    Blood, 1991, Nov-15, Volume: 78, Issue:10

    Topics: Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Cytarabine; Dose-Response Relation

1991
Low-dose versus high-dose methotrexate during remission induction in childhood acute lymphoblastic leukemia (Protocol 81-01 update).
    Blood, 1991, Nov-15, Volume: 78, Issue:10

    Topics: Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Cytarabine; Dose-Response Relation

1991
Low-dose versus high-dose methotrexate during remission induction in childhood acute lymphoblastic leukemia (Protocol 81-01 update).
    Blood, 1991, Nov-15, Volume: 78, Issue:10

    Topics: Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Cytarabine; Dose-Response Relation

1991
Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission after intensive primary and relapse therapy according to the BFM- and CoALL-protocols: results of the German Cooperative Study.
    Blood, 1991, Nov-15, Volume: 78, Issue:10

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transplantatio

1991
Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission after intensive primary and relapse therapy according to the BFM- and CoALL-protocols: results of the German Cooperative Study.
    Blood, 1991, Nov-15, Volume: 78, Issue:10

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transplantatio

1991
Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission after intensive primary and relapse therapy according to the BFM- and CoALL-protocols: results of the German Cooperative Study.
    Blood, 1991, Nov-15, Volume: 78, Issue:10

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transplantatio

1991
[Malignant lymphoma associated with HIV infection].
    Deutsche medizinische Wochenschrift (1946), 1991, Aug-16, Volume: 116, Issue:33

    Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Combined Modalit

1991
[Malignant lymphoma associated with HIV infection].
    Deutsche medizinische Wochenschrift (1946), 1991, Aug-16, Volume: 116, Issue:33

    Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Combined Modalit

1991
[Malignant lymphoma associated with HIV infection].
    Deutsche medizinische Wochenschrift (1946), 1991, Aug-16, Volume: 116, Issue:33

    Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Combined Modalit

1991
Intellectual function in long-term survivors of childhood acute lymphoblastic leukemia: protective effect of pre-irradiation methotrexate? A Childrens Cancer Study Group study.
    Medical and pediatric oncology, 1991, Volume: 19, Issue:6

    Topics: Asparaginase; Brain; Child; Child, Preschool; Combined Modality Therapy; Female; Follow-Up Studies;

1991
Intellectual function in long-term survivors of childhood acute lymphoblastic leukemia: protective effect of pre-irradiation methotrexate? A Childrens Cancer Study Group study.
    Medical and pediatric oncology, 1991, Volume: 19, Issue:6

    Topics: Asparaginase; Brain; Child; Child, Preschool; Combined Modality Therapy; Female; Follow-Up Studies;

1991
Intellectual function in long-term survivors of childhood acute lymphoblastic leukemia: protective effect of pre-irradiation methotrexate? A Childrens Cancer Study Group study.
    Medical and pediatric oncology, 1991, Volume: 19, Issue:6

    Topics: Asparaginase; Brain; Child; Child, Preschool; Combined Modality Therapy; Female; Follow-Up Studies;

1991
High survival rate in advanced-stage B-cell lymphomas and leukemias without CNS involvement with a short intensive polychemotherapy: results from the French Pediatric Oncology Society of a randomized trial of 216 children.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1991, Volume: 9, Issue:1

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamid

1991
High survival rate in advanced-stage B-cell lymphomas and leukemias without CNS involvement with a short intensive polychemotherapy: results from the French Pediatric Oncology Society of a randomized trial of 216 children.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1991, Volume: 9, Issue:1

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamid

1991
High survival rate in advanced-stage B-cell lymphomas and leukemias without CNS involvement with a short intensive polychemotherapy: results from the French Pediatric Oncology Society of a randomized trial of 216 children.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1991, Volume: 9, Issue:1

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamid

1991
Monthly pulses of vincristine and prednisone prevent bone marrow and testicular relapse in low-risk childhood acute lymphoblastic leukemia: a report of the CCG-161 study by the Childrens Cancer Study Group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1991, Volume: 9, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Brain Neoplasms; Child, Presch

1991
Monthly pulses of vincristine and prednisone prevent bone marrow and testicular relapse in low-risk childhood acute lymphoblastic leukemia: a report of the CCG-161 study by the Childrens Cancer Study Group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1991, Volume: 9, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Brain Neoplasms; Child, Presch

1991
Monthly pulses of vincristine and prednisone prevent bone marrow and testicular relapse in low-risk childhood acute lymphoblastic leukemia: a report of the CCG-161 study by the Childrens Cancer Study Group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1991, Volume: 9, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Brain Neoplasms; Child, Presch

1991
Improved treatment results in boys with overt testicular relapse during or shortly after initial therapy for acute lymphoblastic leukemia. A Pediatric Oncology group study.
    Cancer, 1991, Jul-01, Volume: 68, Issue:1

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; C

1991
Improved treatment results in boys with overt testicular relapse during or shortly after initial therapy for acute lymphoblastic leukemia. A Pediatric Oncology group study.
    Cancer, 1991, Jul-01, Volume: 68, Issue:1

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; C

1991
Improved treatment results in boys with overt testicular relapse during or shortly after initial therapy for acute lymphoblastic leukemia. A Pediatric Oncology group study.
    Cancer, 1991, Jul-01, Volume: 68, Issue:1

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; C

1991
Lower incidence of meningeal leukemia when prednisone is replaced by dexamethasone in the treatment of acute lymphocytic leukemia.
    Medical and pediatric oncology, 1991, Volume: 19, Issue:4

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; Dexame

1991
Lower incidence of meningeal leukemia when prednisone is replaced by dexamethasone in the treatment of acute lymphocytic leukemia.
    Medical and pediatric oncology, 1991, Volume: 19, Issue:4

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; Dexame

1991
Lower incidence of meningeal leukemia when prednisone is replaced by dexamethasone in the treatment of acute lymphocytic leukemia.
    Medical and pediatric oncology, 1991, Volume: 19, Issue:4

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; Dexame

1991
Results of Medical Research Council Childhood Leukaemia Trial UKALL VIII (report to the Medical Research Council on behalf of the Working Party on Leukaemia in Childhood).
    British journal of haematology, 1991, Volume: 78, Issue:2

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; C

1991
Results of Medical Research Council Childhood Leukaemia Trial UKALL VIII (report to the Medical Research Council on behalf of the Working Party on Leukaemia in Childhood).
    British journal of haematology, 1991, Volume: 78, Issue:2

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; C

1991
Results of Medical Research Council Childhood Leukaemia Trial UKALL VIII (report to the Medical Research Council on behalf of the Working Party on Leukaemia in Childhood).
    British journal of haematology, 1991, Volume: 78, Issue:2

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; C

1991
Treatment of relapsed acute lymphocytic leukemia in adults.
    Haematology and blood transfusion, 1990, Volume: 33

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transpl

1990
Treatment of relapsed acute lymphocytic leukemia in adults.
    Haematology and blood transfusion, 1990, Volume: 33

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transpl

1990
Treatment of relapsed acute lymphocytic leukemia in adults.
    Haematology and blood transfusion, 1990, Volume: 33

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transpl

1990
Improved prognosis for childhood acute lymphocytic leukemia with very high white blood cell count (greater than 100/nl) with rotation of non-cross-resistant drug combinations.
    Haematology and blood transfusion, 1990, Volume: 33

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; C

1990
Improved prognosis for childhood acute lymphocytic leukemia with very high white blood cell count (greater than 100/nl) with rotation of non-cross-resistant drug combinations.
    Haematology and blood transfusion, 1990, Volume: 33

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; C

1990
Improved prognosis for childhood acute lymphocytic leukemia with very high white blood cell count (greater than 100/nl) with rotation of non-cross-resistant drug combinations.
    Haematology and blood transfusion, 1990, Volume: 33

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; C

1990
The prognostic value of testicular biopsy in childhood acute lymphoblastic leukemia: a report from the Childrens Cancer Study Group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1990, Volume: 8, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Biopsy; Child; Combined Modality Thera

1990
The prognostic value of testicular biopsy in childhood acute lymphoblastic leukemia: a report from the Childrens Cancer Study Group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1990, Volume: 8, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Biopsy; Child; Combined Modality Thera

1990
The prognostic value of testicular biopsy in childhood acute lymphoblastic leukemia: a report from the Childrens Cancer Study Group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1990, Volume: 8, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Biopsy; Child; Combined Modality Thera

1990
Treatment of adult acute lymphoblastic leukaemia.
    Haematology and blood transfusion, 1990, Volume: 33

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Combin

1990
Treatment of adult acute lymphoblastic leukaemia.
    Haematology and blood transfusion, 1990, Volume: 33

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Combin

1990
Treatment of adult acute lymphoblastic leukaemia.
    Haematology and blood transfusion, 1990, Volume: 33

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Combin

1990
[Adult acute lymphoblastic leukemia: preliminary results of the LAL-86 protocol].
    Sangre, 1990, Volume: 35, Issue:1

    Topics: Actuarial Analysis; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase;

1990
[Adult acute lymphoblastic leukemia: preliminary results of the LAL-86 protocol].
    Sangre, 1990, Volume: 35, Issue:1

    Topics: Actuarial Analysis; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase;

1990
[Adult acute lymphoblastic leukemia: preliminary results of the LAL-86 protocol].
    Sangre, 1990, Volume: 35, Issue:1

    Topics: Actuarial Analysis; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase;

1990
Philadelphia chromosome positive childhood acute lymphoblastic leukemia: clinical and cytogenetic characteristics and treatment outcome. A Pediatric Oncology Group study.
    Blood, 1990, Aug-01, Volume: 76, Issue:3

    Topics: Asparaginase; Child; Child, Preschool; Cohort Studies; Cross-Sectional Studies; Female; Humans; Immu

1990
Philadelphia chromosome positive childhood acute lymphoblastic leukemia: clinical and cytogenetic characteristics and treatment outcome. A Pediatric Oncology Group study.
    Blood, 1990, Aug-01, Volume: 76, Issue:3

    Topics: Asparaginase; Child; Child, Preschool; Cohort Studies; Cross-Sectional Studies; Female; Humans; Immu

1990
Philadelphia chromosome positive childhood acute lymphoblastic leukemia: clinical and cytogenetic characteristics and treatment outcome. A Pediatric Oncology Group study.
    Blood, 1990, Aug-01, Volume: 76, Issue:3

    Topics: Asparaginase; Child; Child, Preschool; Cohort Studies; Cross-Sectional Studies; Female; Humans; Immu

1990
Adult acute lymphoblastic leukemia: results of the Iowa HOP-L protocol.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1989, Volume: 7, Issue:1

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Clinical Tria

1989
Adult acute lymphoblastic leukemia: results of the Iowa HOP-L protocol.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1989, Volume: 7, Issue:1

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Clinical Tria

1989
Adult acute lymphoblastic leukemia: results of the Iowa HOP-L protocol.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1989, Volume: 7, Issue:1

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Clinical Tria

1989
Three versus five years of maintenance therapy are equivalent in childhood acute lymphoblastic leukemia: a report from the Childrens Cancer Study Group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1989, Volume: 7, Issue:3

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Biopsy; Child; Clinical Tr

1989
Three versus five years of maintenance therapy are equivalent in childhood acute lymphoblastic leukemia: a report from the Childrens Cancer Study Group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1989, Volume: 7, Issue:3

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Biopsy; Child; Clinical Tr

1989
Three versus five years of maintenance therapy are equivalent in childhood acute lymphoblastic leukemia: a report from the Childrens Cancer Study Group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1989, Volume: 7, Issue:3

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Biopsy; Child; Clinical Tr

1989
Effectiveness of rubidomycin in induction therapy with vincristine, prednisone, and L-asparaginase for standard risk childhood acute lymphocytic leukemia: results of a Dutch phase III study (ALL V). A report on behalf of the Dutch Childhood Leukemia Study
    The American journal of pediatric hematology/oncology, 1989,Summer, Volume: 11, Issue:2

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; C

1989
Effectiveness of rubidomycin in induction therapy with vincristine, prednisone, and L-asparaginase for standard risk childhood acute lymphocytic leukemia: results of a Dutch phase III study (ALL V). A report on behalf of the Dutch Childhood Leukemia Study
    The American journal of pediatric hematology/oncology, 1989,Summer, Volume: 11, Issue:2

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; C

1989
Effectiveness of rubidomycin in induction therapy with vincristine, prednisone, and L-asparaginase for standard risk childhood acute lymphocytic leukemia: results of a Dutch phase III study (ALL V). A report on behalf of the Dutch Childhood Leukemia Study
    The American journal of pediatric hematology/oncology, 1989,Summer, Volume: 11, Issue:2

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; C

1989
[Treatment of childhood acute lymphoblastic leukemia: randomized trials of protocols CCLSG-L 841 and I 841. (Phase III study). Children's Cancer and Leukemia Study Group].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 1989, Volume: 30, Issue:7

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Clinical Tria

1989
[Treatment of childhood acute lymphoblastic leukemia: randomized trials of protocols CCLSG-L 841 and I 841. (Phase III study). Children's Cancer and Leukemia Study Group].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 1989, Volume: 30, Issue:7

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Clinical Tria

1989
[Treatment of childhood acute lymphoblastic leukemia: randomized trials of protocols CCLSG-L 841 and I 841. (Phase III study). Children's Cancer and Leukemia Study Group].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 1989, Volume: 30, Issue:7

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Clinical Tria

1989
Early response to induction therapy as a predictor of disease-free survival and late recurrence of childhood acute lymphoblastic leukemia: a report from the Childrens Cancer Study Group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1989, Volume: 7, Issue:12

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow; Child; Humans; Methotrexa

1989
Early response to induction therapy as a predictor of disease-free survival and late recurrence of childhood acute lymphoblastic leukemia: a report from the Childrens Cancer Study Group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1989, Volume: 7, Issue:12

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow; Child; Humans; Methotrexa

1989
Early response to induction therapy as a predictor of disease-free survival and late recurrence of childhood acute lymphoblastic leukemia: a report from the Childrens Cancer Study Group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1989, Volume: 7, Issue:12

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow; Child; Humans; Methotrexa

1989
Factor VIII/von Willebrand factor abnormalities during L-asparaginase treatment in patients with acute lymphoblastic leukemia.
    Acta haematologica, 1988, Volume: 80, Issue:4

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; C

1988
Factor VIII/von Willebrand factor abnormalities during L-asparaginase treatment in patients with acute lymphoblastic leukemia.
    Acta haematologica, 1988, Volume: 80, Issue:4

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; C

1988
Factor VIII/von Willebrand factor abnormalities during L-asparaginase treatment in patients with acute lymphoblastic leukemia.
    Acta haematologica, 1988, Volume: 80, Issue:4

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; C

1988
Randomized multicentric Italian study on two treatment regimens for marrow relapse in childhood acute lymphoblastic leukemia.
    Pediatric hematology and oncology, 1986, Volume: 3, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow; Combined Modality Therapy

1986
Randomized multicentric Italian study on two treatment regimens for marrow relapse in childhood acute lymphoblastic leukemia.
    Pediatric hematology and oncology, 1986, Volume: 3, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow; Combined Modality Therapy

1986
Randomized multicentric Italian study on two treatment regimens for marrow relapse in childhood acute lymphoblastic leukemia.
    Pediatric hematology and oncology, 1986, Volume: 3, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow; Combined Modality Therapy

1986

Other Studies

401 other studies available for prednisone and Precursor Cell Lymphoblastic Leukemia-Lymphoma

ArticleYear
INCB84344-201: Ponatinib and steroids in frontline therapy for unfit patients with Ph+ acute lymphoblastic leukemia.
    Blood advances, 2022, 03-22, Volume: 6, Issue:6

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Humans; Imidazoles; Phi

2022
INCB84344-201: Ponatinib and steroids in frontline therapy for unfit patients with Ph+ acute lymphoblastic leukemia.
    Blood advances, 2022, 03-22, Volume: 6, Issue:6

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Humans; Imidazoles; Phi

2022
INCB84344-201: Ponatinib and steroids in frontline therapy for unfit patients with Ph+ acute lymphoblastic leukemia.
    Blood advances, 2022, 03-22, Volume: 6, Issue:6

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Humans; Imidazoles; Phi

2022
The first report of complete remission following treatment with venetoclax plus prednisone in elderly patients with Philadelphia chromosome-negative acute lymphoblastic leukemia.
    Annals of hematology, 2022, Volume: 101, Issue:5

    Topics: Aged; Bridged Bicyclo Compounds, Heterocyclic; Hematopoietic Stem Cell Transplantation; Humans; Phil

2022
The first report of complete remission following treatment with venetoclax plus prednisone in elderly patients with Philadelphia chromosome-negative acute lymphoblastic leukemia.
    Annals of hematology, 2022, Volume: 101, Issue:5

    Topics: Aged; Bridged Bicyclo Compounds, Heterocyclic; Hematopoietic Stem Cell Transplantation; Humans; Phil

2022
The first report of complete remission following treatment with venetoclax plus prednisone in elderly patients with Philadelphia chromosome-negative acute lymphoblastic leukemia.
    Annals of hematology, 2022, Volume: 101, Issue:5

    Topics: Aged; Bridged Bicyclo Compounds, Heterocyclic; Hematopoietic Stem Cell Transplantation; Humans; Phil

2022
The incidence of symptomatic osteonecrosis is similar between Japanese children and children in Western countries with acute lymphoblastic leukaemia treated with a Berlin-Frankfurt-Münster (BFM)95-based protocol.
    British journal of haematology, 2022, Volume: 196, Issue:5

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; C

2022
The incidence of symptomatic osteonecrosis is similar between Japanese children and children in Western countries with acute lymphoblastic leukaemia treated with a Berlin-Frankfurt-Münster (BFM)95-based protocol.
    British journal of haematology, 2022, Volume: 196, Issue:5

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; C

2022
The incidence of symptomatic osteonecrosis is similar between Japanese children and children in Western countries with acute lymphoblastic leukaemia treated with a Berlin-Frankfurt-Münster (BFM)95-based protocol.
    British journal of haematology, 2022, Volume: 196, Issue:5

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; C

2022
Childhood acute lymphoblastic leukemia: Four years evaluation of protocols 2013 and 2016 in a single center in Indonesia, a lower-middle-income country.
    Pediatric blood & cancer, 2022, Volume: 69, Issue:11

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dexamethasone; Disease-Free Surviv

2022
Childhood acute lymphoblastic leukemia: Four years evaluation of protocols 2013 and 2016 in a single center in Indonesia, a lower-middle-income country.
    Pediatric blood & cancer, 2022, Volume: 69, Issue:11

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dexamethasone; Disease-Free Surviv

2022
Childhood acute lymphoblastic leukemia: Four years evaluation of protocols 2013 and 2016 in a single center in Indonesia, a lower-middle-income country.
    Pediatric blood & cancer, 2022, Volume: 69, Issue:11

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dexamethasone; Disease-Free Surviv

2022
Polo-like Kinase 4: the Variation During Therapy and its Relation to Treatment Response and Prognostic Risk Stratification in Childhood Acute Lymphoblastic Leukemia Patients.
    Journal of pediatric hematology/oncology, 2023, 05-01, Volume: 45, Issue:4

    Topics: Biomarkers; Humans; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Precursor Cell Lymphoblastic L

2023
Polo-like Kinase 4: the Variation During Therapy and its Relation to Treatment Response and Prognostic Risk Stratification in Childhood Acute Lymphoblastic Leukemia Patients.
    Journal of pediatric hematology/oncology, 2023, 05-01, Volume: 45, Issue:4

    Topics: Biomarkers; Humans; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Precursor Cell Lymphoblastic L

2023
Polo-like Kinase 4: the Variation During Therapy and its Relation to Treatment Response and Prognostic Risk Stratification in Childhood Acute Lymphoblastic Leukemia Patients.
    Journal of pediatric hematology/oncology, 2023, 05-01, Volume: 45, Issue:4

    Topics: Biomarkers; Humans; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Precursor Cell Lymphoblastic L

2023
Long-term results of the treatment of adolescents and adults with acute lymphoblastic leukemia with a pediatric-inspired regimen delivered on an outpatient basis: A single institution experience.
    Leukemia research, 2022, Volume: 121

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cyclophosphamide; Cytarabine; Daunorub

2022
Long-term results of the treatment of adolescents and adults with acute lymphoblastic leukemia with a pediatric-inspired regimen delivered on an outpatient basis: A single institution experience.
    Leukemia research, 2022, Volume: 121

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cyclophosphamide; Cytarabine; Daunorub

2022
Long-term results of the treatment of adolescents and adults with acute lymphoblastic leukemia with a pediatric-inspired regimen delivered on an outpatient basis: A single institution experience.
    Leukemia research, 2022, Volume: 121

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cyclophosphamide; Cytarabine; Daunorub

2022
Dasatinib/prednisone induction followed by blinatumomab/dasatinib in Ph+ acute lymphoblastic leukemia.
    Blood advances, 2023, 04-11, Volume: 7, Issue:7

    Topics: Aged; Aged, 80 and over; Dasatinib; Humans; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Predniso

2023
Dasatinib/prednisone induction followed by blinatumomab/dasatinib in Ph+ acute lymphoblastic leukemia.
    Blood advances, 2023, 04-11, Volume: 7, Issue:7

    Topics: Aged; Aged, 80 and over; Dasatinib; Humans; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Predniso

2023
Dasatinib/prednisone induction followed by blinatumomab/dasatinib in Ph+ acute lymphoblastic leukemia.
    Blood advances, 2023, 04-11, Volume: 7, Issue:7

    Topics: Aged; Aged, 80 and over; Dasatinib; Humans; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Predniso

2023
PH negative acute lymphoblastic leukemia in adolescents and young adults treated according a MRD adapted BFM ALL IC 2009 protocol: Argentine real-world data on 171 patients.
    Annals of hematology, 2023, Volume: 102, Issue:5

    Topics: Disease-Free Survival; Humans; Multicenter Studies as Topic; Neoplasm, Residual; Precursor Cell Lymp

2023
PH negative acute lymphoblastic leukemia in adolescents and young adults treated according a MRD adapted BFM ALL IC 2009 protocol: Argentine real-world data on 171 patients.
    Annals of hematology, 2023, Volume: 102, Issue:5

    Topics: Disease-Free Survival; Humans; Multicenter Studies as Topic; Neoplasm, Residual; Precursor Cell Lymp

2023
PH negative acute lymphoblastic leukemia in adolescents and young adults treated according a MRD adapted BFM ALL IC 2009 protocol: Argentine real-world data on 171 patients.
    Annals of hematology, 2023, Volume: 102, Issue:5

    Topics: Disease-Free Survival; Humans; Multicenter Studies as Topic; Neoplasm, Residual; Precursor Cell Lymp

2023
Polo-like kinase 1 Decrease During Induction Therapy Could Indicate Good Treatment Response, Favorable Risk Stratification, and Prolonged Survival in Pediatric Acute Lymphoblastic Leukemia.
    Journal of pediatric hematology/oncology, 2023, 08-01, Volume: 45, Issue:6

    Topics: Cell Cycle Proteins; Child; Humans; Induction Chemotherapy; Polo-Like Kinase 1; Precursor Cell Lymph

2023
Polo-like kinase 1 Decrease During Induction Therapy Could Indicate Good Treatment Response, Favorable Risk Stratification, and Prolonged Survival in Pediatric Acute Lymphoblastic Leukemia.
    Journal of pediatric hematology/oncology, 2023, 08-01, Volume: 45, Issue:6

    Topics: Cell Cycle Proteins; Child; Humans; Induction Chemotherapy; Polo-Like Kinase 1; Precursor Cell Lymph

2023
Polo-like kinase 1 Decrease During Induction Therapy Could Indicate Good Treatment Response, Favorable Risk Stratification, and Prolonged Survival in Pediatric Acute Lymphoblastic Leukemia.
    Journal of pediatric hematology/oncology, 2023, 08-01, Volume: 45, Issue:6

    Topics: Cell Cycle Proteins; Child; Humans; Induction Chemotherapy; Polo-Like Kinase 1; Precursor Cell Lymph

2023
Outcome of ALL With ALL-BFM-95 Protocol in Nepal.
    JCO global oncology, 2023, Volume: 9

    Topics: Adolescent; Child; Humans; Nepal; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Treatm

2023
Outcome of ALL With ALL-BFM-95 Protocol in Nepal.
    JCO global oncology, 2023, Volume: 9

    Topics: Adolescent; Child; Humans; Nepal; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Treatm

2023
Outcome of ALL With ALL-BFM-95 Protocol in Nepal.
    JCO global oncology, 2023, Volume: 9

    Topics: Adolescent; Child; Humans; Nepal; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Treatm

2023
Moving away from chemotherapy in newly diagnosed Philadelphia chromosome-positive B-cell acute lymphoblastic leukaemia.
    British journal of haematology, 2023, Volume: 202, Issue:6

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Dasatinib; Humans; Philadelphia Chromosome; P

2023
Moving away from chemotherapy in newly diagnosed Philadelphia chromosome-positive B-cell acute lymphoblastic leukaemia.
    British journal of haematology, 2023, Volume: 202, Issue:6

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Dasatinib; Humans; Philadelphia Chromosome; P

2023
Moving away from chemotherapy in newly diagnosed Philadelphia chromosome-positive B-cell acute lymphoblastic leukaemia.
    British journal of haematology, 2023, Volume: 202, Issue:6

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Dasatinib; Humans; Philadelphia Chromosome; P

2023
Invasive mucormycosis during treatment for acute lymphoblastic leukaemia-successful management of two life-threatening diseases.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2020, Volume: 28, Issue:5

    Topics: Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Chi

2020
Invasive mucormycosis during treatment for acute lymphoblastic leukaemia-successful management of two life-threatening diseases.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2020, Volume: 28, Issue:5

    Topics: Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Chi

2020
Invasive mucormycosis during treatment for acute lymphoblastic leukaemia-successful management of two life-threatening diseases.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2020, Volume: 28, Issue:5

    Topics: Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Chi

2020
Disseminated lymphoblastic lymphoma revealed by an isolated third cranial nerve palsy.
    European journal of ophthalmology, 2021, Volume: 31, Issue:2

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Blepharoptosis; Cyclophosphamide; Female; Flu

2021
Disseminated lymphoblastic lymphoma revealed by an isolated third cranial nerve palsy.
    European journal of ophthalmology, 2021, Volume: 31, Issue:2

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Blepharoptosis; Cyclophosphamide; Female; Flu

2021
Disseminated lymphoblastic lymphoma revealed by an isolated third cranial nerve palsy.
    European journal of ophthalmology, 2021, Volume: 31, Issue:2

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Blepharoptosis; Cyclophosphamide; Female; Flu

2021
The Effect of Combination of Steroid and L-Asparaginase on Hyperglycemia in Children with Acute Lymphoblastic Leukemia (ALL).
    Asian Pacific journal of cancer prevention : APJCP, 2019, 09-01, Volume: 20, Issue:9

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; D

2019
The Effect of Combination of Steroid and L-Asparaginase on Hyperglycemia in Children with Acute Lymphoblastic Leukemia (ALL).
    Asian Pacific journal of cancer prevention : APJCP, 2019, 09-01, Volume: 20, Issue:9

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; D

2019
The Effect of Combination of Steroid and L-Asparaginase on Hyperglycemia in Children with Acute Lymphoblastic Leukemia (ALL).
    Asian Pacific journal of cancer prevention : APJCP, 2019, 09-01, Volume: 20, Issue:9

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; D

2019
Unexpected neurologic complications following a novel lymphoma treatment 'expected' to give rise to neurologic toxicity.
    BMJ case reports, 2019, Nov-12, Volume: 12, Issue:11

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Diagnostic Errors; Doxorubicin; Hu

2019
Unexpected neurologic complications following a novel lymphoma treatment 'expected' to give rise to neurologic toxicity.
    BMJ case reports, 2019, Nov-12, Volume: 12, Issue:11

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Diagnostic Errors; Doxorubicin; Hu

2019
Unexpected neurologic complications following a novel lymphoma treatment 'expected' to give rise to neurologic toxicity.
    BMJ case reports, 2019, Nov-12, Volume: 12, Issue:11

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Diagnostic Errors; Doxorubicin; Hu

2019
Optimizing the use of the hyperCVAD regimen: Clinical vignettes and practical management.
    Cancer, 2020, 03-15, Volume: 126, Issue:6

    Topics: Age Factors; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Brai

2020
Optimizing the use of the hyperCVAD regimen: Clinical vignettes and practical management.
    Cancer, 2020, 03-15, Volume: 126, Issue:6

    Topics: Age Factors; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Brai

2020
Optimizing the use of the hyperCVAD regimen: Clinical vignettes and practical management.
    Cancer, 2020, 03-15, Volume: 126, Issue:6

    Topics: Age Factors; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Brai

2020
T-Cell Lymphoblastic Lymphoma Presenting as Acute Clavicular Pain.
    South Dakota medicine : the journal of the South Dakota State Medical Association, 2019, Volume: 72, Issue:10

    Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Daunorubicin; Humans; Pain; Precursor Cell Ly

2019
T-Cell Lymphoblastic Lymphoma Presenting as Acute Clavicular Pain.
    South Dakota medicine : the journal of the South Dakota State Medical Association, 2019, Volume: 72, Issue:10

    Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Daunorubicin; Humans; Pain; Precursor Cell Ly

2019
T-Cell Lymphoblastic Lymphoma Presenting as Acute Clavicular Pain.
    South Dakota medicine : the journal of the South Dakota State Medical Association, 2019, Volume: 72, Issue:10

    Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Daunorubicin; Humans; Pain; Precursor Cell Ly

2019
Outcomes of the cyclophosphamide, vincristine, prednisone (CVP) +/- rituximab (R-CVP) regimen in older patients with newly diagnosed Ph- acute lymphoblastic leukemia.
    Leukemia research, 2020, Volume: 89

    Topics: Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphami

2020
Outcomes of the cyclophosphamide, vincristine, prednisone (CVP) +/- rituximab (R-CVP) regimen in older patients with newly diagnosed Ph- acute lymphoblastic leukemia.
    Leukemia research, 2020, Volume: 89

    Topics: Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphami

2020
Outcomes of the cyclophosphamide, vincristine, prednisone (CVP) +/- rituximab (R-CVP) regimen in older patients with newly diagnosed Ph- acute lymphoblastic leukemia.
    Leukemia research, 2020, Volume: 89

    Topics: Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphami

2020
Reduced-dose intensity therapy for pediatric lymphoblastic leukemia: long-term results of the Recife RELLA05 pilot study.
    Blood, 2020, 04-23, Volume: 135, Issue:17

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; C

2020
Reduced-dose intensity therapy for pediatric lymphoblastic leukemia: long-term results of the Recife RELLA05 pilot study.
    Blood, 2020, 04-23, Volume: 135, Issue:17

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; C

2020
Reduced-dose intensity therapy for pediatric lymphoblastic leukemia: long-term results of the Recife RELLA05 pilot study.
    Blood, 2020, 04-23, Volume: 135, Issue:17

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; C

2020
Implementation of RNA sequencing and array CGH in the diagnostic workflow of the AIEOP-BFM ALL 2017 trial on acute lymphoblastic leukemia.
    Annals of hematology, 2020, Volume: 99, Issue:4

    Topics: Abnormal Karyotype; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Comparative Genomi

2020
Implementation of RNA sequencing and array CGH in the diagnostic workflow of the AIEOP-BFM ALL 2017 trial on acute lymphoblastic leukemia.
    Annals of hematology, 2020, Volume: 99, Issue:4

    Topics: Abnormal Karyotype; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Comparative Genomi

2020
Implementation of RNA sequencing and array CGH in the diagnostic workflow of the AIEOP-BFM ALL 2017 trial on acute lymphoblastic leukemia.
    Annals of hematology, 2020, Volume: 99, Issue:4

    Topics: Abnormal Karyotype; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Comparative Genomi

2020
A Case of Nephrotic Syndrome after Allogeneic Stem Cell Transplantation.
    Clinical journal of the American Society of Nephrology : CJASN, 2020, 06-08, Volume: 15, Issue:6

    Topics: Acute Kidney Injury; Anti-Inflammatory Agents; Diuretics; Graft vs Host Disease; Hematopoietic Stem

2020
A Case of Nephrotic Syndrome after Allogeneic Stem Cell Transplantation.
    Clinical journal of the American Society of Nephrology : CJASN, 2020, 06-08, Volume: 15, Issue:6

    Topics: Acute Kidney Injury; Anti-Inflammatory Agents; Diuretics; Graft vs Host Disease; Hematopoietic Stem

2020
A Case of Nephrotic Syndrome after Allogeneic Stem Cell Transplantation.
    Clinical journal of the American Society of Nephrology : CJASN, 2020, 06-08, Volume: 15, Issue:6

    Topics: Acute Kidney Injury; Anti-Inflammatory Agents; Diuretics; Graft vs Host Disease; Hematopoietic Stem

2020
An oral, chemotherapy-free regimen (dasatinib plus prednisone) as induction and consolidation for adult patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia.
    British journal of haematology, 2020, Volume: 189, Issue:6

    Topics: Administration, Oral; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Conso

2020
An oral, chemotherapy-free regimen (dasatinib plus prednisone) as induction and consolidation for adult patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia.
    British journal of haematology, 2020, Volume: 189, Issue:6

    Topics: Administration, Oral; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Conso

2020
An oral, chemotherapy-free regimen (dasatinib plus prednisone) as induction and consolidation for adult patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia.
    British journal of haematology, 2020, Volume: 189, Issue:6

    Topics: Administration, Oral; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Conso

2020
Acute Kidney Injury With Massively Enlarged Noncystic Kidneys.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2020, Volume: 75, Issue:5

    Topics: Acute Kidney Injury; Adolescent; Biopsy; Diagnosis, Differential; Female; Glomerular Filtration Rate

2020
Acute Kidney Injury With Massively Enlarged Noncystic Kidneys.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2020, Volume: 75, Issue:5

    Topics: Acute Kidney Injury; Adolescent; Biopsy; Diagnosis, Differential; Female; Glomerular Filtration Rate

2020
Acute Kidney Injury With Massively Enlarged Noncystic Kidneys.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2020, Volume: 75, Issue:5

    Topics: Acute Kidney Injury; Adolescent; Biopsy; Diagnosis, Differential; Female; Glomerular Filtration Rate

2020
Peripheral T-cell lymphoma, NOS, with rapidly progressing leukocytosis mimicking acute lymphoblastic leukemia.
    Blood, 2020, 05-14, Volume: 135, Issue:20

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Diagnosis, Differential; Dis

2020
Peripheral T-cell lymphoma, NOS, with rapidly progressing leukocytosis mimicking acute lymphoblastic leukemia.
    Blood, 2020, 05-14, Volume: 135, Issue:20

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Diagnosis, Differential; Dis

2020
Peripheral T-cell lymphoma, NOS, with rapidly progressing leukocytosis mimicking acute lymphoblastic leukemia.
    Blood, 2020, 05-14, Volume: 135, Issue:20

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Diagnosis, Differential; Dis

2020
Effect of lubiprostone on vinca alkaloid-induced constipation in patients with hematological malignancies: a propensity score-matched analysis.
    Annals of hematology, 2020, Volume: 99, Issue:10

    Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Pro

2020
Effect of lubiprostone on vinca alkaloid-induced constipation in patients with hematological malignancies: a propensity score-matched analysis.
    Annals of hematology, 2020, Volume: 99, Issue:10

    Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Pro

2020
Effect of lubiprostone on vinca alkaloid-induced constipation in patients with hematological malignancies: a propensity score-matched analysis.
    Annals of hematology, 2020, Volume: 99, Issue:10

    Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Pro

2020
Salivary immunoglobulin A level during steroids and chemotherapy treatment administered in remission induction phase among pediatric patients with acute lymphoblastic leukemia.
    Medicine, 2020, Oct-16, Volume: 99, Issue:42

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Blood Proteins; Child; Chi

2020
Salivary immunoglobulin A level during steroids and chemotherapy treatment administered in remission induction phase among pediatric patients with acute lymphoblastic leukemia.
    Medicine, 2020, Oct-16, Volume: 99, Issue:42

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Blood Proteins; Child; Chi

2020
Salivary immunoglobulin A level during steroids and chemotherapy treatment administered in remission induction phase among pediatric patients with acute lymphoblastic leukemia.
    Medicine, 2020, Oct-16, Volume: 99, Issue:42

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Blood Proteins; Child; Chi

2020
Results of two consecutive treatment protocols in Polish children with acute lymphoblastic leukemia.
    Scientific reports, 2020, 11-19, Volume: 10, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Antineoplastic Protocols; Asparaginase; Child; Child

2020
Results of two consecutive treatment protocols in Polish children with acute lymphoblastic leukemia.
    Scientific reports, 2020, 11-19, Volume: 10, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Antineoplastic Protocols; Asparaginase; Child; Child

2020
Results of two consecutive treatment protocols in Polish children with acute lymphoblastic leukemia.
    Scientific reports, 2020, 11-19, Volume: 10, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Antineoplastic Protocols; Asparaginase; Child; Child

2020
Reduced intensity of early intensification does not increase the risk of relapse in children with standard risk acute lymphoblastic leukemia - a multi-centric clinical study of GD-2008-ALL protocol.
    BMC cancer, 2021, Jan-13, Volume: 21, Issue:1

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamid

2021
Reduced intensity of early intensification does not increase the risk of relapse in children with standard risk acute lymphoblastic leukemia - a multi-centric clinical study of GD-2008-ALL protocol.
    BMC cancer, 2021, Jan-13, Volume: 21, Issue:1

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamid

2021
Reduced intensity of early intensification does not increase the risk of relapse in children with standard risk acute lymphoblastic leukemia - a multi-centric clinical study of GD-2008-ALL protocol.
    BMC cancer, 2021, Jan-13, Volume: 21, Issue:1

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamid

2021
Long non-coding RNA MEG3 as a candidate prognostic factor for induction therapy response and survival profile in childhood acute lymphoblastic leukemia patients.
    Scandinavian journal of clinical and laboratory investigation, 2021, Volume: 81, Issue:3

    Topics: Biomarkers, Tumor; Bone Marrow Cells; Case-Control Studies; Child; Child, Preschool; Gene Expression

2021
Long non-coding RNA MEG3 as a candidate prognostic factor for induction therapy response and survival profile in childhood acute lymphoblastic leukemia patients.
    Scandinavian journal of clinical and laboratory investigation, 2021, Volume: 81, Issue:3

    Topics: Biomarkers, Tumor; Bone Marrow Cells; Case-Control Studies; Child; Child, Preschool; Gene Expression

2021
Long non-coding RNA MEG3 as a candidate prognostic factor for induction therapy response and survival profile in childhood acute lymphoblastic leukemia patients.
    Scandinavian journal of clinical and laboratory investigation, 2021, Volume: 81, Issue:3

    Topics: Biomarkers, Tumor; Bone Marrow Cells; Case-Control Studies; Child; Child, Preschool; Gene Expression

2021
Outcomes of pediatric mixed phenotype acute leukemia treated with lymphoid directed therapy: Analysis of an institutional series from India.
    Pediatric hematology and oncology, 2021, Volume: 38, Issue:4

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Daunorubicin; Femal

2021
Outcomes of pediatric mixed phenotype acute leukemia treated with lymphoid directed therapy: Analysis of an institutional series from India.
    Pediatric hematology and oncology, 2021, Volume: 38, Issue:4

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Daunorubicin; Femal

2021
Outcomes of pediatric mixed phenotype acute leukemia treated with lymphoid directed therapy: Analysis of an institutional series from India.
    Pediatric hematology and oncology, 2021, Volume: 38, Issue:4

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Daunorubicin; Femal

2021
Phase-specific risks of outpatient visits, emergency visits, and hospitalizations during Children's Oncology Group-based treatment for childhood acute lymphoblastic leukemia: A population-based study.
    Pediatric blood & cancer, 2021, Volume: 68, Issue:10

    Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Dexamethasone; Emergency Service, Hospital; H

2021
Phase-specific risks of outpatient visits, emergency visits, and hospitalizations during Children's Oncology Group-based treatment for childhood acute lymphoblastic leukemia: A population-based study.
    Pediatric blood & cancer, 2021, Volume: 68, Issue:10

    Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Dexamethasone; Emergency Service, Hospital; H

2021
Phase-specific risks of outpatient visits, emergency visits, and hospitalizations during Children's Oncology Group-based treatment for childhood acute lymphoblastic leukemia: A population-based study.
    Pediatric blood & cancer, 2021, Volume: 68, Issue:10

    Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Dexamethasone; Emergency Service, Hospital; H

2021
Clinical features and prognostic impact of TCF3-PBX1 in childhood acute lymphoblastic leukemia: A single-center retrospective study of 837 patients from China.
    Current problems in cancer, 2021, Volume: 45, Issue:6

    Topics: Adolescent; Antineoplastic Agents, Hormonal; Child; Child, Preschool; China; Female; Humans; Infant;

2021
Clinical features and prognostic impact of TCF3-PBX1 in childhood acute lymphoblastic leukemia: A single-center retrospective study of 837 patients from China.
    Current problems in cancer, 2021, Volume: 45, Issue:6

    Topics: Adolescent; Antineoplastic Agents, Hormonal; Child; Child, Preschool; China; Female; Humans; Infant;

2021
Clinical features and prognostic impact of TCF3-PBX1 in childhood acute lymphoblastic leukemia: A single-center retrospective study of 837 patients from China.
    Current problems in cancer, 2021, Volume: 45, Issue:6

    Topics: Adolescent; Antineoplastic Agents, Hormonal; Child; Child, Preschool; China; Female; Humans; Infant;

2021
Philadelphia chromosome-positive B-lymphoblastic lymphoma successfully treated with chemotherapy regimen containing imatinib: A rare case report and literature review.
    Medicine, 2021, Jun-11, Volume: 100, Issue:23

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Examination; Daunorubicin; Fusion Protei

2021
Philadelphia chromosome-positive B-lymphoblastic lymphoma successfully treated with chemotherapy regimen containing imatinib: A rare case report and literature review.
    Medicine, 2021, Jun-11, Volume: 100, Issue:23

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Examination; Daunorubicin; Fusion Protei

2021
Philadelphia chromosome-positive B-lymphoblastic lymphoma successfully treated with chemotherapy regimen containing imatinib: A rare case report and literature review.
    Medicine, 2021, Jun-11, Volume: 100, Issue:23

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Examination; Daunorubicin; Fusion Protei

2021
Efficacy of chemotherapy protocols for hematological malignancies: H-CVAD versus GELA/BURKIMAB/PETHEMA LAL.
    Experimental hematology, 2021, Volume: 101-102

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Burkitt Lymphoma; Cycloph

2021
Efficacy of chemotherapy protocols for hematological malignancies: H-CVAD versus GELA/BURKIMAB/PETHEMA LAL.
    Experimental hematology, 2021, Volume: 101-102

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Burkitt Lymphoma; Cycloph

2021
Efficacy of chemotherapy protocols for hematological malignancies: H-CVAD versus GELA/BURKIMAB/PETHEMA LAL.
    Experimental hematology, 2021, Volume: 101-102

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Burkitt Lymphoma; Cycloph

2021
Diagnostic value of the dual-luciferase report assay for predicting response to glucocorticoid in children with acute lymphoblastic leukemia.
    Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2017, Volume: 19, Issue:10

    Topics: Adolescent; Child; Child, Preschool; Drug Resistance, Neoplasm; Female; Follow-Up Studies; Glucocort

2017
Diagnostic value of the dual-luciferase report assay for predicting response to glucocorticoid in children with acute lymphoblastic leukemia.
    Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2017, Volume: 19, Issue:10

    Topics: Adolescent; Child; Child, Preschool; Drug Resistance, Neoplasm; Female; Follow-Up Studies; Glucocort

2017
Diagnostic value of the dual-luciferase report assay for predicting response to glucocorticoid in children with acute lymphoblastic leukemia.
    Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2017, Volume: 19, Issue:10

    Topics: Adolescent; Child; Child, Preschool; Drug Resistance, Neoplasm; Female; Follow-Up Studies; Glucocort

2017
Prognostic impact of IKZF1 deletions in association with vincristine-dexamethasone pulses during maintenance treatment of childhood acute lymphoblastic leukemia on trial ALL-BFM 95.
    Leukemia, 2017, Volume: 31, Issue:8

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; C

2017
Prognostic impact of IKZF1 deletions in association with vincristine-dexamethasone pulses during maintenance treatment of childhood acute lymphoblastic leukemia on trial ALL-BFM 95.
    Leukemia, 2017, Volume: 31, Issue:8

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; C

2017
Prognostic impact of IKZF1 deletions in association with vincristine-dexamethasone pulses during maintenance treatment of childhood acute lymphoblastic leukemia on trial ALL-BFM 95.
    Leukemia, 2017, Volume: 31, Issue:8

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; C

2017
miR-125b predicts childhood acute lymphoblastic leukaemia poor response to BFM chemotherapy treatment.
    British journal of cancer, 2017, Sep-05, Volume: 117, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Biomarkers, Tumor; Bone Marrow; Child;

2017
miR-125b predicts childhood acute lymphoblastic leukaemia poor response to BFM chemotherapy treatment.
    British journal of cancer, 2017, Sep-05, Volume: 117, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Biomarkers, Tumor; Bone Marrow; Child;

2017
miR-125b predicts childhood acute lymphoblastic leukaemia poor response to BFM chemotherapy treatment.
    British journal of cancer, 2017, Sep-05, Volume: 117, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Biomarkers, Tumor; Bone Marrow; Child;

2017
Ponatinib-Induced Graft-versus-Host Disease/Graft-versus-Leukemia Effect in a Patient with Philadelphia-Positive Acute Lymphoblastic Leukemia without the T315I Mutation Relapsing after Allogeneic Transplant.
    Chemotherapy, 2017, Volume: 62, Issue:6

    Topics: Adenine Nucleotides; Adult; Arabinonucleosides; Bone Marrow; Clofarabine; Cyclophosphamide; Disease-

2017
Ponatinib-Induced Graft-versus-Host Disease/Graft-versus-Leukemia Effect in a Patient with Philadelphia-Positive Acute Lymphoblastic Leukemia without the T315I Mutation Relapsing after Allogeneic Transplant.
    Chemotherapy, 2017, Volume: 62, Issue:6

    Topics: Adenine Nucleotides; Adult; Arabinonucleosides; Bone Marrow; Clofarabine; Cyclophosphamide; Disease-

2017
Ponatinib-Induced Graft-versus-Host Disease/Graft-versus-Leukemia Effect in a Patient with Philadelphia-Positive Acute Lymphoblastic Leukemia without the T315I Mutation Relapsing after Allogeneic Transplant.
    Chemotherapy, 2017, Volume: 62, Issue:6

    Topics: Adenine Nucleotides; Adult; Arabinonucleosides; Bone Marrow; Clofarabine; Cyclophosphamide; Disease-

2017
High-dose chemotherapy and autologous peripheral blood stem cell transplantation with BCVAC regimen followed by maintenance chemotherapy for children with very high risk acute lymphoblastic leukemia.
    International journal of hematology, 2018, Volume: 107, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Autografts; Carmustine; Child; Child, Preschool; Com

2018
High-dose chemotherapy and autologous peripheral blood stem cell transplantation with BCVAC regimen followed by maintenance chemotherapy for children with very high risk acute lymphoblastic leukemia.
    International journal of hematology, 2018, Volume: 107, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Autografts; Carmustine; Child; Child, Preschool; Com

2018
High-dose chemotherapy and autologous peripheral blood stem cell transplantation with BCVAC regimen followed by maintenance chemotherapy for children with very high risk acute lymphoblastic leukemia.
    International journal of hematology, 2018, Volume: 107, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Autografts; Carmustine; Child; Child, Preschool; Com

2018
Non-alcoholic steatohepatitis induced by induction chemotherapy for pediatric acute lymphoblastic leukemia.
    International journal of hematology, 2018, Volume: 107, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Biomarkers; Child; Daunorubicin; gamma

2018
Non-alcoholic steatohepatitis induced by induction chemotherapy for pediatric acute lymphoblastic leukemia.
    International journal of hematology, 2018, Volume: 107, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Biomarkers; Child; Daunorubicin; gamma

2018
Non-alcoholic steatohepatitis induced by induction chemotherapy for pediatric acute lymphoblastic leukemia.
    International journal of hematology, 2018, Volume: 107, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Biomarkers; Child; Daunorubicin; gamma

2018
DNA variants in DHFR gene and response to treatment in children with childhood B ALL: revisited in AIEOP-BFM protocol.
    Pharmacogenomics, 2018, Volume: 19, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Biomarkers, Tumor; Child; Daunorubicin

2018
DNA variants in DHFR gene and response to treatment in children with childhood B ALL: revisited in AIEOP-BFM protocol.
    Pharmacogenomics, 2018, Volume: 19, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Biomarkers, Tumor; Child; Daunorubicin

2018
DNA variants in DHFR gene and response to treatment in children with childhood B ALL: revisited in AIEOP-BFM protocol.
    Pharmacogenomics, 2018, Volume: 19, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Biomarkers, Tumor; Child; Daunorubicin

2018
Influence of thiopurine methyltransferase gene polymorphism on Egyptian children with acute lymphoblastic leukaemia.
    Journal of genetics, 2017, Volume: 96, Issue:6

    Topics: Adolescent; Alleles; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Pre

2017
Influence of thiopurine methyltransferase gene polymorphism on Egyptian children with acute lymphoblastic leukaemia.
    Journal of genetics, 2017, Volume: 96, Issue:6

    Topics: Adolescent; Alleles; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Pre

2017
Influence of thiopurine methyltransferase gene polymorphism on Egyptian children with acute lymphoblastic leukaemia.
    Journal of genetics, 2017, Volume: 96, Issue:6

    Topics: Adolescent; Alleles; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Pre

2017
Severe hypofibrinogenemia associated with imatinib and prednisone therapy in Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Leukemia & lymphoma, 2018, Volume: 59, Issue:10

    Topics: Adult; Afibrinogenemia; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Fibrinogen; Hu

2018
Severe hypofibrinogenemia associated with imatinib and prednisone therapy in Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Leukemia & lymphoma, 2018, Volume: 59, Issue:10

    Topics: Adult; Afibrinogenemia; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Fibrinogen; Hu

2018
Severe hypofibrinogenemia associated with imatinib and prednisone therapy in Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Leukemia & lymphoma, 2018, Volume: 59, Issue:10

    Topics: Adult; Afibrinogenemia; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Fibrinogen; Hu

2018
Remission Rate of Acute Lymphoblastic Leukemia (ALL) in Adolescents and Young Adults (AYA).
    Journal of the College of Physicians and Surgeons--Pakistan : JCPSP, 2018, Volume: 28, Issue:2

    Topics: Adolescent; Adult; Asparaginase; Bone Marrow; Daunorubicin; Female; Humans; Immunophenotyping; Male;

2018
Remission Rate of Acute Lymphoblastic Leukemia (ALL) in Adolescents and Young Adults (AYA).
    Journal of the College of Physicians and Surgeons--Pakistan : JCPSP, 2018, Volume: 28, Issue:2

    Topics: Adolescent; Adult; Asparaginase; Bone Marrow; Daunorubicin; Female; Humans; Immunophenotyping; Male;

2018
Remission Rate of Acute Lymphoblastic Leukemia (ALL) in Adolescents and Young Adults (AYA).
    Journal of the College of Physicians and Surgeons--Pakistan : JCPSP, 2018, Volume: 28, Issue:2

    Topics: Adolescent; Adult; Asparaginase; Bone Marrow; Daunorubicin; Female; Humans; Immunophenotyping; Male;

2018
Clinical utility of miR-143/miR-182 levels in prognosis and risk stratification specificity of BFM-treated childhood acute lymphoblastic leukemia.
    Annals of hematology, 2018, Volume: 97, Issue:7

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Cells; Child;

2018
Clinical utility of miR-143/miR-182 levels in prognosis and risk stratification specificity of BFM-treated childhood acute lymphoblastic leukemia.
    Annals of hematology, 2018, Volume: 97, Issue:7

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Cells; Child;

2018
Clinical utility of miR-143/miR-182 levels in prognosis and risk stratification specificity of BFM-treated childhood acute lymphoblastic leukemia.
    Annals of hematology, 2018, Volume: 97, Issue:7

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Cells; Child;

2018
Incidence and Risk Factors for Hypertension During Childhood Acute Lymphoblastic Leukemia Therapy.
    Indian pediatrics, 2018, Oct-15, Volume: 55, Issue:10

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; D

2018
Incidence and Risk Factors for Hypertension During Childhood Acute Lymphoblastic Leukemia Therapy.
    Indian pediatrics, 2018, Oct-15, Volume: 55, Issue:10

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; D

2018
Incidence and Risk Factors for Hypertension During Childhood Acute Lymphoblastic Leukemia Therapy.
    Indian pediatrics, 2018, Oct-15, Volume: 55, Issue:10

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; D

2018
[Relationship between Early Treatment Response and Prognosis in Children with Acute Lymphoblastic Leukemia].
    Zhongguo shi yan xue ye xue za zhi, 2018, Volume: 26, Issue:3

    Topics: Child; Disease-Free Survival; Humans; Neoplasm, Residual; Precursor Cell Lymphoblastic Leukemia-Lymp

2018
[Relationship between Early Treatment Response and Prognosis in Children with Acute Lymphoblastic Leukemia].
    Zhongguo shi yan xue ye xue za zhi, 2018, Volume: 26, Issue:3

    Topics: Child; Disease-Free Survival; Humans; Neoplasm, Residual; Precursor Cell Lymphoblastic Leukemia-Lymp

2018
[Relationship between Early Treatment Response and Prognosis in Children with Acute Lymphoblastic Leukemia].
    Zhongguo shi yan xue ye xue za zhi, 2018, Volume: 26, Issue:3

    Topics: Child; Disease-Free Survival; Humans; Neoplasm, Residual; Precursor Cell Lymphoblastic Leukemia-Lymp

2018
Acute lymphoblastic leukemia in children with Down syndrome: Comparative analysis versus patients without Down syndrome.
    Archivos argentinos de pediatria, 2018, Aug-01, Volume: 116, Issue:4

    Topics: Adolescent; Age Factors; Antineoplastic Agents, Hormonal; Child; Child, Preschool; Disease-Free Surv

2018
Acute lymphoblastic leukemia in children with Down syndrome: Comparative analysis versus patients without Down syndrome.
    Archivos argentinos de pediatria, 2018, Aug-01, Volume: 116, Issue:4

    Topics: Adolescent; Age Factors; Antineoplastic Agents, Hormonal; Child; Child, Preschool; Disease-Free Surv

2018
Acute lymphoblastic leukemia in children with Down syndrome: Comparative analysis versus patients without Down syndrome.
    Archivos argentinos de pediatria, 2018, Aug-01, Volume: 116, Issue:4

    Topics: Adolescent; Age Factors; Antineoplastic Agents, Hormonal; Child; Child, Preschool; Disease-Free Surv

2018
ETV6/RUNX1-positive childhood acute lymphoblastic leukemia in China: excellent prognosis with improved BFM protocol.
    Italian journal of pediatrics, 2018, Aug-16, Volume: 44, Issue:1

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; C

2018
ETV6/RUNX1-positive childhood acute lymphoblastic leukemia in China: excellent prognosis with improved BFM protocol.
    Italian journal of pediatrics, 2018, Aug-16, Volume: 44, Issue:1

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; C

2018
ETV6/RUNX1-positive childhood acute lymphoblastic leukemia in China: excellent prognosis with improved BFM protocol.
    Italian journal of pediatrics, 2018, Aug-16, Volume: 44, Issue:1

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; C

2018
Outcomes of Low-Intensity Treatment of Acute Lymphoblastic Leukemia at Butaro Cancer Center of Excellence in Rwanda.
    Journal of global oncology, 2018, Volume: 4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cancer Care Facilities; Child; Cycloph

2018
Outcomes of Low-Intensity Treatment of Acute Lymphoblastic Leukemia at Butaro Cancer Center of Excellence in Rwanda.
    Journal of global oncology, 2018, Volume: 4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cancer Care Facilities; Child; Cycloph

2018
Outcomes of Low-Intensity Treatment of Acute Lymphoblastic Leukemia at Butaro Cancer Center of Excellence in Rwanda.
    Journal of global oncology, 2018, Volume: 4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cancer Care Facilities; Child; Cycloph

2018
The therapeutic efficacy of pediatric ALL patients with MLL gene rearrangement treated with CCLG-ALL2008 protocol.
    European review for medical and pharmacological sciences, 2018, Volume: 22, Issue:18

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; China; Drug Adm

2018
The therapeutic efficacy of pediatric ALL patients with MLL gene rearrangement treated with CCLG-ALL2008 protocol.
    European review for medical and pharmacological sciences, 2018, Volume: 22, Issue:18

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; China; Drug Adm

2018
The therapeutic efficacy of pediatric ALL patients with MLL gene rearrangement treated with CCLG-ALL2008 protocol.
    European review for medical and pharmacological sciences, 2018, Volume: 22, Issue:18

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; China; Drug Adm

2018
Comparison between Hyper-CVAD and PETHEMA ALL-93 in Adult Acute Lymphoblastic Leukemia: A Single-Center Study.
    Chemotherapy, 2018, Volume: 63, Issue:4

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bacterial Infection

2018
Comparison between Hyper-CVAD and PETHEMA ALL-93 in Adult Acute Lymphoblastic Leukemia: A Single-Center Study.
    Chemotherapy, 2018, Volume: 63, Issue:4

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bacterial Infection

2018
Comparison between Hyper-CVAD and PETHEMA ALL-93 in Adult Acute Lymphoblastic Leukemia: A Single-Center Study.
    Chemotherapy, 2018, Volume: 63, Issue:4

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bacterial Infection

2018
TCF7L2 activated HOXA-AS2 decreased the glucocorticoid sensitivity in acute lymphoblastic leukemia through regulating HOXA3/EGFR/Ras/Raf/MEK/ERK pathway.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2019, Volume: 109

    Topics: Adolescent; Antineoplastic Agents, Hormonal; Cell Survival; Child; Child, Preschool; Drug Resistance

2019
TCF7L2 activated HOXA-AS2 decreased the glucocorticoid sensitivity in acute lymphoblastic leukemia through regulating HOXA3/EGFR/Ras/Raf/MEK/ERK pathway.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2019, Volume: 109

    Topics: Adolescent; Antineoplastic Agents, Hormonal; Cell Survival; Child; Child, Preschool; Drug Resistance

2019
TCF7L2 activated HOXA-AS2 decreased the glucocorticoid sensitivity in acute lymphoblastic leukemia through regulating HOXA3/EGFR/Ras/Raf/MEK/ERK pathway.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2019, Volume: 109

    Topics: Adolescent; Antineoplastic Agents, Hormonal; Cell Survival; Child; Child, Preschool; Drug Resistance

2019
Improved Outcome of Newly Diagnosed Childhood Mature B-Cell Lymphoma/Leukemia With High Tumor Burden Treated With BFM95-based Protocol Combining Rituximab: A Report From Shanghai, China.
    Journal of pediatric hematology/oncology, 2019, Volume: 41, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Case-Control Studies; Child; China; Da

2019
Improved Outcome of Newly Diagnosed Childhood Mature B-Cell Lymphoma/Leukemia With High Tumor Burden Treated With BFM95-based Protocol Combining Rituximab: A Report From Shanghai, China.
    Journal of pediatric hematology/oncology, 2019, Volume: 41, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Case-Control Studies; Child; China; Da

2019
Improved Outcome of Newly Diagnosed Childhood Mature B-Cell Lymphoma/Leukemia With High Tumor Burden Treated With BFM95-based Protocol Combining Rituximab: A Report From Shanghai, China.
    Journal of pediatric hematology/oncology, 2019, Volume: 41, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Case-Control Studies; Child; China; Da

2019
High-dose chemotherapy without transfusion for Philadelphia chromosome negative B-cell acute lymphoblastic leukemia in two Jehovah's Witnesses patients: a feasible option in the age of hematopoietic growth factors.
    Leukemia & lymphoma, 2019, Volume: 60, Issue:9

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Blood Transfusion; Cyclophosphamide; Dose-Res

2019
High-dose chemotherapy without transfusion for Philadelphia chromosome negative B-cell acute lymphoblastic leukemia in two Jehovah's Witnesses patients: a feasible option in the age of hematopoietic growth factors.
    Leukemia & lymphoma, 2019, Volume: 60, Issue:9

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Blood Transfusion; Cyclophosphamide; Dose-Res

2019
High-dose chemotherapy without transfusion for Philadelphia chromosome negative B-cell acute lymphoblastic leukemia in two Jehovah's Witnesses patients: a feasible option in the age of hematopoietic growth factors.
    Leukemia & lymphoma, 2019, Volume: 60, Issue:9

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Blood Transfusion; Cyclophosphamide; Dose-Res

2019
Posterior reversible encephalopathy syndrome in children with acute lymphoblastic leukemia: Experience of a single center using BFM protocols.
    Pediatric blood & cancer, 2019, Volume: 66, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Daunorubicin; Humans; Posterior

2019
Posterior reversible encephalopathy syndrome in children with acute lymphoblastic leukemia: Experience of a single center using BFM protocols.
    Pediatric blood & cancer, 2019, Volume: 66, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Daunorubicin; Humans; Posterior

2019
Posterior reversible encephalopathy syndrome in children with acute lymphoblastic leukemia: Experience of a single center using BFM protocols.
    Pediatric blood & cancer, 2019, Volume: 66, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Daunorubicin; Humans; Posterior

2019
Visualization of Vertebral Body Deformities in Childhood by MRI in a Boy with ALL.
    RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin, 2019, Volume: 191, Issue:8

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Density; Bone Marrow; Child, Pres

2019
Visualization of Vertebral Body Deformities in Childhood by MRI in a Boy with ALL.
    RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin, 2019, Volume: 191, Issue:8

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Density; Bone Marrow; Child, Pres

2019
Visualization of Vertebral Body Deformities in Childhood by MRI in a Boy with ALL.
    RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin, 2019, Volume: 191, Issue:8

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Density; Bone Marrow; Child, Pres

2019
Analysis of apoptotic, platelet-derived, endothelial-derived, and tissue factor-positive microparticles of children with acute lymphoblastic leukemia during induction therapy.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2019, Volume: 30, Issue:4

    Topics: Adolescent; Apoptosis; Asparaginase; Blood Platelets; Cell-Derived Microparticles; Child; Child, Pre

2019
Analysis of apoptotic, platelet-derived, endothelial-derived, and tissue factor-positive microparticles of children with acute lymphoblastic leukemia during induction therapy.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2019, Volume: 30, Issue:4

    Topics: Adolescent; Apoptosis; Asparaginase; Blood Platelets; Cell-Derived Microparticles; Child; Child, Pre

2019
Analysis of apoptotic, platelet-derived, endothelial-derived, and tissue factor-positive microparticles of children with acute lymphoblastic leukemia during induction therapy.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2019, Volume: 30, Issue:4

    Topics: Adolescent; Apoptosis; Asparaginase; Blood Platelets; Cell-Derived Microparticles; Child; Child, Pre

2019
[Bmi-1 as A Molecular Marker for Prognosis of Pediatric ALL].
    Zhongguo shi yan xue ye xue za zhi, 2019, Volume: 27, Issue:3

    Topics: Biomarkers; Child; Humans; Kaplan-Meier Estimate; Polycomb Repressive Complex 1; Precursor Cell Lymp

2019
[Bmi-1 as A Molecular Marker for Prognosis of Pediatric ALL].
    Zhongguo shi yan xue ye xue za zhi, 2019, Volume: 27, Issue:3

    Topics: Biomarkers; Child; Humans; Kaplan-Meier Estimate; Polycomb Repressive Complex 1; Precursor Cell Lymp

2019
[Bmi-1 as A Molecular Marker for Prognosis of Pediatric ALL].
    Zhongguo shi yan xue ye xue za zhi, 2019, Volume: 27, Issue:3

    Topics: Biomarkers; Child; Humans; Kaplan-Meier Estimate; Polycomb Repressive Complex 1; Precursor Cell Lymp

2019
Risk group assignment differs for children and adults 1-45 yr with acute lymphoblastic leukemia treated by the NOPHO ALL-2008 protocol.
    European journal of haematology, 2013, Volume: 90, Issue:5

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cytogene

2013
Risk group assignment differs for children and adults 1-45 yr with acute lymphoblastic leukemia treated by the NOPHO ALL-2008 protocol.
    European journal of haematology, 2013, Volume: 90, Issue:5

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cytogene

2013
Risk group assignment differs for children and adults 1-45 yr with acute lymphoblastic leukemia treated by the NOPHO ALL-2008 protocol.
    European journal of haematology, 2013, Volume: 90, Issue:5

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cytogene

2013
Outcome of patients with acute lymphoblastic leukemia (ALL) following induction therapy with a modified (pulsed dexamethasone rather than continuous prednisone) UKALL XII/ECOG E2993 protocol at Tawam Hospital, United Arab Emirates (UAE).
    Medical oncology (Northwood, London, England), 2013, Volume: 30, Issue:2

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cancer Care Facilit

2013
Outcome of patients with acute lymphoblastic leukemia (ALL) following induction therapy with a modified (pulsed dexamethasone rather than continuous prednisone) UKALL XII/ECOG E2993 protocol at Tawam Hospital, United Arab Emirates (UAE).
    Medical oncology (Northwood, London, England), 2013, Volume: 30, Issue:2

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cancer Care Facilit

2013
Outcome of patients with acute lymphoblastic leukemia (ALL) following induction therapy with a modified (pulsed dexamethasone rather than continuous prednisone) UKALL XII/ECOG E2993 protocol at Tawam Hospital, United Arab Emirates (UAE).
    Medical oncology (Northwood, London, England), 2013, Volume: 30, Issue:2

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cancer Care Facilit

2013
Once upon a time--a personal view on episodes in leukemia research in Germany, and beyond.
    Klinische Padiatrie, 2013, Volume: 225 Suppl 1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Biomedical Research; Child; Daunorubic

2013
Once upon a time--a personal view on episodes in leukemia research in Germany, and beyond.
    Klinische Padiatrie, 2013, Volume: 225 Suppl 1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Biomedical Research; Child; Daunorubic

2013
Once upon a time--a personal view on episodes in leukemia research in Germany, and beyond.
    Klinische Padiatrie, 2013, Volume: 225 Suppl 1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Biomedical Research; Child; Daunorubic

2013
Key treatment questions in childhood acute lymphoblastic leukemia: results in 5 consecutive trials performed by the ALL-BFM study group from 1981 to 2000.
    Klinische Padiatrie, 2013, Volume: 225 Suppl 1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Cyclophosphamide; Cytarabine; D

2013
Key treatment questions in childhood acute lymphoblastic leukemia: results in 5 consecutive trials performed by the ALL-BFM study group from 1981 to 2000.
    Klinische Padiatrie, 2013, Volume: 225 Suppl 1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Cyclophosphamide; Cytarabine; D

2013
Key treatment questions in childhood acute lymphoblastic leukemia: results in 5 consecutive trials performed by the ALL-BFM study group from 1981 to 2000.
    Klinische Padiatrie, 2013, Volume: 225 Suppl 1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Cyclophosphamide; Cytarabine; D

2013
ALL-REZ BFM--the consecutive trials for children with relapsed acute lymphoblastic leukemia.
    Klinische Padiatrie, 2013, Volume: 225 Suppl 1

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow; Child; Combin

2013
ALL-REZ BFM--the consecutive trials for children with relapsed acute lymphoblastic leukemia.
    Klinische Padiatrie, 2013, Volume: 225 Suppl 1

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow; Child; Combin

2013
ALL-REZ BFM--the consecutive trials for children with relapsed acute lymphoblastic leukemia.
    Klinische Padiatrie, 2013, Volume: 225 Suppl 1

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow; Child; Combin

2013
Detection of MRD may predict the outcome of patients with Philadelphia chromosome-positive ALL treated with tyrosine kinase inhibitors plus chemotherapy.
    Blood, 2013, Aug-15, Volume: 122, Issue:7

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Cyclopho

2013
Detection of MRD may predict the outcome of patients with Philadelphia chromosome-positive ALL treated with tyrosine kinase inhibitors plus chemotherapy.
    Blood, 2013, Aug-15, Volume: 122, Issue:7

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Cyclopho

2013
Detection of MRD may predict the outcome of patients with Philadelphia chromosome-positive ALL treated with tyrosine kinase inhibitors plus chemotherapy.
    Blood, 2013, Aug-15, Volume: 122, Issue:7

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Cyclopho

2013
Bim polymorphisms: influence on function and response to treatment in children with acute lymphoblastic leukemia.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2013, Sep-15, Volume: 19, Issue:18

    Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Apoptosis Regulatory Proteins; Bcl-2-Like

2013
Bim polymorphisms: influence on function and response to treatment in children with acute lymphoblastic leukemia.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2013, Sep-15, Volume: 19, Issue:18

    Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Apoptosis Regulatory Proteins; Bcl-2-Like

2013
Bim polymorphisms: influence on function and response to treatment in children with acute lymphoblastic leukemia.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2013, Sep-15, Volume: 19, Issue:18

    Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Apoptosis Regulatory Proteins; Bcl-2-Like

2013
The expression of histone deacetylase 4 is associated with prednisone poor-response in childhood acute lymphoblastic leukemia.
    Leukemia research, 2013, Volume: 37, Issue:10

    Topics: Adolescent; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor;

2013
The expression of histone deacetylase 4 is associated with prednisone poor-response in childhood acute lymphoblastic leukemia.
    Leukemia research, 2013, Volume: 37, Issue:10

    Topics: Adolescent; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor;

2013
The expression of histone deacetylase 4 is associated with prednisone poor-response in childhood acute lymphoblastic leukemia.
    Leukemia research, 2013, Volume: 37, Issue:10

    Topics: Adolescent; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor;

2013
HDAC expression patterns in pediatric ALL.
    Leukemia research, 2013, Volume: 37, Issue:10

    Topics: Antineoplastic Agents; Female; Gene Expression; Histone Deacetylases; Humans; Male; Precursor Cell L

2013
HDAC expression patterns in pediatric ALL.
    Leukemia research, 2013, Volume: 37, Issue:10

    Topics: Antineoplastic Agents; Female; Gene Expression; Histone Deacetylases; Humans; Male; Precursor Cell L

2013
HDAC expression patterns in pediatric ALL.
    Leukemia research, 2013, Volume: 37, Issue:10

    Topics: Antineoplastic Agents; Female; Gene Expression; Histone Deacetylases; Humans; Male; Precursor Cell L

2013
The BCL2-938 C > A promoter polymorphism is associated with risk group classification in children with acute lymphoblastic leukemia.
    BMC cancer, 2013, Oct-02, Volume: 13

    Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Female; Genotype; Humans; M

2013
The BCL2-938 C > A promoter polymorphism is associated with risk group classification in children with acute lymphoblastic leukemia.
    BMC cancer, 2013, Oct-02, Volume: 13

    Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Female; Genotype; Humans; M

2013
The BCL2-938 C > A promoter polymorphism is associated with risk group classification in children with acute lymphoblastic leukemia.
    BMC cancer, 2013, Oct-02, Volume: 13

    Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Female; Genotype; Humans; M

2013
Prevalence and risk factors of cataract after chemotherapy with or without central nervous system irradiation for childhood acute lymphoblastic leukaemia: an LEA study.
    British journal of haematology, 2014, Volume: 164, Issue:1

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cataract; Child; Child, Preschool; Crani

2014
Prevalence and risk factors of cataract after chemotherapy with or without central nervous system irradiation for childhood acute lymphoblastic leukaemia: an LEA study.
    British journal of haematology, 2014, Volume: 164, Issue:1

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cataract; Child; Child, Preschool; Crani

2014
Prevalence and risk factors of cataract after chemotherapy with or without central nervous system irradiation for childhood acute lymphoblastic leukaemia: an LEA study.
    British journal of haematology, 2014, Volume: 164, Issue:1

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cataract; Child; Child, Preschool; Crani

2014
Herpes simplex virus reactivation and disease during treatment for childhood acute lymphoblastic leukemia.
    Klinische Padiatrie, 2014, Volume: 226, Issue:3

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bacterial Infections; Chil

2014
Herpes simplex virus reactivation and disease during treatment for childhood acute lymphoblastic leukemia.
    Klinische Padiatrie, 2014, Volume: 226, Issue:3

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bacterial Infections; Chil

2014
Herpes simplex virus reactivation and disease during treatment for childhood acute lymphoblastic leukemia.
    Klinische Padiatrie, 2014, Volume: 226, Issue:3

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bacterial Infections; Chil

2014
[Clinical characteristics and efficacy analysis for patients over 55 years of age with acute lymphoblastic leukemia].
    Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences, 2013, Dec-18, Volume: 45, Issue:6

    Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Consolidation Chemotherapy;

2013
[Clinical characteristics and efficacy analysis for patients over 55 years of age with acute lymphoblastic leukemia].
    Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences, 2013, Dec-18, Volume: 45, Issue:6

    Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Consolidation Chemotherapy;

2013
[Clinical characteristics and efficacy analysis for patients over 55 years of age with acute lymphoblastic leukemia].
    Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences, 2013, Dec-18, Volume: 45, Issue:6

    Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Consolidation Chemotherapy;

2013
Mitoxantrone as a substitute for daunorubicin during induction in newly diagnosed lymphoblastic leukemia and lymphoma.
    Pediatric blood & cancer, 2014, Volume: 61, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Daunorubicin; Dexamethasone; Dr

2014
Mitoxantrone as a substitute for daunorubicin during induction in newly diagnosed lymphoblastic leukemia and lymphoma.
    Pediatric blood & cancer, 2014, Volume: 61, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Daunorubicin; Dexamethasone; Dr

2014
Mitoxantrone as a substitute for daunorubicin during induction in newly diagnosed lymphoblastic leukemia and lymphoma.
    Pediatric blood & cancer, 2014, Volume: 61, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Daunorubicin; Dexamethasone; Dr

2014
The contribution of neurocognitive functioning to quality of life after childhood acute lymphoblastic leukemia.
    Psycho-oncology, 2014, Volume: 23, Issue:6

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cognition; Cros

2014
The contribution of neurocognitive functioning to quality of life after childhood acute lymphoblastic leukemia.
    Psycho-oncology, 2014, Volume: 23, Issue:6

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cognition; Cros

2014
The contribution of neurocognitive functioning to quality of life after childhood acute lymphoblastic leukemia.
    Psycho-oncology, 2014, Volume: 23, Issue:6

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cognition; Cros

2014
Impact on survival and toxicity by duration of weight extremes during treatment for pediatric acute lymphoblastic leukemia: A report from the Children's Oncology Group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2014, May-01, Volume: 32, Issue:13

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; C

2014
Impact on survival and toxicity by duration of weight extremes during treatment for pediatric acute lymphoblastic leukemia: A report from the Children's Oncology Group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2014, May-01, Volume: 32, Issue:13

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; C

2014
Impact on survival and toxicity by duration of weight extremes during treatment for pediatric acute lymphoblastic leukemia: A report from the Children's Oncology Group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2014, May-01, Volume: 32, Issue:13

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; C

2014
Scurvy: a new problem for patients with chronic GVHD involving mucous membranes; an easy problem to resolve.
    Pediatric transplantation, 2014, Volume: 18, Issue:5

    Topics: Administration, Oral; Adolescent; Adult; Ascorbic Acid; Ascorbic Acid Deficiency; Child; Chronic Dis

2014
Scurvy: a new problem for patients with chronic GVHD involving mucous membranes; an easy problem to resolve.
    Pediatric transplantation, 2014, Volume: 18, Issue:5

    Topics: Administration, Oral; Adolescent; Adult; Ascorbic Acid; Ascorbic Acid Deficiency; Child; Chronic Dis

2014
Scurvy: a new problem for patients with chronic GVHD involving mucous membranes; an easy problem to resolve.
    Pediatric transplantation, 2014, Volume: 18, Issue:5

    Topics: Administration, Oral; Adolescent; Adult; Ascorbic Acid; Ascorbic Acid Deficiency; Child; Chronic Dis

2014
Adrenal insufficiency during treatment for childhood acute lymphoblastic leukemia is associated with glucocorticoid receptor polymorphisms ER22/23EK and BclI.
    Haematologica, 2014, Volume: 99, Issue:8

    Topics: Adolescent; Adrenal Insufficiency; Child; Child, Preschool; Female; Follow-Up Studies; Humans; Infan

2014
Adrenal insufficiency during treatment for childhood acute lymphoblastic leukemia is associated with glucocorticoid receptor polymorphisms ER22/23EK and BclI.
    Haematologica, 2014, Volume: 99, Issue:8

    Topics: Adolescent; Adrenal Insufficiency; Child; Child, Preschool; Female; Follow-Up Studies; Humans; Infan

2014
Adrenal insufficiency during treatment for childhood acute lymphoblastic leukemia is associated with glucocorticoid receptor polymorphisms ER22/23EK and BclI.
    Haematologica, 2014, Volume: 99, Issue:8

    Topics: Adolescent; Adrenal Insufficiency; Child; Child, Preschool; Female; Follow-Up Studies; Humans; Infan

2014
[Efficacy observation of polyethylene glycol conjugated asparaginase for induction treatment of children with newly diagnosed acute lymphoblastic leukemia].
    Zhonghua er ke za zhi = Chinese journal of pediatrics, 2014, Volume: 52, Issue:3

    Topics: Adolescent; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bon

2014
[Efficacy observation of polyethylene glycol conjugated asparaginase for induction treatment of children with newly diagnosed acute lymphoblastic leukemia].
    Zhonghua er ke za zhi = Chinese journal of pediatrics, 2014, Volume: 52, Issue:3

    Topics: Adolescent; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bon

2014
[Efficacy observation of polyethylene glycol conjugated asparaginase for induction treatment of children with newly diagnosed acute lymphoblastic leukemia].
    Zhonghua er ke za zhi = Chinese journal of pediatrics, 2014, Volume: 52, Issue:3

    Topics: Adolescent; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bon

2014
Aggressive Cunninghamella pneumonia in an adolescent.
    Journal of pediatric hematology/oncology, 2014, Volume: 36, Issue:7

    Topics: Adolescent; Anti-Inflammatory Agents; Cunninghamella; Humans; Hyperbilirubinemia; Male; Mucormycosis

2014
Aggressive Cunninghamella pneumonia in an adolescent.
    Journal of pediatric hematology/oncology, 2014, Volume: 36, Issue:7

    Topics: Adolescent; Anti-Inflammatory Agents; Cunninghamella; Humans; Hyperbilirubinemia; Male; Mucormycosis

2014
Aggressive Cunninghamella pneumonia in an adolescent.
    Journal of pediatric hematology/oncology, 2014, Volume: 36, Issue:7

    Topics: Adolescent; Anti-Inflammatory Agents; Cunninghamella; Humans; Hyperbilirubinemia; Male; Mucormycosis

2014
Prognostic factors in adolescent and adult patients with acute lymphoblastic leukemia with two protocols of chemotherapy: a cross-sectional study.
    Clinical lymphoma, myeloma & leukemia, 2015, Volume: 15, Issue:1

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Consolidatio

2015
Prognostic factors in adolescent and adult patients with acute lymphoblastic leukemia with two protocols of chemotherapy: a cross-sectional study.
    Clinical lymphoma, myeloma & leukemia, 2015, Volume: 15, Issue:1

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Consolidatio

2015
Prognostic factors in adolescent and adult patients with acute lymphoblastic leukemia with two protocols of chemotherapy: a cross-sectional study.
    Clinical lymphoma, myeloma & leukemia, 2015, Volume: 15, Issue:1

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Consolidatio

2015
[Comparison of HyperCVAD regimen and CHOP regimen in treating patients with lymphoblastic lymphoma].
    Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition, 2014, Volume: 45, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dexamethasone; Disease-Free Surviv

2014
[Comparison of HyperCVAD regimen and CHOP regimen in treating patients with lymphoblastic lymphoma].
    Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition, 2014, Volume: 45, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dexamethasone; Disease-Free Surviv

2014
[Comparison of HyperCVAD regimen and CHOP regimen in treating patients with lymphoblastic lymphoma].
    Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition, 2014, Volume: 45, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dexamethasone; Disease-Free Surviv

2014
[SLCO1B1c. 521T>C gene polymorphisms are associated with high-dose methotrexate pharmacokinetics and clinical outcome of pediatric acute lymphoblastic leukemia].
    Zhonghua er ke za zhi = Chinese journal of pediatrics, 2014, Volume: 52, Issue:10

    Topics: Alleles; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Daunorubicin; Disease-

2014
[SLCO1B1c. 521T>C gene polymorphisms are associated with high-dose methotrexate pharmacokinetics and clinical outcome of pediatric acute lymphoblastic leukemia].
    Zhonghua er ke za zhi = Chinese journal of pediatrics, 2014, Volume: 52, Issue:10

    Topics: Alleles; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Daunorubicin; Disease-

2014
[SLCO1B1c. 521T>C gene polymorphisms are associated with high-dose methotrexate pharmacokinetics and clinical outcome of pediatric acute lymphoblastic leukemia].
    Zhonghua er ke za zhi = Chinese journal of pediatrics, 2014, Volume: 52, Issue:10

    Topics: Alleles; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Daunorubicin; Disease-

2014
[Outcomes of modified NHL-BFM-90 protocol for children and adolescents with lymphoblastic lymphoma].
    Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 2014, Volume: 35, Issue:12

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; D

2014
[Outcomes of modified NHL-BFM-90 protocol for children and adolescents with lymphoblastic lymphoma].
    Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 2014, Volume: 35, Issue:12

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; D

2014
[Outcomes of modified NHL-BFM-90 protocol for children and adolescents with lymphoblastic lymphoma].
    Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 2014, Volume: 35, Issue:12

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; D

2014
Single nucleotide polymorphisms in non-coding region of the glucocorticoid receptor gene and prednisone response in childhood acute lymphoblastic leukemia.
    Leukemia & lymphoma, 2015, Volume: 56, Issue:6

    Topics: Adolescent; Child; Child, Preschool; Female; Genes, bcl-1; Glucocorticoids; Humans; Infant; Infant,

2015
Single nucleotide polymorphisms in non-coding region of the glucocorticoid receptor gene and prednisone response in childhood acute lymphoblastic leukemia.
    Leukemia & lymphoma, 2015, Volume: 56, Issue:6

    Topics: Adolescent; Child; Child, Preschool; Female; Genes, bcl-1; Glucocorticoids; Humans; Infant; Infant,

2015
Single nucleotide polymorphisms in non-coding region of the glucocorticoid receptor gene and prednisone response in childhood acute lymphoblastic leukemia.
    Leukemia & lymphoma, 2015, Volume: 56, Issue:6

    Topics: Adolescent; Child; Child, Preschool; Female; Genes, bcl-1; Glucocorticoids; Humans; Infant; Infant,

2015
Toxicity profile and treatment delays in NOPHO ALL2008-comparing adults and children with Philadelphia chromosome-negative acute lymphoblastic leukemia.
    European journal of haematology, 2016, Volume: 96, Issue:2

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Female;

2016
Toxicity profile and treatment delays in NOPHO ALL2008-comparing adults and children with Philadelphia chromosome-negative acute lymphoblastic leukemia.
    European journal of haematology, 2016, Volume: 96, Issue:2

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Female;

2016
Toxicity profile and treatment delays in NOPHO ALL2008-comparing adults and children with Philadelphia chromosome-negative acute lymphoblastic leukemia.
    European journal of haematology, 2016, Volume: 96, Issue:2

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Female;

2016
Is the BFM Regimen Feasible for the Treatment of Adult Acute Lymphoblastic Leukemia? A Retrospective Analysis of the Outcomes of BFM and Hyper-CVAD Chemotherapy in Two Centers.
    Chemotherapy, 2014, Volume: 60, Issue:4

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cyclophosphamide; D

2014
Is the BFM Regimen Feasible for the Treatment of Adult Acute Lymphoblastic Leukemia? A Retrospective Analysis of the Outcomes of BFM and Hyper-CVAD Chemotherapy in Two Centers.
    Chemotherapy, 2014, Volume: 60, Issue:4

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cyclophosphamide; D

2014
Is the BFM Regimen Feasible for the Treatment of Adult Acute Lymphoblastic Leukemia? A Retrospective Analysis of the Outcomes of BFM and Hyper-CVAD Chemotherapy in Two Centers.
    Chemotherapy, 2014, Volume: 60, Issue:4

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cyclophosphamide; D

2014
Survival of Mexican Children with Acute Lymphoblastic Leukaemia under Treatment with the Protocol from the Dana-Farber Cancer Institute 00-01.
    BioMed research international, 2015, Volume: 2015

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cytarabine; Dis

2015
Survival of Mexican Children with Acute Lymphoblastic Leukaemia under Treatment with the Protocol from the Dana-Farber Cancer Institute 00-01.
    BioMed research international, 2015, Volume: 2015

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cytarabine; Dis

2015
Survival of Mexican Children with Acute Lymphoblastic Leukaemia under Treatment with the Protocol from the Dana-Farber Cancer Institute 00-01.
    BioMed research international, 2015, Volume: 2015

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cytarabine; Dis

2015
Overexpression of BCL2 and BAX following BFM induction therapy predicts ch-ALL patients' poor response to treatment and short-term relapse.
    Journal of cancer research and clinical oncology, 2015, Volume: 141, Issue:11

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; bcl-2-Associated X Protein

2015
Overexpression of BCL2 and BAX following BFM induction therapy predicts ch-ALL patients' poor response to treatment and short-term relapse.
    Journal of cancer research and clinical oncology, 2015, Volume: 141, Issue:11

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; bcl-2-Associated X Protein

2015
Overexpression of BCL2 and BAX following BFM induction therapy predicts ch-ALL patients' poor response to treatment and short-term relapse.
    Journal of cancer research and clinical oncology, 2015, Volume: 141, Issue:11

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; bcl-2-Associated X Protein

2015
[Prognostic Value of Prednisone Response in CCLG-ALL 2008].
    Zhongguo shi yan xue ye xue za zhi, 2015, Volume: 23, Issue:3

    Topics: Disease-Free Survival; Humans; Multivariate Analysis; Neoplasm, Residual; Precursor Cell Lymphoblast

2015
[Prognostic Value of Prednisone Response in CCLG-ALL 2008].
    Zhongguo shi yan xue ye xue za zhi, 2015, Volume: 23, Issue:3

    Topics: Disease-Free Survival; Humans; Multivariate Analysis; Neoplasm, Residual; Precursor Cell Lymphoblast

2015
[Prognostic Value of Prednisone Response in CCLG-ALL 2008].
    Zhongguo shi yan xue ye xue za zhi, 2015, Volume: 23, Issue:3

    Topics: Disease-Free Survival; Humans; Multivariate Analysis; Neoplasm, Residual; Precursor Cell Lymphoblast

2015
Prediction of outcomes by early treatment responses in childhood T-cell acute lymphoblastic leukemia: a retrospective study in China.
    BMC pediatrics, 2015, Jul-15, Volume: 15

    Topics: Adolescent; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Bone Ma

2015
Prediction of outcomes by early treatment responses in childhood T-cell acute lymphoblastic leukemia: a retrospective study in China.
    BMC pediatrics, 2015, Jul-15, Volume: 15

    Topics: Adolescent; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Bone Ma

2015
Prediction of outcomes by early treatment responses in childhood T-cell acute lymphoblastic leukemia: a retrospective study in China.
    BMC pediatrics, 2015, Jul-15, Volume: 15

    Topics: Adolescent; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Bone Ma

2015
Is a New Protocol for Acute Lymphoblastic Leukemia Research or Standard Therapy?
    Pediatrics, 2015, Volume: 136, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Clinical Protocols; Cyclophosph

2015
Is a New Protocol for Acute Lymphoblastic Leukemia Research or Standard Therapy?
    Pediatrics, 2015, Volume: 136, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Clinical Protocols; Cyclophosph

2015
Is a New Protocol for Acute Lymphoblastic Leukemia Research or Standard Therapy?
    Pediatrics, 2015, Volume: 136, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Clinical Protocols; Cyclophosph

2015
A 13-Year-Old Boy with Pancytopenia and a Sacrococcygeal Abscess.
    Pediatric annals, 2015, Volume: 44, Issue:9

    Topics: Abscess; Adolescent; Anti-Bacterial Agents; Diagnosis, Differential; Glucocorticoids; Humans; Male;

2015
A 13-Year-Old Boy with Pancytopenia and a Sacrococcygeal Abscess.
    Pediatric annals, 2015, Volume: 44, Issue:9

    Topics: Abscess; Adolescent; Anti-Bacterial Agents; Diagnosis, Differential; Glucocorticoids; Humans; Male;

2015
A 13-Year-Old Boy with Pancytopenia and a Sacrococcygeal Abscess.
    Pediatric annals, 2015, Volume: 44, Issue:9

    Topics: Abscess; Adolescent; Anti-Bacterial Agents; Diagnosis, Differential; Glucocorticoids; Humans; Male;

2015
Clinical and molecular genetic characterization of wild-type MLL infant acute lymphoblastic leukemia identifies few recurrent abnormalities.
    Haematologica, 2016, Volume: 101, Issue:3

    Topics: Antineoplastic Agents, Hormonal; B-Lymphocytes; Comparative Genomic Hybridization; DNA Copy Number V

2016
Clinical and molecular genetic characterization of wild-type MLL infant acute lymphoblastic leukemia identifies few recurrent abnormalities.
    Haematologica, 2016, Volume: 101, Issue:3

    Topics: Antineoplastic Agents, Hormonal; B-Lymphocytes; Comparative Genomic Hybridization; DNA Copy Number V

2016
Clinical and molecular genetic characterization of wild-type MLL infant acute lymphoblastic leukemia identifies few recurrent abnormalities.
    Haematologica, 2016, Volume: 101, Issue:3

    Topics: Antineoplastic Agents, Hormonal; B-Lymphocytes; Comparative Genomic Hybridization; DNA Copy Number V

2016
[Clinical and Prognostic analysis of 43 Children with Mature B-cell Non-Hodgkin's Lymphoma/Acute Lymphoblastic Leukemia].
    Zhongguo shi yan xue ye xue za zhi, 2016, Volume: 24, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child; Cyclophosphamide; Cytarabin

2016
[Clinical and Prognostic analysis of 43 Children with Mature B-cell Non-Hodgkin's Lymphoma/Acute Lymphoblastic Leukemia].
    Zhongguo shi yan xue ye xue za zhi, 2016, Volume: 24, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child; Cyclophosphamide; Cytarabin

2016
[Clinical and Prognostic analysis of 43 Children with Mature B-cell Non-Hodgkin's Lymphoma/Acute Lymphoblastic Leukemia].
    Zhongguo shi yan xue ye xue za zhi, 2016, Volume: 24, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child; Cyclophosphamide; Cytarabin

2016
Some GCR Polymorphisms (N363S, ER22/23EK, and Bcl-1) May Influence Steroid-induced Toxicities and Survival Rates in Children With ALL.
    Journal of pediatric hematology/oncology, 2016, Volume: 38, Issue:5

    Topics: Adolescent; Child; Child, Preschool; Cyclin D1; Disease-Free Survival; Glucocorticoids; Humans; Infa

2016
Some GCR Polymorphisms (N363S, ER22/23EK, and Bcl-1) May Influence Steroid-induced Toxicities and Survival Rates in Children With ALL.
    Journal of pediatric hematology/oncology, 2016, Volume: 38, Issue:5

    Topics: Adolescent; Child; Child, Preschool; Cyclin D1; Disease-Free Survival; Glucocorticoids; Humans; Infa

2016
Some GCR Polymorphisms (N363S, ER22/23EK, and Bcl-1) May Influence Steroid-induced Toxicities and Survival Rates in Children With ALL.
    Journal of pediatric hematology/oncology, 2016, Volume: 38, Issue:5

    Topics: Adolescent; Child; Child, Preschool; Cyclin D1; Disease-Free Survival; Glucocorticoids; Humans; Infa

2016
The impact of dexamethasone and prednisone on sleep in children with acute lymphoblastic leukemia.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2016, Volume: 24, Issue:9

    Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Child; Child, Preschool; Dexamethasone; Female; H

2016
The impact of dexamethasone and prednisone on sleep in children with acute lymphoblastic leukemia.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2016, Volume: 24, Issue:9

    Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Child; Child, Preschool; Dexamethasone; Female; H

2016
The impact of dexamethasone and prednisone on sleep in children with acute lymphoblastic leukemia.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2016, Volume: 24, Issue:9

    Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Child; Child, Preschool; Dexamethasone; Female; H

2016
Slower early response to treatment and distinct expression profile of childhood high hyperdiploid acute lymphoblastic leukaemia with DNA index < 1.16.
    Genes, chromosomes & cancer, 2016, Volume: 55, Issue:9

    Topics: Antineoplastic Agents, Hormonal; Child; Child, Preschool; Chromosome Aberrations; DNA, Neoplasm; Fem

2016
Slower early response to treatment and distinct expression profile of childhood high hyperdiploid acute lymphoblastic leukaemia with DNA index < 1.16.
    Genes, chromosomes & cancer, 2016, Volume: 55, Issue:9

    Topics: Antineoplastic Agents, Hormonal; Child; Child, Preschool; Chromosome Aberrations; DNA, Neoplasm; Fem

2016
Slower early response to treatment and distinct expression profile of childhood high hyperdiploid acute lymphoblastic leukaemia with DNA index < 1.16.
    Genes, chromosomes & cancer, 2016, Volume: 55, Issue:9

    Topics: Antineoplastic Agents, Hormonal; Child; Child, Preschool; Chromosome Aberrations; DNA, Neoplasm; Fem

2016
The Impact of Socioeconomic Factors on the Outcome of Childhood Acute Lymphoblastic Leukemia (ALL) Treatment in a Low/Middle Income Country (LMIC).
    Journal of pediatric hematology/oncology, 2016, Volume: 38, Issue:8

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; D

2016
The Impact of Socioeconomic Factors on the Outcome of Childhood Acute Lymphoblastic Leukemia (ALL) Treatment in a Low/Middle Income Country (LMIC).
    Journal of pediatric hematology/oncology, 2016, Volume: 38, Issue:8

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; D

2016
The Impact of Socioeconomic Factors on the Outcome of Childhood Acute Lymphoblastic Leukemia (ALL) Treatment in a Low/Middle Income Country (LMIC).
    Journal of pediatric hematology/oncology, 2016, Volume: 38, Issue:8

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; D

2016
Development-associated immunophenotypes reveal the heterogeneous and individualized early responses of adult B-acute lymphoblastic leukemia.
    Medicine, 2016, Volume: 95, Issue:34

    Topics: Adolescent; Adult; Anthracyclines; Antigens, CD19; Antigens, CD20; Antigens, CD34; Antineoplastic Co

2016
Development-associated immunophenotypes reveal the heterogeneous and individualized early responses of adult B-acute lymphoblastic leukemia.
    Medicine, 2016, Volume: 95, Issue:34

    Topics: Adolescent; Adult; Anthracyclines; Antigens, CD19; Antigens, CD20; Antigens, CD34; Antineoplastic Co

2016
Development-associated immunophenotypes reveal the heterogeneous and individualized early responses of adult B-acute lymphoblastic leukemia.
    Medicine, 2016, Volume: 95, Issue:34

    Topics: Adolescent; Adult; Anthracyclines; Antigens, CD19; Antigens, CD20; Antigens, CD34; Antineoplastic Co

2016
The treatment of childhood acute lymphoblastic leukemia in Guatemala: Biologic features, treatment hurdles, and results.
    Cancer, 2017, 02-01, Volume: 123, Issue:3

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; D

2017
The treatment of childhood acute lymphoblastic leukemia in Guatemala: Biologic features, treatment hurdles, and results.
    Cancer, 2017, 02-01, Volume: 123, Issue:3

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; D

2017
The treatment of childhood acute lymphoblastic leukemia in Guatemala: Biologic features, treatment hurdles, and results.
    Cancer, 2017, 02-01, Volume: 123, Issue:3

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; D

2017
Lymphoblastic Lymphoma Presenting as Bilateral Ovarian Mass in an Adolescent Girl.
    Journal of pediatric and adolescent gynecology, 2017, Volume: 30, Issue:3

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Biopsy; Daunorubici

2017
Lymphoblastic Lymphoma Presenting as Bilateral Ovarian Mass in an Adolescent Girl.
    Journal of pediatric and adolescent gynecology, 2017, Volume: 30, Issue:3

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Biopsy; Daunorubici

2017
Lymphoblastic Lymphoma Presenting as Bilateral Ovarian Mass in an Adolescent Girl.
    Journal of pediatric and adolescent gynecology, 2017, Volume: 30, Issue:3

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Biopsy; Daunorubici

2017
Hyper-CVAD Compared With BFM-like Chemotherapy for the Treatment of Adult Acute Lymphoblastic Leukemia. A Retrospective Single-Center Analysis.
    Clinical lymphoma, myeloma & leukemia, 2017, Volume: 17, Issue:3

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cyclophospham

2017
Hyper-CVAD Compared With BFM-like Chemotherapy for the Treatment of Adult Acute Lymphoblastic Leukemia. A Retrospective Single-Center Analysis.
    Clinical lymphoma, myeloma & leukemia, 2017, Volume: 17, Issue:3

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cyclophospham

2017
Hyper-CVAD Compared With BFM-like Chemotherapy for the Treatment of Adult Acute Lymphoblastic Leukemia. A Retrospective Single-Center Analysis.
    Clinical lymphoma, myeloma & leukemia, 2017, Volume: 17, Issue:3

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cyclophospham

2017
Survival Outcome of Filipino Children With Acute Lymphoblastic Leukemia Treated With Modified Berlin-Frankfurt-Muenster/Hong Kong Acute Lymphoblastic Leukemia (BFM95/HKALL97) Protocol in a Tertiary General Hospital From January 2005 to December 2009: A Re
    Journal of pediatric hematology/oncology, 2017, Volume: 39, Issue:3

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; C

2017
Survival Outcome of Filipino Children With Acute Lymphoblastic Leukemia Treated With Modified Berlin-Frankfurt-Muenster/Hong Kong Acute Lymphoblastic Leukemia (BFM95/HKALL97) Protocol in a Tertiary General Hospital From January 2005 to December 2009: A Re
    Journal of pediatric hematology/oncology, 2017, Volume: 39, Issue:3

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; C

2017
Survival Outcome of Filipino Children With Acute Lymphoblastic Leukemia Treated With Modified Berlin-Frankfurt-Muenster/Hong Kong Acute Lymphoblastic Leukemia (BFM95/HKALL97) Protocol in a Tertiary General Hospital From January 2005 to December 2009: A Re
    Journal of pediatric hematology/oncology, 2017, Volume: 39, Issue:3

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; C

2017
Unilateral facial nerve palsy as an early presenting symptom of relapse in a paediatric patient with acute lymphoblastic leukaemia.
    BMJ case reports, 2017, Mar-10, Volume: 2017

    Topics: Acyclovir; Adolescent; Antiviral Agents; Bell Palsy; Central Nervous System Neoplasms; Facial Nerve;

2017
Unilateral facial nerve palsy as an early presenting symptom of relapse in a paediatric patient with acute lymphoblastic leukaemia.
    BMJ case reports, 2017, Mar-10, Volume: 2017

    Topics: Acyclovir; Adolescent; Antiviral Agents; Bell Palsy; Central Nervous System Neoplasms; Facial Nerve;

2017
Unilateral facial nerve palsy as an early presenting symptom of relapse in a paediatric patient with acute lymphoblastic leukaemia.
    BMJ case reports, 2017, Mar-10, Volume: 2017

    Topics: Acyclovir; Adolescent; Antiviral Agents; Bell Palsy; Central Nervous System Neoplasms; Facial Nerve;

2017
Initial leukemic gene expression profiles of patients with poor in vivo prednisone response are similar to those of blasts persisting under prednisone treatment in childhood acute lymphoblastic leukemia.
    Annals of hematology, 2008, Volume: 87, Issue:9

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Blast Crisis; Child; Daunorubicin; Gen

2008
Initial leukemic gene expression profiles of patients with poor in vivo prednisone response are similar to those of blasts persisting under prednisone treatment in childhood acute lymphoblastic leukemia.
    Annals of hematology, 2008, Volume: 87, Issue:9

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Blast Crisis; Child; Daunorubicin; Gen

2008
Initial leukemic gene expression profiles of patients with poor in vivo prednisone response are similar to those of blasts persisting under prednisone treatment in childhood acute lymphoblastic leukemia.
    Annals of hematology, 2008, Volume: 87, Issue:9

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Blast Crisis; Child; Daunorubicin; Gen

2008
Treatment of pediatric acute lymphoblastic leukemia.
    Haematologica, 2008, Volume: 93, Issue:8

    Topics: Antineoplastic Agents; Blast Crisis; Child; Child, Preschool; Humans; Injections, Spinal; Meningeal

2008
Treatment of pediatric acute lymphoblastic leukemia.
    Haematologica, 2008, Volume: 93, Issue:8

    Topics: Antineoplastic Agents; Blast Crisis; Child; Child, Preschool; Humans; Injections, Spinal; Meningeal

2008
Treatment of pediatric acute lymphoblastic leukemia.
    Haematologica, 2008, Volume: 93, Issue:8

    Topics: Antineoplastic Agents; Blast Crisis; Child; Child, Preschool; Humans; Injections, Spinal; Meningeal

2008
Clinical problem-solving. Fool's Gold.
    The New England journal of medicine, 2008, Nov-06, Volume: 359, Issue:19

    Topics: Adult; Bundle-Branch Block; Dyspnea; Echocardiography; Electrocardiography; False Negative Reactions

2008
Clinical problem-solving. Fool's Gold.
    The New England journal of medicine, 2008, Nov-06, Volume: 359, Issue:19

    Topics: Adult; Bundle-Branch Block; Dyspnea; Echocardiography; Electrocardiography; False Negative Reactions

2008
Clinical problem-solving. Fool's Gold.
    The New England journal of medicine, 2008, Nov-06, Volume: 359, Issue:19

    Topics: Adult; Bundle-Branch Block; Dyspnea; Echocardiography; Electrocardiography; False Negative Reactions

2008
Role of the erythropoietin receptor in ETV6/RUNX1-positive acute lymphoblastic leukemia.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2008, Nov-15, Volume: 14, Issue:22

    Topics: Animals; Antineoplastic Agents, Hormonal; Apoptosis; Blotting, Western; Cell Line, Tumor; Cell Proli

2008
Role of the erythropoietin receptor in ETV6/RUNX1-positive acute lymphoblastic leukemia.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2008, Nov-15, Volume: 14, Issue:22

    Topics: Animals; Antineoplastic Agents, Hormonal; Apoptosis; Blotting, Western; Cell Line, Tumor; Cell Proli

2008
Role of the erythropoietin receptor in ETV6/RUNX1-positive acute lymphoblastic leukemia.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2008, Nov-15, Volume: 14, Issue:22

    Topics: Animals; Antineoplastic Agents, Hormonal; Apoptosis; Blotting, Western; Cell Line, Tumor; Cell Proli

2008
Kinetics of the in vivo expression of glucocorticoid receptor splice variants during prednisone treatment in childhood acute lymphoblastic leukaemia.
    Pediatric blood & cancer, 2009, Volume: 52, Issue:4

    Topics: Antineoplastic Agents, Hormonal; Case-Control Studies; Child; Child, Preschool; Female; Gene Express

2009
Kinetics of the in vivo expression of glucocorticoid receptor splice variants during prednisone treatment in childhood acute lymphoblastic leukaemia.
    Pediatric blood & cancer, 2009, Volume: 52, Issue:4

    Topics: Antineoplastic Agents, Hormonal; Case-Control Studies; Child; Child, Preschool; Female; Gene Express

2009
Kinetics of the in vivo expression of glucocorticoid receptor splice variants during prednisone treatment in childhood acute lymphoblastic leukaemia.
    Pediatric blood & cancer, 2009, Volume: 52, Issue:4

    Topics: Antineoplastic Agents, Hormonal; Case-Control Studies; Child; Child, Preschool; Female; Gene Express

2009
Effective treatment of advanced-stage childhood lymphoblastic lymphoma without prophylactic cranial irradiation: results of St Jude NHL13 study.
    Leukemia, 2009, Volume: 23, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; B-Lymphocytes; Child; Child, Preschool

2009
Effective treatment of advanced-stage childhood lymphoblastic lymphoma without prophylactic cranial irradiation: results of St Jude NHL13 study.
    Leukemia, 2009, Volume: 23, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; B-Lymphocytes; Child; Child, Preschool

2009
Effective treatment of advanced-stage childhood lymphoblastic lymphoma without prophylactic cranial irradiation: results of St Jude NHL13 study.
    Leukemia, 2009, Volume: 23, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; B-Lymphocytes; Child; Child, Preschool

2009
Changes in bone mineral density during therapy in childhood acute lymphoblastic leukemia.
    Indian pediatrics, 2009, Volume: 46, Issue:3

    Topics: Absorptiometry, Photon; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Antineop

2009
Changes in bone mineral density during therapy in childhood acute lymphoblastic leukemia.
    Indian pediatrics, 2009, Volume: 46, Issue:3

    Topics: Absorptiometry, Photon; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Antineop

2009
Changes in bone mineral density during therapy in childhood acute lymphoblastic leukemia.
    Indian pediatrics, 2009, Volume: 46, Issue:3

    Topics: Absorptiometry, Photon; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Antineop

2009
Prevalence of transient hyperglycemia during induction chemotherapy for pediatric acute lymphoblastic leukemia.
    Pediatric blood & cancer, 2009, Volume: 52, Issue:7

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Body Mass Index; Child; Ch

2009
Prevalence of transient hyperglycemia during induction chemotherapy for pediatric acute lymphoblastic leukemia.
    Pediatric blood & cancer, 2009, Volume: 52, Issue:7

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Body Mass Index; Child; Ch

2009
Prevalence of transient hyperglycemia during induction chemotherapy for pediatric acute lymphoblastic leukemia.
    Pediatric blood & cancer, 2009, Volume: 52, Issue:7

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Body Mass Index; Child; Ch

2009
Additional chromosomal abnormalities and their prognostic significance in adult Philadelphia-positive acute lymphoblastic leukemia: with or without imatinib in chemotherapy.
    Annals of hematology, 2009, Volume: 88, Issue:11

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Benzamides; Chromos

2009
Additional chromosomal abnormalities and their prognostic significance in adult Philadelphia-positive acute lymphoblastic leukemia: with or without imatinib in chemotherapy.
    Annals of hematology, 2009, Volume: 88, Issue:11

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Benzamides; Chromos

2009
Additional chromosomal abnormalities and their prognostic significance in adult Philadelphia-positive acute lymphoblastic leukemia: with or without imatinib in chemotherapy.
    Annals of hematology, 2009, Volume: 88, Issue:11

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Benzamides; Chromos

2009
Hyperglycemia during induction therapy is associated with poorer survival in children with acute lymphocytic leukemia.
    The Journal of pediatrics, 2009, Volume: 155, Issue:1

    Topics: Antineoplastic Agents; Asparaginase; Blood Glucose; Child; Child, Preschool; Daunorubicin; Dexametha

2009
Hyperglycemia during induction therapy is associated with poorer survival in children with acute lymphocytic leukemia.
    The Journal of pediatrics, 2009, Volume: 155, Issue:1

    Topics: Antineoplastic Agents; Asparaginase; Blood Glucose; Child; Child, Preschool; Daunorubicin; Dexametha

2009
Hyperglycemia during induction therapy is associated with poorer survival in children with acute lymphocytic leukemia.
    The Journal of pediatrics, 2009, Volume: 155, Issue:1

    Topics: Antineoplastic Agents; Asparaginase; Blood Glucose; Child; Child, Preschool; Daunorubicin; Dexametha

2009
Good early treatment response in childhood acute lymphoblastic leukemia is associated with Bax nuclear accumulation and PARP cleavage.
    Medical science monitor : international medical journal of experimental and clinical research, 2009, Volume: 15, Issue:6

    Topics: Adolescent; bcl-2-Associated X Protein; Cell Nucleus; Child; Child, Preschool; Female; Fluorescein-5

2009
Good early treatment response in childhood acute lymphoblastic leukemia is associated with Bax nuclear accumulation and PARP cleavage.
    Medical science monitor : international medical journal of experimental and clinical research, 2009, Volume: 15, Issue:6

    Topics: Adolescent; bcl-2-Associated X Protein; Cell Nucleus; Child; Child, Preschool; Female; Fluorescein-5

2009
Good early treatment response in childhood acute lymphoblastic leukemia is associated with Bax nuclear accumulation and PARP cleavage.
    Medical science monitor : international medical journal of experimental and clinical research, 2009, Volume: 15, Issue:6

    Topics: Adolescent; bcl-2-Associated X Protein; Cell Nucleus; Child; Child, Preschool; Female; Fluorescein-5

2009
Thiopurine methyltransferase genetics is not a major risk factor for secondary malignant neoplasms after treatment of childhood acute lymphoblastic leukemia on Berlin-Frankfurt-Münster protocols.
    Blood, 2009, Aug-13, Volume: 114, Issue:7

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Brain Neoplasms; Child; Child, Prescho

2009
Thiopurine methyltransferase genetics is not a major risk factor for secondary malignant neoplasms after treatment of childhood acute lymphoblastic leukemia on Berlin-Frankfurt-Münster protocols.
    Blood, 2009, Aug-13, Volume: 114, Issue:7

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Brain Neoplasms; Child; Child, Prescho

2009
Thiopurine methyltransferase genetics is not a major risk factor for secondary malignant neoplasms after treatment of childhood acute lymphoblastic leukemia on Berlin-Frankfurt-Münster protocols.
    Blood, 2009, Aug-13, Volume: 114, Issue:7

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Brain Neoplasms; Child; Child, Prescho

2009
A comparison of neurocognitive functioning in children previously randomized to dexamethasone or prednisone in the treatment of childhood acute lymphoblastic leukemia.
    Blood, 2009, Aug-27, Volume: 114, Issue:9

    Topics: Antineoplastic Agents, Hormonal; Child; Child, Preschool; Cognition; Cross-Sectional Studies; Dexame

2009
A comparison of neurocognitive functioning in children previously randomized to dexamethasone or prednisone in the treatment of childhood acute lymphoblastic leukemia.
    Blood, 2009, Aug-27, Volume: 114, Issue:9

    Topics: Antineoplastic Agents, Hormonal; Child; Child, Preschool; Cognition; Cross-Sectional Studies; Dexame

2009
A comparison of neurocognitive functioning in children previously randomized to dexamethasone or prednisone in the treatment of childhood acute lymphoblastic leukemia.
    Blood, 2009, Aug-27, Volume: 114, Issue:9

    Topics: Antineoplastic Agents, Hormonal; Child; Child, Preschool; Cognition; Cross-Sectional Studies; Dexame

2009
[Prophylaxis and treatment of modified BFM-90 regimen for lymphoblastic lymphoma in children and adolescents accompanied with infection].
    Ai zheng = Aizheng = Chinese journal of cancer, 2009, Volume: 28, Issue:7

    Topics: Adolescent; Anti-Bacterial Agents; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols

2009
[Prophylaxis and treatment of modified BFM-90 regimen for lymphoblastic lymphoma in children and adolescents accompanied with infection].
    Ai zheng = Aizheng = Chinese journal of cancer, 2009, Volume: 28, Issue:7

    Topics: Adolescent; Anti-Bacterial Agents; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols

2009
[Prophylaxis and treatment of modified BFM-90 regimen for lymphoblastic lymphoma in children and adolescents accompanied with infection].
    Ai zheng = Aizheng = Chinese journal of cancer, 2009, Volume: 28, Issue:7

    Topics: Adolescent; Anti-Bacterial Agents; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols

2009
Weight patterns in children with higher risk ALL: A report from the Children's Oncology Group (COG) for CCG 1961.
    Pediatric blood & cancer, 2009, Dec-15, Volume: 53, Issue:7

    Topics: Adolescent; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Body Mass Ind

2009
Weight patterns in children with higher risk ALL: A report from the Children's Oncology Group (COG) for CCG 1961.
    Pediatric blood & cancer, 2009, Dec-15, Volume: 53, Issue:7

    Topics: Adolescent; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Body Mass Ind

2009
Weight patterns in children with higher risk ALL: A report from the Children's Oncology Group (COG) for CCG 1961.
    Pediatric blood & cancer, 2009, Dec-15, Volume: 53, Issue:7

    Topics: Adolescent; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Body Mass Ind

2009
Philadelphia-negative acute lymphoblastic leukemia in a chronic myeloid leukemia patient receiving dasatinib.
    Cytotherapy, 2010, Volume: 12, Issue:1

    Topics: Aged; Antineoplastic Agents; Benzamides; Blast Crisis; Dasatinib; Hematopoietic Stem Cell Transplant

2010
Philadelphia-negative acute lymphoblastic leukemia in a chronic myeloid leukemia patient receiving dasatinib.
    Cytotherapy, 2010, Volume: 12, Issue:1

    Topics: Aged; Antineoplastic Agents; Benzamides; Blast Crisis; Dasatinib; Hematopoietic Stem Cell Transplant

2010
Philadelphia-negative acute lymphoblastic leukemia in a chronic myeloid leukemia patient receiving dasatinib.
    Cytotherapy, 2010, Volume: 12, Issue:1

    Topics: Aged; Antineoplastic Agents; Benzamides; Blast Crisis; Dasatinib; Hematopoietic Stem Cell Transplant

2010
Hyperammonemic encephalopathy after induction chemotherapy for acute lymphoblastic leukemia.
    Journal of pediatric hematology/oncology, 2009, Volume: 31, Issue:12

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Daunorubicin; Humans; Hyperammonemia;

2009
Hyperammonemic encephalopathy after induction chemotherapy for acute lymphoblastic leukemia.
    Journal of pediatric hematology/oncology, 2009, Volume: 31, Issue:12

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Daunorubicin; Humans; Hyperammonemia;

2009
Hyperammonemic encephalopathy after induction chemotherapy for acute lymphoblastic leukemia.
    Journal of pediatric hematology/oncology, 2009, Volume: 31, Issue:12

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Daunorubicin; Humans; Hyperammonemia;

2009
Methylene tetrahydrofolate reductase gene polymorphism in Egyptian children with acute lymphoblastic leukemia.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2010, Volume: 21, Issue:1

    Topics: Alleles; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Chemical and Drug Induced Liv

2010
Methylene tetrahydrofolate reductase gene polymorphism in Egyptian children with acute lymphoblastic leukemia.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2010, Volume: 21, Issue:1

    Topics: Alleles; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Chemical and Drug Induced Liv

2010
Methylene tetrahydrofolate reductase gene polymorphism in Egyptian children with acute lymphoblastic leukemia.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2010, Volume: 21, Issue:1

    Topics: Alleles; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Chemical and Drug Induced Liv

2010
[Comparison of the efficiency of CHOP-based regimen with or without high dose consolidation treatment combined with hematopoietic stem cell transplantation in 63 lymphoblastic lymphoma patients].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 2009, Volume: 31, Issue:6

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Child; Child,

2009
[Comparison of the efficiency of CHOP-based regimen with or without high dose consolidation treatment combined with hematopoietic stem cell transplantation in 63 lymphoblastic lymphoma patients].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 2009, Volume: 31, Issue:6

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Child; Child,

2009
[Comparison of the efficiency of CHOP-based regimen with or without high dose consolidation treatment combined with hematopoietic stem cell transplantation in 63 lymphoblastic lymphoma patients].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 2009, Volume: 31, Issue:6

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Child; Child,

2009
Association of high-level MCL-1 expression with in vitro and in vivo prednisone resistance in MLL-rearranged infant acute lymphoblastic leukemia.
    Blood, 2010, Feb-04, Volume: 115, Issue:5

    Topics: Cell Survival; Child; Drug Resistance, Neoplasm; Gene Expression Profiling; Gene Expression Regulati

2010
Association of high-level MCL-1 expression with in vitro and in vivo prednisone resistance in MLL-rearranged infant acute lymphoblastic leukemia.
    Blood, 2010, Feb-04, Volume: 115, Issue:5

    Topics: Cell Survival; Child; Drug Resistance, Neoplasm; Gene Expression Profiling; Gene Expression Regulati

2010
Association of high-level MCL-1 expression with in vitro and in vivo prednisone resistance in MLL-rearranged infant acute lymphoblastic leukemia.
    Blood, 2010, Feb-04, Volume: 115, Issue:5

    Topics: Cell Survival; Child; Drug Resistance, Neoplasm; Gene Expression Profiling; Gene Expression Regulati

2010
Concurrent treatment of steroid-related mood and psychotic symptoms with risperidone.
    Pediatrics, 2010, Volume: 125, Issue:5

    Topics: Administration, Oral; Adolescent; Antineoplastic Agents, Hormonal; Antipsychotic Agents; Child; Dexa

2010
Concurrent treatment of steroid-related mood and psychotic symptoms with risperidone.
    Pediatrics, 2010, Volume: 125, Issue:5

    Topics: Administration, Oral; Adolescent; Antineoplastic Agents, Hormonal; Antipsychotic Agents; Child; Dexa

2010
Concurrent treatment of steroid-related mood and psychotic symptoms with risperidone.
    Pediatrics, 2010, Volume: 125, Issue:5

    Topics: Administration, Oral; Adolescent; Antineoplastic Agents, Hormonal; Antipsychotic Agents; Child; Dexa

2010
Prospective study of hemostatic alterations in children with acute lymphoblastic leukemia.
    American journal of hematology, 2010, Volume: 85, Issue:5

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Antithrombins; Asparaginase; Case-Contro

2010
Prospective study of hemostatic alterations in children with acute lymphoblastic leukemia.
    American journal of hematology, 2010, Volume: 85, Issue:5

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Antithrombins; Asparaginase; Case-Contro

2010
Prospective study of hemostatic alterations in children with acute lymphoblastic leukemia.
    American journal of hematology, 2010, Volume: 85, Issue:5

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Antithrombins; Asparaginase; Case-Contro

2010
Central nervous system complications during treatment of acute lymphoblastic leukemia in a single pediatric institution.
    Leukemia & lymphoma, 2010, Volume: 51, Issue:6

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Central Nervous System; Ce

2010
Central nervous system complications during treatment of acute lymphoblastic leukemia in a single pediatric institution.
    Leukemia & lymphoma, 2010, Volume: 51, Issue:6

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Central Nervous System; Ce

2010
Central nervous system complications during treatment of acute lymphoblastic leukemia in a single pediatric institution.
    Leukemia & lymphoma, 2010, Volume: 51, Issue:6

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Central Nervous System; Ce

2010
Schistocytic hemolytic anemia owing to central venous catheter in a child with acute lymphoblastic leukemia.
    Journal of pediatric hematology/oncology, 2010, Volume: 32, Issue:6

    Topics: Anemia, Hemolytic; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Catheterization, Ce

2010
Schistocytic hemolytic anemia owing to central venous catheter in a child with acute lymphoblastic leukemia.
    Journal of pediatric hematology/oncology, 2010, Volume: 32, Issue:6

    Topics: Anemia, Hemolytic; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Catheterization, Ce

2010
Schistocytic hemolytic anemia owing to central venous catheter in a child with acute lymphoblastic leukemia.
    Journal of pediatric hematology/oncology, 2010, Volume: 32, Issue:6

    Topics: Anemia, Hemolytic; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Catheterization, Ce

2010
Chemotherapy resistance in acute lymphoblastic leukemia requires hERG1 channels and is overcome by hERG1 blockers.
    Blood, 2011, Jan-20, Volume: 117, Issue:3

    Topics: Animals; Antineoplastic Agents; Blotting, Western; Cell Membrane; Cells, Cultured; Coculture Techniq

2011
Chemotherapy resistance in acute lymphoblastic leukemia requires hERG1 channels and is overcome by hERG1 blockers.
    Blood, 2011, Jan-20, Volume: 117, Issue:3

    Topics: Animals; Antineoplastic Agents; Blotting, Western; Cell Membrane; Cells, Cultured; Coculture Techniq

2011
Chemotherapy resistance in acute lymphoblastic leukemia requires hERG1 channels and is overcome by hERG1 blockers.
    Blood, 2011, Jan-20, Volume: 117, Issue:3

    Topics: Animals; Antineoplastic Agents; Blotting, Western; Cell Membrane; Cells, Cultured; Coculture Techniq

2011
Puffiness of the eyelids and lips with multiple subcutaneous masses in 2-month-old infant.
    Hematology/oncology and stem cell therapy, 2010, Volume: 3, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Common Cold; Daunorubicin; Eyelids; Fe

2010
Puffiness of the eyelids and lips with multiple subcutaneous masses in 2-month-old infant.
    Hematology/oncology and stem cell therapy, 2010, Volume: 3, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Common Cold; Daunorubicin; Eyelids; Fe

2010
Puffiness of the eyelids and lips with multiple subcutaneous masses in 2-month-old infant.
    Hematology/oncology and stem cell therapy, 2010, Volume: 3, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Common Cold; Daunorubicin; Eyelids; Fe

2010
Simultaneous assessment of p53 and MDM2 expression in leukemic cells in response to initial prednisone therapy in children with acute lymphoblastic leukemia.
    Polish journal of pathology : official journal of the Polish Society of Pathologists, 2010, Volume: 61, Issue:4

    Topics: Adolescent; Antineoplastic Agents, Hormonal; Biomarkers, Tumor; Child; Child, Preschool; Female; Hum

2010
Simultaneous assessment of p53 and MDM2 expression in leukemic cells in response to initial prednisone therapy in children with acute lymphoblastic leukemia.
    Polish journal of pathology : official journal of the Polish Society of Pathologists, 2010, Volume: 61, Issue:4

    Topics: Adolescent; Antineoplastic Agents, Hormonal; Biomarkers, Tumor; Child; Child, Preschool; Female; Hum

2010
Simultaneous assessment of p53 and MDM2 expression in leukemic cells in response to initial prednisone therapy in children with acute lymphoblastic leukemia.
    Polish journal of pathology : official journal of the Polish Society of Pathologists, 2010, Volume: 61, Issue:4

    Topics: Adolescent; Antineoplastic Agents, Hormonal; Biomarkers, Tumor; Child; Child, Preschool; Female; Hum

2010
Second neoplasm in children treated in EORTC 58881 trial for acute lymphoblastic malignancies: low incidence of CNS tumours.
    Pediatric blood & cancer, 2011, Jul-15, Volume: 57, Issue:1

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Central Nervous System Neo

2011
Second neoplasm in children treated in EORTC 58881 trial for acute lymphoblastic malignancies: low incidence of CNS tumours.
    Pediatric blood & cancer, 2011, Jul-15, Volume: 57, Issue:1

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Central Nervous System Neo

2011
Second neoplasm in children treated in EORTC 58881 trial for acute lymphoblastic malignancies: low incidence of CNS tumours.
    Pediatric blood & cancer, 2011, Jul-15, Volume: 57, Issue:1

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Central Nervous System Neo

2011
Significant 25-hydroxyvitamin D deficiency in child and adolescent survivors of acute lymphoblastic leukemia: treatment with chemotherapy compared with allogeneic stem cell transplant.
    Pediatric blood & cancer, 2011, Jul-01, Volume: 56, Issue:7

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy;

2011
Significant 25-hydroxyvitamin D deficiency in child and adolescent survivors of acute lymphoblastic leukemia: treatment with chemotherapy compared with allogeneic stem cell transplant.
    Pediatric blood & cancer, 2011, Jul-01, Volume: 56, Issue:7

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy;

2011
Significant 25-hydroxyvitamin D deficiency in child and adolescent survivors of acute lymphoblastic leukemia: treatment with chemotherapy compared with allogeneic stem cell transplant.
    Pediatric blood & cancer, 2011, Jul-01, Volume: 56, Issue:7

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy;

2011
The influence of Bcl-2 and myeloid antigen expression on response to therapy in childhood acute lymphoblastic leukemia.
    Archives of Iranian medicine, 2011, Volume: 14, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Biomarkers, Tumor; CD13 Antigens; Chil

2011
The influence of Bcl-2 and myeloid antigen expression on response to therapy in childhood acute lymphoblastic leukemia.
    Archives of Iranian medicine, 2011, Volume: 14, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Biomarkers, Tumor; CD13 Antigens; Chil

2011
The influence of Bcl-2 and myeloid antigen expression on response to therapy in childhood acute lymphoblastic leukemia.
    Archives of Iranian medicine, 2011, Volume: 14, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Biomarkers, Tumor; CD13 Antigens; Chil

2011
Prognostic impact of t(1;19)/ TCF3-PBX1 in childhood acute lymphoblastic leukemia in the context of Berlin-Frankfurt-Münster-based protocols.
    Leukemia & lymphoma, 2011, Volume: 52, Issue:7

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Basic Helix-Loop-Helix Tra

2011
Prognostic impact of t(1;19)/ TCF3-PBX1 in childhood acute lymphoblastic leukemia in the context of Berlin-Frankfurt-Münster-based protocols.
    Leukemia & lymphoma, 2011, Volume: 52, Issue:7

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Basic Helix-Loop-Helix Tra

2011
Prognostic impact of t(1;19)/ TCF3-PBX1 in childhood acute lymphoblastic leukemia in the context of Berlin-Frankfurt-Münster-based protocols.
    Leukemia & lymphoma, 2011, Volume: 52, Issue:7

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Basic Helix-Loop-Helix Tra

2011
Neurobehavioral side effects of corticosteroids during active treatment for acute lymphoblastic leukemia in children are age-dependent: report from Dana-Farber Cancer Institute ALL Consortium Protocol 00-01.
    Pediatric blood & cancer, 2011, Volume: 57, Issue:3

    Topics: Adolescent; Adrenal Cortex Hormones; Adult; Age Factors; Behavior; Child; Child, Preschool; Data Col

2011
Neurobehavioral side effects of corticosteroids during active treatment for acute lymphoblastic leukemia in children are age-dependent: report from Dana-Farber Cancer Institute ALL Consortium Protocol 00-01.
    Pediatric blood & cancer, 2011, Volume: 57, Issue:3

    Topics: Adolescent; Adrenal Cortex Hormones; Adult; Age Factors; Behavior; Child; Child, Preschool; Data Col

2011
Neurobehavioral side effects of corticosteroids during active treatment for acute lymphoblastic leukemia in children are age-dependent: report from Dana-Farber Cancer Institute ALL Consortium Protocol 00-01.
    Pediatric blood & cancer, 2011, Volume: 57, Issue:3

    Topics: Adolescent; Adrenal Cortex Hormones; Adult; Age Factors; Behavior; Child; Child, Preschool; Data Col

2011
Activation of NF-ĸB in leukemic cells in response to initial prednisone therapy in children with acute lymphoblastic leukaemia: relation to other prognostic factors.
    Polish journal of pathology : official journal of the Polish Society of Pathologists, 2011, Volume: 62, Issue:1

    Topics: Adolescent; Antineoplastic Agents, Hormonal; Biomarkers, Tumor; Child; Child, Preschool; Female; Hum

2011
Activation of NF-ĸB in leukemic cells in response to initial prednisone therapy in children with acute lymphoblastic leukaemia: relation to other prognostic factors.
    Polish journal of pathology : official journal of the Polish Society of Pathologists, 2011, Volume: 62, Issue:1

    Topics: Adolescent; Antineoplastic Agents, Hormonal; Biomarkers, Tumor; Child; Child, Preschool; Female; Hum

2011
Activation of NF-ĸB in leukemic cells in response to initial prednisone therapy in children with acute lymphoblastic leukaemia: relation to other prognostic factors.
    Polish journal of pathology : official journal of the Polish Society of Pathologists, 2011, Volume: 62, Issue:1

    Topics: Adolescent; Antineoplastic Agents, Hormonal; Biomarkers, Tumor; Child; Child, Preschool; Female; Hum

2011
Bone mineral density in adult survivors of childhood acute leukemia: impact of hematopoietic stem cell transplantation and other treatment modalities.
    Blood, 2011, Aug-11, Volume: 118, Issue:6

    Topics: Absorptiometry, Photon; Acute Disease; Adolescent; Antineoplastic Combined Chemotherapy Protocols; B

2011
Bone mineral density in adult survivors of childhood acute leukemia: impact of hematopoietic stem cell transplantation and other treatment modalities.
    Blood, 2011, Aug-11, Volume: 118, Issue:6

    Topics: Absorptiometry, Photon; Acute Disease; Adolescent; Antineoplastic Combined Chemotherapy Protocols; B

2011
Bone mineral density in adult survivors of childhood acute leukemia: impact of hematopoietic stem cell transplantation and other treatment modalities.
    Blood, 2011, Aug-11, Volume: 118, Issue:6

    Topics: Absorptiometry, Photon; Acute Disease; Adolescent; Antineoplastic Combined Chemotherapy Protocols; B

2011
Numb chin syndrome in acute lymphoblastic leukemia.
    Indian pediatrics, 2011, Volume: 48, Issue:6

    Topics: Antineoplastic Agents; Child; Chin; Cytarabine; Female; Humans; Hypesthesia; Magnetic Resonance Imag

2011
Numb chin syndrome in acute lymphoblastic leukemia.
    Indian pediatrics, 2011, Volume: 48, Issue:6

    Topics: Antineoplastic Agents; Child; Chin; Cytarabine; Female; Humans; Hypesthesia; Magnetic Resonance Imag

2011
Numb chin syndrome in acute lymphoblastic leukemia.
    Indian pediatrics, 2011, Volume: 48, Issue:6

    Topics: Antineoplastic Agents; Child; Chin; Cytarabine; Female; Humans; Hypesthesia; Magnetic Resonance Imag

2011
Homozygosity for the rs9939609T allele of the FTO gene may have protective effect on becoming overweight in survivors of childhood acute lymphoblastic leukaemia.
    Journal of genetics, 2011, Volume: 90, Issue:2

    Topics: Adolescent; Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Antineoplastic Combined Chemotherapy Prot

2011
Homozygosity for the rs9939609T allele of the FTO gene may have protective effect on becoming overweight in survivors of childhood acute lymphoblastic leukaemia.
    Journal of genetics, 2011, Volume: 90, Issue:2

    Topics: Adolescent; Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Antineoplastic Combined Chemotherapy Prot

2011
Homozygosity for the rs9939609T allele of the FTO gene may have protective effect on becoming overweight in survivors of childhood acute lymphoblastic leukaemia.
    Journal of genetics, 2011, Volume: 90, Issue:2

    Topics: Adolescent; Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Antineoplastic Combined Chemotherapy Prot

2011
Anti-Escherichia coli asparaginase antibody levels determine the activity of second-line treatment with pegylated E coli asparaginase: a retrospective analysis within the ALL-BFM trials.
    Blood, 2011, Nov-24, Volume: 118, Issue:22

    Topics: Adolescent; Adult; Antibodies; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols

2011
Anti-Escherichia coli asparaginase antibody levels determine the activity of second-line treatment with pegylated E coli asparaginase: a retrospective analysis within the ALL-BFM trials.
    Blood, 2011, Nov-24, Volume: 118, Issue:22

    Topics: Adolescent; Adult; Antibodies; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols

2011
Anti-Escherichia coli asparaginase antibody levels determine the activity of second-line treatment with pegylated E coli asparaginase: a retrospective analysis within the ALL-BFM trials.
    Blood, 2011, Nov-24, Volume: 118, Issue:22

    Topics: Adolescent; Adult; Antibodies; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols

2011
Anti-Escherichia coli asparaginase antibody levels determine the activity of second-line treatment with pegylated E coli asparaginase: a retrospective analysis within the ALL-BFM trials.
    Blood, 2011, Nov-24, Volume: 118, Issue:22

    Topics: Adolescent; Adult; Antibodies; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols

2011
Anti-Escherichia coli asparaginase antibody levels determine the activity of second-line treatment with pegylated E coli asparaginase: a retrospective analysis within the ALL-BFM trials.
    Blood, 2011, Nov-24, Volume: 118, Issue:22

    Topics: Adolescent; Adult; Antibodies; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols

2011
Anti-Escherichia coli asparaginase antibody levels determine the activity of second-line treatment with pegylated E coli asparaginase: a retrospective analysis within the ALL-BFM trials.
    Blood, 2011, Nov-24, Volume: 118, Issue:22

    Topics: Adolescent; Adult; Antibodies; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols

2011
Anti-Escherichia coli asparaginase antibody levels determine the activity of second-line treatment with pegylated E coli asparaginase: a retrospective analysis within the ALL-BFM trials.
    Blood, 2011, Nov-24, Volume: 118, Issue:22

    Topics: Adolescent; Adult; Antibodies; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols

2011
Anti-Escherichia coli asparaginase antibody levels determine the activity of second-line treatment with pegylated E coli asparaginase: a retrospective analysis within the ALL-BFM trials.
    Blood, 2011, Nov-24, Volume: 118, Issue:22

    Topics: Adolescent; Adult; Antibodies; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols

2011
Anti-Escherichia coli asparaginase antibody levels determine the activity of second-line treatment with pegylated E coli asparaginase: a retrospective analysis within the ALL-BFM trials.
    Blood, 2011, Nov-24, Volume: 118, Issue:22

    Topics: Adolescent; Adult; Antibodies; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols

2011
Anti-Escherichia coli asparaginase antibody levels determine the activity of second-line treatment with pegylated E coli asparaginase: a retrospective analysis within the ALL-BFM trials.
    Blood, 2011, Nov-24, Volume: 118, Issue:22

    Topics: Adolescent; Adult; Antibodies; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols

2011
Anti-Escherichia coli asparaginase antibody levels determine the activity of second-line treatment with pegylated E coli asparaginase: a retrospective analysis within the ALL-BFM trials.
    Blood, 2011, Nov-24, Volume: 118, Issue:22

    Topics: Adolescent; Adult; Antibodies; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols

2011
Anti-Escherichia coli asparaginase antibody levels determine the activity of second-line treatment with pegylated E coli asparaginase: a retrospective analysis within the ALL-BFM trials.
    Blood, 2011, Nov-24, Volume: 118, Issue:22

    Topics: Adolescent; Adult; Antibodies; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols

2011
Acute lymphoblastic leukemia in a 10-year-old boy with cystic fibrosis - improvement of pulmonary function during chemotherapy in spite of intermittent Pseudomonas aeruginosa colonisation.
    Klinische Padiatrie, 2011, Volume: 223, Issue:6

    Topics: Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Child; Comorbidity; Cystic Fi

2011
Acute lymphoblastic leukemia in a 10-year-old boy with cystic fibrosis - improvement of pulmonary function during chemotherapy in spite of intermittent Pseudomonas aeruginosa colonisation.
    Klinische Padiatrie, 2011, Volume: 223, Issue:6

    Topics: Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Child; Comorbidity; Cystic Fi

2011
Acute lymphoblastic leukemia in a 10-year-old boy with cystic fibrosis - improvement of pulmonary function during chemotherapy in spite of intermittent Pseudomonas aeruginosa colonisation.
    Klinische Padiatrie, 2011, Volume: 223, Issue:6

    Topics: Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Child; Comorbidity; Cystic Fi

2011
Medication induced diabetes during induction in pediatric acute lymphoblastic leukemia: prevalence, risk factors and characteristics.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2012, Volume: 20, Issue:9

    Topics: Adolescent; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Asparagine; Child; C

2012
Medication induced diabetes during induction in pediatric acute lymphoblastic leukemia: prevalence, risk factors and characteristics.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2012, Volume: 20, Issue:9

    Topics: Adolescent; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Asparagine; Child; C

2012
Medication induced diabetes during induction in pediatric acute lymphoblastic leukemia: prevalence, risk factors and characteristics.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2012, Volume: 20, Issue:9

    Topics: Adolescent; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Asparagine; Child; C

2012
Posterior reversible encephalopathy syndrome in an adult patient with acute lymphoblastic leukemia after remission induction chemotherapy.
    International journal of hematology, 2012, Volume: 95, Issue:2

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cyclophosphamide; Daunorubicin;

2012
Posterior reversible encephalopathy syndrome in an adult patient with acute lymphoblastic leukemia after remission induction chemotherapy.
    International journal of hematology, 2012, Volume: 95, Issue:2

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cyclophosphamide; Daunorubicin;

2012
Posterior reversible encephalopathy syndrome in an adult patient with acute lymphoblastic leukemia after remission induction chemotherapy.
    International journal of hematology, 2012, Volume: 95, Issue:2

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cyclophosphamide; Daunorubicin;

2012
Elevated S100A8/S100A9 expression causes glucocorticoid resistance in MLL-rearranged infant acute lymphoblastic leukemia.
    Leukemia, 2012, Volume: 26, Issue:6

    Topics: Apoptosis; Blotting, Western; Calgranulin A; Calgranulin B; Drug Resistance, Neoplasm; Flow Cytometr

2012
Elevated S100A8/S100A9 expression causes glucocorticoid resistance in MLL-rearranged infant acute lymphoblastic leukemia.
    Leukemia, 2012, Volume: 26, Issue:6

    Topics: Apoptosis; Blotting, Western; Calgranulin A; Calgranulin B; Drug Resistance, Neoplasm; Flow Cytometr

2012
Elevated S100A8/S100A9 expression causes glucocorticoid resistance in MLL-rearranged infant acute lymphoblastic leukemia.
    Leukemia, 2012, Volume: 26, Issue:6

    Topics: Apoptosis; Blotting, Western; Calgranulin A; Calgranulin B; Drug Resistance, Neoplasm; Flow Cytometr

2012
[Blastic plasmacytoid dendritic cell neoplasm: report of a case].
    Zhonghua bing li xue za zhi = Chinese journal of pathology, 2011, Volume: 40, Issue:10

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; CD4 Antigens; CD56 Antigen; Cyclophosphamide;

2011
[Blastic plasmacytoid dendritic cell neoplasm: report of a case].
    Zhonghua bing li xue za zhi = Chinese journal of pathology, 2011, Volume: 40, Issue:10

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; CD4 Antigens; CD56 Antigen; Cyclophosphamide;

2011
[Blastic plasmacytoid dendritic cell neoplasm: report of a case].
    Zhonghua bing li xue za zhi = Chinese journal of pathology, 2011, Volume: 40, Issue:10

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; CD4 Antigens; CD56 Antigen; Cyclophosphamide;

2011
Orbital plasmablastic lymphoma with remission following chemotherapy.
    Journal of radiology case reports, 2011, Volume: 5, Issue:2

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Fil

2011
Orbital plasmablastic lymphoma with remission following chemotherapy.
    Journal of radiology case reports, 2011, Volume: 5, Issue:2

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Fil

2011
Orbital plasmablastic lymphoma with remission following chemotherapy.
    Journal of radiology case reports, 2011, Volume: 5, Issue:2

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Fil

2011
Management of hypertriglyceridemia in children with acute lymphoblastic leukemia under persistent therapy with glucocorticoids and L-asparaginase during induction chemotherapy.
    Pediatric blood & cancer, 2012, Volume: 59, Issue:4

    Topics: Antineoplastic Agents; Asparaginase; Child; Female; Glucocorticoids; Humans; Hypertriglyceridemia; M

2012
Management of hypertriglyceridemia in children with acute lymphoblastic leukemia under persistent therapy with glucocorticoids and L-asparaginase during induction chemotherapy.
    Pediatric blood & cancer, 2012, Volume: 59, Issue:4

    Topics: Antineoplastic Agents; Asparaginase; Child; Female; Glucocorticoids; Humans; Hypertriglyceridemia; M

2012
Management of hypertriglyceridemia in children with acute lymphoblastic leukemia under persistent therapy with glucocorticoids and L-asparaginase during induction chemotherapy.
    Pediatric blood & cancer, 2012, Volume: 59, Issue:4

    Topics: Antineoplastic Agents; Asparaginase; Child; Female; Glucocorticoids; Humans; Hypertriglyceridemia; M

2012
Clinical features, early treatment responses, and outcomes of pediatric acute lymphoblastic leukemia in China with or without specific fusion transcripts: a single institutional study of 1,004 patients.
    American journal of hematology, 2012, Volume: 87, Issue:11

    Topics: Antineoplastic Agents, Hormonal; Child; Child, Preschool; China; Cohort Studies; Cytogenetic Analysi

2012
Clinical features, early treatment responses, and outcomes of pediatric acute lymphoblastic leukemia in China with or without specific fusion transcripts: a single institutional study of 1,004 patients.
    American journal of hematology, 2012, Volume: 87, Issue:11

    Topics: Antineoplastic Agents, Hormonal; Child; Child, Preschool; China; Cohort Studies; Cytogenetic Analysi

2012
Clinical features, early treatment responses, and outcomes of pediatric acute lymphoblastic leukemia in China with or without specific fusion transcripts: a single institutional study of 1,004 patients.
    American journal of hematology, 2012, Volume: 87, Issue:11

    Topics: Antineoplastic Agents, Hormonal; Child; Child, Preschool; China; Cohort Studies; Cytogenetic Analysi

2012
Glucocorticoid withdrawal - heterozygous carriers of congenital adrenal hyperplasia at risk?
    Klinische Padiatrie, 2012, Volume: 224, Issue:6

    Topics: Adrenal Hyperplasia, Congenital; Adrenocorticotropic Hormone; Adrenogenital Syndrome; Antineoplastic

2012
Glucocorticoid withdrawal - heterozygous carriers of congenital adrenal hyperplasia at risk?
    Klinische Padiatrie, 2012, Volume: 224, Issue:6

    Topics: Adrenal Hyperplasia, Congenital; Adrenocorticotropic Hormone; Adrenogenital Syndrome; Antineoplastic

2012
Glucocorticoid withdrawal - heterozygous carriers of congenital adrenal hyperplasia at risk?
    Klinische Padiatrie, 2012, Volume: 224, Issue:6

    Topics: Adrenal Hyperplasia, Congenital; Adrenocorticotropic Hormone; Adrenogenital Syndrome; Antineoplastic

2012
Acute lymphoblastic leukemia presenting as bilateral serous macular detachment and lacrimal gland enlargement.
    Canadian journal of ophthalmology. Journal canadien d'ophtalmologie, 2012, Volume: 47, Issue:5

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Coloring Agents; Daunorubicin; Eye Neopl

2012
Acute lymphoblastic leukemia presenting as bilateral serous macular detachment and lacrimal gland enlargement.
    Canadian journal of ophthalmology. Journal canadien d'ophtalmologie, 2012, Volume: 47, Issue:5

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Coloring Agents; Daunorubicin; Eye Neopl

2012
Acute lymphoblastic leukemia presenting as bilateral serous macular detachment and lacrimal gland enlargement.
    Canadian journal of ophthalmology. Journal canadien d'ophtalmologie, 2012, Volume: 47, Issue:5

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Coloring Agents; Daunorubicin; Eye Neopl

2012
The evaluation of protein Z levels of children with acute lymphoblastic leukaemia during induction therapy.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2013, Volume: 24, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Blood Proteins; Case-Control Studies;

2013
The evaluation of protein Z levels of children with acute lymphoblastic leukaemia during induction therapy.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2013, Volume: 24, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Blood Proteins; Case-Control Studies;

2013
The evaluation of protein Z levels of children with acute lymphoblastic leukaemia during induction therapy.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2013, Volume: 24, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Blood Proteins; Case-Control Studies;

2013
Symptomatic hypoglycemia in children receiving oral purine analogues for treatment of childhood acute lymphoblastic leukemia.
    Medical and pediatric oncology, 2002, Volume: 39, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Blood Glucose; Child, Preschool; Cyclo

2002
Symptomatic hypoglycemia in children receiving oral purine analogues for treatment of childhood acute lymphoblastic leukemia.
    Medical and pediatric oncology, 2002, Volume: 39, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Blood Glucose; Child, Preschool; Cyclo

2002
Symptomatic hypoglycemia in children receiving oral purine analogues for treatment of childhood acute lymphoblastic leukemia.
    Medical and pediatric oncology, 2002, Volume: 39, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Blood Glucose; Child, Preschool; Cyclo

2002
Variant translocations of 11q23 in infant acute lymphoblastic leukemia (ALL): do outcomes differ from t(4;11)?
    Medical and pediatric oncology, 2002, Volume: 39, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Chromosomes, Human, Pair 11; Chromosom

2002
Variant translocations of 11q23 in infant acute lymphoblastic leukemia (ALL): do outcomes differ from t(4;11)?
    Medical and pediatric oncology, 2002, Volume: 39, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Chromosomes, Human, Pair 11; Chromosom

2002
Variant translocations of 11q23 in infant acute lymphoblastic leukemia (ALL): do outcomes differ from t(4;11)?
    Medical and pediatric oncology, 2002, Volume: 39, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Chromosomes, Human, Pair 11; Chromosom

2002
Increased factor VIII activity and dural sinus thrombosis.
    Medical and pediatric oncology, 2002, Volume: 39, Issue:1

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Cyclophosphamide; C

2002
Increased factor VIII activity and dural sinus thrombosis.
    Medical and pediatric oncology, 2002, Volume: 39, Issue:1

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Cyclophosphamide; C

2002
Increased factor VIII activity and dural sinus thrombosis.
    Medical and pediatric oncology, 2002, Volume: 39, Issue:1

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Cyclophosphamide; C

2002
Association of initial response to prednisone treatment in childhood acute lymphoblastic leukaemia and polymorphisms within the tumour necrosis factor and the interleukin-10 genes.
    Leukemia, 2002, Volume: 16, Issue:8

    Topics: Adolescent; Alleles; Antineoplastic Combined Chemotherapy Protocols; Case-Control Studies; Child; Ch

2002
Association of initial response to prednisone treatment in childhood acute lymphoblastic leukaemia and polymorphisms within the tumour necrosis factor and the interleukin-10 genes.
    Leukemia, 2002, Volume: 16, Issue:8

    Topics: Adolescent; Alleles; Antineoplastic Combined Chemotherapy Protocols; Case-Control Studies; Child; Ch

2002
Association of initial response to prednisone treatment in childhood acute lymphoblastic leukaemia and polymorphisms within the tumour necrosis factor and the interleukin-10 genes.
    Leukemia, 2002, Volume: 16, Issue:8

    Topics: Adolescent; Alleles; Antineoplastic Combined Chemotherapy Protocols; Case-Control Studies; Child; Ch

2002
Tuberculosis and immune thrombocytopenia.
    Haematologica, 2002, Volume: 87, Issue:8

    Topics: Adrenal Cortex Hormones; Antineoplastic Combined Chemotherapy Protocols; Antitubercular Agents; Aspa

2002
Tuberculosis and immune thrombocytopenia.
    Haematologica, 2002, Volume: 87, Issue:8

    Topics: Adrenal Cortex Hormones; Antineoplastic Combined Chemotherapy Protocols; Antitubercular Agents; Aspa

2002
Tuberculosis and immune thrombocytopenia.
    Haematologica, 2002, Volume: 87, Issue:8

    Topics: Adrenal Cortex Hormones; Antineoplastic Combined Chemotherapy Protocols; Antitubercular Agents; Aspa

2002
The role of local radiation therapy for mediastinal disease in adults with T-cell lymphoblastic lymphoma.
    Cancer, 2002, May-15, Volume: 94, Issue:10

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dexamethasone; Disease-Free

2002
The role of local radiation therapy for mediastinal disease in adults with T-cell lymphoblastic lymphoma.
    Cancer, 2002, May-15, Volume: 94, Issue:10

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dexamethasone; Disease-Free

2002
The role of local radiation therapy for mediastinal disease in adults with T-cell lymphoblastic lymphoma.
    Cancer, 2002, May-15, Volume: 94, Issue:10

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dexamethasone; Disease-Free

2002
The role of posttransplantation maintenance chemotherapy in improving the outcome of autotransplantation in adult acute lymphoblastic leukemia.
    Blood, 2002, Sep-01, Volume: 100, Issue:5

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Diseas

2002
The role of posttransplantation maintenance chemotherapy in improving the outcome of autotransplantation in adult acute lymphoblastic leukemia.
    Blood, 2002, Sep-01, Volume: 100, Issue:5

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Diseas

2002
The role of posttransplantation maintenance chemotherapy in improving the outcome of autotransplantation in adult acute lymphoblastic leukemia.
    Blood, 2002, Sep-01, Volume: 100, Issue:5

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Diseas

2002
Improvement over time in outcome for children with acute lymphoblastic leukemia in second remission given hematopoietic stem cell transplantation from unrelated donors.
    Leukemia, 2002, Volume: 16, Issue:11

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; C

2002
Improvement over time in outcome for children with acute lymphoblastic leukemia in second remission given hematopoietic stem cell transplantation from unrelated donors.
    Leukemia, 2002, Volume: 16, Issue:11

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; C

2002
Improvement over time in outcome for children with acute lymphoblastic leukemia in second remission given hematopoietic stem cell transplantation from unrelated donors.
    Leukemia, 2002, Volume: 16, Issue:11

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; C

2002
Determination of the in vivo effects of prednisone on Bcl-2 family protein expression in childhood acute lymphoblastic leukemia.
    International journal of oncology, 2003, Volume: 22, Issue:1

    Topics: Adolescent; Apoptosis; bcl-2-Associated X Protein; bcl-X Protein; Child; Child, Preschool; Female; H

2003
Determination of the in vivo effects of prednisone on Bcl-2 family protein expression in childhood acute lymphoblastic leukemia.
    International journal of oncology, 2003, Volume: 22, Issue:1

    Topics: Adolescent; Apoptosis; bcl-2-Associated X Protein; bcl-X Protein; Child; Child, Preschool; Female; H

2003
Determination of the in vivo effects of prednisone on Bcl-2 family protein expression in childhood acute lymphoblastic leukemia.
    International journal of oncology, 2003, Volume: 22, Issue:1

    Topics: Adolescent; Apoptosis; bcl-2-Associated X Protein; bcl-X Protein; Child; Child, Preschool; Female; H

2003
Dental abnormalities in children after chemotherapy treatment for acute lymphoid leukemia.
    Leukemia research, 2003, Volume: 27, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Combined Moda

2003
Dental abnormalities in children after chemotherapy treatment for acute lymphoid leukemia.
    Leukemia research, 2003, Volume: 27, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Combined Moda

2003
Dental abnormalities in children after chemotherapy treatment for acute lymphoid leukemia.
    Leukemia research, 2003, Volume: 27, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Combined Moda

2003
[Primary renal non-Hodgkin lymphoma].
    La Tunisie medicale, 2002, Volume: 80, Issue:5

    Topics: Abdominal Pain; Acute Kidney Injury; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bio

2002
[Primary renal non-Hodgkin lymphoma].
    La Tunisie medicale, 2002, Volume: 80, Issue:5

    Topics: Abdominal Pain; Acute Kidney Injury; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bio

2002
[Primary renal non-Hodgkin lymphoma].
    La Tunisie medicale, 2002, Volume: 80, Issue:5

    Topics: Abdominal Pain; Acute Kidney Injury; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bio

2002
Successful reintroduction of methotrexate after acute pneumonitis in a patient with acute lymphoblastic leukemia.
    Annals of hematology, 2003, Volume: 82, Issue:3

    Topics: Acute Disease; Female; Humans; Mercaptopurine; Methotrexate; Middle Aged; Pneumonia; Precursor Cell

2003
Successful reintroduction of methotrexate after acute pneumonitis in a patient with acute lymphoblastic leukemia.
    Annals of hematology, 2003, Volume: 82, Issue:3

    Topics: Acute Disease; Female; Humans; Mercaptopurine; Methotrexate; Middle Aged; Pneumonia; Precursor Cell

2003
Successful reintroduction of methotrexate after acute pneumonitis in a patient with acute lymphoblastic leukemia.
    Annals of hematology, 2003, Volume: 82, Issue:3

    Topics: Acute Disease; Female; Humans; Mercaptopurine; Methotrexate; Middle Aged; Pneumonia; Precursor Cell

2003
Induction of long-term remission of a relapsed childhood B-acute lymphoblastic leukemia with rituximab chimeric anti-CD20 monoclonal antibody and autologous stem cell transplantation.
    Journal of pediatric hematology/oncology, 2003, Volume: 25, Issue:4

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antigens, Neoplasm;

2003
Induction of long-term remission of a relapsed childhood B-acute lymphoblastic leukemia with rituximab chimeric anti-CD20 monoclonal antibody and autologous stem cell transplantation.
    Journal of pediatric hematology/oncology, 2003, Volume: 25, Issue:4

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antigens, Neoplasm;

2003
Induction of long-term remission of a relapsed childhood B-acute lymphoblastic leukemia with rituximab chimeric anti-CD20 monoclonal antibody and autologous stem cell transplantation.
    Journal of pediatric hematology/oncology, 2003, Volume: 25, Issue:4

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antigens, Neoplasm;

2003
Imatinib Mesylate (Gleevec) is a useful agent in the salvage treatment of adults with relapsed/refractory Philadelphia positive acute leukemias.
    Hematology (Amsterdam, Netherlands), 2003, Volume: 8, Issue:3

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Benzamides; Cytarabine; D

2003
Imatinib Mesylate (Gleevec) is a useful agent in the salvage treatment of adults with relapsed/refractory Philadelphia positive acute leukemias.
    Hematology (Amsterdam, Netherlands), 2003, Volume: 8, Issue:3

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Benzamides; Cytarabine; D

2003
Imatinib Mesylate (Gleevec) is a useful agent in the salvage treatment of adults with relapsed/refractory Philadelphia positive acute leukemias.
    Hematology (Amsterdam, Netherlands), 2003, Volume: 8, Issue:3

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Benzamides; Cytarabine; D

2003
Treatment outcome of adult acute lymphocytic leukemia with VPD(L) regimen: analysis of prognostic factors.
    The Korean journal of internal medicine, 2003, Volume: 18, Issue:1

    Topics: Administration, Oral; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Aspar

2003
Treatment outcome of adult acute lymphocytic leukemia with VPD(L) regimen: analysis of prognostic factors.
    The Korean journal of internal medicine, 2003, Volume: 18, Issue:1

    Topics: Administration, Oral; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Aspar

2003
Treatment outcome of adult acute lymphocytic leukemia with VPD(L) regimen: analysis of prognostic factors.
    The Korean journal of internal medicine, 2003, Volume: 18, Issue:1

    Topics: Administration, Oral; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Aspar

2003
[De novo acute lymphocytic leukemia with t(14;18) complicated by tumor lysis syndrome].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 2003, May-10, Volume: 92, Issue:5

    Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot

2003
[De novo acute lymphocytic leukemia with t(14;18) complicated by tumor lysis syndrome].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 2003, May-10, Volume: 92, Issue:5

    Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot

2003
[De novo acute lymphocytic leukemia with t(14;18) complicated by tumor lysis syndrome].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 2003, May-10, Volume: 92, Issue:5

    Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot

2003
Plasmapheresis as treatment for transient iatrogenic severe hyperlipidemia in a child with leukemia.
    Medical and pediatric oncology, 2003, Volume: 41, Issue:2

    Topics: Adolescent; Antineoplastic Agents; Asparaginase; Female; Humans; Hyperlipidemias; Iatrogenic Disease

2003
Plasmapheresis as treatment for transient iatrogenic severe hyperlipidemia in a child with leukemia.
    Medical and pediatric oncology, 2003, Volume: 41, Issue:2

    Topics: Adolescent; Antineoplastic Agents; Asparaginase; Female; Humans; Hyperlipidemias; Iatrogenic Disease

2003
Plasmapheresis as treatment for transient iatrogenic severe hyperlipidemia in a child with leukemia.
    Medical and pediatric oncology, 2003, Volume: 41, Issue:2

    Topics: Adolescent; Antineoplastic Agents; Asparaginase; Female; Humans; Hyperlipidemias; Iatrogenic Disease

2003
Expression and structural analysis of glucocorticoid receptor isoform gamma in human leukaemia cells using an isoform-specific real-time polymerase chain reaction approach.
    British journal of haematology, 2003, Volume: 122, Issue:2

    Topics: Apoptosis; Base Sequence; Case-Control Studies; Child; Dexamethasone; DNA Primers; Glucocorticoids;

2003
Expression and structural analysis of glucocorticoid receptor isoform gamma in human leukaemia cells using an isoform-specific real-time polymerase chain reaction approach.
    British journal of haematology, 2003, Volume: 122, Issue:2

    Topics: Apoptosis; Base Sequence; Case-Control Studies; Child; Dexamethasone; DNA Primers; Glucocorticoids;

2003
Expression and structural analysis of glucocorticoid receptor isoform gamma in human leukaemia cells using an isoform-specific real-time polymerase chain reaction approach.
    British journal of haematology, 2003, Volume: 122, Issue:2

    Topics: Apoptosis; Base Sequence; Case-Control Studies; Child; Dexamethasone; DNA Primers; Glucocorticoids;

2003
Analysis of single nucleotide polymorphism C3435T of the multidrug resistance gene MDR1 in acute lymphoblastic leukemia.
    International journal of oncology, 2003, Volume: 23, Issue:2

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Case-Control St

2003
Analysis of single nucleotide polymorphism C3435T of the multidrug resistance gene MDR1 in acute lymphoblastic leukemia.
    International journal of oncology, 2003, Volume: 23, Issue:2

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Case-Control St

2003
Analysis of single nucleotide polymorphism C3435T of the multidrug resistance gene MDR1 in acute lymphoblastic leukemia.
    International journal of oncology, 2003, Volume: 23, Issue:2

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Case-Control St

2003
Expression of heat-shock protein 90 in glucocorticoid-sensitive and -resistant childhood acute lymphoblastic leukaemia.
    Leukemia, 2003, Volume: 17, Issue:8

    Topics: Adolescent; Blotting, Western; Case-Control Studies; Child; Child, Preschool; Drug Resistance, Neopl

2003
Expression of heat-shock protein 90 in glucocorticoid-sensitive and -resistant childhood acute lymphoblastic leukaemia.
    Leukemia, 2003, Volume: 17, Issue:8

    Topics: Adolescent; Blotting, Western; Case-Control Studies; Child; Child, Preschool; Drug Resistance, Neopl

2003
Expression of heat-shock protein 90 in glucocorticoid-sensitive and -resistant childhood acute lymphoblastic leukaemia.
    Leukemia, 2003, Volume: 17, Issue:8

    Topics: Adolescent; Blotting, Western; Case-Control Studies; Child; Child, Preschool; Drug Resistance, Neopl

2003
ITP and empiric steroid treatment.
    Journal of pediatric hematology/oncology, 2003, Volume: 25, Issue:8

    Topics: Antineoplastic Agents, Hormonal; Bone Marrow Examination; Child; Diagnosis, Differential; Diagnostic

2003
ITP and empiric steroid treatment.
    Journal of pediatric hematology/oncology, 2003, Volume: 25, Issue:8

    Topics: Antineoplastic Agents, Hormonal; Bone Marrow Examination; Child; Diagnosis, Differential; Diagnostic

2003
ITP and empiric steroid treatment.
    Journal of pediatric hematology/oncology, 2003, Volume: 25, Issue:8

    Topics: Antineoplastic Agents, Hormonal; Bone Marrow Examination; Child; Diagnosis, Differential; Diagnostic

2003
Effects of prednisone and genetic polymorphisms on etoposide disposition in children with acute lymphoblastic leukemia.
    Blood, 2004, Jan-01, Volume: 103, Issue:1

    Topics: Base Sequence; Child; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; DNA, Neoplasm; Etoposi

2004
Effects of prednisone and genetic polymorphisms on etoposide disposition in children with acute lymphoblastic leukemia.
    Blood, 2004, Jan-01, Volume: 103, Issue:1

    Topics: Base Sequence; Child; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; DNA, Neoplasm; Etoposi

2004
Effects of prednisone and genetic polymorphisms on etoposide disposition in children with acute lymphoblastic leukemia.
    Blood, 2004, Jan-01, Volume: 103, Issue:1

    Topics: Base Sequence; Child; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; DNA, Neoplasm; Etoposi

2004
Lymphoblastic lymphoma of childhood and the LSA2-L2 protocol: the 30-year experience at Memorial-Sloan-Kettering Cancer Center.
    Cancer, 2003, Sep-15, Volume: 98, Issue:6

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamid

2003
Lymphoblastic lymphoma of childhood and the LSA2-L2 protocol: the 30-year experience at Memorial-Sloan-Kettering Cancer Center.
    Cancer, 2003, Sep-15, Volume: 98, Issue:6

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamid

2003
Lymphoblastic lymphoma of childhood and the LSA2-L2 protocol: the 30-year experience at Memorial-Sloan-Kettering Cancer Center.
    Cancer, 2003, Sep-15, Volume: 98, Issue:6

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamid

2003
Polyneuritis preceding lymphoblastic lymphoma.
    Journal of the Indian Medical Association, 1963, Jun-16, Volume: 40

    Topics: Humans; Lymphoma; Lymphoma, Non-Hodgkin; Neuritis; Polyradiculopathy; Precursor Cell Lymphoblastic L

1963
Polyneuritis preceding lymphoblastic lymphoma.
    Journal of the Indian Medical Association, 1963, Jun-16, Volume: 40

    Topics: Humans; Lymphoma; Lymphoma, Non-Hodgkin; Neuritis; Polyradiculopathy; Precursor Cell Lymphoblastic L

1963
Polyneuritis preceding lymphoblastic lymphoma.
    Journal of the Indian Medical Association, 1963, Jun-16, Volume: 40

    Topics: Humans; Lymphoma; Lymphoma, Non-Hodgkin; Neuritis; Polyradiculopathy; Precursor Cell Lymphoblastic L

1963
SERUM COMPLEMENT LEVELS IN CHILDREN WITH ACUTE LYMPHOCYTIC LEUKEMIA.
    The Journal of pediatrics, 1964, Volume: 64

    Topics: Adolescent; Antineoplastic Agents; Blood; Child; Complement System Proteins; Cyclophosphamide; Human

1964
SERUM COMPLEMENT LEVELS IN CHILDREN WITH ACUTE LYMPHOCYTIC LEUKEMIA.
    The Journal of pediatrics, 1964, Volume: 64

    Topics: Adolescent; Antineoplastic Agents; Blood; Child; Complement System Proteins; Cyclophosphamide; Human

1964
SERUM COMPLEMENT LEVELS IN CHILDREN WITH ACUTE LYMPHOCYTIC LEUKEMIA.
    The Journal of pediatrics, 1964, Volume: 64

    Topics: Adolescent; Antineoplastic Agents; Blood; Child; Complement System Proteins; Cyclophosphamide; Human

1964
INTRACRANIAL EXTRACEREBRAL HEMORRHAGES IN ACUTE LYMPHOCYTIC LEUKEMIA. A PROBLEM RESULTING FROM THE CHEMOTHERAPEUTIC MODIFICATIONS OF ACUTE LEUKEMIA.
    Cancer, 1964, Volume: 17

    Topics: Adolescent; Child; Hematoma; Hematoma, Epidural, Cranial; Hematoma, Subdural; Humans; Hydrocephalus;

1964
INTRACRANIAL EXTRACEREBRAL HEMORRHAGES IN ACUTE LYMPHOCYTIC LEUKEMIA. A PROBLEM RESULTING FROM THE CHEMOTHERAPEUTIC MODIFICATIONS OF ACUTE LEUKEMIA.
    Cancer, 1964, Volume: 17

    Topics: Adolescent; Child; Hematoma; Hematoma, Epidural, Cranial; Hematoma, Subdural; Humans; Hydrocephalus;

1964
INTRACRANIAL EXTRACEREBRAL HEMORRHAGES IN ACUTE LYMPHOCYTIC LEUKEMIA. A PROBLEM RESULTING FROM THE CHEMOTHERAPEUTIC MODIFICATIONS OF ACUTE LEUKEMIA.
    Cancer, 1964, Volume: 17

    Topics: Adolescent; Child; Hematoma; Hematoma, Epidural, Cranial; Hematoma, Subdural; Humans; Hydrocephalus;

1964
EXTREME HYPERURICEMIA ASSOCIATED WITH PREDNISONE THERAPY FOR ACUTE LYMPHOBLASTIC LEUKEMIA.
    Texas state journal of medicine, 1964, Volume: 60

    Topics: Adolescent; Blood; Blood Urea Nitrogen; Humans; Hyperuricemia; Leukemia; Leukemia, Lymphoid; Lymphoc

1964
EXTREME HYPERURICEMIA ASSOCIATED WITH PREDNISONE THERAPY FOR ACUTE LYMPHOBLASTIC LEUKEMIA.
    Texas state journal of medicine, 1964, Volume: 60

    Topics: Adolescent; Blood; Blood Urea Nitrogen; Humans; Hyperuricemia; Leukemia; Leukemia, Lymphoid; Lymphoc

1964
EXTREME HYPERURICEMIA ASSOCIATED WITH PREDNISONE THERAPY FOR ACUTE LYMPHOBLASTIC LEUKEMIA.
    Texas state journal of medicine, 1964, Volume: 60

    Topics: Adolescent; Blood; Blood Urea Nitrogen; Humans; Hyperuricemia; Leukemia; Leukemia, Lymphoid; Lymphoc

1964
Protein expression of the glucocorticoid receptor in childhood acute lymphoblastic leukemia.
    Haematologica, 2003, Volume: 88, Issue:11

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Case-Control Studies; Chil

2003
Protein expression of the glucocorticoid receptor in childhood acute lymphoblastic leukemia.
    Haematologica, 2003, Volume: 88, Issue:11

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Case-Control Studies; Chil

2003
Protein expression of the glucocorticoid receptor in childhood acute lymphoblastic leukemia.
    Haematologica, 2003, Volume: 88, Issue:11

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Case-Control Studies; Chil

2003
Role of macrophages and stellate cells in the pathogenesis of veno-occlusive disease: an electron microscopic case study.
    Experimental and molecular pathology, 2003, Volume: 75, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Female; Hepatic Veno-Occlusive

2003
Role of macrophages and stellate cells in the pathogenesis of veno-occlusive disease: an electron microscopic case study.
    Experimental and molecular pathology, 2003, Volume: 75, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Female; Hepatic Veno-Occlusive

2003
Role of macrophages and stellate cells in the pathogenesis of veno-occlusive disease: an electron microscopic case study.
    Experimental and molecular pathology, 2003, Volume: 75, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Female; Hepatic Veno-Occlusive

2003
[Iatrogenic hyperlipidemia after l-asparaginase and glucocorticoid treatment in two children with acute lymphoblastic leukemia].
    Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego, 2003, Volume: 15, Issue:87

    Topics: Adolescent; Anti-Inflammatory Agents; Asparagine; Female; Humans; Hyperlipidemias; Iatrogenic Diseas

2003
[Iatrogenic hyperlipidemia after l-asparaginase and glucocorticoid treatment in two children with acute lymphoblastic leukemia].
    Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego, 2003, Volume: 15, Issue:87

    Topics: Adolescent; Anti-Inflammatory Agents; Asparagine; Female; Humans; Hyperlipidemias; Iatrogenic Diseas

2003
[Iatrogenic hyperlipidemia after l-asparaginase and glucocorticoid treatment in two children with acute lymphoblastic leukemia].
    Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego, 2003, Volume: 15, Issue:87

    Topics: Adolescent; Anti-Inflammatory Agents; Asparagine; Female; Humans; Hyperlipidemias; Iatrogenic Diseas

2003
Glucocorticoids induce G1 arrest of lymphoblastic cells through retinoblastoma protein Rb1 dephosphorylation in childhood acute lymphoblastic leukemia in vivo.
    Cancer biology & therapy, 2004, Volume: 3, Issue:5

    Topics: Blast Crisis; Cell Cycle Proteins; Child; Cyclins; Female; G1 Phase; Glucocorticoids; Humans; Male;

2004
Glucocorticoids induce G1 arrest of lymphoblastic cells through retinoblastoma protein Rb1 dephosphorylation in childhood acute lymphoblastic leukemia in vivo.
    Cancer biology & therapy, 2004, Volume: 3, Issue:5

    Topics: Blast Crisis; Cell Cycle Proteins; Child; Cyclins; Female; G1 Phase; Glucocorticoids; Humans; Male;

2004
Glucocorticoids induce G1 arrest of lymphoblastic cells through retinoblastoma protein Rb1 dephosphorylation in childhood acute lymphoblastic leukemia in vivo.
    Cancer biology & therapy, 2004, Volume: 3, Issue:5

    Topics: Blast Crisis; Cell Cycle Proteins; Child; Cyclins; Female; G1 Phase; Glucocorticoids; Humans; Male;

2004
Dose increase of imatinib mesylate may overcome acquired resistance in bcr/abl-positive acute lymphoid leukaemia.
    European journal of haematology, 2004, Volume: 72, Issue:4

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Benzamides; Doxorubicin; Drug R

2004
Dose increase of imatinib mesylate may overcome acquired resistance in bcr/abl-positive acute lymphoid leukaemia.
    European journal of haematology, 2004, Volume: 72, Issue:4

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Benzamides; Doxorubicin; Drug R

2004
Dose increase of imatinib mesylate may overcome acquired resistance in bcr/abl-positive acute lymphoid leukaemia.
    European journal of haematology, 2004, Volume: 72, Issue:4

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Benzamides; Doxorubicin; Drug R

2004
Evolution of BFM trials for childhood ALL.
    Annals of hematology, 2004, Volume: 83 Suppl 1

    Topics: Bone Marrow Transplantation; Child; Child, Preschool; Clinical Trials as Topic; Humans; Infant; Neop

2004
Evolution of BFM trials for childhood ALL.
    Annals of hematology, 2004, Volume: 83 Suppl 1

    Topics: Bone Marrow Transplantation; Child; Child, Preschool; Clinical Trials as Topic; Humans; Infant; Neop

2004
Evolution of BFM trials for childhood ALL.
    Annals of hematology, 2004, Volume: 83 Suppl 1

    Topics: Bone Marrow Transplantation; Child; Child, Preschool; Clinical Trials as Topic; Humans; Infant; Neop

2004
Chemotherapy-induced leukonychia.
    Haematologica, 2004, Volume: 89, Issue:7

    Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Daunorub

2004
Chemotherapy-induced leukonychia.
    Haematologica, 2004, Volume: 89, Issue:7

    Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Daunorub

2004
Chemotherapy-induced leukonychia.
    Haematologica, 2004, Volume: 89, Issue:7

    Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Daunorub

2004
Prolonged fever of unknown origin and hemophagocytosis evolving into acute lymphoblastic leukemia.
    American journal of hematology, 2004, Volume: 76, Issue:4

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy

2004
Prolonged fever of unknown origin and hemophagocytosis evolving into acute lymphoblastic leukemia.
    American journal of hematology, 2004, Volume: 76, Issue:4

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy

2004
Prolonged fever of unknown origin and hemophagocytosis evolving into acute lymphoblastic leukemia.
    American journal of hematology, 2004, Volume: 76, Issue:4

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy

2004
Osteonecrosis: a treatment related toxicity in childhood acute lymphoblastic leukemia (ALL)--experiences from trial ALL-BFM 95.
    Pediatric blood & cancer, 2005, Volume: 44, Issue:3

    Topics: Adolescent; Child; Child, Preschool; Dexamethasone; Female; Glucocorticoids; Hip Joint; Humans; Infa

2005
Osteonecrosis: a treatment related toxicity in childhood acute lymphoblastic leukemia (ALL)--experiences from trial ALL-BFM 95.
    Pediatric blood & cancer, 2005, Volume: 44, Issue:3

    Topics: Adolescent; Child; Child, Preschool; Dexamethasone; Female; Glucocorticoids; Hip Joint; Humans; Infa

2005
Osteonecrosis: a treatment related toxicity in childhood acute lymphoblastic leukemia (ALL)--experiences from trial ALL-BFM 95.
    Pediatric blood & cancer, 2005, Volume: 44, Issue:3

    Topics: Adolescent; Child; Child, Preschool; Dexamethasone; Female; Glucocorticoids; Hip Joint; Humans; Infa

2005
The analysis of correlations between drug resistance and clinical/laboratory measures found in a group of children with all treated by ALL-BFM 90 protocol.
    Bulletin du cancer, 2004, Volume: 91, Issue:4

    Topics: Adolescent; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child,

2004
The analysis of correlations between drug resistance and clinical/laboratory measures found in a group of children with all treated by ALL-BFM 90 protocol.
    Bulletin du cancer, 2004, Volume: 91, Issue:4

    Topics: Adolescent; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child,

2004
The analysis of correlations between drug resistance and clinical/laboratory measures found in a group of children with all treated by ALL-BFM 90 protocol.
    Bulletin du cancer, 2004, Volume: 91, Issue:4

    Topics: Adolescent; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child,

2004
Cerebrospinal fluid excitatory amino acids and tau protein in children with acute lymphoblastic leukemia treated according to the BFM protocol.
    Acta haematologica, 2004, Volume: 112, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Aspartic Acid; Child; Daunorubicin; Ex

2004
Cerebrospinal fluid excitatory amino acids and tau protein in children with acute lymphoblastic leukemia treated according to the BFM protocol.
    Acta haematologica, 2004, Volume: 112, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Aspartic Acid; Child; Daunorubicin; Ex

2004
Cerebrospinal fluid excitatory amino acids and tau protein in children with acute lymphoblastic leukemia treated according to the BFM protocol.
    Acta haematologica, 2004, Volume: 112, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Aspartic Acid; Child; Daunorubicin; Ex

2004
[Primary study of relationship between serum level of VEGF and non-Hodgkin's lymphoma in children and adolescent patients].
    Ai zheng = Aizheng = Chinese journal of cancer, 2004, Volume: 23, Issue:11 Suppl

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Burkitt Lymphoma; C

2004
[Primary study of relationship between serum level of VEGF and non-Hodgkin's lymphoma in children and adolescent patients].
    Ai zheng = Aizheng = Chinese journal of cancer, 2004, Volume: 23, Issue:11 Suppl

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Burkitt Lymphoma; C

2004
[Primary study of relationship between serum level of VEGF and non-Hodgkin's lymphoma in children and adolescent patients].
    Ai zheng = Aizheng = Chinese journal of cancer, 2004, Volume: 23, Issue:11 Suppl

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Burkitt Lymphoma; C

2004
[Analysis of 32 cases of acute leukemia with abnormality of chromosome 7].
    Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics, 2004, Volume: 21, Issue:6

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Chromosome Aberratio

2004
[Analysis of 32 cases of acute leukemia with abnormality of chromosome 7].
    Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics, 2004, Volume: 21, Issue:6

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Chromosome Aberratio

2004
[Analysis of 32 cases of acute leukemia with abnormality of chromosome 7].
    Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics, 2004, Volume: 21, Issue:6

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Chromosome Aberratio

2004
[Efficacy of modified BFM-90 regimen on children and adolescents with T cell lymphoblastic lymphoma: a report of 20 cases].
    Ai zheng = Aizheng = Chinese journal of cancer, 2004, Volume: 23, Issue:12

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; C

2004
[Efficacy of modified BFM-90 regimen on children and adolescents with T cell lymphoblastic lymphoma: a report of 20 cases].
    Ai zheng = Aizheng = Chinese journal of cancer, 2004, Volume: 23, Issue:12

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; C

2004
[Efficacy of modified BFM-90 regimen on children and adolescents with T cell lymphoblastic lymphoma: a report of 20 cases].
    Ai zheng = Aizheng = Chinese journal of cancer, 2004, Volume: 23, Issue:12

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; C

2004
[Results of treatment of children with acute lymphoblastic leukemia with a modified BFM protocol].
    Srpski arhiv za celokupno lekarstvo, 2004, Volume: 132 Suppl 1

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; D

2004
[Results of treatment of children with acute lymphoblastic leukemia with a modified BFM protocol].
    Srpski arhiv za celokupno lekarstvo, 2004, Volume: 132 Suppl 1

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; D

2004
[Results of treatment of children with acute lymphoblastic leukemia with a modified BFM protocol].
    Srpski arhiv za celokupno lekarstvo, 2004, Volume: 132 Suppl 1

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; D

2004
[Immunologic monitoring in children with acute lymphoblastic leukemia during maintenance treatment with regard to co-existing infections].
    Wiadomosci lekarskie (Warsaw, Poland : 1960), 2004, Volume: 57, Issue:7-8

    Topics: Adolescent; Antigens; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Biomarkers; Chil

2004
[Immunologic monitoring in children with acute lymphoblastic leukemia during maintenance treatment with regard to co-existing infections].
    Wiadomosci lekarskie (Warsaw, Poland : 1960), 2004, Volume: 57, Issue:7-8

    Topics: Adolescent; Antigens; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Biomarkers; Chil

2004
[Immunologic monitoring in children with acute lymphoblastic leukemia during maintenance treatment with regard to co-existing infections].
    Wiadomosci lekarskie (Warsaw, Poland : 1960), 2004, Volume: 57, Issue:7-8

    Topics: Adolescent; Antigens; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Biomarkers; Chil

2004
Severe hyperlipidemia in a child with acute lymphoblastic leukemia treated with L-asparaginase and prednisone.
    Pediatrics international : official journal of the Japan Pediatric Society, 2004, Volume: 46, Issue:6

    Topics: Asparaginase; Blood Chemical Analysis; Child; Drug Therapy, Combination; Female; Follow-Up Studies;

2004
Severe hyperlipidemia in a child with acute lymphoblastic leukemia treated with L-asparaginase and prednisone.
    Pediatrics international : official journal of the Japan Pediatric Society, 2004, Volume: 46, Issue:6

    Topics: Asparaginase; Blood Chemical Analysis; Child; Drug Therapy, Combination; Female; Follow-Up Studies;

2004
Severe hyperlipidemia in a child with acute lymphoblastic leukemia treated with L-asparaginase and prednisone.
    Pediatrics international : official journal of the Japan Pediatric Society, 2004, Volume: 46, Issue:6

    Topics: Asparaginase; Blood Chemical Analysis; Child; Drug Therapy, Combination; Female; Follow-Up Studies;

2004
[Treatment results in children with standard-risk acute lymphoblastic leukemia. Report of the Polish Pediatric Leukemia/Lymphoma Study Group].
    Przeglad lekarski, 2004, Volume: 61 Suppl 2

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow; Bone Neoplasm

2004
[Treatment results in children with standard-risk acute lymphoblastic leukemia. Report of the Polish Pediatric Leukemia/Lymphoma Study Group].
    Przeglad lekarski, 2004, Volume: 61 Suppl 2

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow; Bone Neoplasm

2004
[Treatment results in children with standard-risk acute lymphoblastic leukemia. Report of the Polish Pediatric Leukemia/Lymphoma Study Group].
    Przeglad lekarski, 2004, Volume: 61 Suppl 2

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow; Bone Neoplasm

2004
Second induction in pediatric patients with recurrent acute lymphoid leukemia using DFCI-ALL protocols.
    Journal of pediatric hematology/oncology, 2005, Volume: 27, Issue:2

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; C

2005
Second induction in pediatric patients with recurrent acute lymphoid leukemia using DFCI-ALL protocols.
    Journal of pediatric hematology/oncology, 2005, Volume: 27, Issue:2

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; C

2005
Second induction in pediatric patients with recurrent acute lymphoid leukemia using DFCI-ALL protocols.
    Journal of pediatric hematology/oncology, 2005, Volume: 27, Issue:2

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; C

2005
Immunodeficiency in children with acute lymphoblastic leukemia after completion of modern aggressive chemotherapeutic regimens.
    The Journal of pediatrics, 2005, Volume: 146, Issue:5

    Topics: Antibody Formation; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Pres

2005
Immunodeficiency in children with acute lymphoblastic leukemia after completion of modern aggressive chemotherapeutic regimens.
    The Journal of pediatrics, 2005, Volume: 146, Issue:5

    Topics: Antibody Formation; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Pres

2005
Immunodeficiency in children with acute lymphoblastic leukemia after completion of modern aggressive chemotherapeutic regimens.
    The Journal of pediatrics, 2005, Volume: 146, Issue:5

    Topics: Antibody Formation; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Pres

2005
An adult case of acute lymphoblastic leukaemia presenting as hepatic dysfunction.
    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2005, Volume: 37, Issue:3

    Topics: Antineoplastic Agents; Asparaginase; Bone Marrow; Drug Therapy, Combination; Female; Glucocorticoids

2005
An adult case of acute lymphoblastic leukaemia presenting as hepatic dysfunction.
    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2005, Volume: 37, Issue:3

    Topics: Antineoplastic Agents; Asparaginase; Bone Marrow; Drug Therapy, Combination; Female; Glucocorticoids

2005
An adult case of acute lymphoblastic leukaemia presenting as hepatic dysfunction.
    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2005, Volume: 37, Issue:3

    Topics: Antineoplastic Agents; Asparaginase; Bone Marrow; Drug Therapy, Combination; Female; Glucocorticoids

2005
HRQOL implications of treatment with dexamethasone for children with acute lymphoblastic leukemia (ALL).
    Pediatric blood & cancer, 2006, Volume: 46, Issue:1

    Topics: Anti-Inflammatory Agents; Child; Child Behavior; Child, Preschool; Dexamethasone; Female; Health Sta

2006
HRQOL implications of treatment with dexamethasone for children with acute lymphoblastic leukemia (ALL).
    Pediatric blood & cancer, 2006, Volume: 46, Issue:1

    Topics: Anti-Inflammatory Agents; Child; Child Behavior; Child, Preschool; Dexamethasone; Female; Health Sta

2006
HRQOL implications of treatment with dexamethasone for children with acute lymphoblastic leukemia (ALL).
    Pediatric blood & cancer, 2006, Volume: 46, Issue:1

    Topics: Anti-Inflammatory Agents; Child; Child Behavior; Child, Preschool; Dexamethasone; Female; Health Sta

2006
[Lymphoproliferative disease following kidney transplantation].
    Deutsche medizinische Wochenschrift (1946), 2005, Jul-15, Volume: 130, Issue:28-29

    Topics: Abdominal Pain; Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Diagnosis,

2005
[Lymphoproliferative disease following kidney transplantation].
    Deutsche medizinische Wochenschrift (1946), 2005, Jul-15, Volume: 130, Issue:28-29

    Topics: Abdominal Pain; Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Diagnosis,

2005
[Lymphoproliferative disease following kidney transplantation].
    Deutsche medizinische Wochenschrift (1946), 2005, Jul-15, Volume: 130, Issue:28-29

    Topics: Abdominal Pain; Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Diagnosis,

2005
Decreased numbers of CD4+ T lymphocytes in peripheral blood after treatment of childhood acute lymphoblastic leukemia.
    Leukemia research, 2006, Volume: 30, Issue:1

    Topics: Adolescent; Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; CD4 Lymphocy

2006
Decreased numbers of CD4+ T lymphocytes in peripheral blood after treatment of childhood acute lymphoblastic leukemia.
    Leukemia research, 2006, Volume: 30, Issue:1

    Topics: Adolescent; Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; CD4 Lymphocy

2006
Decreased numbers of CD4+ T lymphocytes in peripheral blood after treatment of childhood acute lymphoblastic leukemia.
    Leukemia research, 2006, Volume: 30, Issue:1

    Topics: Adolescent; Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; CD4 Lymphocy

2006
Herpes simplex virus pneumonia during standard induction chemotherapy for acute leukemia: case report and review of literature.
    Leukemia, 2005, Volume: 19, Issue:11

    Topics: Acyclovir; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Daunorubicin; Female; H

2005
Herpes simplex virus pneumonia during standard induction chemotherapy for acute leukemia: case report and review of literature.
    Leukemia, 2005, Volume: 19, Issue:11

    Topics: Acyclovir; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Daunorubicin; Female; H

2005
Herpes simplex virus pneumonia during standard induction chemotherapy for acute leukemia: case report and review of literature.
    Leukemia, 2005, Volume: 19, Issue:11

    Topics: Acyclovir; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Daunorubicin; Female; H

2005
Treatment reduction in highly selected standard-risk childhood acute lymphoblastic leukemia. The AIEOP ALL-9501 study.
    Haematologica, 2005, Volume: 90, Issue:9

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Daunorubicin;

2005
Treatment reduction in highly selected standard-risk childhood acute lymphoblastic leukemia. The AIEOP ALL-9501 study.
    Haematologica, 2005, Volume: 90, Issue:9

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Daunorubicin;

2005
Treatment reduction in highly selected standard-risk childhood acute lymphoblastic leukemia. The AIEOP ALL-9501 study.
    Haematologica, 2005, Volume: 90, Issue:9

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Daunorubicin;

2005
[Mediastinal (thymic) large B-cell lymphoma: three cases reports].
    Zhonghua bing li xue za zhi = Chinese journal of pathology, 2005, Volume: 34, Issue:5

    Topics: Adolescent; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Diagnosis, Diffe

2005
[Mediastinal (thymic) large B-cell lymphoma: three cases reports].
    Zhonghua bing li xue za zhi = Chinese journal of pathology, 2005, Volume: 34, Issue:5

    Topics: Adolescent; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Diagnosis, Diffe

2005
[Mediastinal (thymic) large B-cell lymphoma: three cases reports].
    Zhonghua bing li xue za zhi = Chinese journal of pathology, 2005, Volume: 34, Issue:5

    Topics: Adolescent; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Diagnosis, Diffe

2005
Recent steroid therapy increases severity of varicella infections in children with acute lymphoblastic leukemia.
    Pediatrics, 2005, Volume: 116, Issue:4

    Topics: Chickenpox; Child; Female; Glucocorticoids; Humans; Immunocompromised Host; Male; Precursor Cell Lym

2005
Recent steroid therapy increases severity of varicella infections in children with acute lymphoblastic leukemia.
    Pediatrics, 2005, Volume: 116, Issue:4

    Topics: Chickenpox; Child; Female; Glucocorticoids; Humans; Immunocompromised Host; Male; Precursor Cell Lym

2005
Recent steroid therapy increases severity of varicella infections in children with acute lymphoblastic leukemia.
    Pediatrics, 2005, Volume: 116, Issue:4

    Topics: Chickenpox; Child; Female; Glucocorticoids; Humans; Immunocompromised Host; Male; Precursor Cell Lym

2005
The MIF-173G/C polymorphism does not contribute to prednisone poor response in vivo in childhood acute lymphoblastic leukemia.
    Leukemia, 2005, Volume: 19, Issue:12

    Topics: Case-Control Studies; Drug Resistance, Neoplasm; Gene Frequency; Genotype; Humans; Macrophage Migrat

2005
The MIF-173G/C polymorphism does not contribute to prednisone poor response in vivo in childhood acute lymphoblastic leukemia.
    Leukemia, 2005, Volume: 19, Issue:12

    Topics: Case-Control Studies; Drug Resistance, Neoplasm; Gene Frequency; Genotype; Humans; Macrophage Migrat

2005
The MIF-173G/C polymorphism does not contribute to prednisone poor response in vivo in childhood acute lymphoblastic leukemia.
    Leukemia, 2005, Volume: 19, Issue:12

    Topics: Case-Control Studies; Drug Resistance, Neoplasm; Gene Frequency; Genotype; Humans; Macrophage Migrat

2005
Treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Hematology. American Society of Hematology. Education Program, 2005

    Topics: Adult; Antineoplastic Agents; Benzamides; Chromosomes, Human, Pair 22; Chromosomes, Human, Pair 9; C

2005
Treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Hematology. American Society of Hematology. Education Program, 2005

    Topics: Adult; Antineoplastic Agents; Benzamides; Chromosomes, Human, Pair 22; Chromosomes, Human, Pair 9; C

2005
Treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Hematology. American Society of Hematology. Education Program, 2005

    Topics: Adult; Antineoplastic Agents; Benzamides; Chromosomes, Human, Pair 22; Chromosomes, Human, Pair 9; C

2005
Could Candida dubliniensis be involved in lung fungus balls?
    Revista iberoamericana de micologia, 2005, Volume: 22, Issue:3

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bronchoalveolar Lavage Fluid; Candida; C

2005
Could Candida dubliniensis be involved in lung fungus balls?
    Revista iberoamericana de micologia, 2005, Volume: 22, Issue:3

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bronchoalveolar Lavage Fluid; Candida; C

2005
Could Candida dubliniensis be involved in lung fungus balls?
    Revista iberoamericana de micologia, 2005, Volume: 22, Issue:3

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bronchoalveolar Lavage Fluid; Candida; C

2005
West Nile virus infection in a teenage boy with acute lymphocytic leukemia in remission.
    Journal of pediatric hematology/oncology, 2005, Volume: 27, Issue:12

    Topics: Acyclovir; Adolescent; Animals; Antibodies, Viral; Antineoplastic Combined Chemotherapy Protocols; A

2005
West Nile virus infection in a teenage boy with acute lymphocytic leukemia in remission.
    Journal of pediatric hematology/oncology, 2005, Volume: 27, Issue:12

    Topics: Acyclovir; Adolescent; Animals; Antibodies, Viral; Antineoplastic Combined Chemotherapy Protocols; A

2005
West Nile virus infection in a teenage boy with acute lymphocytic leukemia in remission.
    Journal of pediatric hematology/oncology, 2005, Volume: 27, Issue:12

    Topics: Acyclovir; Adolescent; Animals; Antibodies, Viral; Antineoplastic Combined Chemotherapy Protocols; A

2005
p16 inactivation associated with aggressive clinical course and fatal outcome in TEL/AML1-positive acute lymphoblastic leukemia.
    Journal of pediatric hematology/oncology, 2005, Volume: 27, Issue:12

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transplantation; Child; Ch

2005
p16 inactivation associated with aggressive clinical course and fatal outcome in TEL/AML1-positive acute lymphoblastic leukemia.
    Journal of pediatric hematology/oncology, 2005, Volume: 27, Issue:12

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transplantation; Child; Ch

2005
p16 inactivation associated with aggressive clinical course and fatal outcome in TEL/AML1-positive acute lymphoblastic leukemia.
    Journal of pediatric hematology/oncology, 2005, Volume: 27, Issue:12

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transplantation; Child; Ch

2005
bcr-abl-positive T-cell acute lymphoblastic leukemia associated with parvovirus B19 infection.
    Journal of pediatric hematology/oncology, 2006, Volume: 28, Issue:2

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow; Cerebral Hemo

2006
bcr-abl-positive T-cell acute lymphoblastic leukemia associated with parvovirus B19 infection.
    Journal of pediatric hematology/oncology, 2006, Volume: 28, Issue:2

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow; Cerebral Hemo

2006
bcr-abl-positive T-cell acute lymphoblastic leukemia associated with parvovirus B19 infection.
    Journal of pediatric hematology/oncology, 2006, Volume: 28, Issue:2

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow; Cerebral Hemo

2006
Roles of protein C, protein S, and antithrombin III in acute leukemia.
    American journal of hematology, 2006, Volume: 81, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Antithrombin III; Asparaginase; Cyclophosphamide; Cy

2006
Roles of protein C, protein S, and antithrombin III in acute leukemia.
    American journal of hematology, 2006, Volume: 81, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Antithrombin III; Asparaginase; Cyclophosphamide; Cy

2006
Roles of protein C, protein S, and antithrombin III in acute leukemia.
    American journal of hematology, 2006, Volume: 81, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Antithrombin III; Asparaginase; Cyclophosphamide; Cy

2006
Unsupervised proteome analysis of human leukaemia cells identifies the Valosin-containing protein as a putative marker for glucocorticoid resistance.
    Leukemia, 2006, Volume: 20, Issue:5

    Topics: Adenosine Triphosphatases; Biomarkers, Tumor; Blotting, Western; Case-Control Studies; Catalase; Cel

2006
Unsupervised proteome analysis of human leukaemia cells identifies the Valosin-containing protein as a putative marker for glucocorticoid resistance.
    Leukemia, 2006, Volume: 20, Issue:5

    Topics: Adenosine Triphosphatases; Biomarkers, Tumor; Blotting, Western; Case-Control Studies; Catalase; Cel

2006
Unsupervised proteome analysis of human leukaemia cells identifies the Valosin-containing protein as a putative marker for glucocorticoid resistance.
    Leukemia, 2006, Volume: 20, Issue:5

    Topics: Adenosine Triphosphatases; Biomarkers, Tumor; Blotting, Western; Case-Control Studies; Catalase; Cel

2006
Acute lymphoblastic leukemia in adolescents between 10 and 19 years of age in Denmark--secondary publication.
    Danish medical bulletin, 2006, Volume: 53, Issue:1

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy;

2006
Acute lymphoblastic leukemia in adolescents between 10 and 19 years of age in Denmark--secondary publication.
    Danish medical bulletin, 2006, Volume: 53, Issue:1

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy;

2006
Acute lymphoblastic leukemia in adolescents between 10 and 19 years of age in Denmark--secondary publication.
    Danish medical bulletin, 2006, Volume: 53, Issue:1

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy;

2006
Treatment of cavitary pulmonary zygomycosis with surgical resection and posaconazole.
    The Annals of thoracic surgery, 2006, Volume: 82, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Ben

2006
Treatment of cavitary pulmonary zygomycosis with surgical resection and posaconazole.
    The Annals of thoracic surgery, 2006, Volume: 82, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Ben

2006
Treatment of cavitary pulmonary zygomycosis with surgical resection and posaconazole.
    The Annals of thoracic surgery, 2006, Volume: 82, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Ben

2006
[Acute lymphoblastic leukaemia in Danish children and young people 10 to 19 years of age. Should young adults with acute lymphoblastic leukaemia be treated in the same way as children?].
    Ugeskrift for laeger, 2006, Jun-26, Volume: 168, Issue:26-32

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophosphamide; Daunorub

2006
[Acute lymphoblastic leukaemia in Danish children and young people 10 to 19 years of age. Should young adults with acute lymphoblastic leukaemia be treated in the same way as children?].
    Ugeskrift for laeger, 2006, Jun-26, Volume: 168, Issue:26-32

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophosphamide; Daunorub

2006
[Acute lymphoblastic leukaemia in Danish children and young people 10 to 19 years of age. Should young adults with acute lymphoblastic leukaemia be treated in the same way as children?].
    Ugeskrift for laeger, 2006, Jun-26, Volume: 168, Issue:26-32

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophosphamide; Daunorub

2006
[Acute lymphoblastic leukemia in children with initial leucocytosis above 50,000/mm3: summary of treatment results of Polish Pediatric Leukemia/Lymphoma Study Group].
    Przeglad lekarski, 2006, Volume: 63, Issue:1

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; C

2006
[Acute lymphoblastic leukemia in children with initial leucocytosis above 50,000/mm3: summary of treatment results of Polish Pediatric Leukemia/Lymphoma Study Group].
    Przeglad lekarski, 2006, Volume: 63, Issue:1

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; C

2006
[Acute lymphoblastic leukemia in children with initial leucocytosis above 50,000/mm3: summary of treatment results of Polish Pediatric Leukemia/Lymphoma Study Group].
    Przeglad lekarski, 2006, Volume: 63, Issue:1

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; C

2006
Oral outpatient chemotherapy medication errors in children with acute lymphoblastic leukemia.
    Cancer, 2006, Sep-15, Volume: 107, Issue:6

    Topics: Administration, Oral; Adolescent; Child; Child, Preschool; Dexamethasone; Humans; Infant; Medication

2006
Oral outpatient chemotherapy medication errors in children with acute lymphoblastic leukemia.
    Cancer, 2006, Sep-15, Volume: 107, Issue:6

    Topics: Administration, Oral; Adolescent; Child; Child, Preschool; Dexamethasone; Humans; Infant; Medication

2006
Oral outpatient chemotherapy medication errors in children with acute lymphoblastic leukemia.
    Cancer, 2006, Sep-15, Volume: 107, Issue:6

    Topics: Administration, Oral; Adolescent; Child; Child, Preschool; Dexamethasone; Humans; Infant; Medication

2006
[Twenty years of treating childhood acute lymphoblastic leukemia].
    Anales de pediatria (Barcelona, Spain : 2003), 2006, Volume: 65, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cyclophospham

2006
[Twenty years of treating childhood acute lymphoblastic leukemia].
    Anales de pediatria (Barcelona, Spain : 2003), 2006, Volume: 65, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cyclophospham

2006
[Twenty years of treating childhood acute lymphoblastic leukemia].
    Anales de pediatria (Barcelona, Spain : 2003), 2006, Volume: 65, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cyclophospham

2006
Avascular necrosis--an antineoplastic-treatment-related toxicity: the experiences of two institutions.
    Pediatric hematology and oncology, 2006, Volume: 23, Issue:8

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cyclophosphamide; Cytarabi

2006
Avascular necrosis--an antineoplastic-treatment-related toxicity: the experiences of two institutions.
    Pediatric hematology and oncology, 2006, Volume: 23, Issue:8

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cyclophosphamide; Cytarabi

2006
Avascular necrosis--an antineoplastic-treatment-related toxicity: the experiences of two institutions.
    Pediatric hematology and oncology, 2006, Volume: 23, Issue:8

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cyclophosphamide; Cytarabi

2006
[Infection status and clinical significance of Epstein-Barr virus in pediatric leukemia---a report of 35 cases].
    Ai zheng = Aizheng = Chinese journal of cancer, 2007, Volume: 26, Issue:1

    Topics: Antineoplastic Agents, Hormonal; Child; Child, Preschool; DNA, Viral; Epstein-Barr Virus Infections;

2007
[Infection status and clinical significance of Epstein-Barr virus in pediatric leukemia---a report of 35 cases].
    Ai zheng = Aizheng = Chinese journal of cancer, 2007, Volume: 26, Issue:1

    Topics: Antineoplastic Agents, Hormonal; Child; Child, Preschool; DNA, Viral; Epstein-Barr Virus Infections;

2007
[Infection status and clinical significance of Epstein-Barr virus in pediatric leukemia---a report of 35 cases].
    Ai zheng = Aizheng = Chinese journal of cancer, 2007, Volume: 26, Issue:1

    Topics: Antineoplastic Agents, Hormonal; Child; Child, Preschool; DNA, Viral; Epstein-Barr Virus Infections;

2007
Possible increase of the neurotoxicity of vincristine by the concurrent use of posaconazole in a young adult with leukemia.
    Journal of pediatric hematology/oncology, 2007, Volume: 29, Issue:2

    Topics: Adult; Antifungal Agents; Antineoplastic Agents; Demyelinating Diseases; Electromyography; Fever; Hu

2007
Possible increase of the neurotoxicity of vincristine by the concurrent use of posaconazole in a young adult with leukemia.
    Journal of pediatric hematology/oncology, 2007, Volume: 29, Issue:2

    Topics: Adult; Antifungal Agents; Antineoplastic Agents; Demyelinating Diseases; Electromyography; Fever; Hu

2007
Possible increase of the neurotoxicity of vincristine by the concurrent use of posaconazole in a young adult with leukemia.
    Journal of pediatric hematology/oncology, 2007, Volume: 29, Issue:2

    Topics: Adult; Antifungal Agents; Antineoplastic Agents; Demyelinating Diseases; Electromyography; Fever; Hu

2007
[Reults of treatment with protocols BFM 90 and BFM 95].
    Medicinski arhiv, 2006, Volume: 60, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cyclophospham

2006
[Reults of treatment with protocols BFM 90 and BFM 95].
    Medicinski arhiv, 2006, Volume: 60, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cyclophospham

2006
[Reults of treatment with protocols BFM 90 and BFM 95].
    Medicinski arhiv, 2006, Volume: 60, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cyclophospham

2006
Air-leak syndrome associated with bronchiolitis obliterans after allogeneic peripheral blood stem cell transplantation.
    International journal of hematology, 2007, Volume: 85, Issue:2

    Topics: Acute Disease; Adult; Anti-Inflammatory Agents; Bronchiolitis Obliterans; Cyclosporine; Cytomegalovi

2007
Air-leak syndrome associated with bronchiolitis obliterans after allogeneic peripheral blood stem cell transplantation.
    International journal of hematology, 2007, Volume: 85, Issue:2

    Topics: Acute Disease; Adult; Anti-Inflammatory Agents; Bronchiolitis Obliterans; Cyclosporine; Cytomegalovi

2007
Air-leak syndrome associated with bronchiolitis obliterans after allogeneic peripheral blood stem cell transplantation.
    International journal of hematology, 2007, Volume: 85, Issue:2

    Topics: Acute Disease; Adult; Anti-Inflammatory Agents; Bronchiolitis Obliterans; Cyclosporine; Cytomegalovi

2007
Gene expression shift towards normal B cells, decreased proliferative capacity and distinct surface receptors characterize leukemic blasts persisting during induction therapy in childhood acute lymphoblastic leukemia.
    Leukemia, 2007, Volume: 21, Issue:5

    Topics: Adolescent; B-Lymphocytes; Blast Crisis; CD11b Antigen; Cell Cycle; Cell Proliferation; Child; Child

2007
Gene expression shift towards normal B cells, decreased proliferative capacity and distinct surface receptors characterize leukemic blasts persisting during induction therapy in childhood acute lymphoblastic leukemia.
    Leukemia, 2007, Volume: 21, Issue:5

    Topics: Adolescent; B-Lymphocytes; Blast Crisis; CD11b Antigen; Cell Cycle; Cell Proliferation; Child; Child

2007
Gene expression shift towards normal B cells, decreased proliferative capacity and distinct surface receptors characterize leukemic blasts persisting during induction therapy in childhood acute lymphoblastic leukemia.
    Leukemia, 2007, Volume: 21, Issue:5

    Topics: Adolescent; B-Lymphocytes; Blast Crisis; CD11b Antigen; Cell Cycle; Cell Proliferation; Child; Child

2007
High body mass index increases the risk for osteonecrosis in children with acute lymphoblastic leukemia.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2007, Apr-20, Volume: 25, Issue:12

    Topics: Adolescent; Adrenal Cortex Hormones; Age Distribution; Analysis of Variance; Body Mass Index; Causal

2007
High body mass index increases the risk for osteonecrosis in children with acute lymphoblastic leukemia.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2007, Apr-20, Volume: 25, Issue:12

    Topics: Adolescent; Adrenal Cortex Hormones; Age Distribution; Analysis of Variance; Body Mass Index; Causal

2007
High body mass index increases the risk for osteonecrosis in children with acute lymphoblastic leukemia.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2007, Apr-20, Volume: 25, Issue:12

    Topics: Adolescent; Adrenal Cortex Hormones; Age Distribution; Analysis of Variance; Body Mass Index; Causal

2007
Low-dose arsenic trioxide sensitizes glucocorticoid-resistant acute lymphoblastic leukemia cells to dexamethasone via an Akt-dependent pathway.
    Blood, 2007, Sep-15, Volume: 110, Issue:6

    Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; bcl-Associated Death Protein; Blotti

2007
Low-dose arsenic trioxide sensitizes glucocorticoid-resistant acute lymphoblastic leukemia cells to dexamethasone via an Akt-dependent pathway.
    Blood, 2007, Sep-15, Volume: 110, Issue:6

    Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; bcl-Associated Death Protein; Blotti

2007
Low-dose arsenic trioxide sensitizes glucocorticoid-resistant acute lymphoblastic leukemia cells to dexamethasone via an Akt-dependent pathway.
    Blood, 2007, Sep-15, Volume: 110, Issue:6

    Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; bcl-Associated Death Protein; Blotti

2007
Vincristine-induced acute neurotoxicity versus Guillain-Barré syndrome: a diagnostic dilemma.
    European journal of neurology, 2007, Volume: 14, Issue:7

    Topics: Action Potentials; Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin;

2007
Vincristine-induced acute neurotoxicity versus Guillain-Barré syndrome: a diagnostic dilemma.
    European journal of neurology, 2007, Volume: 14, Issue:7

    Topics: Action Potentials; Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin;

2007
Vincristine-induced acute neurotoxicity versus Guillain-Barré syndrome: a diagnostic dilemma.
    European journal of neurology, 2007, Volume: 14, Issue:7

    Topics: Action Potentials; Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin;

2007
Disseminated intravascular coagulation in acute leukemia at presentation and during induction therapy.
    Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 2007, Volume: 13, Issue:3

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Presc

2007
Disseminated intravascular coagulation in acute leukemia at presentation and during induction therapy.
    Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 2007, Volume: 13, Issue:3

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Presc

2007
Disseminated intravascular coagulation in acute leukemia at presentation and during induction therapy.
    Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 2007, Volume: 13, Issue:3

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Presc

2007
Coenzyme Q10 concentration in the plasma of children suffering from acute lymphoblastic leukaemia before and during induction treatment.
    BioFactors (Oxford, England), 2007, Volume: 29, Issue:2-3

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Asparaginase; Child; Child

2007
Coenzyme Q10 concentration in the plasma of children suffering from acute lymphoblastic leukaemia before and during induction treatment.
    BioFactors (Oxford, England), 2007, Volume: 29, Issue:2-3

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Asparaginase; Child; Child

2007
Coenzyme Q10 concentration in the plasma of children suffering from acute lymphoblastic leukaemia before and during induction treatment.
    BioFactors (Oxford, England), 2007, Volume: 29, Issue:2-3

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Asparaginase; Child; Child

2007
[Comparative study on clinical features between TEL-AML1 positive and negative childhood acute lymphoblastic leukemia].
    Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics, 2007, Volume: 24, Issue:5

    Topics: Adolescent; Bone Marrow; Child; Child, Preschool; Core Binding Factor Alpha 2 Subunit; ETS Transloca

2007
[Comparative study on clinical features between TEL-AML1 positive and negative childhood acute lymphoblastic leukemia].
    Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics, 2007, Volume: 24, Issue:5

    Topics: Adolescent; Bone Marrow; Child; Child, Preschool; Core Binding Factor Alpha 2 Subunit; ETS Transloca

2007
[Comparative study on clinical features between TEL-AML1 positive and negative childhood acute lymphoblastic leukemia].
    Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics, 2007, Volume: 24, Issue:5

    Topics: Adolescent; Bone Marrow; Child; Child, Preschool; Core Binding Factor Alpha 2 Subunit; ETS Transloca

2007
[Primary esophageal lymphoma in a acquired immunodeficiency syndrome: a case report].
    Anales de medicina interna (Madrid, Spain : 1984), 2007, Volume: 24, Issue:5

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Esophageal Neo

2007
[Primary esophageal lymphoma in a acquired immunodeficiency syndrome: a case report].
    Anales de medicina interna (Madrid, Spain : 1984), 2007, Volume: 24, Issue:5

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Esophageal Neo

2007
[Primary esophageal lymphoma in a acquired immunodeficiency syndrome: a case report].
    Anales de medicina interna (Madrid, Spain : 1984), 2007, Volume: 24, Issue:5

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Esophageal Neo

2007
Incidence and outcome of TCF3-PBX1-positive acute lymphoblastic leukemia in Austrian children.
    Haematologica, 2007, Volume: 92, Issue:11

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Austria; Basic Helix-Loop-

2007
Incidence and outcome of TCF3-PBX1-positive acute lymphoblastic leukemia in Austrian children.
    Haematologica, 2007, Volume: 92, Issue:11

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Austria; Basic Helix-Loop-

2007
Incidence and outcome of TCF3-PBX1-positive acute lymphoblastic leukemia in Austrian children.
    Haematologica, 2007, Volume: 92, Issue:11

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Austria; Basic Helix-Loop-

2007
The NQO1 C609T polymorphism is associated with risk of secondary malignant neoplasms after treatment for childhood acute lymphoblastic leukemia: a matched-pair analysis from the ALL-BFM study group.
    Haematologica, 2007, Volume: 92, Issue:11

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Daunorubicin;

2007
The NQO1 C609T polymorphism is associated with risk of secondary malignant neoplasms after treatment for childhood acute lymphoblastic leukemia: a matched-pair analysis from the ALL-BFM study group.
    Haematologica, 2007, Volume: 92, Issue:11

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Daunorubicin;

2007
The NQO1 C609T polymorphism is associated with risk of secondary malignant neoplasms after treatment for childhood acute lymphoblastic leukemia: a matched-pair analysis from the ALL-BFM study group.
    Haematologica, 2007, Volume: 92, Issue:11

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Daunorubicin;

2007
[Clinical, morphologic immunologic and cytogenetic characteristics of childhood acute lymphoblastic leukemia: a comparison between prednisone poor responders and good responders].
    Zhonghua er ke za zhi = Chinese journal of pediatrics, 2007, Volume: 45, Issue:11

    Topics: Anti-Inflammatory Agents; Child, Preschool; Humans; Infant; Infant, Newborn; Precursor Cell Lymphobl

2007
[Clinical, morphologic immunologic and cytogenetic characteristics of childhood acute lymphoblastic leukemia: a comparison between prednisone poor responders and good responders].
    Zhonghua er ke za zhi = Chinese journal of pediatrics, 2007, Volume: 45, Issue:11

    Topics: Anti-Inflammatory Agents; Child, Preschool; Humans; Infant; Infant, Newborn; Precursor Cell Lymphobl

2007
[Clinical, morphologic immunologic and cytogenetic characteristics of childhood acute lymphoblastic leukemia: a comparison between prednisone poor responders and good responders].
    Zhonghua er ke za zhi = Chinese journal of pediatrics, 2007, Volume: 45, Issue:11

    Topics: Anti-Inflammatory Agents; Child, Preschool; Humans; Infant; Infant, Newborn; Precursor Cell Lymphobl

2007
Effects of prednisolone on specifically expressed genes in pediatric acute B-lymphoblastic leukemia.
    Journal of pediatric hematology/oncology, 2008, Volume: 30, Issue:4

    Topics: Gene Expression Regulation, Neoplastic; Humans; Infant; Lymphoma, B-Cell; Neoplasm Staging; Oligonuc

2008
Effects of prednisolone on specifically expressed genes in pediatric acute B-lymphoblastic leukemia.
    Journal of pediatric hematology/oncology, 2008, Volume: 30, Issue:4

    Topics: Gene Expression Regulation, Neoplastic; Humans; Infant; Lymphoma, B-Cell; Neoplasm Staging; Oligonuc

2008
Effects of prednisolone on specifically expressed genes in pediatric acute B-lymphoblastic leukemia.
    Journal of pediatric hematology/oncology, 2008, Volume: 30, Issue:4

    Topics: Gene Expression Regulation, Neoplastic; Humans; Infant; Lymphoma, B-Cell; Neoplasm Staging; Oligonuc

2008
Outcomes of a modified CALGB 19802 regimen in adult acute lymphoblastic leukemia.
    Journal of Korean medical science, 2008, Volume: 23, Issue:2

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Daunorubi

2008
Outcomes of a modified CALGB 19802 regimen in adult acute lymphoblastic leukemia.
    Journal of Korean medical science, 2008, Volume: 23, Issue:2

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Daunorubi

2008
Outcomes of a modified CALGB 19802 regimen in adult acute lymphoblastic leukemia.
    Journal of Korean medical science, 2008, Volume: 23, Issue:2

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Daunorubi

2008
Obesity after successful treatment of acute lymphoblastic leukemia in childhood.
    Pediatric research, 1995, Volume: 38, Issue:1

    Topics: Adolescent; Age Factors; Antineoplastic Agents, Hormonal; Child; Child, Preschool; Dexamethasone; Fe

1995
Obesity after successful treatment of acute lymphoblastic leukemia in childhood.
    Pediatric research, 1995, Volume: 38, Issue:1

    Topics: Adolescent; Age Factors; Antineoplastic Agents, Hormonal; Child; Child, Preschool; Dexamethasone; Fe

1995
Obesity after successful treatment of acute lymphoblastic leukemia in childhood.
    Pediatric research, 1995, Volume: 38, Issue:1

    Topics: Adolescent; Age Factors; Antineoplastic Agents, Hormonal; Child; Child, Preschool; Dexamethasone; Fe

1995
Lymphoma-associated pancreatitis as a presenting manifestation of immunoblastic lymphoma.
    Leukemia & lymphoma, 1994, Volume: 12, Issue:3-4

    Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Diagnosi

1994
Lymphoma-associated pancreatitis as a presenting manifestation of immunoblastic lymphoma.
    Leukemia & lymphoma, 1994, Volume: 12, Issue:3-4

    Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Diagnosi

1994
Lymphoma-associated pancreatitis as a presenting manifestation of immunoblastic lymphoma.
    Leukemia & lymphoma, 1994, Volume: 12, Issue:3-4

    Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Diagnosi

1994
CD34 expression is associated with major adverse prognostic factors in adult acute lymphoblastic leukemia.
    Leukemia, 1995, Volume: 9, Issue:2

    Topics: Adolescent; Adult; Aged; Amsacrine; Aneuploidy; Antibiotics, Antineoplastic; Antigens, CD; Antigens,

1995
CD34 expression is associated with major adverse prognostic factors in adult acute lymphoblastic leukemia.
    Leukemia, 1995, Volume: 9, Issue:2

    Topics: Adolescent; Adult; Aged; Amsacrine; Aneuploidy; Antibiotics, Antineoplastic; Antigens, CD; Antigens,

1995
CD34 expression is associated with major adverse prognostic factors in adult acute lymphoblastic leukemia.
    Leukemia, 1995, Volume: 9, Issue:2

    Topics: Adolescent; Adult; Aged; Amsacrine; Aneuploidy; Antibiotics, Antineoplastic; Antigens, CD; Antigens,

1995
[The significance of preventive CNS irradiation during antineoplastic therapy in childhood with regard to late odontogenic and mandibulofacial injuries].
    Fortschritte der Kieferorthopadie, 1995, Volume: 56, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cephalometry; Child, Preschool; Combin

1995
[The significance of preventive CNS irradiation during antineoplastic therapy in childhood with regard to late odontogenic and mandibulofacial injuries].
    Fortschritte der Kieferorthopadie, 1995, Volume: 56, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cephalometry; Child, Preschool; Combin

1995
[The significance of preventive CNS irradiation during antineoplastic therapy in childhood with regard to late odontogenic and mandibulofacial injuries].
    Fortschritte der Kieferorthopadie, 1995, Volume: 56, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cephalometry; Child, Preschool; Combin

1995
Acute lymphoblastic leukemia in the elderly: results of two different treatment approaches in 49 patients during a 25-year period.
    Leukemia, 1995, Volume: 9, Issue:10

    Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Daunorubicin;

1995
Acute lymphoblastic leukemia in the elderly: results of two different treatment approaches in 49 patients during a 25-year period.
    Leukemia, 1995, Volume: 9, Issue:10

    Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Daunorubicin;

1995
Acute lymphoblastic leukemia in the elderly: results of two different treatment approaches in 49 patients during a 25-year period.
    Leukemia, 1995, Volume: 9, Issue:10

    Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Daunorubicin;

1995
[Electrolytic changes in children with acute lymphoblastic leukemia during remission induction].
    Sangre, 1995, Volume: 40, Issue:3

    Topics: Adolescent; Allopurinol; Anions; Antineoplastic Combined Chemotherapy Protocols; Bicarbonates; Blood

1995
[Electrolytic changes in children with acute lymphoblastic leukemia during remission induction].
    Sangre, 1995, Volume: 40, Issue:3

    Topics: Adolescent; Allopurinol; Anions; Antineoplastic Combined Chemotherapy Protocols; Bicarbonates; Blood

1995
[Electrolytic changes in children with acute lymphoblastic leukemia during remission induction].
    Sangre, 1995, Volume: 40, Issue:3

    Topics: Adolescent; Allopurinol; Anions; Antineoplastic Combined Chemotherapy Protocols; Bicarbonates; Blood

1995
Prognosis and treatment of seizures in children with acute lymphoblastic leukemia.
    Epilepsia, 1995, Volume: 36, Issue:8

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Daunorubicin; Epile

1995
Prognosis and treatment of seizures in children with acute lymphoblastic leukemia.
    Epilepsia, 1995, Volume: 36, Issue:8

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Daunorubicin; Epile

1995
Prognosis and treatment of seizures in children with acute lymphoblastic leukemia.
    Epilepsia, 1995, Volume: 36, Issue:8

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Daunorubicin; Epile

1995
The value of high-dose systemic chemotherapy and intrathecal therapy for central nervous system prophylaxis in different risk groups of adult acute lymphoblastic leukemia.
    Blood, 1995, Sep-15, Volume: 86, Issue:6

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amsacrine; Antineoplastic Combined Chemotherapy Protocol

1995
The value of high-dose systemic chemotherapy and intrathecal therapy for central nervous system prophylaxis in different risk groups of adult acute lymphoblastic leukemia.
    Blood, 1995, Sep-15, Volume: 86, Issue:6

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amsacrine; Antineoplastic Combined Chemotherapy Protocol

1995
The value of high-dose systemic chemotherapy and intrathecal therapy for central nervous system prophylaxis in different risk groups of adult acute lymphoblastic leukemia.
    Blood, 1995, Sep-15, Volume: 86, Issue:6

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amsacrine; Antineoplastic Combined Chemotherapy Protocol

1995
MACOP-B +/- radiation therapy for diffuse large cell lymphoma. Analysis of the Stanford results according to prognostic indices.
    Cancer, 1993, Jun-15, Volume: 71, Issue:12

    Topics: Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality The

1993
MACOP-B +/- radiation therapy for diffuse large cell lymphoma. Analysis of the Stanford results according to prognostic indices.
    Cancer, 1993, Jun-15, Volume: 71, Issue:12

    Topics: Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality The

1993
MACOP-B +/- radiation therapy for diffuse large cell lymphoma. Analysis of the Stanford results according to prognostic indices.
    Cancer, 1993, Jun-15, Volume: 71, Issue:12

    Topics: Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality The

1993
[High dose chemoradiotherapy and autologous bone marrow transplantation (ABMT) as a first line therapy to treat advanced adult high-grade malignant T-cell non-Hodgkin's lymphoma--a pilot clinical study].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 1993, Volume: 15, Issue:1

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplant

1993
[High dose chemoradiotherapy and autologous bone marrow transplantation (ABMT) as a first line therapy to treat advanced adult high-grade malignant T-cell non-Hodgkin's lymphoma--a pilot clinical study].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 1993, Volume: 15, Issue:1

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplant

1993
[High dose chemoradiotherapy and autologous bone marrow transplantation (ABMT) as a first line therapy to treat advanced adult high-grade malignant T-cell non-Hodgkin's lymphoma--a pilot clinical study].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 1993, Volume: 15, Issue:1

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplant

1993
The frequency of micronuclei in bone-marrow erythroblasts during the treatment of childhood acute lymphoblastic leukaemia.
    Mutation research, 1993, Volume: 303, Issue:1

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow; Child; Child,

1993
The frequency of micronuclei in bone-marrow erythroblasts during the treatment of childhood acute lymphoblastic leukaemia.
    Mutation research, 1993, Volume: 303, Issue:1

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow; Child; Child,

1993
The frequency of micronuclei in bone-marrow erythroblasts during the treatment of childhood acute lymphoblastic leukaemia.
    Mutation research, 1993, Volume: 303, Issue:1

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow; Child; Child,

1993
Treatment of poor prognosis non-Hodgkin's lymphoma with intensive, inpatient combination chemotherapy of brief duration: long-term followup.
    Leukemia & lymphoma, 1993, Volume: 10, Issue:6

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide

1993
Treatment of poor prognosis non-Hodgkin's lymphoma with intensive, inpatient combination chemotherapy of brief duration: long-term followup.
    Leukemia & lymphoma, 1993, Volume: 10, Issue:6

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide

1993
Treatment of poor prognosis non-Hodgkin's lymphoma with intensive, inpatient combination chemotherapy of brief duration: long-term followup.
    Leukemia & lymphoma, 1993, Volume: 10, Issue:6

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide

1993
[DNA index and proliferative activity of blastic cells in childhood ALL].
    Acta haematologica Polonica, 1995, Volume: 26, Issue:1

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cell Division; Child; Child, Preschool;

1995
[DNA index and proliferative activity of blastic cells in childhood ALL].
    Acta haematologica Polonica, 1995, Volume: 26, Issue:1

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cell Division; Child; Child, Preschool;

1995
[DNA index and proliferative activity of blastic cells in childhood ALL].
    Acta haematologica Polonica, 1995, Volume: 26, Issue:1

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cell Division; Child; Child, Preschool;

1995
Recurrent lymphoma in a cardiac allograft recipient.
    Transplantation science, 1994, Volume: 4, Issue:1

    Topics: Azathioprine; Cyclosporine; Follow-Up Studies; Graft Rejection; Heart Transplantation; Humans; Lung

1994
Recurrent lymphoma in a cardiac allograft recipient.
    Transplantation science, 1994, Volume: 4, Issue:1

    Topics: Azathioprine; Cyclosporine; Follow-Up Studies; Graft Rejection; Heart Transplantation; Humans; Lung

1994
Recurrent lymphoma in a cardiac allograft recipient.
    Transplantation science, 1994, Volume: 4, Issue:1

    Topics: Azathioprine; Cyclosporine; Follow-Up Studies; Graft Rejection; Heart Transplantation; Humans; Lung

1994
Aggressive chemotherapy for acute leukemia relapsed after transplantation.
    Leukemia & lymphoma, 1994, Volume: 15, Issue:1-2

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cyta

1994
Aggressive chemotherapy for acute leukemia relapsed after transplantation.
    Leukemia & lymphoma, 1994, Volume: 15, Issue:1-2

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cyta

1994
Aggressive chemotherapy for acute leukemia relapsed after transplantation.
    Leukemia & lymphoma, 1994, Volume: 15, Issue:1-2

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cyta

1994
Childhood acute lymphoblastic leukemia (ALL): sister chromatid exchange (SCE) frequency and lymphocyte subpopulations during therapy.
    Leukemia, 1995, Volume: 9, Issue:3

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; C

1995
Childhood acute lymphoblastic leukemia (ALL): sister chromatid exchange (SCE) frequency and lymphocyte subpopulations during therapy.
    Leukemia, 1995, Volume: 9, Issue:3

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; C

1995
Childhood acute lymphoblastic leukemia (ALL): sister chromatid exchange (SCE) frequency and lymphocyte subpopulations during therapy.
    Leukemia, 1995, Volume: 9, Issue:3

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; C

1995
Transient, severe hyperlipidemia in patients with acute lymphoblastic leukemia treated with prednisone and asparaginase.
    Cancer, 1994, Dec-15, Volume: 74, Issue:12

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Female; Humans; Hyp

1994
Transient, severe hyperlipidemia in patients with acute lymphoblastic leukemia treated with prednisone and asparaginase.
    Cancer, 1994, Dec-15, Volume: 74, Issue:12

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Female; Humans; Hyp

1994
Transient, severe hyperlipidemia in patients with acute lymphoblastic leukemia treated with prednisone and asparaginase.
    Cancer, 1994, Dec-15, Volume: 74, Issue:12

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Female; Humans; Hyp

1994
A dental complication involving Pseudomonas during chemotherapy for acute lymphoblastic leukemia.
    The Journal of clinical pediatric dentistry, 1994,Spring, Volume: 18, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Cytarabine; Dental Care for Chr

1994
A dental complication involving Pseudomonas during chemotherapy for acute lymphoblastic leukemia.
    The Journal of clinical pediatric dentistry, 1994,Spring, Volume: 18, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Cytarabine; Dental Care for Chr

1994
A dental complication involving Pseudomonas during chemotherapy for acute lymphoblastic leukemia.
    The Journal of clinical pediatric dentistry, 1994,Spring, Volume: 18, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Cytarabine; Dental Care for Chr

1994
Treatment of acute lymphoblastic leukaemia in adults with modified BFM regimen.
    Indian journal of cancer, 1994, Volume: 31, Issue:1

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Burkitt Lymph

1994
Treatment of acute lymphoblastic leukaemia in adults with modified BFM regimen.
    Indian journal of cancer, 1994, Volume: 31, Issue:1

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Burkitt Lymph

1994
Treatment of acute lymphoblastic leukaemia in adults with modified BFM regimen.
    Indian journal of cancer, 1994, Volume: 31, Issue:1

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Burkitt Lymph

1994
Poor outcome of intensive chemotherapy for adult acute lymphoblastic leukemia: a possible dose effect.
    Leukemia, 1994, Volume: 8, Issue:9

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cyclophosphamide; Cytarab

1994
Poor outcome of intensive chemotherapy for adult acute lymphoblastic leukemia: a possible dose effect.
    Leukemia, 1994, Volume: 8, Issue:9

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cyclophosphamide; Cytarab

1994
Poor outcome of intensive chemotherapy for adult acute lymphoblastic leukemia: a possible dose effect.
    Leukemia, 1994, Volume: 8, Issue:9

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cyclophosphamide; Cytarab

1994
Teratogenicity and carcinogenicity in a twin exposed in utero to cyclophosphamide.
    Teratogenesis, carcinogenesis, and mutagenesis, 1993, Volume: 13, Issue:3

    Topics: Abnormalities, Drug-Induced; Abnormalities, Multiple; Adrenal Gland Neoplasms; Adult; Aminopterin; A

1993
Teratogenicity and carcinogenicity in a twin exposed in utero to cyclophosphamide.
    Teratogenesis, carcinogenesis, and mutagenesis, 1993, Volume: 13, Issue:3

    Topics: Abnormalities, Drug-Induced; Abnormalities, Multiple; Adrenal Gland Neoplasms; Adult; Aminopterin; A

1993
Teratogenicity and carcinogenicity in a twin exposed in utero to cyclophosphamide.
    Teratogenesis, carcinogenesis, and mutagenesis, 1993, Volume: 13, Issue:3

    Topics: Abnormalities, Drug-Induced; Abnormalities, Multiple; Adrenal Gland Neoplasms; Adult; Aminopterin; A

1993
Successful treatment of acute lymphoblastic leukemia in a child with cystic fibrosis.
    Medical and pediatric oncology, 1994, Volume: 22, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child, Preschool; Cystic Fibrosis; Cyt

1994
Successful treatment of acute lymphoblastic leukemia in a child with cystic fibrosis.
    Medical and pediatric oncology, 1994, Volume: 22, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child, Preschool; Cystic Fibrosis; Cyt

1994
Successful treatment of acute lymphoblastic leukemia in a child with cystic fibrosis.
    Medical and pediatric oncology, 1994, Volume: 22, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child, Preschool; Cystic Fibrosis; Cyt

1994
Incidence and prognostic significance of immunophenotypic subgroups in childhood acute lymphoblastic leukemia: the experience of the AIEOP Cooperative Study. Associazione Italiana Ematologia Oncologia Pediatrica.
    Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer, 1993, Volume: 131

    Topics: Child; Humans; Immunophenotyping; Incidence; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednis

1993
Incidence and prognostic significance of immunophenotypic subgroups in childhood acute lymphoblastic leukemia: the experience of the AIEOP Cooperative Study. Associazione Italiana Ematologia Oncologia Pediatrica.
    Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer, 1993, Volume: 131

    Topics: Child; Humans; Immunophenotyping; Incidence; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednis

1993
Incidence and prognostic significance of immunophenotypic subgroups in childhood acute lymphoblastic leukemia: the experience of the AIEOP Cooperative Study. Associazione Italiana Ematologia Oncologia Pediatrica.
    Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer, 1993, Volume: 131

    Topics: Child; Humans; Immunophenotyping; Incidence; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednis

1993
Excessive hepatitis-B surface antigen production after corticosteroids and the development of immunoblastic lymphoma.
    Leukemia & lymphoma, 1993, Volume: 10, Issue:3

    Topics: Breast Neoplasms; Fatal Outcome; Female; Gene Expression Regulation, Viral; Glomerulonephritis, Memb

1993
Excessive hepatitis-B surface antigen production after corticosteroids and the development of immunoblastic lymphoma.
    Leukemia & lymphoma, 1993, Volume: 10, Issue:3

    Topics: Breast Neoplasms; Fatal Outcome; Female; Gene Expression Regulation, Viral; Glomerulonephritis, Memb

1993
Excessive hepatitis-B surface antigen production after corticosteroids and the development of immunoblastic lymphoma.
    Leukemia & lymphoma, 1993, Volume: 10, Issue:3

    Topics: Breast Neoplasms; Fatal Outcome; Female; Gene Expression Regulation, Viral; Glomerulonephritis, Memb

1993
Relapses after termination of therapy of acute lymphoblastic leukemia in children.
    Acta paediatrica Japonica : Overseas edition, 1993, Volume: 35, Issue:5

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; D

1993
Relapses after termination of therapy of acute lymphoblastic leukemia in children.
    Acta paediatrica Japonica : Overseas edition, 1993, Volume: 35, Issue:5

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; D

1993
Relapses after termination of therapy of acute lymphoblastic leukemia in children.
    Acta paediatrica Japonica : Overseas edition, 1993, Volume: 35, Issue:5

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; D

1993
Late relapse after allogeneic bone marrow transplantation for Philadelphia-positive acute lymphoblastic leukaemia.
    Acta haematologica, 1993, Volume: 89, Issue:3

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transplantation; Co

1993
Late relapse after allogeneic bone marrow transplantation for Philadelphia-positive acute lymphoblastic leukaemia.
    Acta haematologica, 1993, Volume: 89, Issue:3

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transplantation; Co

1993
Late relapse after allogeneic bone marrow transplantation for Philadelphia-positive acute lymphoblastic leukaemia.
    Acta haematologica, 1993, Volume: 89, Issue:3

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transplantation; Co

1993
[Acute lymphoblastic leukemia in infants--results of treatment according to infant leukemia protocol--POG 8493].
    Acta haematologica Polonica, 1993, Volume: 24, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cortisone; Cyclophosphamide; Cytarabin

1993
[Acute lymphoblastic leukemia in infants--results of treatment according to infant leukemia protocol--POG 8493].
    Acta haematologica Polonica, 1993, Volume: 24, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cortisone; Cyclophosphamide; Cytarabin

1993
[Acute lymphoblastic leukemia in infants--results of treatment according to infant leukemia protocol--POG 8493].
    Acta haematologica Polonica, 1993, Volume: 24, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cortisone; Cyclophosphamide; Cytarabin

1993
Ten years' experience with LSA2-L2 therapy for childhood advanced lymphoblastic lymphoma.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1993, Volume: 11, Issue:10

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclopho

1993
Ten years' experience with LSA2-L2 therapy for childhood advanced lymphoblastic lymphoma.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1993, Volume: 11, Issue:10

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclopho

1993
Ten years' experience with LSA2-L2 therapy for childhood advanced lymphoblastic lymphoma.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1993, Volume: 11, Issue:10

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclopho

1993
Hemorrhagic cystitis associated with BKV in patients with refractory acute lymphoblastic leukemia.
    American journal of hematology, 1996, Volume: 52, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; BK Virus; Cyclophosphamide; Cystitis; Cytarabine; He

1996
Hemorrhagic cystitis associated with BKV in patients with refractory acute lymphoblastic leukemia.
    American journal of hematology, 1996, Volume: 52, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; BK Virus; Cyclophosphamide; Cystitis; Cytarabine; He

1996
Hemorrhagic cystitis associated with BKV in patients with refractory acute lymphoblastic leukemia.
    American journal of hematology, 1996, Volume: 52, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; BK Virus; Cyclophosphamide; Cystitis; Cytarabine; He

1996
Influence of treatment modalities on body weight in acute lymphoblastic leukemia.
    Medical and pediatric oncology, 1996, Volume: 27, Issue:2

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cranial Irradia

1996
Influence of treatment modalities on body weight in acute lymphoblastic leukemia.
    Medical and pediatric oncology, 1996, Volume: 27, Issue:2

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cranial Irradia

1996
Influence of treatment modalities on body weight in acute lymphoblastic leukemia.
    Medical and pediatric oncology, 1996, Volume: 27, Issue:2

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cranial Irradia

1996
True histiocytic lymphoma following therapy for lymphoblastic neoplasms.
    Blood, 1996, Jun-15, Volume: 87, Issue:12

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Neoplasms; Child; Cisplati

1996
True histiocytic lymphoma following therapy for lymphoblastic neoplasms.
    Blood, 1996, Jun-15, Volume: 87, Issue:12

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Neoplasms; Child; Cisplati

1996
True histiocytic lymphoma following therapy for lymphoblastic neoplasms.
    Blood, 1996, Jun-15, Volume: 87, Issue:12

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Neoplasms; Child; Cisplati

1996
A T cell lymphoblastic lymphoma patient with two malignant cell populations carrying different 9p deletions including the p16INK4 and p15INK4B genes: Clinical response to interferon-alpha therapy in one of the subclones.
    Leukemia, 1996, Volume: 10, Issue:5

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carrier Proteins; Cell Cycle Proteins; C

1996
A T cell lymphoblastic lymphoma patient with two malignant cell populations carrying different 9p deletions including the p16INK4 and p15INK4B genes: Clinical response to interferon-alpha therapy in one of the subclones.
    Leukemia, 1996, Volume: 10, Issue:5

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carrier Proteins; Cell Cycle Proteins; C

1996
A T cell lymphoblastic lymphoma patient with two malignant cell populations carrying different 9p deletions including the p16INK4 and p15INK4B genes: Clinical response to interferon-alpha therapy in one of the subclones.
    Leukemia, 1996, Volume: 10, Issue:5

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carrier Proteins; Cell Cycle Proteins; C

1996
Childhood acute lymphoblastic leukemia relapse in the uterine cervix.
    Journal of pediatric hematology/oncology, 1996, Volume: 18, Issue:3

    Topics: Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Brain Neoplasms; Child;

1996
Childhood acute lymphoblastic leukemia relapse in the uterine cervix.
    Journal of pediatric hematology/oncology, 1996, Volume: 18, Issue:3

    Topics: Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Brain Neoplasms; Child;

1996
Childhood acute lymphoblastic leukemia relapse in the uterine cervix.
    Journal of pediatric hematology/oncology, 1996, Volume: 18, Issue:3

    Topics: Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Brain Neoplasms; Child;

1996
Pyomyositis during induction chemotherapy for acute lymphocytic leukemia.
    Journal of pediatric hematology/oncology, 1996, Volume: 18, Issue:3

    Topics: Abscess; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bacterial Infections; Child;

1996
Pyomyositis during induction chemotherapy for acute lymphocytic leukemia.
    Journal of pediatric hematology/oncology, 1996, Volume: 18, Issue:3

    Topics: Abscess; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bacterial Infections; Child;

1996
Pyomyositis during induction chemotherapy for acute lymphocytic leukemia.
    Journal of pediatric hematology/oncology, 1996, Volume: 18, Issue:3

    Topics: Abscess; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bacterial Infections; Child;

1996
Effectiveness of intensified rotational combination chemotherapy for late hematologic relapse of childhood acute lymphoblastic leukemia.
    Blood, 1996, Aug-01, Volume: 88, Issue:3

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Combined Mod

1996
Effectiveness of intensified rotational combination chemotherapy for late hematologic relapse of childhood acute lymphoblastic leukemia.
    Blood, 1996, Aug-01, Volume: 88, Issue:3

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Combined Mod

1996
Effectiveness of intensified rotational combination chemotherapy for late hematologic relapse of childhood acute lymphoblastic leukemia.
    Blood, 1996, Aug-01, Volume: 88, Issue:3

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Combined Mod

1996
[Paraplegia following intrathecal chemotherapy].
    Schweizerische medizinische Wochenschrift, 1996, Jun-22, Volume: 126, Issue:25

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cisplatin;

1996
[Paraplegia following intrathecal chemotherapy].
    Schweizerische medizinische Wochenschrift, 1996, Jun-22, Volume: 126, Issue:25

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cisplatin;

1996
[Paraplegia following intrathecal chemotherapy].
    Schweizerische medizinische Wochenschrift, 1996, Jun-22, Volume: 126, Issue:25

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cisplatin;

1996
Post-transplantation complications of unrelated bone marrow.
    Oncology (Williston Park, N.Y.), 1996, Volume: 10, Issue:4

    Topics: Adult; Antilymphocyte Serum; Bone Marrow Transplantation; Graft vs Host Disease; Humans; Immunosuppr

1996
Post-transplantation complications of unrelated bone marrow.
    Oncology (Williston Park, N.Y.), 1996, Volume: 10, Issue:4

    Topics: Adult; Antilymphocyte Serum; Bone Marrow Transplantation; Graft vs Host Disease; Humans; Immunosuppr

1996
Post-transplantation complications of unrelated bone marrow.
    Oncology (Williston Park, N.Y.), 1996, Volume: 10, Issue:4

    Topics: Adult; Antilymphocyte Serum; Bone Marrow Transplantation; Graft vs Host Disease; Humans; Immunosuppr

1996
Expression and prognostic value of the retinoblastoma tumour suppressor gene (RB-1) in childhood acute lymphoblastic leukaemia.
    British journal of haematology, 1996, Volume: 94, Issue:1

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Base Sequence; beta 2-Micr

1996
Expression and prognostic value of the retinoblastoma tumour suppressor gene (RB-1) in childhood acute lymphoblastic leukaemia.
    British journal of haematology, 1996, Volume: 94, Issue:1

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Base Sequence; beta 2-Micr

1996
Expression and prognostic value of the retinoblastoma tumour suppressor gene (RB-1) in childhood acute lymphoblastic leukaemia.
    British journal of haematology, 1996, Volume: 94, Issue:1

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Base Sequence; beta 2-Micr

1996
Serum levels of insulin-like growth factor-I, -II and insulin-like growth factor binding proteins -2 and -3 in children with acute lymphoblastic leukaemia.
    European journal of pediatrics, 1996, Volume: 155, Issue:2

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cell Division; Chil

1996
Serum levels of insulin-like growth factor-I, -II and insulin-like growth factor binding proteins -2 and -3 in children with acute lymphoblastic leukaemia.
    European journal of pediatrics, 1996, Volume: 155, Issue:2

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cell Division; Chil

1996
Serum levels of insulin-like growth factor-I, -II and insulin-like growth factor binding proteins -2 and -3 in children with acute lymphoblastic leukaemia.
    European journal of pediatrics, 1996, Volume: 155, Issue:2

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cell Division; Chil

1996
Cytarabine with high-dose mitoxantrone induces rapid complete remissions in adult acute lymphoblastic leukemia without the use of vincristine or prednisone.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1996, Volume: 14, Issue:9

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Fema

1996
Cytarabine with high-dose mitoxantrone induces rapid complete remissions in adult acute lymphoblastic leukemia without the use of vincristine or prednisone.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1996, Volume: 14, Issue:9

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Fema

1996
Cytarabine with high-dose mitoxantrone induces rapid complete remissions in adult acute lymphoblastic leukemia without the use of vincristine or prednisone.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1996, Volume: 14, Issue:9

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Fema

1996
Modified BFM protocol for childhood acute lymphoblastic leukemia: a retrospective analysis.
    Medical and pediatric oncology, 1997, Volume: 28, Issue:1

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; D

1997
Modified BFM protocol for childhood acute lymphoblastic leukemia: a retrospective analysis.
    Medical and pediatric oncology, 1997, Volume: 28, Issue:1

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; D

1997
Modified BFM protocol for childhood acute lymphoblastic leukemia: a retrospective analysis.
    Medical and pediatric oncology, 1997, Volume: 28, Issue:1

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; D

1997
Nutritional state alterations in children with acute lymphoblastic leukemia during induction and consolidation of chemotherapy.
    Archives of medical research, 1997,Summer, Volume: 28, Issue:2

    Topics: Adolescent; Anthropometry; Antineoplastic Combined Chemotherapy Protocols; Arm; Asparaginase; Body C

1997
Nutritional state alterations in children with acute lymphoblastic leukemia during induction and consolidation of chemotherapy.
    Archives of medical research, 1997,Summer, Volume: 28, Issue:2

    Topics: Adolescent; Anthropometry; Antineoplastic Combined Chemotherapy Protocols; Arm; Asparaginase; Body C

1997
Nutritional state alterations in children with acute lymphoblastic leukemia during induction and consolidation of chemotherapy.
    Archives of medical research, 1997,Summer, Volume: 28, Issue:2

    Topics: Adolescent; Anthropometry; Antineoplastic Combined Chemotherapy Protocols; Arm; Asparaginase; Body C

1997
Deoxycytidine kinase mRNA expression in childhood acute lymphoblastic leukemia.
    Anti-cancer drugs, 1997, Volume: 8, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cells, Cultured; Child; Daunorubicin;

1997
Deoxycytidine kinase mRNA expression in childhood acute lymphoblastic leukemia.
    Anti-cancer drugs, 1997, Volume: 8, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cells, Cultured; Child; Daunorubicin;

1997
Deoxycytidine kinase mRNA expression in childhood acute lymphoblastic leukemia.
    Anti-cancer drugs, 1997, Volume: 8, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cells, Cultured; Child; Daunorubicin;

1997
Role of cranial radiotherapy for childhood T-cell acute lymphoblastic leukemia with high WBC count and good response to prednisone. Associazione Italiana Ematologia Oncologia Pediatrica and the Berlin-Frankfurt-Münster groups.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1997, Volume: 15, Issue:8

    Topics: Adolescent; Antimetabolites, Antineoplastic; Antineoplastic Agents, Hormonal; Antineoplastic Combine

1997
Role of cranial radiotherapy for childhood T-cell acute lymphoblastic leukemia with high WBC count and good response to prednisone. Associazione Italiana Ematologia Oncologia Pediatrica and the Berlin-Frankfurt-Münster groups.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1997, Volume: 15, Issue:8

    Topics: Adolescent; Antimetabolites, Antineoplastic; Antineoplastic Agents, Hormonal; Antineoplastic Combine

1997
Role of cranial radiotherapy for childhood T-cell acute lymphoblastic leukemia with high WBC count and good response to prednisone. Associazione Italiana Ematologia Oncologia Pediatrica and the Berlin-Frankfurt-Münster groups.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1997, Volume: 15, Issue:8

    Topics: Adolescent; Antimetabolites, Antineoplastic; Antineoplastic Agents, Hormonal; Antineoplastic Combine

1997
Neurophysiological findings in long-term survivors of acute lymphoblastic leukaemia in childhood treated with the BFM protocol 81 SR-A/B.
    European journal of pediatrics, 1997, Volume: 156, Issue:9

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cerebral Cortex; Child; Ch

1997
Neurophysiological findings in long-term survivors of acute lymphoblastic leukaemia in childhood treated with the BFM protocol 81 SR-A/B.
    European journal of pediatrics, 1997, Volume: 156, Issue:9

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cerebral Cortex; Child; Ch

1997
Neurophysiological findings in long-term survivors of acute lymphoblastic leukaemia in childhood treated with the BFM protocol 81 SR-A/B.
    European journal of pediatrics, 1997, Volume: 156, Issue:9

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cerebral Cortex; Child; Ch

1997
Arginine butyrate-induced susceptibility to ganciclovir in an Epstein-Barr-virus-associated lymphoma.
    Blood cells, molecules & diseases, 1998, Volume: 24, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Apoptosis; Arginine; Aspergillosis

1998
Arginine butyrate-induced susceptibility to ganciclovir in an Epstein-Barr-virus-associated lymphoma.
    Blood cells, molecules & diseases, 1998, Volume: 24, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Apoptosis; Arginine; Aspergillosis

1998
Arginine butyrate-induced susceptibility to ganciclovir in an Epstein-Barr-virus-associated lymphoma.
    Blood cells, molecules & diseases, 1998, Volume: 24, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Apoptosis; Arginine; Aspergillosis

1998
Acute lymphoblastic leukemia: dental health of children in maintenance therapy.
    The Journal of clinical pediatric dentistry, 1998,Spring, Volume: 22, Issue:3

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Case-Control Studies; Chil

1998
Acute lymphoblastic leukemia: dental health of children in maintenance therapy.
    The Journal of clinical pediatric dentistry, 1998,Spring, Volume: 22, Issue:3

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Case-Control Studies; Chil

1998
Acute lymphoblastic leukemia: dental health of children in maintenance therapy.
    The Journal of clinical pediatric dentistry, 1998,Spring, Volume: 22, Issue:3

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Case-Control Studies; Chil

1998
Immunophenotypic and clinical features of T-cell receptor gammadelta+ T-lineage acute lymphoblastic leukaemia.
    British journal of haematology, 1998, Volume: 101, Issue:4

    Topics: Acute Disease; Antigens, CD; Antineoplastic Agents, Hormonal; Disease-Free Survival; Humans; Immunop

1998
Immunophenotypic and clinical features of T-cell receptor gammadelta+ T-lineage acute lymphoblastic leukaemia.
    British journal of haematology, 1998, Volume: 101, Issue:4

    Topics: Acute Disease; Antigens, CD; Antineoplastic Agents, Hormonal; Disease-Free Survival; Humans; Immunop

1998
Immunophenotypic and clinical features of T-cell receptor gammadelta+ T-lineage acute lymphoblastic leukaemia.
    British journal of haematology, 1998, Volume: 101, Issue:4

    Topics: Acute Disease; Antigens, CD; Antineoplastic Agents, Hormonal; Disease-Free Survival; Humans; Immunop

1998
[Peripheral blood stem cell transplantation in adult acute lymphoblastic leukemia as postremission therapy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1998, Volume: 25, Issue:10

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclop

1998
[Peripheral blood stem cell transplantation in adult acute lymphoblastic leukemia as postremission therapy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1998, Volume: 25, Issue:10

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclop

1998
[Peripheral blood stem cell transplantation in adult acute lymphoblastic leukemia as postremission therapy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1998, Volume: 25, Issue:10

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclop

1998
Relation between age, immunophenotype and in vitro drug resistance in 395 children with acute lymphoblastic leukemia--implications for treatment of infants.
    Leukemia, 1998, Volume: 12, Issue:9

    Topics: Adolescent; Adult; Age Distribution; Age Factors; Antineoplastic Agents; Child; Child, Preschool; Cy

1998
Relation between age, immunophenotype and in vitro drug resistance in 395 children with acute lymphoblastic leukemia--implications for treatment of infants.
    Leukemia, 1998, Volume: 12, Issue:9

    Topics: Adolescent; Adult; Age Distribution; Age Factors; Antineoplastic Agents; Child; Child, Preschool; Cy

1998
Relation between age, immunophenotype and in vitro drug resistance in 395 children with acute lymphoblastic leukemia--implications for treatment of infants.
    Leukemia, 1998, Volume: 12, Issue:9

    Topics: Adolescent; Adult; Age Distribution; Age Factors; Antineoplastic Agents; Child; Child, Preschool; Cy

1998
Pharmacokinetics and pharmacodynamics of oral methotrexate and mercaptopurine in children with lower risk acute lymphoblastic leukemia: a joint children's cancer group and pediatric oncology branch study.
    Blood, 1998, Nov-15, Volume: 92, Issue:10

    Topics: Administration, Oral; Adolescent; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemother

1998
Pharmacokinetics and pharmacodynamics of oral methotrexate and mercaptopurine in children with lower risk acute lymphoblastic leukemia: a joint children's cancer group and pediatric oncology branch study.
    Blood, 1998, Nov-15, Volume: 92, Issue:10

    Topics: Administration, Oral; Adolescent; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemother

1998
Pharmacokinetics and pharmacodynamics of oral methotrexate and mercaptopurine in children with lower risk acute lymphoblastic leukemia: a joint children's cancer group and pediatric oncology branch study.
    Blood, 1998, Nov-15, Volume: 92, Issue:10

    Topics: Administration, Oral; Adolescent; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemother

1998
Childhood acute lymphoblastic leukaemia: outcomes of 54 consecutive patients treated in Auckland 1985-1991.
    The New Zealand medical journal, 1998, Nov-27, Volume: 111, Issue:1078

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; C

1998
Childhood acute lymphoblastic leukaemia: outcomes of 54 consecutive patients treated in Auckland 1985-1991.
    The New Zealand medical journal, 1998, Nov-27, Volume: 111, Issue:1078

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; C

1998
Childhood acute lymphoblastic leukaemia: outcomes of 54 consecutive patients treated in Auckland 1985-1991.
    The New Zealand medical journal, 1998, Nov-27, Volume: 111, Issue:1078

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; C

1998
Changes in adhesion molecule expression on lymphoblasts during acute lymphoblastic leukemia treatment.
    The Journal of pediatrics, 1999, Volume: 134, Issue:4

    Topics: Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Cell Adhesion Molec

1999
Changes in adhesion molecule expression on lymphoblasts during acute lymphoblastic leukemia treatment.
    The Journal of pediatrics, 1999, Volume: 134, Issue:4

    Topics: Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Cell Adhesion Molec

1999
Changes in adhesion molecule expression on lymphoblasts during acute lymphoblastic leukemia treatment.
    The Journal of pediatrics, 1999, Volume: 134, Issue:4

    Topics: Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Cell Adhesion Molec

1999
Neurodevelopmental outcome of infants with acute lymphoblastic leukemia: a Children's Cancer Group report.
    Cancer, 1999, Apr-15, Volume: 85, Issue:8

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Brain Damage, Chronic; Cognition Disor

1999
Neurodevelopmental outcome of infants with acute lymphoblastic leukemia: a Children's Cancer Group report.
    Cancer, 1999, Apr-15, Volume: 85, Issue:8

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Brain Damage, Chronic; Cognition Disor

1999
Neurodevelopmental outcome of infants with acute lymphoblastic leukemia: a Children's Cancer Group report.
    Cancer, 1999, Apr-15, Volume: 85, Issue:8

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Brain Damage, Chronic; Cognition Disor

1999
Wilms' tumour gene (wt1) expression at diagnosis has no prognostic relevance in childhood acute lymphoblastic leukaemia treated by an intensive chemotherapy protocol.
    European journal of haematology, 1999, Volume: 63, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow; Cyclophosphamide; Cytarab

1999
Wilms' tumour gene (wt1) expression at diagnosis has no prognostic relevance in childhood acute lymphoblastic leukaemia treated by an intensive chemotherapy protocol.
    European journal of haematology, 1999, Volume: 63, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow; Cyclophosphamide; Cytarab

1999
Wilms' tumour gene (wt1) expression at diagnosis has no prognostic relevance in childhood acute lymphoblastic leukaemia treated by an intensive chemotherapy protocol.
    European journal of haematology, 1999, Volume: 63, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow; Cyclophosphamide; Cytarab

1999
Degree of fatness after treatment for acute lymphoblastic leukemia in childhood.
    The Journal of clinical endocrinology and metabolism, 1999, Volume: 84, Issue:12

    Topics: Absorptiometry, Photon; Adipose Tissue; Adolescent; Adrenal Cortex Hormones; Antineoplastic Agents;

1999
Degree of fatness after treatment for acute lymphoblastic leukemia in childhood.
    The Journal of clinical endocrinology and metabolism, 1999, Volume: 84, Issue:12

    Topics: Absorptiometry, Photon; Adipose Tissue; Adolescent; Adrenal Cortex Hormones; Antineoplastic Agents;

1999
Degree of fatness after treatment for acute lymphoblastic leukemia in childhood.
    The Journal of clinical endocrinology and metabolism, 1999, Volume: 84, Issue:12

    Topics: Absorptiometry, Photon; Adipose Tissue; Adolescent; Adrenal Cortex Hormones; Antineoplastic Agents;

1999
Non-Hodgkin's lymphoma protocols in the treatment of patients with Burkitt's lymphoma and lymphoblastic lymphoma: a report on 58 patients.
    Leukemia & lymphoma, 1999, Volume: 36, Issue:1-2

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophos

1999
Non-Hodgkin's lymphoma protocols in the treatment of patients with Burkitt's lymphoma and lymphoblastic lymphoma: a report on 58 patients.
    Leukemia & lymphoma, 1999, Volume: 36, Issue:1-2

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophos

1999
Non-Hodgkin's lymphoma protocols in the treatment of patients with Burkitt's lymphoma and lymphoblastic lymphoma: a report on 58 patients.
    Leukemia & lymphoma, 1999, Volume: 36, Issue:1-2

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophos

1999
[Acute leukemia in Jehovah's Witnesses].
    Sangre, 1999, Volume: 44, Issue:5

    Topics: Adult; Anemia; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Blood Transfusion; Chri

1999
[Acute leukemia in Jehovah's Witnesses].
    Sangre, 1999, Volume: 44, Issue:5

    Topics: Adult; Anemia; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Blood Transfusion; Chri

1999
[Acute leukemia in Jehovah's Witnesses].
    Sangre, 1999, Volume: 44, Issue:5

    Topics: Adult; Anemia; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Blood Transfusion; Chri

1999
Rapid molecular response during early induction chemotherapy predicts a good outcome in childhood acute lymphoblastic leukemia.
    Blood, 2000, Feb-01, Volume: 95, Issue:3

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow; Child; Child,

2000
Rapid molecular response during early induction chemotherapy predicts a good outcome in childhood acute lymphoblastic leukemia.
    Blood, 2000, Feb-01, Volume: 95, Issue:3

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow; Child; Child,

2000
Rapid molecular response during early induction chemotherapy predicts a good outcome in childhood acute lymphoblastic leukemia.
    Blood, 2000, Feb-01, Volume: 95, Issue:3

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow; Child; Child,

2000
[The efficacy of BFM-90 program in the treatment of acute lymphoblastic leukemia in children in the studies of Polish pediatric leukemia/lymphoma group].
    Wiadomosci lekarskie (Warsaw, Poland : 1960), 1998, Volume: 51 Suppl 4

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transplantatio

1998
[The efficacy of BFM-90 program in the treatment of acute lymphoblastic leukemia in children in the studies of Polish pediatric leukemia/lymphoma group].
    Wiadomosci lekarskie (Warsaw, Poland : 1960), 1998, Volume: 51 Suppl 4

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transplantatio

1998
[The efficacy of BFM-90 program in the treatment of acute lymphoblastic leukemia in children in the studies of Polish pediatric leukemia/lymphoma group].
    Wiadomosci lekarskie (Warsaw, Poland : 1960), 1998, Volume: 51 Suppl 4

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transplantatio

1998
[The analysis of failures in the treatment of children with non-B non-Hodgkin's lymphoma. Polish pediatric leukemia/lymphoma study group report].
    Wiadomosci lekarskie (Warsaw, Poland : 1960), 1998, Volume: 51 Suppl 4

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; C

1998
[The analysis of failures in the treatment of children with non-B non-Hodgkin's lymphoma. Polish pediatric leukemia/lymphoma study group report].
    Wiadomosci lekarskie (Warsaw, Poland : 1960), 1998, Volume: 51 Suppl 4

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; C

1998
[The analysis of failures in the treatment of children with non-B non-Hodgkin's lymphoma. Polish pediatric leukemia/lymphoma study group report].
    Wiadomosci lekarskie (Warsaw, Poland : 1960), 1998, Volume: 51 Suppl 4

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; C

1998
Substituting dexamethasone for prednisone complicates remission induction in children with acute lymphoblastic leukemia.
    Cancer, 2000, Apr-15, Volume: 88, Issue:8

    Topics: Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Presc

2000
Substituting dexamethasone for prednisone complicates remission induction in children with acute lymphoblastic leukemia.
    Cancer, 2000, Apr-15, Volume: 88, Issue:8

    Topics: Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Presc

2000
Substituting dexamethasone for prednisone complicates remission induction in children with acute lymphoblastic leukemia.
    Cancer, 2000, Apr-15, Volume: 88, Issue:8

    Topics: Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Presc

2000
Circulating CD4+ T lymphocytes with intracellular but no surface CD3 antigen in five of seven patients consecutively diagnosed with angioimmunoblastic T-cell lymphoma.
    Cytometry, 2000, Jun-15, Volume: 42, Issue:3

    Topics: Adult; Aged; Antigens, CD7; Antigens, Surface; Antineoplastic Combined Chemotherapy Protocols; Bone

2000
Circulating CD4+ T lymphocytes with intracellular but no surface CD3 antigen in five of seven patients consecutively diagnosed with angioimmunoblastic T-cell lymphoma.
    Cytometry, 2000, Jun-15, Volume: 42, Issue:3

    Topics: Adult; Aged; Antigens, CD7; Antigens, Surface; Antineoplastic Combined Chemotherapy Protocols; Bone

2000
Circulating CD4+ T lymphocytes with intracellular but no surface CD3 antigen in five of seven patients consecutively diagnosed with angioimmunoblastic T-cell lymphoma.
    Cytometry, 2000, Jun-15, Volume: 42, Issue:3

    Topics: Adult; Aged; Antigens, CD7; Antigens, Surface; Antineoplastic Combined Chemotherapy Protocols; Bone

2000
Precursor B-cell lymphoblastic lymphoma in childhood and adolescence: clinical features, treatment, and results in trials NHL-BFM 86 and 90.
    Medical and pediatric oncology, 2000, Volume: 35, Issue:1

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Austria; B-Lymphocytes; Ch

2000
Precursor B-cell lymphoblastic lymphoma in childhood and adolescence: clinical features, treatment, and results in trials NHL-BFM 86 and 90.
    Medical and pediatric oncology, 2000, Volume: 35, Issue:1

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Austria; B-Lymphocytes; Ch

2000
Precursor B-cell lymphoblastic lymphoma in childhood and adolescence: clinical features, treatment, and results in trials NHL-BFM 86 and 90.
    Medical and pediatric oncology, 2000, Volume: 35, Issue:1

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Austria; B-Lymphocytes; Ch

2000
Prothrombotic risk factors in children with acute lymphoblastic leukemia treated with delayed E. coli asparaginase (COALL-92 and 97 protocols).
    Thrombosis and haemostasis, 2000, Volume: 83, Issue:6

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; C

2000
Prothrombotic risk factors in children with acute lymphoblastic leukemia treated with delayed E. coli asparaginase (COALL-92 and 97 protocols).
    Thrombosis and haemostasis, 2000, Volume: 83, Issue:6

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; C

2000
Prothrombotic risk factors in children with acute lymphoblastic leukemia treated with delayed E. coli asparaginase (COALL-92 and 97 protocols).
    Thrombosis and haemostasis, 2000, Volume: 83, Issue:6

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; C

2000
[A study on apoptotic cell death during chemotherapy of patients with acute leukemia].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 1998, Volume: 20, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Daunorubicin; Humans; Leukemia, Myeloid,

1998
[A study on apoptotic cell death during chemotherapy of patients with acute leukemia].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 1998, Volume: 20, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Daunorubicin; Humans; Leukemia, Myeloid,

1998
[A study on apoptotic cell death during chemotherapy of patients with acute leukemia].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 1998, Volume: 20, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Daunorubicin; Humans; Leukemia, Myeloid,

1998
Molecular and clinical prognostic factors in BFM-treated childhood acute lymphoblastic leukemia patients: a single institution series.
    Haematologica, 2000, Volume: 85, Issue:8

    Topics: Adolescent; Aneuploidy; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Biomarkers, Tu

2000
Molecular and clinical prognostic factors in BFM-treated childhood acute lymphoblastic leukemia patients: a single institution series.
    Haematologica, 2000, Volume: 85, Issue:8

    Topics: Adolescent; Aneuploidy; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Biomarkers, Tu

2000
Molecular and clinical prognostic factors in BFM-treated childhood acute lymphoblastic leukemia patients: a single institution series.
    Haematologica, 2000, Volume: 85, Issue:8

    Topics: Adolescent; Aneuploidy; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Biomarkers, Tu

2000
Acute lymphoblastic leukemia presenting as acute hepatic failure in childhood.
    Leukemia & lymphoma, 2000, Volume: 38, Issue:5-6

    Topics: Anti-Inflammatory Agents; Antineoplastic Agents, Phytogenic; Child; Diagnosis, Differential; Etoposi

2000
Acute lymphoblastic leukemia presenting as acute hepatic failure in childhood.
    Leukemia & lymphoma, 2000, Volume: 38, Issue:5-6

    Topics: Anti-Inflammatory Agents; Antineoplastic Agents, Phytogenic; Child; Diagnosis, Differential; Etoposi

2000
Acute lymphoblastic leukemia presenting as acute hepatic failure in childhood.
    Leukemia & lymphoma, 2000, Volume: 38, Issue:5-6

    Topics: Anti-Inflammatory Agents; Antineoplastic Agents, Phytogenic; Child; Diagnosis, Differential; Etoposi

2000
Clinical importance of minimal residual disease in childhood acute lymphoblastic leukemia.
    Blood, 2000, Oct-15, Volume: 96, Issue:8

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; C

2000
Clinical importance of minimal residual disease in childhood acute lymphoblastic leukemia.
    Blood, 2000, Oct-15, Volume: 96, Issue:8

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; C

2000
Clinical importance of minimal residual disease in childhood acute lymphoblastic leukemia.
    Blood, 2000, Oct-15, Volume: 96, Issue:8

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; C

2000
Acute lymphoblastic leukemia in infants: a decade of experience in the Czech Republic.
    Medical and pediatric oncology, 2000, Volume: 35, Issue:5

    Topics: Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Chromosomes, Hum

2000
Acute lymphoblastic leukemia in infants: a decade of experience in the Czech Republic.
    Medical and pediatric oncology, 2000, Volume: 35, Issue:5

    Topics: Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Chromosomes, Hum

2000
Acute lymphoblastic leukemia in infants: a decade of experience in the Czech Republic.
    Medical and pediatric oncology, 2000, Volume: 35, Issue:5

    Topics: Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Chromosomes, Hum

2000
[Changes in gonadal function in post-pubertal male survivors of acute lymphoblastic leukemia and Hodgkin's disease].
    Anales espanoles de pediatria, 2000, Volume: 53, Issue:4

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Case-Control Studies; Child; Cycl

2000
[Changes in gonadal function in post-pubertal male survivors of acute lymphoblastic leukemia and Hodgkin's disease].
    Anales espanoles de pediatria, 2000, Volume: 53, Issue:4

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Case-Control Studies; Child; Cycl

2000
[Changes in gonadal function in post-pubertal male survivors of acute lymphoblastic leukemia and Hodgkin's disease].
    Anales espanoles de pediatria, 2000, Volume: 53, Issue:4

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Case-Control Studies; Child; Cycl

2000
Dose-response analysis for radiotherapy delivered to patients with intermediate-grade and large-cell immunoblastic lymphomas that have completely responded to CHOP-based induction chemotherapy.
    International journal of radiation oncology, biology, physics, 2001, Jan-01, Volume: 49, Issue:1

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Combined

2001
Dose-response analysis for radiotherapy delivered to patients with intermediate-grade and large-cell immunoblastic lymphomas that have completely responded to CHOP-based induction chemotherapy.
    International journal of radiation oncology, biology, physics, 2001, Jan-01, Volume: 49, Issue:1

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Combined

2001
Dose-response analysis for radiotherapy delivered to patients with intermediate-grade and large-cell immunoblastic lymphomas that have completely responded to CHOP-based induction chemotherapy.
    International journal of radiation oncology, biology, physics, 2001, Jan-01, Volume: 49, Issue:1

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Combined

2001
Polymorphisms within glutathione S-transferase genes and initial response to glucocorticoids in childhood acute lymphoblastic leukaemia.
    Pharmacogenetics, 2000, Volume: 10, Issue:8

    Topics: Adolescent; Adult; Case-Control Studies; Child; Child, Preschool; Female; Glucocorticoids; Glutathio

2000
Polymorphisms within glutathione S-transferase genes and initial response to glucocorticoids in childhood acute lymphoblastic leukaemia.
    Pharmacogenetics, 2000, Volume: 10, Issue:8

    Topics: Adolescent; Adult; Case-Control Studies; Child; Child, Preschool; Female; Glucocorticoids; Glutathio

2000
Polymorphisms within glutathione S-transferase genes and initial response to glucocorticoids in childhood acute lymphoblastic leukaemia.
    Pharmacogenetics, 2000, Volume: 10, Issue:8

    Topics: Adolescent; Adult; Case-Control Studies; Child; Child, Preschool; Female; Glucocorticoids; Glutathio

2000
[Life threatening hypercalcemia in a young man with ALL].
    Deutsche medizinische Wochenschrift (1946), 2001, Jan-05, Volume: 126, Issue:1-2

    Topics: Adolescent; Biopsy, Needle; Bone Marrow; Calcitonin; Combined Modality Therapy; Diagnosis, Different

2001
[Life threatening hypercalcemia in a young man with ALL].
    Deutsche medizinische Wochenschrift (1946), 2001, Jan-05, Volume: 126, Issue:1-2

    Topics: Adolescent; Biopsy, Needle; Bone Marrow; Calcitonin; Combined Modality Therapy; Diagnosis, Different

2001
[Life threatening hypercalcemia in a young man with ALL].
    Deutsche medizinische Wochenschrift (1946), 2001, Jan-05, Volume: 126, Issue:1-2

    Topics: Adolescent; Biopsy, Needle; Bone Marrow; Calcitonin; Combined Modality Therapy; Diagnosis, Different

2001
Outcome of relapsed or refractory childhood B-cell acute lymphoblastic leukaemia and B-cell non-Hodgkin's lymphoma treated with the UKCCSG 9003/9002 protocols.
    British journal of haematology, 2001, Volume: 112, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Burkitt Lymphoma; Child

2001
Outcome of relapsed or refractory childhood B-cell acute lymphoblastic leukaemia and B-cell non-Hodgkin's lymphoma treated with the UKCCSG 9003/9002 protocols.
    British journal of haematology, 2001, Volume: 112, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Burkitt Lymphoma; Child

2001
Outcome of relapsed or refractory childhood B-cell acute lymphoblastic leukaemia and B-cell non-Hodgkin's lymphoma treated with the UKCCSG 9003/9002 protocols.
    British journal of haematology, 2001, Volume: 112, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Burkitt Lymphoma; Child

2001
Killer T-cell induction in patients with blastic natural killer cell lymphoma/leukaemia: implications for successful treatment and possible therapeutic strategies.
    British journal of haematology, 2001, Volume: 113, Issue:1

    Topics: Aged; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antineoplastic Combined Chemotherapy

2001
Killer T-cell induction in patients with blastic natural killer cell lymphoma/leukaemia: implications for successful treatment and possible therapeutic strategies.
    British journal of haematology, 2001, Volume: 113, Issue:1

    Topics: Aged; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antineoplastic Combined Chemotherapy

2001
Killer T-cell induction in patients with blastic natural killer cell lymphoma/leukaemia: implications for successful treatment and possible therapeutic strategies.
    British journal of haematology, 2001, Volume: 113, Issue:1

    Topics: Aged; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antineoplastic Combined Chemotherapy

2001
Bony morbidity in children treated for acute lymphoblastic leukemia.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001, Jun-15, Volume: 19, Issue:12

    Topics: Adolescent; Analysis of Variance; Antineoplastic Agents, Hormonal; Boston; Child; Child, Preschool;

2001
Bony morbidity in children treated for acute lymphoblastic leukemia.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001, Jun-15, Volume: 19, Issue:12

    Topics: Adolescent; Analysis of Variance; Antineoplastic Agents, Hormonal; Boston; Child; Child, Preschool;

2001
Bony morbidity in children treated for acute lymphoblastic leukemia.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001, Jun-15, Volume: 19, Issue:12

    Topics: Adolescent; Analysis of Variance; Antineoplastic Agents, Hormonal; Boston; Child; Child, Preschool;

2001
Magnetic resonance imaging detection of avascular necrosis of the bone in children receiving intensive prednisone therapy for acute lymphoblastic leukemia or non-Hodgkin lymphoma.
    Leukemia, 2001, Volume: 15, Issue:6

    Topics: Adolescent; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Arthralgia; Arthroplasty, R

2001
Magnetic resonance imaging detection of avascular necrosis of the bone in children receiving intensive prednisone therapy for acute lymphoblastic leukemia or non-Hodgkin lymphoma.
    Leukemia, 2001, Volume: 15, Issue:6

    Topics: Adolescent; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Arthralgia; Arthroplasty, R

2001
Magnetic resonance imaging detection of avascular necrosis of the bone in children receiving intensive prednisone therapy for acute lymphoblastic leukemia or non-Hodgkin lymphoma.
    Leukemia, 2001, Volume: 15, Issue:6

    Topics: Adolescent; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Arthralgia; Arthroplasty, R

2001
Intact T-cell regenerative capacity in childhood acute lymphoblastic leukemia after remission induction therapy.
    Medical and pediatric oncology, 2001, Volume: 36, Issue:2

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; D

2001
Intact T-cell regenerative capacity in childhood acute lymphoblastic leukemia after remission induction therapy.
    Medical and pediatric oncology, 2001, Volume: 36, Issue:2

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; D

2001
Intact T-cell regenerative capacity in childhood acute lymphoblastic leukemia after remission induction therapy.
    Medical and pediatric oncology, 2001, Volume: 36, Issue:2

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; D

2001
Thrombotic events revisited in children with acute lymphoblastic leukemia: impact of concomitant Escherichia coli asparaginase/prednisone administration.
    Thrombosis research, 2001, Aug-01, Volume: 103, Issue:3

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; D

2001
Thrombotic events revisited in children with acute lymphoblastic leukemia: impact of concomitant Escherichia coli asparaginase/prednisone administration.
    Thrombosis research, 2001, Aug-01, Volume: 103, Issue:3

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; D

2001
Thrombotic events revisited in children with acute lymphoblastic leukemia: impact of concomitant Escherichia coli asparaginase/prednisone administration.
    Thrombosis research, 2001, Aug-01, Volume: 103, Issue:3

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; D

2001
[Acute lymphoblastic leukemia complicated with tumor lysis syndrome--four cases report].
    Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 1999, Volume: 20, Issue:6

    Topics: Adult; Allopurinol; Antimetabolites; Antineoplastic Combined Chemotherapy Protocols; Daunorubicin; F

1999
[Acute lymphoblastic leukemia complicated with tumor lysis syndrome--four cases report].
    Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 1999, Volume: 20, Issue:6

    Topics: Adult; Allopurinol; Antimetabolites; Antineoplastic Combined Chemotherapy Protocols; Daunorubicin; F

1999
[Acute lymphoblastic leukemia complicated with tumor lysis syndrome--four cases report].
    Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 1999, Volume: 20, Issue:6

    Topics: Adult; Allopurinol; Antimetabolites; Antineoplastic Combined Chemotherapy Protocols; Daunorubicin; F

1999
Adult lymphoblastic lymphoma in Taiwan: an analysis of treatment results of 26 patients.
    Annals of hematology, 2001, Volume: 80, Issue:11

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow T

2001
Adult lymphoblastic lymphoma in Taiwan: an analysis of treatment results of 26 patients.
    Annals of hematology, 2001, Volume: 80, Issue:11

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow T

2001
Adult lymphoblastic lymphoma in Taiwan: an analysis of treatment results of 26 patients.
    Annals of hematology, 2001, Volume: 80, Issue:11

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow T

2001
Late effects of anticancer therapy on kidney function in children with acute lymphoblastic leukemia.
    Bratislavske lekarske listy, 2001, Volume: 102, Issue:8

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; C

2001
Late effects of anticancer therapy on kidney function in children with acute lymphoblastic leukemia.
    Bratislavske lekarske listy, 2001, Volume: 102, Issue:8

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; C

2001
Late effects of anticancer therapy on kidney function in children with acute lymphoblastic leukemia.
    Bratislavske lekarske listy, 2001, Volume: 102, Issue:8

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; C

2001
[Effective treatment with Lamivudine of patients with reactivation of hepatitis B following chemotherapy administration].
    Harefuah, 2001, Volume: 140, Issue:12

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Doxo

2001
[Effective treatment with Lamivudine of patients with reactivation of hepatitis B following chemotherapy administration].
    Harefuah, 2001, Volume: 140, Issue:12

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Doxo

2001
[Effective treatment with Lamivudine of patients with reactivation of hepatitis B following chemotherapy administration].
    Harefuah, 2001, Volume: 140, Issue:12

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Doxo

2001
Diversity of the apoptotic response to chemotherapy in childhood leukemia.
    Leukemia, 2002, Volume: 16, Issue:2

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; bcl-2-Associated X Protein; b

2002
Diversity of the apoptotic response to chemotherapy in childhood leukemia.
    Leukemia, 2002, Volume: 16, Issue:2

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; bcl-2-Associated X Protein; b

2002
Diversity of the apoptotic response to chemotherapy in childhood leukemia.
    Leukemia, 2002, Volume: 16, Issue:2

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; bcl-2-Associated X Protein; b

2002
Childhood acute lymphoblastic leukemia: prognostic value of initial peripheral blast count in good responders to prednisone.
    Journal of pediatric hematology/oncology, 2001, Volume: 23, Issue:7

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Blast Crisis; Child; Child, Preschool; D

2001
Childhood acute lymphoblastic leukemia: prognostic value of initial peripheral blast count in good responders to prednisone.
    Journal of pediatric hematology/oncology, 2001, Volume: 23, Issue:7

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Blast Crisis; Child; Child, Preschool; D

2001
Childhood acute lymphoblastic leukemia: prognostic value of initial peripheral blast count in good responders to prednisone.
    Journal of pediatric hematology/oncology, 2001, Volume: 23, Issue:7

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Blast Crisis; Child; Child, Preschool; D

2001
Epstein-Barr virus-negative precursor B cell lymphoblastic lymphoma after liver transplantation: a unique form of posttransplant lymphoproliferative disease.
    Transplantation, 2002, Feb-27, Volume: 73, Issue:4

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease Progression; D

2002
Epstein-Barr virus-negative precursor B cell lymphoblastic lymphoma after liver transplantation: a unique form of posttransplant lymphoproliferative disease.
    Transplantation, 2002, Feb-27, Volume: 73, Issue:4

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease Progression; D

2002
Epstein-Barr virus-negative precursor B cell lymphoblastic lymphoma after liver transplantation: a unique form of posttransplant lymphoproliferative disease.
    Transplantation, 2002, Feb-27, Volume: 73, Issue:4

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease Progression; D

2002
No major cognitive impairment in young children with acute lymphoblastic leukemia using chemotherapy only: a prospective longitudinal study.
    Journal of pediatric hematology/oncology, 2002, Volume: 24, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Attention; Child, Preschool; Cognition

2002
No major cognitive impairment in young children with acute lymphoblastic leukemia using chemotherapy only: a prospective longitudinal study.
    Journal of pediatric hematology/oncology, 2002, Volume: 24, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Attention; Child, Preschool; Cognition

2002
No major cognitive impairment in young children with acute lymphoblastic leukemia using chemotherapy only: a prospective longitudinal study.
    Journal of pediatric hematology/oncology, 2002, Volume: 24, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Attention; Child, Preschool; Cognition

2002
Pediatric acute lymphoblastic leukemia: redefining outcomes.
    Journal of pediatric hematology/oncology, 2002, Volume: 24, Issue:2

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Attention; Child; Child, Preschool; Cogn

2002
Pediatric acute lymphoblastic leukemia: redefining outcomes.
    Journal of pediatric hematology/oncology, 2002, Volume: 24, Issue:2

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Attention; Child; Child, Preschool; Cogn

2002
Pediatric acute lymphoblastic leukemia: redefining outcomes.
    Journal of pediatric hematology/oncology, 2002, Volume: 24, Issue:2

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Attention; Child; Child, Preschool; Cogn

2002
CD56 expression predicts occurrence of CNS disease in acute lymphoblastic leukemia.
    Leukemia research, 2002, Volume: 26, Issue:7

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarke

2002
CD56 expression predicts occurrence of CNS disease in acute lymphoblastic leukemia.
    Leukemia research, 2002, Volume: 26, Issue:7

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarke

2002
CD56 expression predicts occurrence of CNS disease in acute lymphoblastic leukemia.
    Leukemia research, 2002, Volume: 26, Issue:7

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarke

2002
Intensified and shortened cyclical chemotherapy for adult acute lymphoblastic leukemia.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2002, May-15, Volume: 20, Issue:10

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cytarabine; Daunoru

2002
Intensified and shortened cyclical chemotherapy for adult acute lymphoblastic leukemia.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2002, May-15, Volume: 20, Issue:10

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cytarabine; Daunoru

2002
Intensified and shortened cyclical chemotherapy for adult acute lymphoblastic leukemia.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2002, May-15, Volume: 20, Issue:10

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cytarabine; Daunoru

2002
[High risk acute lymphoblastic leukaemia in children. Preliminary report after introducing a new version of New York (1997) protocol adjusted to the age of the patients. Report of the Polish Paediatric Leukaemia/Lymphoma Study Group].
    Medycyna wieku rozwojowego, 2000, Volume: 4, Issue:1 Suppl 2

    Topics: Adolescent; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child,

2000
[High risk acute lymphoblastic leukaemia in children. Preliminary report after introducing a new version of New York (1997) protocol adjusted to the age of the patients. Report of the Polish Paediatric Leukaemia/Lymphoma Study Group].
    Medycyna wieku rozwojowego, 2000, Volume: 4, Issue:1 Suppl 2

    Topics: Adolescent; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child,

2000
[High risk acute lymphoblastic leukaemia in children. Preliminary report after introducing a new version of New York (1997) protocol adjusted to the age of the patients. Report of the Polish Paediatric Leukaemia/Lymphoma Study Group].
    Medycyna wieku rozwojowego, 2000, Volume: 4, Issue:1 Suppl 2

    Topics: Adolescent; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child,

2000
[Preliminary results of BFM 96 protocol in treatment of childhood ALL relapse in the experience of the Polish Paediatric Leukaemia /Lymphoma Study Group].
    Medycyna wieku rozwojowego, 2000, Volume: 4, Issue:1 Suppl 2

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transplantatio

2000
[Preliminary results of BFM 96 protocol in treatment of childhood ALL relapse in the experience of the Polish Paediatric Leukaemia /Lymphoma Study Group].
    Medycyna wieku rozwojowego, 2000, Volume: 4, Issue:1 Suppl 2

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transplantatio

2000
[Preliminary results of BFM 96 protocol in treatment of childhood ALL relapse in the experience of the Polish Paediatric Leukaemia /Lymphoma Study Group].
    Medycyna wieku rozwojowego, 2000, Volume: 4, Issue:1 Suppl 2

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transplantatio

2000
Urate-oxidase in the prevention and treatment of metabolic complications in patients with B-cell lymphoma and leukemia, treated in the Société Française d'Oncologie Pédiatrique LMB89 protocol.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2002, Volume: 13, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide

2002
Urate-oxidase in the prevention and treatment of metabolic complications in patients with B-cell lymphoma and leukemia, treated in the Société Française d'Oncologie Pédiatrique LMB89 protocol.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2002, Volume: 13, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide

2002
Urate-oxidase in the prevention and treatment of metabolic complications in patients with B-cell lymphoma and leukemia, treated in the Société Française d'Oncologie Pédiatrique LMB89 protocol.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2002, Volume: 13, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide

2002
Fifteen-year secondary leukaemia risk observed in 761 patients with Hodgkin's disease prospectively treated by MOPP or ABVD chemotherapy plus high-dose irradiation.
    British journal of haematology, 2002, Volume: 118, Issue:1

    Topics: Actuarial Analysis; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbaz

2002
Fifteen-year secondary leukaemia risk observed in 761 patients with Hodgkin's disease prospectively treated by MOPP or ABVD chemotherapy plus high-dose irradiation.
    British journal of haematology, 2002, Volume: 118, Issue:1

    Topics: Actuarial Analysis; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbaz

2002
Fifteen-year secondary leukaemia risk observed in 761 patients with Hodgkin's disease prospectively treated by MOPP or ABVD chemotherapy plus high-dose irradiation.
    British journal of haematology, 2002, Volume: 118, Issue:1

    Topics: Actuarial Analysis; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbaz

2002
Cytomegalovirus infection in children with blood diseases.
    Acta haematologica Polonica, 1992, Volume: 23, Issue:3

    Topics: Adolescent; Anemia, Aplastic; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; C

1992
Cytomegalovirus infection in children with blood diseases.
    Acta haematologica Polonica, 1992, Volume: 23, Issue:3

    Topics: Adolescent; Anemia, Aplastic; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; C

1992
Cytomegalovirus infection in children with blood diseases.
    Acta haematologica Polonica, 1992, Volume: 23, Issue:3

    Topics: Adolescent; Anemia, Aplastic; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; C

1992
Analyses of salivary components in leukemia patients receiving chemotherapy.
    Oral surgery, oral medicine, and oral pathology, 1992, Volume: 73, Issue:1

    Topics: Adolescent; Adult; Aged; Amylases; Analysis of Variance; Antibiotics, Antineoplastic; Antineoplastic

1992
Analyses of salivary components in leukemia patients receiving chemotherapy.
    Oral surgery, oral medicine, and oral pathology, 1992, Volume: 73, Issue:1

    Topics: Adolescent; Adult; Aged; Amylases; Analysis of Variance; Antibiotics, Antineoplastic; Antineoplastic

1992
Analyses of salivary components in leukemia patients receiving chemotherapy.
    Oral surgery, oral medicine, and oral pathology, 1992, Volume: 73, Issue:1

    Topics: Adolescent; Adult; Aged; Amylases; Analysis of Variance; Antibiotics, Antineoplastic; Antineoplastic

1992
[Treatment of elderly patients with hematological malignancies].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1992, Volume: 19, Issue:11

    Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit

1992
[Treatment of elderly patients with hematological malignancies].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1992, Volume: 19, Issue:11

    Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit

1992
[Treatment of elderly patients with hematological malignancies].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1992, Volume: 19, Issue:11

    Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit

1992
[Treatment of various types of acute leukemia in adult. An analysis of 98 cases. The Leukemia Cooperation Group of Beijing City].
    Zhonghua nei ke za zhi, 1992, Volume: 31, Issue:3

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabin

1992
[Treatment of various types of acute leukemia in adult. An analysis of 98 cases. The Leukemia Cooperation Group of Beijing City].
    Zhonghua nei ke za zhi, 1992, Volume: 31, Issue:3

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabin

1992
[Treatment of various types of acute leukemia in adult. An analysis of 98 cases. The Leukemia Cooperation Group of Beijing City].
    Zhonghua nei ke za zhi, 1992, Volume: 31, Issue:3

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabin

1992
Incidence of thrombotic complications in adult patients with acute lymphoblastic leukaemia receiving L-asparaginase during induction therapy: a retrospective study. The GIMEMA Group.
    European journal of haematology, 1992, Volume: 49, Issue:2

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Antithrombins; Asparaginase

1992
Incidence of thrombotic complications in adult patients with acute lymphoblastic leukaemia receiving L-asparaginase during induction therapy: a retrospective study. The GIMEMA Group.
    European journal of haematology, 1992, Volume: 49, Issue:2

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Antithrombins; Asparaginase

1992
Incidence of thrombotic complications in adult patients with acute lymphoblastic leukaemia receiving L-asparaginase during induction therapy: a retrospective study. The GIMEMA Group.
    European journal of haematology, 1992, Volume: 49, Issue:2

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Antithrombins; Asparaginase

1992
Relation of 5'-nucleotidase and phosphatase activities with immunophenotype, drug resistance and clinical prognosis in childhood leukemia.
    Leukemia research, 1992, Volume: 16, Issue:9

    Topics: 5'-Nucleotidase; Acid Phosphatase; Adolescent; Alkaline Phosphatase; Antineoplastic Combined Chemoth

1992
Relation of 5'-nucleotidase and phosphatase activities with immunophenotype, drug resistance and clinical prognosis in childhood leukemia.
    Leukemia research, 1992, Volume: 16, Issue:9

    Topics: 5'-Nucleotidase; Acid Phosphatase; Adolescent; Alkaline Phosphatase; Antineoplastic Combined Chemoth

1992
Relation of 5'-nucleotidase and phosphatase activities with immunophenotype, drug resistance and clinical prognosis in childhood leukemia.
    Leukemia research, 1992, Volume: 16, Issue:9

    Topics: 5'-Nucleotidase; Acid Phosphatase; Adolescent; Alkaline Phosphatase; Antineoplastic Combined Chemoth

1992
[Disparity of the bone marrow involvement in a 5-year-old boy with primary non-Hodgkin's malignant lymphoma of the bone].
    Przeglad lekarski, 1992, Volume: 49, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow; Bone Neoplasms; Child, Pr

1992
[Disparity of the bone marrow involvement in a 5-year-old boy with primary non-Hodgkin's malignant lymphoma of the bone].
    Przeglad lekarski, 1992, Volume: 49, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow; Bone Neoplasms; Child, Pr

1992
[Disparity of the bone marrow involvement in a 5-year-old boy with primary non-Hodgkin's malignant lymphoma of the bone].
    Przeglad lekarski, 1992, Volume: 49, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow; Bone Neoplasms; Child, Pr

1992
Childhood acute lymphoblastic leukemia immunophenotypes and their prognostic significance: experience of the IGCI-study in 389 children. International Society for Chemo-immunotherapy (IGCI-Vienna) Cooperative Group.
    Leukemia & lymphoma, 1992, Volume: 7, Issue:3

    Topics: Adolescent; Age Factors; Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Asparaginase;

1992
Childhood acute lymphoblastic leukemia immunophenotypes and their prognostic significance: experience of the IGCI-study in 389 children. International Society for Chemo-immunotherapy (IGCI-Vienna) Cooperative Group.
    Leukemia & lymphoma, 1992, Volume: 7, Issue:3

    Topics: Adolescent; Age Factors; Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Asparaginase;

1992
Childhood acute lymphoblastic leukemia immunophenotypes and their prognostic significance: experience of the IGCI-study in 389 children. International Society for Chemo-immunotherapy (IGCI-Vienna) Cooperative Group.
    Leukemia & lymphoma, 1992, Volume: 7, Issue:3

    Topics: Adolescent; Age Factors; Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Asparaginase;

1992
Growth after radiotherapy and chemotherapy in children with leukemia or lymphoma.
    Hormone research, 1992, Volume: 37, Issue:3

    Topics: Analysis of Variance; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Asparag

1992
Growth after radiotherapy and chemotherapy in children with leukemia or lymphoma.
    Hormone research, 1992, Volume: 37, Issue:3

    Topics: Analysis of Variance; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Asparag

1992
Growth after radiotherapy and chemotherapy in children with leukemia or lymphoma.
    Hormone research, 1992, Volume: 37, Issue:3

    Topics: Analysis of Variance; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Asparag

1992
[Anemia and recurrences in acute lymphoblastic leukemia in children after the treatment and the frequency of the erythroblasts with micronuclei].
    Acta haematologica Polonica, 1992, Volume: 23, Issue:2

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; beta-Thalassemia; Bone Mar

1992
[Anemia and recurrences in acute lymphoblastic leukemia in children after the treatment and the frequency of the erythroblasts with micronuclei].
    Acta haematologica Polonica, 1992, Volume: 23, Issue:2

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; beta-Thalassemia; Bone Mar

1992
[Anemia and recurrences in acute lymphoblastic leukemia in children after the treatment and the frequency of the erythroblasts with micronuclei].
    Acta haematologica Polonica, 1992, Volume: 23, Issue:2

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; beta-Thalassemia; Bone Mar

1992
Corticosteroid induced tumor lysis syndrome in acute lymphoblastic leukemia.
    American journal of hematology, 1992, Volume: 41, Issue:1

    Topics: Adrenal Cortex Hormones; Adult; Female; Humans; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pred

1992
Corticosteroid induced tumor lysis syndrome in acute lymphoblastic leukemia.
    American journal of hematology, 1992, Volume: 41, Issue:1

    Topics: Adrenal Cortex Hormones; Adult; Female; Humans; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pred

1992
Corticosteroid induced tumor lysis syndrome in acute lymphoblastic leukemia.
    American journal of hematology, 1992, Volume: 41, Issue:1

    Topics: Adrenal Cortex Hormones; Adult; Female; Humans; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pred

1992
[High dose cinobufocini in attenuation and treatment of infection and granulocytopenia during combined chemotherapy of malignant blood diseases].
    Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine, 1992, Volume: 12, Issue:3

    Topics: Adolescent; Adult; Aged; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Bufanolide

1992
[High dose cinobufocini in attenuation and treatment of infection and granulocytopenia during combined chemotherapy of malignant blood diseases].
    Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine, 1992, Volume: 12, Issue:3

    Topics: Adolescent; Adult; Aged; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Bufanolide

1992
[High dose cinobufocini in attenuation and treatment of infection and granulocytopenia during combined chemotherapy of malignant blood diseases].
    Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine, 1992, Volume: 12, Issue:3

    Topics: Adolescent; Adult; Aged; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Bufanolide

1992
Cellular immunosuppression in children with acute lymphoblastic leukemia: effect of consolidation chemotherapy.
    Cancer immunology, immunotherapy : CII, 1992, Volume: 35, Issue:4

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide;

1992
Cellular immunosuppression in children with acute lymphoblastic leukemia: effect of consolidation chemotherapy.
    Cancer immunology, immunotherapy : CII, 1992, Volume: 35, Issue:4

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide;

1992
Cellular immunosuppression in children with acute lymphoblastic leukemia: effect of consolidation chemotherapy.
    Cancer immunology, immunotherapy : CII, 1992, Volume: 35, Issue:4

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide;

1992
[Tactics of adjuvant therapy in the treatment of acute lymphoblastic leukemia according to the BFM program].
    Pediatriia, 1992, Issue:2

    Topics: Adolescent; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Combined

1992
[Tactics of adjuvant therapy in the treatment of acute lymphoblastic leukemia according to the BFM program].
    Pediatriia, 1992, Issue:2

    Topics: Adolescent; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Combined

1992
[Tactics of adjuvant therapy in the treatment of acute lymphoblastic leukemia according to the BFM program].
    Pediatriia, 1992, Issue:2

    Topics: Adolescent; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Combined

1992
Management of children with acute lymphoblastic leukemia by the Dana-Farber Cancer Institute protocols. An update of the Ontario experience.
    The American journal of pediatric hematology/oncology, 1992, Volume: 14, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cohort Studie

1992
Management of children with acute lymphoblastic leukemia by the Dana-Farber Cancer Institute protocols. An update of the Ontario experience.
    The American journal of pediatric hematology/oncology, 1992, Volume: 14, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cohort Studie

1992
Management of children with acute lymphoblastic leukemia by the Dana-Farber Cancer Institute protocols. An update of the Ontario experience.
    The American journal of pediatric hematology/oncology, 1992, Volume: 14, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cohort Studie

1992
Therapeutic adherence to oral medication regimens by adolescents with cancer. I. Laboratory assessment.
    The Journal of pediatrics, 1992, Volume: 120, Issue:5

    Topics: Administration, Oral; Adolescent; Adult; Ambulatory Care; Biological Assay; Dehydroepiandrosterone;

1992
Therapeutic adherence to oral medication regimens by adolescents with cancer. I. Laboratory assessment.
    The Journal of pediatrics, 1992, Volume: 120, Issue:5

    Topics: Administration, Oral; Adolescent; Adult; Ambulatory Care; Biological Assay; Dehydroepiandrosterone;

1992
Therapeutic adherence to oral medication regimens by adolescents with cancer. I. Laboratory assessment.
    The Journal of pediatrics, 1992, Volume: 120, Issue:5

    Topics: Administration, Oral; Adolescent; Adult; Ambulatory Care; Biological Assay; Dehydroepiandrosterone;

1992
Therapeutic adherence to oral medication regimens by adolescents with cancer. II. Clinical and psychologic correlates.
    The Journal of pediatrics, 1992, Volume: 120, Issue:5

    Topics: Administration, Oral; Adolescent; Adult; Ambulatory Care; Attitude to Health; Denial, Psychological;

1992
Therapeutic adherence to oral medication regimens by adolescents with cancer. II. Clinical and psychologic correlates.
    The Journal of pediatrics, 1992, Volume: 120, Issue:5

    Topics: Administration, Oral; Adolescent; Adult; Ambulatory Care; Attitude to Health; Denial, Psychological;

1992
Therapeutic adherence to oral medication regimens by adolescents with cancer. II. Clinical and psychologic correlates.
    The Journal of pediatrics, 1992, Volume: 120, Issue:5

    Topics: Administration, Oral; Adolescent; Adult; Ambulatory Care; Attitude to Health; Denial, Psychological;

1992
[Late recurrence (11 years) in a case of ALL. Recurrence or a second disease?].
    Sangre, 1992, Volume: 37, Issue:2

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Central Nervous System Neo

1992
[Late recurrence (11 years) in a case of ALL. Recurrence or a second disease?].
    Sangre, 1992, Volume: 37, Issue:2

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Central Nervous System Neo

1992
[Late recurrence (11 years) in a case of ALL. Recurrence or a second disease?].
    Sangre, 1992, Volume: 37, Issue:2

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Central Nervous System Neo

1992
Use of a synthetic protease inhibitor for the treatment of L-asparaginase-induced acute pancreatitis complicated by disseminated intravascular coagulation.
    Annals of hematology, 1992, Volume: 64, Issue:5

    Topics: Acute Disease; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Benz

1992
Use of a synthetic protease inhibitor for the treatment of L-asparaginase-induced acute pancreatitis complicated by disseminated intravascular coagulation.
    Annals of hematology, 1992, Volume: 64, Issue:5

    Topics: Acute Disease; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Benz

1992
Use of a synthetic protease inhibitor for the treatment of L-asparaginase-induced acute pancreatitis complicated by disseminated intravascular coagulation.
    Annals of hematology, 1992, Volume: 64, Issue:5

    Topics: Acute Disease; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Benz

1992
Intensive chemotherapy for adult lymphoblastic lymphomas.
    Cancer chemotherapy and pharmacology, 1991, Volume: 29, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dexamethasone; D

1991
Intensive chemotherapy for adult lymphoblastic lymphomas.
    Cancer chemotherapy and pharmacology, 1991, Volume: 29, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dexamethasone; D

1991
Intensive chemotherapy for adult lymphoblastic lymphomas.
    Cancer chemotherapy and pharmacology, 1991, Volume: 29, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dexamethasone; D

1991
Behavioral effects of corticosteroids in children with acute lymphoblastic leukemia.
    Medical and pediatric oncology, 1992, Volume: 20, Issue:1

    Topics: Age Factors; Analysis of Variance; Attention; Child; Child Behavior; Child, Preschool; Cytarabine; D

1992
Behavioral effects of corticosteroids in children with acute lymphoblastic leukemia.
    Medical and pediatric oncology, 1992, Volume: 20, Issue:1

    Topics: Age Factors; Analysis of Variance; Attention; Child; Child Behavior; Child, Preschool; Cytarabine; D

1992
Behavioral effects of corticosteroids in children with acute lymphoblastic leukemia.
    Medical and pediatric oncology, 1992, Volume: 20, Issue:1

    Topics: Age Factors; Analysis of Variance; Attention; Child; Child Behavior; Child, Preschool; Cytarabine; D

1992
Bone marrow necrosis and thrombotic complications in childhood acute lymphoblastic leukemia.
    Medical and pediatric oncology, 1992, Volume: 20, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Blood Proteins; Bone Marrow; Child; Ch

1992
Bone marrow necrosis and thrombotic complications in childhood acute lymphoblastic leukemia.
    Medical and pediatric oncology, 1992, Volume: 20, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Blood Proteins; Bone Marrow; Child; Ch

1992
Bone marrow necrosis and thrombotic complications in childhood acute lymphoblastic leukemia.
    Medical and pediatric oncology, 1992, Volume: 20, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Blood Proteins; Bone Marrow; Child; Ch

1992
Treatment of relapsed or refractory adult acute lymphocytic leukemia.
    Cancer, 1992, Feb-01, Volume: 69, Issue:3

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transplantation; Cy

1992
Treatment of relapsed or refractory adult acute lymphocytic leukemia.
    Cancer, 1992, Feb-01, Volume: 69, Issue:3

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transplantation; Cy

1992
Treatment of relapsed or refractory adult acute lymphocytic leukemia.
    Cancer, 1992, Feb-01, Volume: 69, Issue:3

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transplantation; Cy

1992
Results of the LMT81 protocol, a modified LSA2L2 protocol with high dose methotrexate, on 84 children with non-B-cell (lymphoblastic) lymphoma.
    Medical and pediatric oncology, 1992, Volume: 20, Issue:2

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Child; Child, Preschool; Cy

1992
Results of the LMT81 protocol, a modified LSA2L2 protocol with high dose methotrexate, on 84 children with non-B-cell (lymphoblastic) lymphoma.
    Medical and pediatric oncology, 1992, Volume: 20, Issue:2

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Child; Child, Preschool; Cy

1992
Results of the LMT81 protocol, a modified LSA2L2 protocol with high dose methotrexate, on 84 children with non-B-cell (lymphoblastic) lymphoma.
    Medical and pediatric oncology, 1992, Volume: 20, Issue:2

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Child; Child, Preschool; Cy

1992
Prognostic factors and outcome of therapy in adult acute lymphoblastic leukemia.
    Indian journal of cancer, 1991, Volume: 28, Issue:3

    Topics: Adolescent; Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Child; Doxorubicin;

1991
Prognostic factors and outcome of therapy in adult acute lymphoblastic leukemia.
    Indian journal of cancer, 1991, Volume: 28, Issue:3

    Topics: Adolescent; Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Child; Doxorubicin;

1991
Prognostic factors and outcome of therapy in adult acute lymphoblastic leukemia.
    Indian journal of cancer, 1991, Volume: 28, Issue:3

    Topics: Adolescent; Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Child; Doxorubicin;

1991
Laboratory correlates and prognostic significance of granular acute lymphoblastic leukemia in children. A Pediatric Oncology Group study.
    American journal of clinical pathology, 1991, Volume: 95, Issue:4

    Topics: Azure Stains; Child; Child, Preschool; Cytoplasmic Granules; Histocytochemistry; Humans; Immunopheno

1991
Laboratory correlates and prognostic significance of granular acute lymphoblastic leukemia in children. A Pediatric Oncology Group study.
    American journal of clinical pathology, 1991, Volume: 95, Issue:4

    Topics: Azure Stains; Child; Child, Preschool; Cytoplasmic Granules; Histocytochemistry; Humans; Immunopheno

1991
Laboratory correlates and prognostic significance of granular acute lymphoblastic leukemia in children. A Pediatric Oncology Group study.
    American journal of clinical pathology, 1991, Volume: 95, Issue:4

    Topics: Azure Stains; Child; Child, Preschool; Cytoplasmic Granules; Histocytochemistry; Humans; Immunopheno

1991
Effect of corticoid therapy on growth hormone secretion.
    Hormone research, 1991, Volume: 36, Issue:5-6

    Topics: Arginine; Child; Child, Preschool; Female; Growth; Growth Hormone; Growth Hormone-Releasing Hormone;

1991
Effect of corticoid therapy on growth hormone secretion.
    Hormone research, 1991, Volume: 36, Issue:5-6

    Topics: Arginine; Child; Child, Preschool; Female; Growth; Growth Hormone; Growth Hormone-Releasing Hormone;

1991
Effect of corticoid therapy on growth hormone secretion.
    Hormone research, 1991, Volume: 36, Issue:5-6

    Topics: Arginine; Child; Child, Preschool; Female; Growth; Growth Hormone; Growth Hormone-Releasing Hormone;

1991
[The fate of children after discontinuation of treatment for acute lymphoblastic leukemia].
    Acta haematologica Polonica, 1991, Volume: 22, Issue:2

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; C

1991
[The fate of children after discontinuation of treatment for acute lymphoblastic leukemia].
    Acta haematologica Polonica, 1991, Volume: 22, Issue:2

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; C

1991
[The fate of children after discontinuation of treatment for acute lymphoblastic leukemia].
    Acta haematologica Polonica, 1991, Volume: 22, Issue:2

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; C

1991
Skin manifestation of extramedullary relapse in adult with acute lymphoblastic leukaemia.
    Haematologia, 1991, Volume: 24, Issue:4

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cyclophosphamide; C

1991
Skin manifestation of extramedullary relapse in adult with acute lymphoblastic leukaemia.
    Haematologia, 1991, Volume: 24, Issue:4

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cyclophosphamide; C

1991
Skin manifestation of extramedullary relapse in adult with acute lymphoblastic leukaemia.
    Haematologia, 1991, Volume: 24, Issue:4

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cyclophosphamide; C

1991
Immunization response varies with intensity of acute lymphoblastic leukemia therapy.
    American journal of diseases of children (1960), 1991, Volume: 145, Issue:8

    Topics: Antibodies, Bacterial; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bacterial Capsu

1991
Immunization response varies with intensity of acute lymphoblastic leukemia therapy.
    American journal of diseases of children (1960), 1991, Volume: 145, Issue:8

    Topics: Antibodies, Bacterial; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bacterial Capsu

1991
Immunization response varies with intensity of acute lymphoblastic leukemia therapy.
    American journal of diseases of children (1960), 1991, Volume: 145, Issue:8

    Topics: Antibodies, Bacterial; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bacterial Capsu

1991
The F-MACHOP regimen in advanced diffuse aggressive lymphomas: summary of ten years' experience at a single institution.
    Leukemia, 1991, Volume: 5 Suppl 1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Doxorubicin; Fluoroura

1991
The F-MACHOP regimen in advanced diffuse aggressive lymphomas: summary of ten years' experience at a single institution.
    Leukemia, 1991, Volume: 5 Suppl 1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Doxorubicin; Fluoroura

1991
The F-MACHOP regimen in advanced diffuse aggressive lymphomas: summary of ten years' experience at a single institution.
    Leukemia, 1991, Volume: 5 Suppl 1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Doxorubicin; Fluoroura

1991
Acute tumour lysis syndrome in a patient with acute lymphoblastic leukemia after a single dose of prednisone.
    British journal of haematology, 1991, Volume: 77, Issue:1

    Topics: Acute Disease; Adolescent; Humans; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone;

1991
Acute tumour lysis syndrome in a patient with acute lymphoblastic leukemia after a single dose of prednisone.
    British journal of haematology, 1991, Volume: 77, Issue:1

    Topics: Acute Disease; Adolescent; Humans; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone;

1991
Acute tumour lysis syndrome in a patient with acute lymphoblastic leukemia after a single dose of prednisone.
    British journal of haematology, 1991, Volume: 77, Issue:1

    Topics: Acute Disease; Adolescent; Humans; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone;

1991
Decreased cytotoxic potential of fresh and recombinant interleukin 2-cultured large granular lymphocytes in childhood acute lymphoblastic leukemia.
    Leukemia research, 1991, Volume: 15, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cells, Cultured; Child; Cytotoxicity,

1991
Decreased cytotoxic potential of fresh and recombinant interleukin 2-cultured large granular lymphocytes in childhood acute lymphoblastic leukemia.
    Leukemia research, 1991, Volume: 15, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cells, Cultured; Child; Cytotoxicity,

1991
Decreased cytotoxic potential of fresh and recombinant interleukin 2-cultured large granular lymphocytes in childhood acute lymphoblastic leukemia.
    Leukemia research, 1991, Volume: 15, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cells, Cultured; Child; Cytotoxicity,

1991
[Granular CALLA-positive acute lymphoblastic leukemia].
    Investigacion clinica, 1990, Volume: 31, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Biomarkers, Tumor; Child, Preschool; C

1990
[Granular CALLA-positive acute lymphoblastic leukemia].
    Investigacion clinica, 1990, Volume: 31, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Biomarkers, Tumor; Child, Preschool; C

1990
[Granular CALLA-positive acute lymphoblastic leukemia].
    Investigacion clinica, 1990, Volume: 31, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Biomarkers, Tumor; Child, Preschool; C

1990
Prognosis of acute lymphoblastic leukaemia in Ibadan, Nigeria.
    African journal of medicine and medical sciences, 1990, Volume: 19, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Drug Combinations; Hos

1990
Prognosis of acute lymphoblastic leukaemia in Ibadan, Nigeria.
    African journal of medicine and medical sciences, 1990, Volume: 19, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Drug Combinations; Hos

1990
Prognosis of acute lymphoblastic leukaemia in Ibadan, Nigeria.
    African journal of medicine and medical sciences, 1990, Volume: 19, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Drug Combinations; Hos

1990
Multiagent chemotherapy in relapsed acute lymphoblastic leukemia in children.
    Cancer, 1990, Dec-15, Volume: 66, Issue:12

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Presc

1990
Multiagent chemotherapy in relapsed acute lymphoblastic leukemia in children.
    Cancer, 1990, Dec-15, Volume: 66, Issue:12

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Presc

1990
Multiagent chemotherapy in relapsed acute lymphoblastic leukemia in children.
    Cancer, 1990, Dec-15, Volume: 66, Issue:12

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Presc

1990
Osteonecrosis in pediatric patients with acute lymphoblastic leukemia.
    Cancer, 1990, Apr-15, Volume: 65, Issue:8

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Dexamethasone; Female; Femur; Fem

1990
Osteonecrosis in pediatric patients with acute lymphoblastic leukemia.
    Cancer, 1990, Apr-15, Volume: 65, Issue:8

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Dexamethasone; Female; Femur; Fem

1990
Osteonecrosis in pediatric patients with acute lymphoblastic leukemia.
    Cancer, 1990, Apr-15, Volume: 65, Issue:8

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Dexamethasone; Female; Femur; Fem

1990
[Successful induction chemotherapy after colectomy in a case of acute lymphoblastic leukemia associated with obstructive ileus caused by sigmoid colon carcinoma].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 1990, Volume: 31, Issue:2

    Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Colectomy; Combined Modality

1990
[Successful induction chemotherapy after colectomy in a case of acute lymphoblastic leukemia associated with obstructive ileus caused by sigmoid colon carcinoma].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 1990, Volume: 31, Issue:2

    Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Colectomy; Combined Modality

1990
[Successful induction chemotherapy after colectomy in a case of acute lymphoblastic leukemia associated with obstructive ileus caused by sigmoid colon carcinoma].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 1990, Volume: 31, Issue:2

    Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Colectomy; Combined Modality

1990
[Transverse leukonychia and anti-leukemia chemotherapy].
    Annales de pediatrie, 1990, Volume: 37, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child, Preschool; Cyclophosphamide

1990
[Transverse leukonychia and anti-leukemia chemotherapy].
    Annales de pediatrie, 1990, Volume: 37, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child, Preschool; Cyclophosphamide

1990
[Transverse leukonychia and anti-leukemia chemotherapy].
    Annales de pediatrie, 1990, Volume: 37, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child, Preschool; Cyclophosphamide

1990
Successful treatment of adult acute lymphoblastic leukemia after relapse with prednisone, intermediate-dose cytarabine, mitoxantrone, and etoposide (PAME) chemotherapy.
    Cancer, 1990, Aug-15, Volume: 66, Issue:4

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Comb

1990
Successful treatment of adult acute lymphoblastic leukemia after relapse with prednisone, intermediate-dose cytarabine, mitoxantrone, and etoposide (PAME) chemotherapy.
    Cancer, 1990, Aug-15, Volume: 66, Issue:4

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Comb

1990
Successful treatment of adult acute lymphoblastic leukemia after relapse with prednisone, intermediate-dose cytarabine, mitoxantrone, and etoposide (PAME) chemotherapy.
    Cancer, 1990, Aug-15, Volume: 66, Issue:4

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Comb

1990
Dehydroepiandrosterone sulfate levels are not suppressible by glucocorticoids before adrenarche.
    The Journal of clinical endocrinology and metabolism, 1989, Volume: 69, Issue:6

    Topics: Adolescent; Adrenal Cortex Hormones; Child, Preschool; Dehydroepiandrosterone; Dehydroepiandrosteron

1989
Dehydroepiandrosterone sulfate levels are not suppressible by glucocorticoids before adrenarche.
    The Journal of clinical endocrinology and metabolism, 1989, Volume: 69, Issue:6

    Topics: Adolescent; Adrenal Cortex Hormones; Child, Preschool; Dehydroepiandrosterone; Dehydroepiandrosteron

1989
Dehydroepiandrosterone sulfate levels are not suppressible by glucocorticoids before adrenarche.
    The Journal of clinical endocrinology and metabolism, 1989, Volume: 69, Issue:6

    Topics: Adolescent; Adrenal Cortex Hormones; Child, Preschool; Dehydroepiandrosterone; Dehydroepiandrosteron

1989
Immunoreactive beta-endorphin levels in cerebrospinal fluid of children with acute lymphoblastic leukemia: relationship with glucocorticoid therapy and neurological complications.
    Journal of endocrinological investigation, 1989, Volume: 12, Issue:9

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; beta-Endorphin; Child; Child, Preschool;

1989
Immunoreactive beta-endorphin levels in cerebrospinal fluid of children with acute lymphoblastic leukemia: relationship with glucocorticoid therapy and neurological complications.
    Journal of endocrinological investigation, 1989, Volume: 12, Issue:9

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; beta-Endorphin; Child; Child, Preschool;

1989
Immunoreactive beta-endorphin levels in cerebrospinal fluid of children with acute lymphoblastic leukemia: relationship with glucocorticoid therapy and neurological complications.
    Journal of endocrinological investigation, 1989, Volume: 12, Issue:9

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; beta-Endorphin; Child; Child, Preschool;

1989
Maintenance chemotherapy for childhood acute lymphoblastic leukemia: relation of bone-marrow and hepatotoxicity to the concentration of methotrexate in erythrocytes.
    Cancer chemotherapy and pharmacology, 1989, Volume: 25, Issue:1

    Topics: Administration, Oral; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Child

1989
Maintenance chemotherapy for childhood acute lymphoblastic leukemia: relation of bone-marrow and hepatotoxicity to the concentration of methotrexate in erythrocytes.
    Cancer chemotherapy and pharmacology, 1989, Volume: 25, Issue:1

    Topics: Administration, Oral; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Child

1989
Maintenance chemotherapy for childhood acute lymphoblastic leukemia: relation of bone-marrow and hepatotoxicity to the concentration of methotrexate in erythrocytes.
    Cancer chemotherapy and pharmacology, 1989, Volume: 25, Issue:1

    Topics: Administration, Oral; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Child

1989
[Study of reinduction chemotherapy in bone marrow relapse of childhood acute lymphoblastic leukemia].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 1989, Volume: 30, Issue:11

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow; Child;

1989
[Study of reinduction chemotherapy in bone marrow relapse of childhood acute lymphoblastic leukemia].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 1989, Volume: 30, Issue:11

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow; Child;

1989
[Study of reinduction chemotherapy in bone marrow relapse of childhood acute lymphoblastic leukemia].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 1989, Volume: 30, Issue:11

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow; Child;

1989
Attenuation of asparaginase-induced hyperglycemia after substitution of the Erwinia carotovora for the Escherichia coli enzyme preparation.
    Cancer, 1989, Feb-01, Volume: 63, Issue:3

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child, Preschool; Erwinia;

1989
Attenuation of asparaginase-induced hyperglycemia after substitution of the Erwinia carotovora for the Escherichia coli enzyme preparation.
    Cancer, 1989, Feb-01, Volume: 63, Issue:3

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child, Preschool; Erwinia;

1989
Attenuation of asparaginase-induced hyperglycemia after substitution of the Erwinia carotovora for the Escherichia coli enzyme preparation.
    Cancer, 1989, Feb-01, Volume: 63, Issue:3

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child, Preschool; Erwinia;

1989
Reinduction therapy for advanced or refractory acute lymphoblastic leukemia of childhood.
    Cancer, 1989, Apr-15, Volume: 63, Issue:8

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transpl

1989
Reinduction therapy for advanced or refractory acute lymphoblastic leukemia of childhood.
    Cancer, 1989, Apr-15, Volume: 63, Issue:8

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transpl

1989
Reinduction therapy for advanced or refractory acute lymphoblastic leukemia of childhood.
    Cancer, 1989, Apr-15, Volume: 63, Issue:8

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transpl

1989
Pharmacokinetics of prednisolone in children with acute lymphoblastic leukaemia.
    Cancer chemotherapy and pharmacology, 1989, Volume: 23, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Female; Half-Life; Humans;

1989
Pharmacokinetics of prednisolone in children with acute lymphoblastic leukaemia.
    Cancer chemotherapy and pharmacology, 1989, Volume: 23, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Female; Half-Life; Humans;

1989
Pharmacokinetics of prednisolone in children with acute lymphoblastic leukaemia.
    Cancer chemotherapy and pharmacology, 1989, Volume: 23, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Female; Half-Life; Humans;

1989
Management of Ontario children with acute lymphoblastic leukemia by the Dana-Farber Cancer Institute protocols.
    CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 1989, Oct-01, Volume: 141, Issue:7

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Boston; Child; Clinical Protocols; Fem

1989
Management of Ontario children with acute lymphoblastic leukemia by the Dana-Farber Cancer Institute protocols.
    CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 1989, Oct-01, Volume: 141, Issue:7

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Boston; Child; Clinical Protocols; Fem

1989
Management of Ontario children with acute lymphoblastic leukemia by the Dana-Farber Cancer Institute protocols.
    CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 1989, Oct-01, Volume: 141, Issue:7

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Boston; Child; Clinical Protocols; Fem

1989
Inappropriate increase in erythropoietin titers during chemotherapy.
    American journal of hematology, 1989, Volume: 32, Issue:4

    Topics: Adult; Aged; Antineoplastic Agents; Asparaginase; Cyclophosphamide; Cytarabine; Daunorubicin; Erythr

1989
Inappropriate increase in erythropoietin titers during chemotherapy.
    American journal of hematology, 1989, Volume: 32, Issue:4

    Topics: Adult; Aged; Antineoplastic Agents; Asparaginase; Cyclophosphamide; Cytarabine; Daunorubicin; Erythr

1989
Inappropriate increase in erythropoietin titers during chemotherapy.
    American journal of hematology, 1989, Volume: 32, Issue:4

    Topics: Adult; Aged; Antineoplastic Agents; Asparaginase; Cyclophosphamide; Cytarabine; Daunorubicin; Erythr

1989
Avascular necrosis of the femoral head in acute leukemia patients treated with combination therapy including steroids.
    European journal of haematology, 1989, Volume: 42, Issue:2

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Female; Femur Head Necrosis; Huma

1989
Avascular necrosis of the femoral head in acute leukemia patients treated with combination therapy including steroids.
    European journal of haematology, 1989, Volume: 42, Issue:2

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Female; Femur Head Necrosis; Huma

1989
Avascular necrosis of the femoral head in acute leukemia patients treated with combination therapy including steroids.
    European journal of haematology, 1989, Volume: 42, Issue:2

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Female; Femur Head Necrosis; Huma

1989
[Intravenous immunoglobulin preparations in the adjuvant treatment of acute lymphoblastic leukemia in children].
    Polski tygodnik lekarski (Warsaw, Poland : 1960), 1988, Aug-22, Volume: 43, Issue:34

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamid

1988
[Intravenous immunoglobulin preparations in the adjuvant treatment of acute lymphoblastic leukemia in children].
    Polski tygodnik lekarski (Warsaw, Poland : 1960), 1988, Aug-22, Volume: 43, Issue:34

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamid

1988
[Intravenous immunoglobulin preparations in the adjuvant treatment of acute lymphoblastic leukemia in children].
    Polski tygodnik lekarski (Warsaw, Poland : 1960), 1988, Aug-22, Volume: 43, Issue:34

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamid

1988
High-dose methotrexate therapy (6-8 g/m2) in childhood malignancies: clinical tolerability and pharmacokinetics.
    Pediatric hematology and oncology, 1987, Volume: 4, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Cytarabin

1987
High-dose methotrexate therapy (6-8 g/m2) in childhood malignancies: clinical tolerability and pharmacokinetics.
    Pediatric hematology and oncology, 1987, Volume: 4, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Cytarabin

1987
High-dose methotrexate therapy (6-8 g/m2) in childhood malignancies: clinical tolerability and pharmacokinetics.
    Pediatric hematology and oncology, 1987, Volume: 4, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Cytarabin

1987
Changes in the EEG background activity of children with acute lymphoblastic leukemia during cytotoxic therapy.
    Pediatric hematology and oncology, 1987, Volume: 4, Issue:1

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Brain Diseases; Child; Chi

1987
Changes in the EEG background activity of children with acute lymphoblastic leukemia during cytotoxic therapy.
    Pediatric hematology and oncology, 1987, Volume: 4, Issue:1

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Brain Diseases; Child; Chi

1987
Changes in the EEG background activity of children with acute lymphoblastic leukemia during cytotoxic therapy.
    Pediatric hematology and oncology, 1987, Volume: 4, Issue:1

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Brain Diseases; Child; Chi

1987
Convulsions and intracranial calcifications in a leukemic infant receiving only intrathecal methotrexate as central nervous system prophylaxis.
    Pediatric hematology and oncology, 1987, Volume: 4, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Brain Diseases; Calcinosis; Cyclophosp

1987
Convulsions and intracranial calcifications in a leukemic infant receiving only intrathecal methotrexate as central nervous system prophylaxis.
    Pediatric hematology and oncology, 1987, Volume: 4, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Brain Diseases; Calcinosis; Cyclophosp

1987
Convulsions and intracranial calcifications in a leukemic infant receiving only intrathecal methotrexate as central nervous system prophylaxis.
    Pediatric hematology and oncology, 1987, Volume: 4, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Brain Diseases; Calcinosis; Cyclophosp

1987
Fungal pneumonias masquerading as thromboses during induction therapy of acute lymphoblastic leukemia.
    Pediatric hematology and oncology, 1986, Volume: 3, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Aspergillosis; Child, Preschool; Dauno

1986
Fungal pneumonias masquerading as thromboses during induction therapy of acute lymphoblastic leukemia.
    Pediatric hematology and oncology, 1986, Volume: 3, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Aspergillosis; Child, Preschool; Dauno

1986
Fungal pneumonias masquerading as thromboses during induction therapy of acute lymphoblastic leukemia.
    Pediatric hematology and oncology, 1986, Volume: 3, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Aspergillosis; Child, Preschool; Dauno

1986
Childhood non-Hodgkin's lymphoma and "leukemia-lymphoma syndrome": long-term results with the modified LSA2-L2 protocol.
    Pediatric hematology and oncology, 1986, Volume: 3, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; Cranial Irradiatio

1986
Childhood non-Hodgkin's lymphoma and "leukemia-lymphoma syndrome": long-term results with the modified LSA2-L2 protocol.
    Pediatric hematology and oncology, 1986, Volume: 3, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; Cranial Irradiatio

1986
Childhood non-Hodgkin's lymphoma and "leukemia-lymphoma syndrome": long-term results with the modified LSA2-L2 protocol.
    Pediatric hematology and oncology, 1986, Volume: 3, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; Cranial Irradiatio

1986
An overdose of vincristine.
    Pediatric hematology and oncology, 1987, Volume: 4, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Epilepsy, Tonic-Clonic; Humans; Ma

1987
An overdose of vincristine.
    Pediatric hematology and oncology, 1987, Volume: 4, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Epilepsy, Tonic-Clonic; Humans; Ma

1987
An overdose of vincristine.
    Pediatric hematology and oncology, 1987, Volume: 4, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Epilepsy, Tonic-Clonic; Humans; Ma

1987
Reinduction therapy in 297 children with acute lymphoblastic leukemia in first bone marrow relapse: a Pediatric Oncology Group Study.
    Blood, 1988, Volume: 72, Issue:4

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow; Child; Daunorubici

1988
Reinduction therapy in 297 children with acute lymphoblastic leukemia in first bone marrow relapse: a Pediatric Oncology Group Study.
    Blood, 1988, Volume: 72, Issue:4

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow; Child; Daunorubici

1988
Reinduction therapy in 297 children with acute lymphoblastic leukemia in first bone marrow relapse: a Pediatric Oncology Group Study.
    Blood, 1988, Volume: 72, Issue:4

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow; Child; Daunorubici

1988
Secondary mania with steroid withdrawal.
    Canadian journal of psychiatry. Revue canadienne de psychiatrie, 1988, Volume: 33, Issue:7

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bipolar Disorder; Dose-Response Relationship,

1988
Secondary mania with steroid withdrawal.
    Canadian journal of psychiatry. Revue canadienne de psychiatrie, 1988, Volume: 33, Issue:7

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bipolar Disorder; Dose-Response Relationship,

1988
Secondary mania with steroid withdrawal.
    Canadian journal of psychiatry. Revue canadienne de psychiatrie, 1988, Volume: 33, Issue:7

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bipolar Disorder; Dose-Response Relationship,

1988
[Long-term survival following acute lymphoblastic leukemia (ALL) in childhood].
    Archiv fur Geschwulstforschung, 1988, Volume: 58, Issue:5

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamid

1988
[Long-term survival following acute lymphoblastic leukemia (ALL) in childhood].
    Archiv fur Geschwulstforschung, 1988, Volume: 58, Issue:5

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamid

1988
[Long-term survival following acute lymphoblastic leukemia (ALL) in childhood].
    Archiv fur Geschwulstforschung, 1988, Volume: 58, Issue:5

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamid

1988
Short-term intensive treatment (V.A.A.P.) of adult acute lymphoblastic leukemia and lymphoblastic lymphoma.
    European journal of haematology, 1988, Volume: 41, Issue:5

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cytara

1988
Short-term intensive treatment (V.A.A.P.) of adult acute lymphoblastic leukemia and lymphoblastic lymphoma.
    European journal of haematology, 1988, Volume: 41, Issue:5

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cytara

1988
Short-term intensive treatment (V.A.A.P.) of adult acute lymphoblastic leukemia and lymphoblastic lymphoma.
    European journal of haematology, 1988, Volume: 41, Issue:5

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cytara

1988
[Acute lymphoblastic leukemia in adults: results of the DATOP-79 protocol].
    Medicina clinica, 1988, Nov-19, Volume: 91, Issue:17

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; D

1988
[Acute lymphoblastic leukemia in adults: results of the DATOP-79 protocol].
    Medicina clinica, 1988, Nov-19, Volume: 91, Issue:17

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; D

1988
[Acute lymphoblastic leukemia in adults: results of the DATOP-79 protocol].
    Medicina clinica, 1988, Nov-19, Volume: 91, Issue:17

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; D

1988
The influence of corticosteroids on human erythropoiesis. An in vivo study.
    The American journal of pediatric hematology/oncology, 1988,Winter, Volume: 10, Issue:4

    Topics: Child; Erythropoiesis; Humans; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Purpura,

1988
The influence of corticosteroids on human erythropoiesis. An in vivo study.
    The American journal of pediatric hematology/oncology, 1988,Winter, Volume: 10, Issue:4

    Topics: Child; Erythropoiesis; Humans; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Purpura,

1988
The influence of corticosteroids on human erythropoiesis. An in vivo study.
    The American journal of pediatric hematology/oncology, 1988,Winter, Volume: 10, Issue:4

    Topics: Child; Erythropoiesis; Humans; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Purpura,

1988
[Preliminary evaluation of the treatment of recurrences of acute lymphoblastic leukemia by the BFM (Henze) method].
    Pediatria polska, 1988, Volume: 63, Issue:11

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamid

1988
[Preliminary evaluation of the treatment of recurrences of acute lymphoblastic leukemia by the BFM (Henze) method].
    Pediatria polska, 1988, Volume: 63, Issue:11

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamid

1988
[Preliminary evaluation of the treatment of recurrences of acute lymphoblastic leukemia by the BFM (Henze) method].
    Pediatria polska, 1988, Volume: 63, Issue:11

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamid

1988
[Effect of prognostic factors on the course of acute lymphoblastic leukemia in children].
    Pediatria polska, 1988, Volume: 63, Issue:11

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamid

1988
[Effect of prognostic factors on the course of acute lymphoblastic leukemia in children].
    Pediatria polska, 1988, Volume: 63, Issue:11

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamid

1988
[Effect of prognostic factors on the course of acute lymphoblastic leukemia in children].
    Pediatria polska, 1988, Volume: 63, Issue:11

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamid

1988
Deoxycoformycin treatment for childhood T-cell acute lymphoblastic leukemia early in second remission: a Pediatric Oncology Group Study.
    Medical and pediatric oncology, 1988, Volume: 16, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Coformycin; Cytarabine; Daunoru

1988
Deoxycoformycin treatment for childhood T-cell acute lymphoblastic leukemia early in second remission: a Pediatric Oncology Group Study.
    Medical and pediatric oncology, 1988, Volume: 16, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Coformycin; Cytarabine; Daunoru

1988
Deoxycoformycin treatment for childhood T-cell acute lymphoblastic leukemia early in second remission: a Pediatric Oncology Group Study.
    Medical and pediatric oncology, 1988, Volume: 16, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Coformycin; Cytarabine; Daunoru

1988
Plasma protein fractions and alpha 1-acidglycoprotein as tumor markers in acute lymphoblastic leukemia.
    Chemioterapia : international journal of the Mediterranean Society of Chemotherapy, 1987, Volume: 6, Issue:2 Suppl

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Biomarkers, Tumor; Blood Proteins; Bra

1987
Plasma protein fractions and alpha 1-acidglycoprotein as tumor markers in acute lymphoblastic leukemia.
    Chemioterapia : international journal of the Mediterranean Society of Chemotherapy, 1987, Volume: 6, Issue:2 Suppl

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Biomarkers, Tumor; Blood Proteins; Bra

1987
Plasma protein fractions and alpha 1-acidglycoprotein as tumor markers in acute lymphoblastic leukemia.
    Chemioterapia : international journal of the Mediterranean Society of Chemotherapy, 1987, Volume: 6, Issue:2 Suppl

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Biomarkers, Tumor; Blood Proteins; Bra

1987
chemdatabank.com